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ABSTRACT
The d ia s te re o se le c t i ve  a l k y l a t i o n  o f  c h i r a l  2 -oxazol id inone imide 
enola tes i s  described. The re q u is i te  c h i r a l  N-acyl 2-oxazo l id inones are 
prepared from re a d i l y  a v a i l a b l e  amino acid and amino a lcohol precursors. 
The l i t h i u m  and sodium enola tes, der ived from these c h i r a l  imides, react 
in  a h ig h ly  d ia s te re o se le c t i ve  manner w i th  a v a r ie t y  o f  e l e c t r o p h i1es. 
Fu r the rmore ,  the  d ias te reom ers  are o f t e n  s e p a ra b le  by l i q u i d  chroma­
tog raphy  a f f o r d i n g  p roduc ts  w i t h  a d ia s te r e o m e r ic  p u r i t y  > 99:1. 
Several methods are described f o r  th e  n o n - d e s t r u c t i v e  removal o f  the  
c h i r a l  a u x i l i a r y  to  a f fo rd  enant iomerical  l y  pure a lco h o ls ,  aldehydes, 
c a r b o x y l i c  a c id s ,  a c id  c h l o r i d e s ,  e s t e r s ,  h y d ra z id e s ,  and ketones. 
Through the  use o f  c h i r a l  im ides 16 and 20 e i t h e r  o f  th e  e n an t io m e r ic  
products can be obtained.
An approach to  the enan t io se le c t ive  t o t a l  synthesis o f  the p o ly ­
e ther  ionophore a n t i b i o t i c  ferensimycin B (2) i s  described. The synthe­
s is  employs the d ia s te re o se le c t i ve  a l k y l a t i o n  and a ld o l  condensation o f  
c h i r a l  2 - o x a z o l id in o n e  im ide e n o la te s  t o  both  c o n s t r u c t  th e  carbon 
backbone and genera te  the necessary s te reocenters .  This research has 
culminated in  the preparat ion o f  the advanced intermediate 49.
0 0 0 0
16
An e n a n t io s e le c t iv e  t o t a l  synthesis o f  (R) and (S)-thiorphan [N - ( l -  
oxo-2-mercaptomethyl-3-phenyl p ropy lJg lyc ine ]  v ia  a s ix -s te p  sequence is 
reported. The key step, e s ta b l i sh in g  the absolu te  stereochemistry, is  
the d ia s te re o s e le c t i v e  a l k y l a t i o n  o f  the enola te  der ived from ch i ra l  2- 
oxazol idinone imide 16 (R = PhCHg) or 20 (R = PhCHg) w ith  benzyl bromo- 
methyl s u l f i d e .  The l e v e l  o f  a l k y l a t i o n  d ias te reose lec t ion  i s  in excess 
o f  95:5.
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CHAPTER I
DIASTEREOSELECTIVE ALKYLATION OF CHIRAL 
2-0XAZ0LIDINONE IMIDE ENOLATES
- 2 -
I .  INTRODUCTION
Enant iomers can evoke d i v e r s e  b io lo g ic a l  responses. ( l ) -Carvone 
s m e l l s  l i k e  spearm in t ,  whereas (d ) -ca rvone  s m e l l s  l i k e  an ise. One 
enan t iomer  o f  an in s e c t  pheromone can produce a h u n d re d - fo ld  g re a te r  
response than th e  o th e r  enan t iom er .1 Only th e  (S ) -enan t iomer  o f  th e  
s e d a t i v e  t h a l id o m id e  causes b i r t h  d e fe c t s . 2 In ves t iga t ions  in to  the 
enan t io t rop ic  behavior o f c h i ra l  molecules require  tha t  both enantiomers 
are a v a i la b le .  The synthesis o f c h i ra l  molecules i s  thus an important 
aspect o f  organic chemistry.
The synthesis o f both simple and complex c h i ra l  molecules hinges on 
the a b i l i t y  to  e i t h e r  acquire or create asymmetry. Chiral  molecules can 
be prepared in  th re e  ways: 1 ) r e s o l v i n g  racemic m ix tu re s  to  a f f o r d
enantiomers; 2 ) acqui r ing asymmetry from a v a i l a b le  c h i ra l  molecules; 
and 3) p re pa r ing  c h i r a l i t y  by asymmetr ic s yn th e s is .  Each approach is  
usefu l  f o r  preparing various types of c h i ra l  molecules.
The r e s o l u t i o n  o f  a racemic m ix tu re  i s  the  c l a s s i c a l  method to  
ob ta in  an o p t i c a l l y  a c t i v e  substance. Many re so lu t io n  techniques are 
k n o w n . 3  But most are not g e n e ra l ,  and some o n ly  r e s o l v e  a s i n g l e  
racemic pa ir .  Unless both enantiomers of a c h i ra l  molecule are needed, 
the re so lu t io n  o f  a racemate wastes at least  h a l f  of  the mixture. Only 
i f  the racemic mixture is  r e a d i l y  obtained and e f f i c i e n t l y  reso lved ,  is  
re s o lu t io n  a useful  method to  procure c h i r a l i t y .
Nature produces a wide v a r ie ty  o f  ch i ra l  molecules.4 This "ch i ra l  
pool"  i s  the o r ig in  of c h i r a l i t y  f o r  the preparation o f  numerous c h i ra l  
molecules.  ̂  Natural  products are an economical source o f  enan t iomer-  
i c a l  l y  pure c h i ra l  precursors. But nature on ly  produces one enantiomer
- 3 -
o f  most c h i r a l  p re c u rs o rs ,  th e re b y  i n h i b i t i n g  th e  sy n th e s is  o f  both 
enantiomers o f  a c h i ra l  molecule.
Asymmetr ic s y n th e s is  i s  a more f l e x i b l e  approach f o r  p re p a r in g  
c h i r a l i t y .  N e i th e r  r e s o l u t i o n  te ch n iq u e s  nor n a tu ra l  p roduc ts  t h a t  
c o n ta in  the  d e s i re d  c h i r a l i t y  are  necessary. Asymmetr ic s y n th e s is  
creates new c h i r a l i t y  under the in f lu e n ce  exerted by ex is t in g  c h i r a l i t y .  
The asymmetry t h a t  d i r e c t s  th e  c r e a t i o n  o f  new c h i r a l i t y  can e i t h e r  
res ide w i t h in  the same molecule { in t ra m o le cu la r  asymmetric induct ion) or 
be part  o f  another molecule { in te rmolecu l  ar asymmetric induct ion).  The 
methods o f asymmetric synthes is  have s i g n i f i c a n t l y  improved o v e r  the  
l a s t  50 years . 6 A b e t te r  understanding o f  stereochemistry and react ion 
mechanisms now perm i ts  asymmetr ic r e a c t i o n s  to  be designed on a more 
ra t io na l  basis.
Asymmetric synthesis embodies th ree  modes o f  asymmetric induct ion: 
1 ) the d i f f e r e n t i a l  react ion o f  a c h i r a l  reagent with  a p roch i ra l  sub­
s t ra te  (s to ich iom e t r ic  asymmetric induc t ion) ;  2 } the d i f f e r e n t i a l  reac­
t i o n  o f an ach i ra l  reagent w ith  a p roch i ra l  substrate under the i n f l u ­
ence exerted by a c h i ra l  c a ta ly s t  ( c a t a l y t i c  asymmetric induct ion) ;  and 
3 ) the d i f f e r e n t i a l  react ion of an ach i ra l  reagent at a p roch i ra l  center 
w i th in  a c h i r a l  molecule ( r e l a t i v e  asymmetric induct ion).  Each o f  these 
processes i s  k i n e t i c a l l y  c o n t r o l  le d .  T h e re fo re ,  the  e x te n t  o f  asym­
metr ic induct ion is  re la ted  to  the d i f fe re nce  in  the a c t i v a t io n  energy 
(AAG ) between the two competing pathways.^
In a s im p le  a p p ro x im a t io n ,  as th e  r a t i o  o f  the  r e a c t io n  p roducts  
in c re a s e s ,  the  r e q u i s i t e  d i f f e r e n c e  i n  th e  a c t i v a t i o n  energy o f  the  
competing t r a n s i t i o n  s ta te s ,  AaG inc reases  in  an exponential  manner. 
Th is  r e l a t i o n s h i p  i s  i l l u s t r a t e d  in  F ig u re  1. For example, a 98:2
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Figure 1 The Rela t ionsh ip  Between Trans it ion  State Free Energies and 
Product Rat ios.
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product r a t i o  at -78°C corresponds to  a AAG of 1.5 kca l/mo l.  The same 
product r a t i o  a t 25°C requires a AAG o f  2.5 kca l/mo l.  Although these 
requirements seem sm a l l ,  when compared with the ty p ic a l  carbon-carbon 
bond d i s a s s o c i a t i o n  energy (2.5 k c a l /m o l  vs 84 k c a l / m o l ) ,  they  have 
proven s i g n i f i c a n t  f o r  designing asymmetric biases tha t  d i f f e r e n t i a l l y  
con t ro l  react ions occurr ing at p roch i ra l  react ion s i tes .
Macrol ide and po lye ther  ionophores often e l i c i t  s i g n i f i c a n t  a n t i ­
b a c t e r i a l  and a n t i t u m o r  a c t i v i t i e s . ^  This c lass  o f  natura l  products, 
i s o la te d  from a v a r ie t y  o f  microb ia l  sources, contains numerous stereo- 
centers and oxygenated l igands on a carbon backbone. The a rch i te c tu ra l  
c o m p le x i t y  o f  m a c r o l id e  and p o l y e t h e r  ionophores i s  i l l u s t r a t e d  in  
F i g u r e  2 .
The t o t a l  synthesis o f macrol ide and po lyether  ionophores provides 
a c r i t i c a l  method o f  eva lua t ing  the d i f f e r e n t  approaches to  asymmetric 
s y n th e s is .  Most s y n t h e t i c  pathways to  these natural  products proceed 
through a c y c l i c  intermediates c o n ta in in g  numerous asymmetr ic ce n te rs .  
Reactions based on both c a t a l y t i c  and s to ich iometr ic  asymmetric induc­
t i o n ,  however, are more suited f o r  preparing simple c h i ra l  molecules. 
Even r e l a t i v e  asymmetric induct ion can become bogged down as the number 
and v a r i e t y  o f  s te re o c e n te rs  inc rease .  Desp i te  these d i f f i c u l t i e s ,  
K i s h i  has made some s i g n i f i c a n t  advances in  the  use o f  r e l a t i v e  asym-
g
metr ic  induc t ion .
We, however, sought a more genera l  approach to  syn th e s ize  these 
complex natura l  products. Nature constructs the macrol ide and po lyether  
ionophores in  a 1 i n e a r  f a s h io n ,  s i m i l a r  to  the  b io s y n th e s is  o f  f a t t y
g























Figure 2 Macrol ide and Polyether  lonophore A n t ib io t i c s .
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Scheme 1 i l l u s t r a t e s  the proposed biosynthesis o f t y l o s in .  A s t r a i g h t ­
fo rw a rd  approach t o  t h e i r  s y n th e s is  would be to  mimic t h i s  p ro cess - -a  
method, whereby both  th e  carbon backbone i s  c o n s t r u c te d ,  and th e  new 
s te re o c e n te rs  are s e t ,  independent o f  o th e r  s te re o c h e m is t r y  in  the  
molecule. This would necessita te  a set of asymmetric carbon-carbon bond 
forming react ions based on c h i ra l  C2, C3 , and C4 precursors. An i t e r a ­
t i v e  series o f  these react ions would enable the synthesis o f  the macro- 
l i d e  and po lyether  ionophores, as w e l l  as re la ted  molecules not a v a i l ­
able from nature.
We envisioned using a c h i ra l  a cyc l i c  enolate synthon to  mimic iono- 
phore b iosynthesis.  A c h i r a l  enolate synthon is  an enola te  or an eno l -  
a te  e q u i v a l e n t  t o  which an asymmetr ic b ias  i s  appl i e d . ^  A t t a c h in g  a 
removable c h i ra l  a u x i l i a r y  (Xc ) to an a c y c l i c  enolate precursor a ffo rds 
a c h i ra l  a c y c l i c  enolate  synthon. The ch i ra l  a u x i l i a r y  d i f f e r e n t i a t e s  
the prochi ra l  n-faces o f  the enolate to  the approaching e le c t r o p h i 1 e, 
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I I .  DESIGN OF A CHIRAL ACYCLIC ENOLATE SYNTHON
The e n an t iose lec t i  ve a lk y l  a t ion  of a c h i ra l  a cyc l i c  enol ate synthon 
requi res con tro l  over three in d iv id u a l  steps. The o v e r a l l  process f o r  
a l k y l a t i o n  o f  a c h i r a l  propanoate synthon is  i l l u s t r a t e d  in Scheme 2. 
The stereochemisty o f  the product i s  d i r e c t l y  re la ted  to  both the geom­
e t r y  o f the enol ate and the c h i r a l i t y  of the a u x i l i a r y .  Therefore, both 
the generation o f  a s in g le  enolate isomer (Step A) and the a l k y l a t i o n  of 
a s in g le  d iastereoface o f  the enolate (Step B) is  required to  obtain a 
s p e c i f i c  diastereomer. In order to  be s y n th e t i c a l l y  u s e fu l ,  both steps 
must be h ig h ly  s te re o se le c t ive .  F i n a l l y ,  the ch i ra l  a u x i l i a r y  must be 
removab le  under c o n d i t i o n s  t h a t  m in im ize  ra ce m iza t io n  o f  the  newly 
formed c h i ra l  center (Step C).
DM 0 0
02
A) E flo trzo fio ft- B) D ia s t c r f o t t l t c f i v t  A ifcyloH pn. C) Cfciral A u x ilia ry  Rum orol
Scheme 2
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For a c h i r a l  a c y c l i c  enolate synthon to  be useful  in  an i t e r a t i v e  
sense, as would  be re q u i re d  f o r  the  s yn th e s is  o f  th e  m a c ro l id e  and 
po lye the r  ionophores, the e n t i r e  process must be h ig h ly  enant iose lec-  
t i v e .  Six re p e t i t io n s  o f  a 95:5 process decrease the proport ion o f the 
m a jo r  s te re o iso m e r  be low 75%. The a t ta in m e n t  o f  an o v e r a l  1 e n a n t io -  
s e le c t io n  o f  >95:5 f o r  the a lk y l a t i o n  o f  a c h i ra l  enolate  synthon neces­
s i ta te s  an enolate s te reose lec t ion  o f  >98:2, an a l k y l a t i o n  d iastereo- 
se le c t io n  o f  >98:2, and less than 1% product racemization during removal 
o f  the c h i r a l  a u x i l i a r y .  As p re v io u s ly  ind icated, a s e l e c t i v i t y  o f  98:2 
cor responds to  a aaG o f  1.5 k c a l /m o l  at -78°C, o r  2.5 k c a l /m o l  at 
25°C.
The f i r s t  r e a c t i o n  s tep  to  address f o r  the  des ign  o f  a c h i r a l  
a c y c l i c  enolate synthon is  s te re o se le c t ive  e n o l iza t io n .  Deprotonation 
o f  an a c y c l i c  carbonyl d e r i v a t i v e  can a f fo rd  two geom etr ica l ly  isomeric 
e n o la te s  (eq 2). A l th o ug h  e n o la te s  p la y  an im p o r ta n t  r o l e  in  o rgan ic  
chemistry,  the process of e n o l i za t io n  is  not f u l l y  understood. A number 
o f  th e  f a c t o r s  t h a t  c o n t r o l  t h i s  t r a n s fo r m a t i o n ,  however, are emp ir ­
i c a l  l y  known.
0  OM
Me
(E )-en o lo te
The k i n e t i c  r a t i o  (E:Z) o f  e n o la te  s te reo isom ers  ob ta ined by the 
deprotonat ion o f var ious ester ,  ketone, and N,N-dial kylcarboxamides with 
1 i t h i  urn d i  i s opr opyl amide (IDA) i s  summari zed in  Tab le  1. With ketone
OM




s u b s t r a te s  (Tab le  1 e n t r i e s  A-D), both the  magnitude and th e  sense o f  
enolate  s te reose lec t ion  depends on the size o f  the R subs t i tuent .  Enol­
ate s te reose lec t ion  f o r  esters  (Table 1, en t r ies  E-F) and N,N -d ia lky l  - 
carboxamides (T a b le  1, e n t r i e s  G-H), however, i s  independent o f  the  R 
s u b s t i t u e n t .  Es te rs  p r e f e r e n t i a l  l y  (E:Z = 95:5) form th e  (E) e n o la te  
isomer, whereas N,N-dialkylcarboxamides e x c lu s i v e ly  (E:Z _< 3:97) a f fo rd  
th e  (Z) e n o la te  isomer. The s t e r e o s e l e c t i v e  g e n e ra t io n  o f  th e  (Z)-  
enola te  isomer by deprotonat ion o f  N,N-dialkylcarboxamides with  LDA can 
be r a t i o n a l  ized on th e  b a s is  o f  a d e v e lo p in g  A ^ - s t e r i c  i n t e r a c t i o n  
between the C-2 methyl and the n i t rogen subst i tuent R, in  the t r a n s i t i o n  
s ta te  leading to  the (E) enolate  isomer (Scheme 3).
Table 1. E no l iza t ion  o f  Esters, Ketones and N,N-Dialkylcarboxamides 
w i th  Li th ium Di isopropylamide (eq 2).
Entry R E: Z Ref.
A Et 70:30 12
B j_-Pr 40:60 12
C t-Bu _< 2:98 12
D Ph < 2:98 12
E MeO 95:51 12
F jt-BuO 95:51 12
G Et2N 1  3:97 13
H C(CH2)4]N i  3:97 13
a) For assignment o f  e s t e r  e n o la te  c o n f i g u r a t i o n ,  the  OLi group 
a r b i t r a r i l y  is  given a higher p r i o r i t y  than the OR group.
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Since N.N-di a l k y l  carboxamides s a t i s f y  the f i r s t  design requirement, 
we e lec ted  to  in ve s t ig a te  c h i ra l  N,N-dialkylcarboxamides as po ten t ia l  
c h i r a l  a c y c l i c  e n o la te  synthon candidates. The two ni t rogen s u b s t i t ­
uents p ro v id e  c o n ve n ie n t  l o c a t i o n s  t o  s i t u a t e  an asymmetr ic b ias .  
Placement o f the res ident c h i r a l i t y  on one o f  the n i trogen subst i tuents , 
however, introduces the problem of amide ro ta t io n a l  isomer izat ion. The 
U-form and the  W-form o f  the unsymmetrica 1 1 y N ,N - d i s u b s t i t u te d  (Z)- 
carboxamide enola te  fa vo r  opposite diastereofaces of the enolate to  the 
approach ing el e c t ro p h i  1 e, and thereby lead to  diastereomeric products 
{Scheme 4). Therefore, the le ve l  of a l k y l a t i o n  d ias te reose lec t ion  w i l l  
a lso  depend on the proport ion of the two rotameric forms present during 
a lk y la t i o n .
- 1 3 -
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Scheme 4
A c h i ra l  carboxamide enola te  lack ing  preference f o r  e i t h e r  ro ta -  
meric form w i l l  be non-d ias te reose lec t ive .  Indeed, a l k y l a t i o n  of the 
l i t h i u m  e n o la te  o f  N - [ (R )- l -pheny le thy l ]p ropanam ide  with  ethy l  iodide 
a f f o r d s  a 1:1 m ix tu re  o f  d ias te reom ers  (eq 3 ).14 T h e re fo re ,  an a d d i ­
t i o n a l  design element is  requi red to  obta in a high le v e l  o f  a l k y l a t i o n  
d ias te reose lec t ion :  the s e le c t io n  and immobi l izat ion o f  a s in g le  amide 
ro ta t io n a l  isomer.
Me o
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One method to  s e le c t i v e l y  fa vo r  and immobil ize one amide ro ta t io n a l  
isomer in v o lv e s  che la t ion .  A che la t ing  l igand (Y) is  located on one o f 
th e  n i t r o g e n  s u b s t i t u e n t s .  Only one o f  the  amide r o t a t i o n a l  isomers 
p l a c e s t h e c h e l a t i n g  l i g a n d  in  p r o x im i t y  to  th e  e n o la te  oxygen. The 
formation o f  a metal-centered che la te  r ing then immobi lizes t h i s  amide 
conformation (eq 4).
Two d i f f e r e n t  c h i ra l  N,N-disubst i tu ted carboxamide systems employ 
che la t io n  to  i n h i b i t  amide ro ta t io n a l  isomerizat ion. A l k y la t io n  o f the 
l i t h i u m  enola te of (L)-ephedrine propanamide w ith  ethyl  iod ide at -20°C
d ias te reose lec t ion  is  ra t io n a l i z e d  by the e le c t r o p h i le  approaching the 
s te r i c a l  l y  less encumbered p-face o f  seven-membered chelated (Z) enola te  
1. A l k y la t i o n  o f  the corresponding magnesium enolate at 25°C improves 
the diastereomer r a t i o  to  95:5. Presumably, magnesium as the d ica t io n ,  
forms a t i g h t e r ,  more s t a b le  c h e la te d  s t r u c t u r e ,  w i th  less  c o n f o r ­
mational freedom.
Me O Me 0 Me 0
hov ^ n - I ) b - t e ------------  H O ^ X ^ n J l ^ M e  , J - l ^ M e  (5)
: I 2} Etl I | I £ I -
Ph Me Ph Me Et Pit Me Et
(4)
YR H R H
a f fo rds  a 76:24 r a t i o  of diastereomers (eq 5 ) . ^  The observed sense o f
base = LDA 7 6  ! 2 4
base *  LDA*MgBr2 9 5  - 5
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Both Takacs in our l a b o r a t o r i e s , 13>16 and S o n n e t ^  have i n v e s t i ­
gated the di as te reose  1 e c t i  ve a l k y l a t i o n  of carboxamides der ived from 
(S ) -p ro l i n o l .  A l k y la t i o n  o f the l i t h iu m  enola te  o f (S ) -p ro l ino  1 propan­
amide w i t h  e th y l  i o d id e  a f f o r d s  a 92:8 r a t i o  o f  d ias te reom ers  (eq 6 ). 
In t h i s  case, the observed sense of d ias te reose lec t ion  is  explained by 
the e le c t r o p h i l e  approaching the s t e r i c a l l y  less encumbered a-face of 
seven-membered chelated (Z) enolate 2.
In both of these examples the res ident c h i r a l i t y  is located on the 
ni t rogen subst i tuen t  corresponding to  the W-rotameric isomer. An exami­
n a t io n  o f  the two ro ta m e r ic  forms shows t h a t  the  U - ro ta m e r ic  isomer 
p laces  th e  r e s id e n t  c h i r a l i t y  in  c l o s e r  p r o x im i t y  t o  the  p r o c h i r a l  
r e a c t i o n  s i t e  (F ig u re  3). The re fo re ,  a l k y l a t i o n  o f  the  U - ro tam e r ic  
isomer should in p r i n c i p le  be more d ia s te re o se le c t i ve  than a l k y l a t i o n  o f  
the W-rotameric isomer. In order to  s e le c t i v e l y  favo r  and immobil ize 
the U-rotameric isomer, the che la t ing  l igand and the res ident c h i r a l i t y  
would have to  be located on d i f f e r e n t  n i trogen subst i tuents  (eq 7).














Based on the  p re v io u s  d is c u s s io n ,  we e n v is io n e d  t h a t  c h i r a l  4- 
s u b s t i t u t e d  2 -o x a z o l id in o n e  imides 3 meet the  des ign c r i t e r i a  f o r  a 
c h i r a l  a c y c l i c  enolate synthon. Eno l iza t ion  of 3 should stereosel ec­
t i  v e ly  i f  not e x c lu s iv e ly  a f fo rd  the meta l-centered, six-membered che­
la ted  (Z) enola te  4 {eq 8 ). This conformational l y  r i g i d  enolate s t ru c ­
t u r e  p la ce s  the  oxazol i d in o n e  C-4 p o s i t i o n  in  c lo s e  p r o x im i t y  t o  the 
p roch i ra l  enolate  react ion s i te .  Introducing c h i r a l i t y  at the C-4 posi ­
t i o n  would be expected to  d i f f e r e n t i a l l y  bias the two diastereofaces of 
the enola te. The e le c t r o p h i le  approaching the leas t  hindered d iastereo- 
face o f  the enola te  would fa vo r  a s ing le  diastereomer (Scheme 5).
Li
(8)
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Scheme 5
In the  f o l  1 owing r e p o r t ,  we d iscuss  the s yn th e s is  and d ia s t e r e o ­
sel e c t i  ve a l k y l a t i o n  o f  c h i r a l  4 -subs t i tu ted  2-oxazol id inone imides, as 
wel 1 as the  t r a n s fo r m a t i o n  o f  the  r e s u l t a n t  a l k y l a t e d  p roduc ts  i n t o  
usefu l  ch i ra l  intermediates. The repor ted  k i n e t i c  d ia s te re o s e l  e c t i  on 
f o r  a l k y l a t i o n  o f  o th e r  c h i r a l  e s te rs  and N,N-dial kyl  carboxamides is  
summarized in Appendix 1.
- 1 8 -
I I I .  RESULTS AND DISCUSSION
A. P reparation  o f the C h ira l A u x ilia ry . Dyen has rev iewed the  
synthesis and chemistry o f  2 - o x a z o l i d i n o n e s . ^  Of the  many s y n t h e t i c  
approaches to  t h i s  c lass  o f  molecules, c y c l i z a t i o n  o f  c h i r a l  2 - s u b s t i -  
tu ted  amino a lcoho ls  with  carbonyl d ica t ion  equ iva len ts  i s  e s p e c ia l l y  
w e l l  su i ted f o r  preparing a v a r ie t y  o f  c h i ra l  4 -subs t i tu ted  2 -o xazo l i -  
dinones (eq 9). The re q u is i te  c h i ra l  amino a lcoho ls  are commercial ly 
a v a i l a b l e ,  o r  e a s i l y  p repared,  e i t h e r  by reduc ing  the  co r respond ing  
amino ac ids  w i t h  borane,*® or  by reduc ing  th e  amino ac id  e s te r  s a l t s  
w ith  sodium borohydr ide .^
Pi P,
©c© II
HO NH -------------------------------0"’ *ry|H (9)
L___il b il
Reduct ion o f  the  amino ac id  ( S ) - v a l i n e  w i th  b o ra n e - -d im e th y l  
su l f id e /b o ro n  t r i f l u o r i d e — d ie thy l  e therate, fo l l o w in g  the procedure of 
L a n e , affords (2S)-2-amino-3-methyl-1-butanol [ (S ) - v a l in o l  ]  in  45-55% 
y i e l d  (eq 10). This  p rocedure,  however, a l s o  a f f o r d s  a c o n s id e ra b le  
quan t i ty  of 4-methy lmercapto- l-butanol , which in te r fe res  with i s o la t i o n  
o f  the  ( S ) - v a l i n o l .  Brown has re p o r te d  t h a t  the  r a te  o f  amide reduc­
t i o n ,  w i th  b o ra n e - -d im e th y l  s u l f i d e ,  i s - in c re a s e d  by removing the  
dimethyl s u l f i d e  from the react ion mix ture . ^ 0 We appl ied th i s  modif ica­
t i o n  to  the reduct ion o f (S ) -va l ine .  Thus, as borane--dimethyl s u l f i d e  
i s  added t o  th e  m ix tu re  o f  ( S ) - v a l i n e  and boron t r i f l u o r i d e - - d i e t h y l  
e th e ra te  in  t e t r a h y d r o f u r a n  (THF), both d im e thy l  s u l f i d e  and d i e t h y l
- 1 9 -
e th e r  are removed by d i s t i l l a t i o n .  This both inc reases  th e  r a t e  o f  
r e d u c t io n  and decreases the amount o f  b ip ro d u c t  formed. The m o d i f ie d  
r e d u c t io n  p rocedure ,  performed on 1 arge se a le  (1 -8  m o l ) ,  a f f o r d s  (S)- 
v a l i n o l  in  55-70% y ie ld .
HO NH, I) BHj-MejS/BF3-E!20, THF H9 NH2
J y  1 in T o ^  ---
(5 5 -7 0 % )
A l t e r n a t e l y ,  c h i r a l  amino a lcoho ls  can be prepared by reducing the 
co r resp o n d in g  amino ac id  e s te r  s a l t s  w i th  sodium b o r o h y d r i d e . ^  A1 - 
though t h i s  p rocedure  re q u i re s  the  a d d i t i o n a l  s tep o f  p re p a r in g  the  
amino acid es te r  s a l t ,  i t  uses the less  expensive sodium borohydride as 
the reductant.  Reduction of ethyl  (S)-phenyl alan ine hydrochlor ide with 
sodium borohydride a ffo rds  (2S)-2-amino-3-phenyl-1-butanol [(S)-phenyl -  
a l a n i n o l ]  in  63% y i e l d  (eq 1 1 ) . 2 1
EtO NHjCl I) NoBH,. EtOH H? ^H*
. M ,  ----------------------------------------  L - S
Ph Ph
(6 4%)
By examination o f  the NMR spectrum o f  amides derived from these 
c h i ra l  amino a lco h o ls  and Mosher's a c i d , 22 Meyers has demonstrated tha t  
less than 2% racemizat ion occurs during e i t h e r  of these reduct ion pro­
cedures. We show t h a t  the amount o f  ra ce m iz a t io n  i s  a c tu a l  l y  l e s s  
than 0.5%, based on the enant iomeric p u r i t y  o f  c h i ra l  2-oxazol idinones 
prepared from these amino a lcohols.
- 2 0 -
Both (S)-phenyl a lan ino l  and (S ) -v a l in o l  are derived from n a t u r a l l y  
o c c u r r i  ng amino ac ids .  In o rde r  f o r  the  proposed c h i r a l  a u x i l i a r y  t o  
induce e i t h e r  sense o f  asymmetry would require both C-4 con f igu ra t ions  of 
the 4 -subs t i tu ted  2-oxazol id inone .  The re fo re ,  a source o f  (2R)-amino 
a lc o h o ls  i s  necessary. Of the "unnatura l"  amino acids, as precursors to  
(2R)-amino al cohol s, on ly  (R)-phenyl g lyc ine  is  commercial l y  avai 1 abl e at 
re a so n a b le  cos t .  F o r t u n a t e l y ,  the  amino a lc o h o l  (15 ,2R)-2 -am ino -1 -  
phenyl-1-propanol [( lS,2R)-norephedr ine],  reso lved as i t s  t a r t r a t e  s a l t ,  
a ls o  is  commercial ly a v a i la b le .
With both (2R)- and (2S)-amino a l c o h o l s  a t o u r d i s p o s a l ,  we p re -  
0
pared a v a r ie t y  of (4R)- and (4S)-4-subst i tuted 2-oxazol idinones. Three 
d i f f e r e n t  carbony l  d i c a t i o n  e q u i v a le n t s  were employed to  c y c l i z e  the 
ami no a l  c o h o ls :  1 ) d i e t h y l  ca rbonate  (eq 1 2 ); 2 } d ip h e n y l  ca rbona te
(eq 13); and 3) phosgene (eq 14). The c y c l i z a t i o n  re s u l t s  are summar­
i z e d  i n  Tab le  2. 2 4  Other than ( ± ) - 4 - m e t h y l - 2 - o x a z o l i d i n o n e  [ (± ) - 
a la n in o l  2 -oxazol id inone, 5 ] ,  a l l  o f  the 2 -oxazol idinones are c o lo r l e s s  
c r y s t a l l i n e  so l ids .  The 2-oxazol idinones prepared fo r  t h i s  i n v e s t ig a ­
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Homeyer has reported tha t  amino a lcoho ls  react with d ia l k y l  carbo­
nates in the presence o f  base to  a f fo rd  2-oxazol idinones .26  This i s  the 
basis fo r  the f i r s t  two c y c l i z a t i o n  procedures. The d ie thy l  carbonate 
procedure is  opera t  i ona1 1 y ve ry  s imp le .  A neat m ix tu re  o f  the  ami no 
a lc o h o l ,  d ie thy l  carbonate, and a c a t a l y t i c  amount o f anhydrous potas­
sium carbonate  is  heated a t 125°C u n t i l  two e q u iv a le n ts  o f  e thano l  
d i s t i l l s  from the react ion mixture. The product is separated from the
- 2 2 -
Table 2. Preparat ion of 2-0xazol idinones.





p i_t cn 00 UD
A (±)-5 A 46% (100°C, 12 mm)
B (4R,5S)-6 A 0-95% 121-122°C +177.2°
(c 2.21, CHC13)
C (4R,5S)-6 B 82-95% 121-122°C +177.2°
(c 2.21, CHC13)
D (4R ,5S)-6 C 8 8 % 121-122cC +177.2°
(£ 2.21, CHC13 )
E ( ± ) - 6 C 73% 136°C
F (4S,5S)-7 A 90% 119-120°C +15.7°
(c 1.83, EtOH)
G (4S)-8 A 85-95% 69-70°C -16.6°
(c 5.81, EtOH)
H ( ± ) - 8 C 58% 64-65°C
I (4R)-9 A 79% 123.5-124.5°C -58.6°
(c i . 0 6 ,  ch2 c i 2;
J (4S)-10 A 77% 82-83°C +5.1°
(c 0.76, EtOH)
a) A = d ie thy l  carbonate (eq 12); B - diphenyl carbonate (eq 13); 
C = phosgene (eq 14).
potassium carbonate and p u r i f i e d  by c r y s t a l l i z a t i o n  or reduced-pressure 
d i s t i l l a t i o n .  The react ion can e a s i l y  be performed on a large sca le  (1- 
3 mol). U sua l ly ,  the y i e l d  o f  2-oxazol idinone obtained by the d ie thy l  
ca rbona te  procedure (Tab le  2, e n t r i e s  F, G, I ,  and J) i s  good to  e x c e l ­
le n t  (79-95%). We a t t r i b u t e  the poor y i e l d  (46%) of 2-oxazol id inone 5 
(Table 2, entry A) to  the water s o l u b i l i t y  of t h i s  product.
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The react ion o f  (lS,2R)-norephedrine with  d ie thy l  carbonate (Table 
2, e n t r y  B) presents  a more se r io u s  problem. N o r m a l l y ,  th e  y i e l d  o f  
(4R,5S)- 4 -methy l  -  5 - p h e n y l - 2 -o x a z o l id in o n e  [ (4R ,5S ) -no rephed r ine  2- 
o x a z o l i d in o n e ,  6 ]  i s  ve ry  good (85-95%). P e r i o d i c a l l y ,  however, the  
react ion f a i l s ,  a f fo rd ing  ne ither  product nor s ta r t i n g  m a te r ia l .  When 
t h i s  occurs ,  N -e th y ln o re p h e d r in e  2 - o x a z o l id in o n e  and a po lymer are 
formed. (lS,2R)-Norephedrine often takes longer to  c y c l i z e  than other 
amino a lcoho ls . The slower rate of c y c l i z a t i o n  f o r  t h i s  amino alcohol 
may be the r e s u l t  of  the developing c is  s te r i c  i n te ra c t io n  between the 
C-4 methyl and C-5 phenyl subst i tuents in  2-oxazol id inone 6 . Raising 
the  r e a c t i o n  tem pera tu re  to  140-180°C in  an a t tempt t o  a c c e le r a te  the  
r a t e  o f  c y c l i z a t i o n  o n l y  inc reases  the amount o f  byproduc ts  formed. 
Rather, we suggest tha t  the react ion be maintained at 125°C, and tha t  a 
f u l l  equ iva len t  o f  potassium carbonate is  used to  ca ta lyze  t h i s  c y c l i z a ­
t i o n .
Because of the incons is tent y i e l d  o f 2-oxazol id inone 6 , we i n v e s t i ­
gated two other c y c l i z a t i o n  procedures. The diphenyl carbonate proce­
dure f o r  p re p a r in g  2 -o x a z o l i d in o n e s  i s  e s s e n t i a l l y  the  same as the 
d i e t h y l  carbonate  p r o c e d u r e . ^  A neat m ix tu re  o f  amino a l c o h o l  and 
diphenyl carbonate in  the presence o f  anhydrous potassium carbonate at 
110°C re a c ts  t o  a f f o r d  the  2 - o x a z o l id in o n e .  The two e q u i v a le n t s  o f  
phenol formed d u r in g  t h i s  r e a c t i o n  are removed from the  product by 
ex t rac t ion  with  aqueous base. The product i s  p u r i f ie d  by c r y s t a l l i z a ­
t i o n .  The r e a c t i o n  can be performed on a l a r g e  s c a le  (0.5-3 mol) .  
C yc l i za t io n  o f  ( lS,2R)-norephedrine w i th  d ipheny l  ca rbona te  (Tab le  2, 
e n t r y  C) a f f o r d s  2-oxazo l  id inone  6  in  82-93% y i e l d .  Desp i te  the  more 
in v o lv e d  work-up procedure, t h i s  is  the preferred synthesis o f  the 2 -
- 2 4 -
oxazol idinone der ived from (lS,2R)-norephedrine.
Phosgene also reacts with amino a lcoho ls  in  the presence o f  base to 
a f fo rd  2 -oxazol idinones.^? Although phosgene is  a gas a t room tempera­
t u r e  (bp 8 °C), i t  can be suppl ied as a s o l u t i o n  in  t o lu e n e .  The amino 
a lcoho l  and t r i e t h y l  amine in  to luene at 0°C react instantaneously w ith  
phosgene to a f fo rd  the 2 -oxazol id inone and a voluminous white p r e c ip i ­
t a te  o f  t r i e t h y l  amine hydrochlor ide. Un fo r tuna te ly ,  the high r e a c t i v i t y  
o f phosgene can lead to  the formation o f  two byproducts: N -ch lo ro fo rmy l - 
2 -oxazo l id inone, and N,N-carbonyldi -2-oxazol idinone. Therefore, excess 
phosgene must be avo ided. C y c l i z a t i o n  o f  ( lS ,2 R ) -n o re ph e d r in e  w i t h  
phosgene (Tab le  2, e n t r y  D) a f f o r d s  2 - o x a z o l id in o n e  6 i n  8 8 % y i e l d .  
Thi s i s  the  method o f  cho ice  f o r  smal 1 s c a le  c y c l i z a t i o n s ,  when neat 
procedures are imprac t ica l .
B. Determination o f  the Enantiomeric P u r i t y  o f  Chira l  2 -Oxazo l i -  
d inones.  The le v e l  o f asymmetric induct ion exerted by a ch i ra l  a u x i l ­
i a r y  is  d i r e c t l y  proport ional to  the enant iomeric p u r i t y  o f the c h i r a l  
a u x i l i a r y .  An asymmetr ic r e a c t i o n ,  100% s t e r e o s e l e c t i v e ,  but whose 
d i re c t in g  c h i r a l i t y  i s  on ly  75% enantiomerical  l y  pure, can on ly  a f fo rd  a 
c h i r a l  product 75% enantiomerical l y  pure. Therefore, the enant iomeric 
p u r i t y  of the c h i r a l  2-oxazol idinone is  of v i t a l  importance. The spe­
c i f i c  ro ta t io n  o f  ch i ra l  2 -oxazol idinones is  both so lven t  and concentra­
t i o n  dependent. Thus, i t  is  d i f f i c u l t  to accurate ly  re la te  the sp e c i f i c  
ro ta t io n  and enant iomeric p u r i t y  of c h i r a l  2 -oxazol idinones.
An a l t e r n a t e  method o f  d e te rm in in g  the e n an t iom er ic  p u r i t y  o f  a 
c h i r a l  molecule in v o lv e s  preparat ion o f  a diasteromeric d e r iv a t i v e .  A 
c h i r a l  m o le cu le  o f  known e n an t iom er ic  p u r i t y  i s  coup led ,  under non-
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racemizing condi t ions, to  the c h i ra l  molecule o f unknown enantiomeric 
p u r i t y .  The r a t i o  of diastereomers in  the re su l ta n t  product is  d i r e c t l y  
r e l a t e d  t o  the  e n a n t io m e r ic  p u r i t y  o f  the  two c h i r a l  m o le cu le s .  To 
a c c u r a t e l y  r e f l e c t  th e  e n a n t io m e r ic  p u r i t y ,  the two c h i r a l  molecules 
must complete ly  react. A lso, diastereomer re so lu t io n  p r io r  to  ana lys is ,  
must be prevented. Cognizant of these fac to rs ,  diastereomeric d e r iva ­
t i v e s  are u se fu l  f o r  d e te rm in in g ,  to  a h igh degree o f  p r e c i s i o n ,  the  
enantiomeric p u r i t y  of c h i r a l  molecules.
We su cce ss fu l ly  employed t h i s  technique to  determine the enant io­
meric p u r i t y  of c h i r a l  2-oxazol idinones. Meta la t ion  o f  the c h i r a l  2- 
o x a z o l i d in o n e  w i t h  j i - b u t y l  l i t h i u m  a t  -78°C, and N - a c y l a t i o n  o f  the  
r e s u l t a n t  anion w i t h  (2 R ) -2 -m e th o xy -2 -p h e ny l -3 ,3 ,3 - t r i f  1 uoropropanoyl 
c h lo r i d e  [(R)-Mosher‘ s acid c h lo r id e ,  1 1 ] ^ 2  a f fo rds  the diastereomers 12 
and 13 {eq 15). The r a t i o  o f  d ias te reom ers  (12 :13)  was measured by 
c a p i l l a r y  GC and independently confirmed by HPLC. A standard mixture of 
diastereomers was prepared by coupl ing racemic 2 -oxazol idinone to  (R ) - l l  
o r  c h i r a l  2 -oxazo l  i d in o n e  t o  ( ± ) - 1 1  in  o rde r  to  demonstra te  t h a t  the  
a n a ly t i c a l  technique separated the diastereomers. The re s u l t s  are sum­
marized in  Table 3. In a l l  cases, the diastereomer r a t i o  (major:minor) 
is  200:1. Therefore, the enant iomeric p u r i t y  of the c h i r a l  2 -o xazo l i -  
dinones and t h e i r  precursor amino a lcoho ls  i s  ^99%.
o
12 13
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Table 3. Enantiomeric Pur i ty  o f the 2-0xazolidinones (eq 15).
F i r s t  Diastereomer to  E luted 
2-0xazol idinone R a t ia i  GC GC HPLC
Entry R R' C h i r a l i t y  12:13 Carbowax 20M DB-5 S i l i c a  gel
A 6 Me Ph (4R.5S) >_ 2 0 0 : 1 (4S) ------ (4S)
B 7 Me Ph (4S,5S) < 1 : 2 0 0 ------ (4R) (4S)
C 8 j^-Pr H (4S) < 1 : 2 0 0 (4S) ------ (45)
D 9 Ph H {4R) > 2 0 0 : 1 ------ (4R) (45)
E 10 PhCH2 H (4S) < 1 : 2 0 0 ------ (4R) (45)
a) Diastereomer r a t i o  determined by c a p i l l a r y  GC analys is  of the unfrac­
t i o n a t e d  product ,  b) Chromatographic c o n d i t i o n s  f o r  each se p a ra t io n  
are reported in  the experimental section.
C. P reparation  o f N-Acyl 2 -0xazo lid in o n es . N-Acyl 2 - o x a z o l i -  
d inones are prepared in  high y i e l d  from t h e i r  r e s p e c t i v e  "pa ren t "  2 -  
oxazol idinones (eq 16). Meta la t ion of the 2-oxazol idinone with  n -b u ty l -  
l i t h i u m  at -78°C, fo l lowed by N-acylat ion o f  the re su l tan t  anion with 
th e  d e s i re d  ac id  c h l o r i d e  or anhydr ide  a f f o r d s  the  N-acyl  2 - o x a z o l i  - 
dinone. The product  i s  p u r i f i e d  by reduced-p ressure  d i s t i l l a t i o n ,  
l i q u i d  chromatography on s i l i c a  g e l ,  or both, as indicated in  the exper­
im en ta l  s e c t io n .  The N - a c y la t i o n  r e s u l t s  are summarized i n  Tab le  4. 
Most N-acyl 2 -oxazol idinones are col o r less  c rys ta l  1 ine sol ids. Figure 5 
i l l u s t r a t e s  the s t ruc tu re  of the N-acyl 2-oxazol idinones.
2-0xazol id inones 6 , 7, 9, and 10 contain benzy l ic  protons. Metala-  
t i o n  o f  these 2 -oxazo l  i d i  nones w i th  excess j i -b u ty l  1 i t h i  urn re su l t s  in  
benzy l ic  deprotonation. A f te r  one equ iva lent  o f  base is added, a deep 
burgundy c o lo r  develops, ind ica t ing  formation of the dianion. As the
- 2 7 -





Table 4. Preparation of N-Acyl 2-0xazolidonones (eq 16).
Entry Imide R’ Y ie ld mp (bp) ^ 5 8 9 (£ ) i
A 14c Et 6 6 % (75°C, 0.005 mm)
B 16a H 93% 65.5-66°C +47.6° 2.06)
C 16b Me 94% (135°C, 0.008 mm) +43.4° 3.61)
D 16c Et 87% 55.5-56°C +40.4° 4.90)
E 16d Me2CH 90% 52-53°C +38.5° 2.36)
F 16e ch2=chch2 92% 59-60°C +34.6° 1.35)
G 16f Me3C 00 '-sj ** 79-80°C +36.3° 2.63)
H 16g Ph 90% 101-102°C +0.5° 0.97)
I 16h PhCH2 8 8% 95-96°C +28.7° 0.45)
J 161 Me(CH2 ) 7 89% 41-42°C +27.4° 3.03)
K 16j 1-Naphthyl 8 8 % 103-104°C -40.1° 0.584)
L 16k MeO 80% 63-64°C +30.4° 1.07)
M 161 BnO 87% 99-100°C +16.2° 2.47)
N 18c Et 95% (140°C, 0.01 mm) +2 1 . 8 ° 2.95)
0 20b Me 93% (100°C, 0.01 mm) +91.9° 0.377)
Pb 20c Et 93% (150°C, 0.005 mm)
- - J -
+89.9° 3.80)
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Table 4. Continued
Entry Imide R' Y ie ld mp (bp) [ a ]5 89 (c_)—
Q 2 0 h PhCH2 91% 63-64°C +71.0° (4.61)
R 2 0 i Me(CH2 ) 7 56% (160°C, 0.008 mm) +63.7° (2.07)
S 2 2 b Me 85% 76-77°C -84.1° (1.44)
T 2 2 c Et 84% 50-51°C -79.5° ( 2 . 2 1 )
U 24b Me 99% 44.5-45.5°C +80.7° ( 1 . 0 0 )
V 24c Et 95% (140°C, 0.01 mm) +74.8° (1.34)
a) Specif ic  ro ta t ion  determined in  d ich l  oromethane (£ = g/100 mL).
b) We thank Dr. M. D. Ennis f o r  t h i s  r e s u l t ,  r e f .  29.
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Figure 5. N-Acyl 2-0xazol idinones.
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d ian ion ,  2-oxazo l id inone 9 can racemize, and 2-oxazol id inones 6, and 7 
can ep im e r ize .  D ia n ion  fo rm a t io n  at -78°C i s  much s i  ower than at 0°C. 
Therefore, at -78°C, a small  excess o f  base can be to le ra te d .  The c o lo r  
change can even be used as a t i t r a t i o n  ind ica to r ,  provided the anion is  
immediately t rea ted  with  the acy la t ing  agent.
D. D iastereoselective A lkylation of Chiral 2-0xazolidinone Imide 
E n o la te s .  Based on th e  d is c u s s io n  in  s e c t io n  I I ,  we expected t h a t  
e n o l i z a t i o n  o f  N-acy l  2 - o x a z o l id in o n e s  would p re d o m in a n t ly ,  i f  not 
e x c lu s i v e l y ,  a f fo rd  the six-membered chelated (Z) enolate isomer. Sub­
s t i t u t i o n  at the C-4 p o s i t io n  o f the 2-oxazol idinone r ing  was ant ic ipated 
t o  provide the enola te  with a d ias te reo fac ia l  b ias, and thereby d i re c t  
the e le c t r o p h i le  to  approach the leas t  hindered diastereoface. There­
f o r e ,  i t  was our e x p e c ta t i o n  t h a t  the  {4R)- and (4 S ) - 4 - s u b s t i t u t e d  2- 
oxazol idinone imide enolates would lead to  the opposite sense o f c h i r a l ­
i t y  at the newly formed asymmetric center. The s te re o se le c t ive  e n o l i za ­
t i o n  and d ia s te re o se le c t i ve  a l k y l a t i o n  o f  ch i ra l  N-acyl 2-oxazol idinones 
i s  i l l u s t r a t e d  in  Scheme 6.
With a v a r i e t y  o f  e n a n t io m e r ic a l  l y  pure N-acyl 2-oxazol idinones 
re a d i l y  a v a i l a b le ,  we inves t iga ted  t h e i r  use as c h i r a l  a cyc l i c  enolate 
synthons.28 At the  onset ,  we imposed th re e  c r i t e r i a  w i t h  which to  
eva lua te  the a l k y l a t i o n  re s u l t s :  1) high l e v e l s  o f  d ias te reose lec t ion
(_> 95:5); 2) syn the t ica l  l y  useful rates o f  a l k y l a t i o n ;  and 3) the f a c i l e  
non-des truc t ive  removal o f  the ch i ra l  a u x i l i a r i e s  under non-racemizing 
cond i t ions .
A lk y la t io n  r e s u l t s  (diastereomer r a t i o  and percent react ion) were 
de term ined by GC a n a l y s i s  o f  the  u n f r a c t i o n a te d  r e a c t i o n  m ix tu re  on
- 3 0 -
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Scheme 6
commercia l ly  a v a i l a b le  f u s e d - s i l i c a  c a p i l l a r y  columns (see Experimental 
Section).  A standard mixture o f  diastereomers was prepared by N-acy la­
t i o n  o f  th e  c h i r a l  2 -oxazo1 id in o n e  w i t h  racemic a c id  c h l o r i d e .  In 
a lmost a l l  instances, c a p i l l a r y  GC provides basel ine separat ion o f  the 
diastereomers. Under rout ine cond i t ions ,  diastereomer ra t io s  o f >200:1 
can be determined. This is  s i g n i f i c a n t l y  b e t te r  prec is ion than can be 
obtained by in te g ra t io n  o f NMR spectra.
Deprotonat ion o f  imide 20b with  LDA (1.1 equiv) in  THF fo r  0.5 h at 
-78°C c l e a n l y  a f f o r d s  the  l i t h i u m  e n o la te .  Treatment o f  the  1 i th iu m  
eno la te  w ith  benzyl bromide (3 equiv) f o r  2-4 h at 0°C affords a lk y la te d  
imide 21g [{2R)-21g:(2S)-21g = 120:1] in  97% y i e l d  (eq 17).29 Although 
th e  magni tude o f  a l k y l a t i o n  d i a s t e r e o s e l e c t i o n  i s  lower  w i t h  o th e r  
e l e c t r o p h i 1es, t h i s  r a t i o  places a lower l i m i t  on e n o l iza t io n  stereo- 
se lec t ion .  Therefore, we are conf ident tha t  we are deal ing e s s e n t ia l l y  
w i th  a s in g le  enolate isomer.
- 3 1 -
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T ra n s e s te r i  f  i c a t i  on (LiOBn, THF, 0°C, 0.5 h) o f  a l k y l a t e d  imide 
(2R)-21g fo l lo w e d  by hydrogenolysis (H2 » 5% Pd on C, EtOH) o f  the r e s u l ­
t a n t  benzyl e s te r  a f f o r d s  (2 R ) -2 -m e th y l -3 -p h e n y l  p ropano ic  ac id  26g 
( [ a ] 5 8 9  = -25.1° (nea t ) )  in  68% y i e l  d (eq 18).29 The s p e c i f i c  r o t a t i o n  
corresponds in  both magnitude and sign t o  the highest reported l i t e r a ­
t u r e  r o t a t i o n  f o r  (2R)-ac id  26g ( [a ]5 8 9  = "25.4° {n e a t ) ) . 2^ The sense 
o f d ias te reose lec t ion  is  consistent w ith  our proposed model—wherein the 
e l e c t r o p h i l e  approaches the  l e a s t  h indered face  o f  the  six-membered 
c h e la te d  (Z) im ide e n o la te  (see Scheme 6). T h e re fo re ,  the  hypo thes is  
upon which t h i s  p ro jec t  was undertaken is  shown to  be i n t e r n a l l y  consis­
t e n t .
2) H ,, Pd/C , E10H
(18)
(2R ) -2 lg (2R)~26g  
H s„ -  -25 .1° (nea t)  
L i t .2* [<*]„,= -2 5  4* (nea t)
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E. A na lys is  o f  A lk y la t io n  Reaction Parameters. The im p re s s iv e  
l e v e l  o f  d i a s t e r e o s e l e c t i o n  in  th e  p r e v io u s  example prompted us t o  
de l in ea te  the f u l l  range of c a p a b i l i t i e s  and l im i t a t i o n s  of t h i s  asym­
m e t r i c  a l k y l a t i o n  r e a c t i o n .  D ep ro to n a t io n  (LDA, THF, -78°C, 0.5 h) o f  
imide 16c fo l low ed  by a l k y l a t i o n  with  methyl iod ide (3 equiv) at 0°C fo r  
2 h a f fo rds  a lk y la te d  imide 17h [(2R)-17h:(2S)-17h = 87:13] in  75% y i e l d  
(eq 19). The l e v e l  o f  a l k y l a t i o n  d ias te reose lec t ion  f o r  t h i s  methyla- 
t i o n  reac t ion  is  lower than the p re v io u s ly  described benzylat ion. Many 
n a t u r a l  p roduc ts  c o n ta in  c h i r a l  methy l ce n te rs .  T h e re fo re ,  we were 
in te res ted  in  improving the l e v e l  o f  d ias te reose lec t ion  f o r  the i n t r o ­
duct ion  o f  methyl centers.
Several react ion parameters may in f lu e n ce  the a l k y l a t i o n  re su l ts .  
Base, so l  v e n t ,  and tem pera tu re  are expected to  a f f e c t  th e  r a te  and 
s t e r e o s e l e c t i v i t y  o f  e n o l i z a t io n .  We already have presented evidence 
th a t  LDA in  THF at -78°C c le a n ly  deprotonates N-acyl 2-oxazol idinones to  
a f fo rd  the six-membered chelated (Z) imide enolate. The r e l a t i v e  s ta ­
b i l i t y  o f the che la te  could in f luence  both the nucleophi1i c i t y  and the 
d ia s t e r e o s e le c t i v i t y  o f  the enolate. Chelate s t a b i l i t y  depends on the 
nature o f  the counter ion, so lve n t ,  and temperature. The size o f  the C-4 
subs t i tuen t  on the 2-oxazol id inone was an t ic ipa ted  to a f fe c t  the magni­
tude o f  d ias te reose lec t ion .  A lso, the nature o f  the e le c t r o p h i le  and 
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o f d ias te reose lec t ion .  We i n v e s t ig a te d  each o f  these r e a c t i o n  param­
eters  in  order to  opt imize both the y i e l d  and the diastereomeric p u r i t y  
o f the a lk y la te d  product.
A l k y la t i o n  of the enolate  derived from imide 16c with methyl iod ide 
was chosen as the  model reac t ion  (eq 19). As p re v io u s ly  noted, a l k y l a ­
t i o n  o f  the l i t h i u m  enolate of 16c with methyl iodide at 0°C a ffords an 
87:13 r a t i o  o f  d ia s te re o m e rs .  Th is  r a t i o  corresponds t o  a aaG* o f  ca.
1.0 kca l/mol (see Figure 2). Thus, the same react ion  performed at -78°C 
should improve the le v e l  o f  d ias te reose lec t ion  to  ca. 93:7. Therefore, 
we inves t iga ted  the e f fe c t  of react ion temperature on a l k y l a t i o n  d ia ­
stereosel ec t ion  and product y i e l d .  Imide 16c was deprotonated with LDA 
(THF, -78°C, 0.5 h) and th e  r e s u l t a n t  l i t h i u m  e n o la te  t r e a te d  w i th  
methyl  i o d id e  (3 e q u iv )  a t a v a r i e t y  o f  tem pera tu res  (eq 19). The 
re s u l t s  are summarized in  Table 5.
JUL* ^ — cAÂ . JUU (in
I I  2)Mel I I ■ * I I 5
Ph*^ Me Ph Me P h *  *"M eMe
16c <2R)-!Zh (2SM 7h
As expected, the le v e l  o f k in e t i c  d ias te reose lec t ion  increases by 
d ecreas ing  th e  r e a c t i o n  tempera tu re .  For example, a l k y l a t i o n  of the 
l i t h i u m  e n o la te  d e r i v e d  from imide 16c w i t h  methy l io d id e  a t -20°C 
a f fo rds  an 88:12 r a t i o  o f  diastereomers (Table 5, entry  C), whereas the 
same react ion  performed at -78°C affords a 92:8 r a t i o  of diastereomers. 
The ra te  of a l k y l a t i o n ,  however, s i g n i f i c a n t l y  decreases at temperatures 
be low -2 0 CC. Only  5% o f  the  e n o la te  r e a c ts  a f t e r  2 h a t  -78°C. In 
terms o f  r e a c t i o n  r a te  and a l k y l a t i o n  d i a s t e r e o s e l e c t i o n ,  the  best
- 3 4 -
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T a b le  5. E f fec t  
(eq. 19).
o f Temperature on A lk y la t io n Diastereoselect ion
Entry




A -78°C, 2 h 92:8 (5%)
B ~50°C, 2 h 89:11 (57%)
C -20°C, 2 h 88:12 (96%)
D 0°C, 1 h 87:13 (97%)
a ) Di aste reomer r a t  i o determi ned by capi 1 1ary  GC ana lys  i s o f  the 
unfract ionated product, b) Percentage of enola te  a lk y la te d  as de ter­
mined by c a p i l l a r y  GC.
temperature f o r  the a l k y l a t i o n  of the l i t h iu m  enola te  derived from imide 
16c l i e s  between -20°C and 0°C.
The l i t h i u m  enolate derived from N-acyl 2-oxazol idinones is  t h e r ­
m a l l y  unstable. At temperatures above 0°C, the l i t h i u m  enolate decom­
poses a t  ra te s  c o m p e t i t i v e  w i th  a l k y l a t i o n .  Decomposit ion o f  the 2- 
oxazol id inone imide enola te  a ffords the “parent" 2-oxazol idinone and a 
ketene d e r i v a t i v e .  The ketene in turn  acy la tes the remaining enolate 
(Scheme 7 ) . ^ c Thus, fo r  each enolate molecule tha t  decomposes, two are 
l o s t .  Therefore, the enola te  should be a lk y la te d  at the lowest tempera­
tu re  p rov id ing  a useful y i e l d  o f product.
Scheme 7
The so lven t  can p lay an important r o le  in  any che la t io n  c o n t ro l l e d  
react ion. I t  a lso  may in f luence  the s ta te  o f  enolate aggregat ion.^! A 
decrease in  so lven t  p o la r i t y  should increase the r e l a t i v e  s t a b i l i t y  o f  
the chelate. This could , by decreasing the conformational m o b i l i t y  of 
the chelated imide enola te , increase the le v e l  o f d ias te reose lec t ion .  
But, a more s tab le  che la te  could a lso decrease the nuc leophi1i c i t y  of 
the enolate. With t h i s  in  mind, we inves t iga ted  the e f fe c t  of react ion 
media on both a l k y l a t i o n  d ias te reose lec t ion  and product y i e l d .  Imide 
16c, in a v a r ie ty  o f  so lve n ts ,  was deprotonated (LDA, -78°C, 0.5 h) and 
the re s u l ta n t  l i t h i u m  enolate  t reated with  methyl iodide (3 equiv).  The 
a l k y l a t i o n  re s u l t s  are summarized in  Table 6.
Decreasing th e  s o l v e n t  p o l a r i t y  from THF, t o  d i e t h y l  e th e r ,  to  
t o l u e n e  s l i g h t l y  inc reases  the  l e v e l  o f diastereosel ect ion (Table 5, 
en t r ie s  A, C, and D). The ra te  o f  a l k y l a t i o n ,  however, decreases dras­
t i c a l l y .  Adding hexamethyl phosphoric t r iam ide  (HMPT) to  a s o lu t io n  of 
the preformed l i t h iu m  enolate in  THF s l i g h t l y  decreases the l e v e l  of
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Table 6. E f fec t  of Solvent on A lk y la t io n  Diaste reose lect ion 
(eq. 19).
Entry Sol vent




A THF 0°C, 2 h 87:13 (97%)
B THF, HMPT£ 0°C, 2 h 83:17 (75%)
C Et2o 0°C, 2 h 88:12 (15%)
D toluene 0°C, 2 h 90:10 (10%)
a) Diastereomer r a t i o  determined by c a p i l l a r y  GC a n a l y s i s  o f  
u n f r a c t i o n a t e d  p roduc t ,  b) Percentage o f  e n o la te  a l k y l a t e d  
as determined by c a p i l l a r y  GC. c) 3 equiv o f HMPT (hexamethyl- 
phosphor ic  t r i a m id e )  added to  th e  preformed l i t h i u m  e n o la te  
p r i o r  to  a lk y la t i o n .
d ias te reose lec t ion  (Table 6, en try  B). That the s t rong ly  coordinat ing 
HMPT bare ly  decreases the l e v e l  o f d ias te reose lec t ion  demonstrates the 
h igh  s t a b i 1 i t y  o f  th e  c h e la te d  imide e n o la te .  From these  data  i t  i s 
apparent  t h a t  THF i s  th e  s o l v e n t  o f  cho ice  f o r  the a l k y l a t i o n  o f  2- 
oxazol id inone imide enolates.
A major fa c to r  in f lu e n c in g  che la te  s t a b i l i t y  is  the nature o f  the 
c o u n te r io n .  As p r e v i o u s l y  noted, th e  s t a b i l i t y  o f  th e  c h e la t e  may 
a f f e c t  both the  n u c l e o p h i l i c i t y  and the  d i a s t e r e o s e l e c t i  v i t y  o f  the 
che la ted imide enolate. By decreasing the s t a b i l i t y  o f  the che la te ,  the
nuc leoph i1 i c i t y  o f  the eno la te  should increase. Simultaneously, how­
e v e r ,  th e  c o n fo rm a t io n a l  r i g i d i t y  o f  the c h e la te d  in te rm e d ia te  may 
decrease, and thus reduce the the l e v e l  o f d ias te reose lec t ion .  There­
fo re ,  a compromise must be achieved between ra te  of a l k y l a t i o n  and the 
l e v e l  o f d ias te reose lec t ion .  We examined a v a r ie t y  o f  a l k a l i  metal and 
a l k a l i n e  earth cat ions in  order to  determine t h e i r  e f fe c t  on a l k y l a t i o n  
ra te  and product d ias te reose lec t ion .
Imides 16c, 20c, and 22c were depro tona ted  w i t h  l i t h i u m  d i i s o -  
propylamide (LDA), sodium hexam ethy ld is i l y l  amide (NaHMDS), or potassium 
h e x a m e t h y l d i s i l y l a m i d e  (KHMDS) t o  a f f o r d  t h e i r  r e s p e c t i v e  l i t h i u m ,  
sodium, and potassium enolates. The magnesium enolate o f imide 16c was 
prepared by adding anhydrous magnesium bromide to  the preformed l i t h iu m  
enolate. The various metal enolates were trea ted  with 3 equiv o f  methyl 
iod ide (eq 20). The a l k y l a t i o n  re s u l t s  are summarized in  Table 7.
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Table 7. E f fec t  o f Cat ion on A lk y la t io n  Diastereose lect ion (eq. 20).
Entry Imide Basei
Al k y la t io n  
Conditions
Ratiok
2R:2S Y i e l d —
A 16c LDA 0°C, 2 h 87:13 75% (97%)
B 16c NaHMDS -78°C, 2 h 93:7 00 ro (93%)
C 16c KHMDS -78°C, 2 h 81:19 (95%)
D 16c LDA, M g B r^ 0°C, 2 h 94:6 (76%)
E 20c LDA 0°C, 2 h 10:90 86% (99%)—
F 20c NaHMDS -78°C, 2 h 9:91 79% (99%)e
G 20c KHMDS -78°C, 2 h 14:86 (99%)
H 22c LDA 0°C, 1 h 81:19 (85%)
I 22c NaHMDS -78°C, 1 h 87:13 (97%)
J 22c KHMDS -78°C, 1 h 76:24 (96%)
a) E n o l i z a t i o n  c o n d i t i o n s :  -78°C f o r  0.5 h w i t h  the  i n d i c a te d  base 
(LDA = l i t h i u m  d i isopropy l  amide, NaHMDS = sodium hexamethyl d i s i l y l - 
amide, KHMDS = potass ium h e x a m e th y ld i s i l y l a m id e .  b) Di astereomer 
r a t i o  determined by c a p i l l a r y  GC ana lys is  o f  the un fra t ionated prod­
uct. c) Iso la ted  y i e l d  o f  the major diastereomer. Y ie ld  in  parenthe­
ses re fe rs  to the percentage o f  substrate a lk y la te d ,  d) 1.1 equiv o f  
anhydrous magnesium bromide was added to  the preformed l i t h i u m  e n o l ­
a te  p r i o r  to  a l k y l a t i o n .  e) We thank Dr. M. D. Ennis f o r  these 
resu l  t s ,  r e f .  29.
»
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Both the  sodium and potassium imide e n o la te s  re a c t  w i t h  methyl 
io d id e  a t  -78°C t o  a f f o r d  the a l k y l a t e d  im ide in  good t o  e x c e l l e n t  
y i e l d .  Compared w i th  the l i t h i u m  enolate, not on ly  i s  the sodium eno l ­
ate more r e a c t i v e ,  but i t  i s  a lso  more d ias te re o se le c t ive .  For example, 
t r e a tm e n t  o f  th e  1 i t h iu m  e n o la te  d e r iv e d  from imide 16c w i t h  methy l 
i o d id e  a t 0°C a f f o r d s  an 87:13 r a t i o  o f  d ias te reom ers  (Tab le  7, e n t r y  
A), whereas the corresponding sodium enolate reacts w ith  methyl iodide 
a t  -78°C to  a f f o r d  a 93:7 r a t i o  o f  d ias te reom ers  (Tab le  7, e n t r y  B). 
With the v a l i n o l - d e r i v e d  imide 20c, the percent increase in  d iastereo- 
s e l e c t i v i t y  go ing  from th e  l i t h i u m  to  the  sodium e n o la te  i s  not as 
dramatic as the norephedrine-derived imide 16c (Table 7, compare en t r ies  
A and B w i t h  E and F).
Potassium as the counter ion, al though more reac t ive  than l i t h iu m ,  
i s  s i g n i f i c a n t l y  less  d ias te reose lec t ive  than e i t h e r  l i t h i u m  or sodium. 
Thus, a l k y l a t i o n  o f  the potassium enolate derived from imide 16c with 
methyl iod ide a t  -78°C a ffords an 81:19 r a t i o  o f  diastereomers (Table 7, 
entry  C). Presumably, the potassium is  less capable o f  forming a con­
fo r m a t io n a l  l y  r i g i d  c h e la te d  e n o la te ,  and thus  i s  l e s s  d i a s t e r e o ­
s e le c t i v e .  The sodium and potassium enolates are less th e rm a l ly  s tab le  
than the corresponding l i t h i u m  e n o la te .  At tempera tu res  above -20°C, 
the sodium and potassium enolates decompose more ra p id l y  than they react 
w i th  methyl iodide.
The counter ion a f fo rd ing  the highest le v e l  o f  d ias te reose lec t ion  is  
magnesium. A l k y l a t i o n  o f the magnesium enolate der ived from imide 16c 
w ith  methyl iod ide a f fo rds a 94:6 r a t i o  o f diastereomers (Table 7, entry 
' D). The magnesium e n o la te ,  however, i s  le s s  r e a c t i v e  than  even the  
l i t h i u m  enolate. Only 76% of the magnesium enolate is  a lk y la te d  in  2 h
- 4 0 -
a t  0°C. Presumably , magnesium as th e  d i c a t i o n  forms a more s t a b l e  
c h e l a t e  than a l k a l i  metal  c a t i o n s ,  and as such i s  le s s  nuc1e o p h i1 ic .  
The r e l a t i v e  s t a b i l i t y  o f  the magnesium enola te  a lso  manifests i t s e l f  by 
decreasing the ra te  of enolate decomposition. Despite the higher d ia ­
stereosel  e c t i  v i t y  o f  the magnesium enola te , the l i t h i u m  enola te  at 0°C 
o r  t h e  sodium e n o la te  a t -78° are b e t t e r  s u i te d  in  terms o f  r e a c t i o n  
ra te ,  product y i e l d ,  and a l k y l a t i o n  d ias tereose lec t ion .
The nature o f  the C-4 subs t i tuen t  on the 2-oxazol idinone r ing  was 
e n v is io n e d  to  pi ay a major  r o l e  in  d e te rm in in g  both the.sense and the  
magnitude of a l k y l a t i o n  d ias te reose lec t ion .  Since the C-4 p o s i t io n  o f 
the 2-oxazol id inone r ing  is  in  c lo s e r  prox im i ty  to  the proch i ra l  reac­
t i o n  s i t e  than the  C-5 p o s i t i o n ,  s u b s t i t u t i o n  a t  the  C-4 p o s i t i o n  was 
expected to  have a greater  in f luence  over a l k y l a t i o n  d ias tereose lec t ion .  
In order  to  inves t iga te  the e f fe c t  o f the C-4 subst i tuent ,  imide eno l ­
ates der ived from a v a r ie t y  of 2-oxazo l id inones were a lky la te d  with  3 
equiv of methyl iodide (eq 20). The re s u l t s  are summarized in Table 8.
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Table 8. E f fec t  of 2-0xazol id inone Struc tu re  on A lky la t io n  Diastereo­





R1 C h i r a l i t y Base^




A 14c Me H (±) LDA 0°C, 2 h 86:14 (99%)
B 14c Me H (±) NaHMDS -78°C, 2 h 92:8 (92%)
C 16c Me Ph (4R.5S) ■ LDA 0°C, 2 h 87:13 75% (97%)
D 16c Me Ph (4R,5S) NaHMDS -78°C, 2 h 93:7 82% (93%)
E 18c Me Ph (4S.5S) LDA 0°C, 2 h 14:86 (98%)
f£ 20c j_-Pr H (4S) LDA 0°C, 2 h 10:90 86% (99%)
20c j_-Pr H (45) NaHMDS -78°C, 2 h 9:91 79% (99%)
H 22c Ph H (4R) LDA 0°C, 2 h 81:19 (85%)
I 22c Ph H <4R) NaHMDS -78°C, 2 h 87:13 (97%)
J l 24c PhCH2 H (4S) LDA -30°C, 2 h 6:94
a) E n o l i z a t i o n  c o n d i t i o n s :  -78°C f o r  0.5 h w i t h  th e  i n d i c a te d  base (LDA = 
l i t h i u m  d i i s o p r o p y la m id e ,  NaHMDS = sodium hexamethyl di s i  1 y 1 ami de). b) 
A l k y la t i o n  with  3 equiv o f  methyl iodide, c) Diastereomer r a t i o  determined 
by c a p i l l a r y  GC ana lys is  o f  the unfract ionated product, d) Iso la ted  y i e l d  
of major diastereomer; y i e l d  in  paraentheses re fe rs  to  the percentage of 
s u b s t r a te  a l k y l a t e d ,  e) We thank Dr. M. D. Ennis f o r  these r e s u l t s ,  r e f .  
29. f )  We thank Mr. K. T. Chapman f o r  t h i s  r e s u l t ,  r e f .  32.
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The f i r s t  observat ion to  be made is  th a t  (4RJ- and (4S)-4-subst i -  
tu ted  2-oxazo l id inones induce the opposite sense o f asymmetry, thereby 
c o n f i r m in g  one o f  th e  hypotheses o f  t h i s  p r o je c t .  The s i z e  o f  th e  C-4 
subs t i tuen t  in f luences the l e v e l  o f  d ias tereose lec t ion .  The magnitude 
o f  the d i f fe rence ,  however, i s  not very large. For example, imide 14c 
w i th  a lone C-4 methyl subs t i tuen t  a f fo rds  an 86:14 r a t i o  o f  d ias tereo-  
iners (Table 8, entry  A), whereas imide 20c with  a C-4 isopropyl s u b s t i ­
tuen t  a f fo rds  a 90:10 r a t i o  o f  diastereomers (Table 8, en try  F).
I n te r e s t i n g ly ,  imide 22c w ith  a C-4 phenyl subst i tuent  a f fo rds  an 
81:19 r a t i o  o f  d ias te reom ers  (T a b le  8, e n t r y  H). Thus, a phenyl sub­
s t i t u e n t  presents a sm a l le r  d ia s te re o fa c ia l  bias than a methyl s u b s t i ­
tuent.  Presumably, the p laner  phenyl r ing  adopts a conformation less 
s t e r i c a l  l y  demanding than th e  th re e -d im e n s io n a l  methyl o r  i s o p ro p y l  
subs t i tuen ts .
S u b s t i t u t i o n  a t  the  C-5 p o s i t i o n  o f  the  2-oxazo l  i d in o n e  r i n g  has 
l i t t l e  e f f e c t  on th e  l e v e l  o f  a l k y l a t i o n  d i a s t e r e o s e le c t i o n .  For 
example, a l k y l a t i o n  o f  the l i t h i u m  enolate derived from imide 14c (with 
a C-4 methyl subs t i tuent )  a f fo rds  an 86:14 r a t i o  of diastereomers (Table 
8, e n t r y  A), whereas a l k y l a t i o n  o f  th e  l i t h i u m  e n o la te  d e r i v e d  from 
im ide  16c (w i t h  a C-4 methyl  s u b s t i t u e n t  and a c i s  C-5 phenyl s u b s t i ­
t u e n t )  a f f o r d s  an 87:13 r a t i o  o f  d ias te reom ers  (Tab le  8, e n t r y  C), o r  
a l k y l a t i o n  o f  the  l i t h i u m  e n o la t e  d e r i v e d  from imide 18c ( w i t h  a C-4 
methyl subst i tuent  and a trans C-5 phenyl subst i tuent) a f fo rds  an 86:14 
r a t i o  of diastereomers (Table 8, en try  E).
In summary, the C-4 subs t i tuen t  i s  the most important f a c to r  con­
t r o l l i n g  the le v e l  o f  a l k y l a t i o n  d ias tereose lec t ion .  Indeed, a methyl 
group in  t h i s  p o s i t i o n  i s  s u f f i c i e n t  to  p ro v id e  a high l e v e l  o f  d ia -
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s te reose lec t ion .  Itnides der ived  from (4R,5S)-norephedr ine  2 -oxazo l  i -  
dinone 6 and (4 S ) -v a l in o l  2-oxazo l id inone 8 e x h ib i t  the best le v e l  o f 
d ias te reose lec t ion  f o r  t h e i r  respec t ive  c h i r a l i t i e s .
F i n a l l y ,  we t r e a t e d  the 2 -o x a z o l i d i n o n e  im ide e n o la te s  w i t h  a 
v a r ie t y  of e le c t r o p h i1es in  order t o  determine the e f fe c t  e le c t r o p h i le  
s t ruc tu re  plays on the ra te  o f  a l k y l a t i o n  and the l e v e l  o f  d ias tereo­
se lec t ion .  The re s u l t s  obtained f o r  a l k y l a t i n g  enolates der ived from 
imide 16 (eq 21) are summarized in  Table 9. The corresponding re s u l t s  
f o r  a l k y l a t i n g  enolates der ived from imide 20 (eq 22) are summarized in 
Table 10.
Methyl iod ide a f fo rds  the lowest l e v e l  o f  a l k y l a t i o n  d ias tereo­
s e l e c t i o n .  A l k y l a t i o n  o f  these  l i t h i u m  im ide  e n o la te s  w i t h  methyl 
iod ide a f fo rds  a d ias te reose lec t ion  (D1:D2) o f  ca. 9:1. As p rev ious ly  
noted, the corresponding sodium enolate  e x h ib i t s  a s l i g h t l y  higher l e v e l  
o f  d iastereose l ec t ion  with  t h i s  e le c t r o p h i le .  For example, a l k y l a t i o n  
o f  the l i t h i u m  enolate  der ived from imide 16c a f fo rds  an 87:13 r a t i o  of 
diastereomers (Table 9, entry  K), whereas a l k y l a t i o n  o f the correspond­
ing sodium enola te  a f fo rds  a 93:7 r a t i o  o f  diastereomers (Table 9, entry  
L). The magnitude o f  improvement i s  not as g re a t  w i t h  the  v a l i n o l -  
der ived imides. Thus, a l k y l a t i o n  o f the l i t h i u m  enolate  der ived from 
im ide  20i a f f o r d s  a 91:9 r a t i o  o f  d ia s te re o m e rs  (T a b le  10, e n t r y  J ) ,  
whereas a l k y l a t i o n  o f  the corresponding sodium enola te  a f fo rds  a 93:7 
r a t i o  of diastereomers (Table 10, en try  K).
A l k y l  h a l i d e s  o th e r  than  methy l i o d id e  are s i g n i f i c a n t l y  l e s s  
re a c t i v e  with these enolates. For example, a l k y l a t i o n  o f  the l i t h iu m  
e n o la te  d e r i v e d  from imide 16b (R = m e th y l )  w i t h  e th y l  io d id e  (3-10
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T a b le  9. D ias te reose lec t ive  A lk y la t io n  of Imide Enolates Derived from 16 (eq 21).
Entry Imide H Base^ E lec troph i le  (equiv)
Alkyl at ion 
Conditions
Rat ic£  
D1:D2 Product Y ie ld t
A 16b He LDA E t 1 (3) 0DC, 2 h 91:9 17a 281
B 16b He NaHMDS EtI (A) -20°C, 2 h 94:6 17a 53%
C 16b He LDA CH2=CHCHzBr (3) 0°C, 2 h 98:2 17b 751
D 16b Me NaHMDS ch2=chch2 i  (2) -78°C, 3 h 97:3 17b 831
El 16b He LDA CH2=C(CH3 )CH2Br (3) 0°C, 2 h 97:3 17c 62%







G 16b He LDA BnOCH2Br (2) -45°C, A h 98:2 17e 72%
H 16b Me LDA Et02CCH2Br (3) O X , 2 h 93:7 17f 51%
I 16b Me LDA Bnlir (1 .1 ) 0°C, 2 h 98:2 17g 73%
J 16b Me NaHMDS BnBr (1 .1 ) -78°C , 3 h 98:2 179 79%
K 16c Et LDA Mel (3) OcC, 2 h 87:13 17h 75%
L 16c Et NaHMDS He I (6) -78°C, 3 h 93:7 17h 82%
M 16d 1 -  Pr LDA Mel (3) -10°C, 2 h 87:13 171 54%
N 16f t-Bu LDA Mel (3) -10°C, 2 h 94:6 17j 66%







P 16i n-CgHj? LDA Hel (A) O'C, 2 h 89:11 171 70%
Q 16i n - c 8 Hi7 NaHMDS Mel (A) - 7 8 X . 2 h 94:6 171 85%
a) Enolizat ion  conditions: -78°C for  0.6 h with the indicated base (LDA = l i th iu m  d i is o -  
propylamide, NaHMDS = sodium hexamethyldis ily lamide), b) Diastereomer r a t io  determined by 
c a p i l l a r y  GC a n a ly s is  of the u n f ra c t io n a te d  product, c) I s o la t e d  y i e l d  of the  major 
diastereomer (D1:D2 >. 99:1 unless otherwise noted), d) Me thank Dr. M. D. Ennis fo r  these 
r e s u l t s ,  e) D1:D2 = 98:2.
J — L .
16
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T ab le  10. D ias tereose lect ive  A lk y la t io n  of Imide Enolates Derived from 20 (eq 21).
Entry Imide k Basei E lec tro ph ile  (equiv)
A lky lat ion
Conditions
Hat i ô - 
C1:D2 Product Yie ld£
20b Me LDA EtI (10) 0°C, 2 h 94:6 21a 361
B 20b Me LDA CH2=CHCH2Br (3) -10 'C , 2 h 9B:2 21b 75%
d 20b Me LDA CH2=C(CH3)CH2Br (3) 0°C, 2 h 98:2 21c 62%
20b Me LDA PhCH=CHCH2Br (1 .5 ) -40°C, 1 h, 
O'X, 2 h
99:1 21d 84%
E 20b Me LDA BriOUl2br (2) -45°C , Ah 98:2 21e 62-74%
F 20b Me LDA Et02CC82br (2) - 2 0 ^ ,  2 h 
O^C, 2 h
95:5 21 f 51%
20b Me LDA BnBr (3) 0°C, 2 h >99:1 219 97%
20c Et LDA Mel (3) 0°C, 2 h 90:10 21h 86%
1 20h PnCH2 LDA BnSCh2Br (1 .1 ) -20°C, 2 h 97:3 21k 83%i
J 20i n-C8H17 LDA Mel (3) 0°C, 2 h 91:9 211 83%
K 20i n-CfaHj7 NaHMUb Mel (3) -7B°C, 2 li 93:7 211 77%
a) Eriolization conditions: -78°C for  0.5 h with ttie indicated base (LDA = l i th ium  d i is o -  
propylamide, NaliKiij = Sodium hexamethy! d is i  1 y 1 amide). b) Di astereumer ra t io  determined Dy 
Copil I a ry 6L a n a ly s is  of the u n f fa c t io n a te d  product, c) I s o la t e d  y i e l d  of the major  
diastereomer (D1:D2 > 99:1 unless otherwise noted), d) We thank Dr. M. D. Ennis fo r  these 
r e s u l ts ,  e) We thank Mr. k. L. Dow f o r  t h is  r e s u l t ,  r e f .  34. f )  D1:D2 = 98:2.
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e q u iv )  a f f o r d s  th e  a l k y l a t e d  p roduc t  in  28% i s o l a t e d  y i e l d  (Tab le  9, 
e n t r y  A). Even w i t h  the  more r e a c t i  ve sodium e n o la te ,  a t  -20°C , o n l y  
53% o f  the a lk y la te d  product i s  iso la te d  (Table 9, entry  B). Attempts 
to  a l k y l a t e  2-oxazo l id inone imide enolates w ith  e i t h e r  n-buty l  iodide or 
isobu ty l  iod ide f a i l ;  on ly  recovered s ta r t in g  m a te r ia ls  and/or enolate 
decomposition products are iso la ted .
A l l y l i c  h a l i d e s  and benzyl bromide re a c ts  w i t h  2 - o x a z o l i d i n o n e  
imide enolates to  a f fo rd  the a lk y la te d  products in  moderate to  e x c e l le n t  
y i e l d s  (62-97%). The le v e l  o f a l k y l a t i o n  d ias te reose lec t ion  (D1:D2) is  
c o n s is te n t l y  >95:5. With these more re a c t ive  el e c t ro p h i1es, both the 
1 i th iu rn  and the  sodiurn e n o la te s  p ro v id e  about the  same l e v e l  o f  d i a ­
stereosel ect ion. A l k y la t i o n  o f  the sodium eno la te ,  however, o ften im­
proves the product y i e l d .
Other re a c t ive  e le c t r o p h i1es tha t  react w ith  2-oxazo l id inone imide 
enola tes inc lude benzyl bromomethyl ether (Table 9, entry  G; Table 10, 
e n t r y  E) and benzyl bromomethyl s u l f i d e  (T a b le  9, e n t r y  K; Tab le  10, 
e n t r y  I ) .  In  both  cases, th e  l e v e l  o f  a l k y l a t i o n  d ia s t e r e o s e l e c t i o n  
(D l : D2) i s  97:3. A l k y la t i o n  o f propanoate imides with  benzyl bromo­
methyl ether a f fo rds  c h i ra l  d e r iv a t i v e s  o f  2-methyl-3-benzyl  oxypropanoic 
a c id ,  a u se fu l  c h i r a l  p re cu rso r  p r e v i o u s l y  ob ta ined  by th e  m ic r o b ia l  
h y d r o x y l a t i o n  o f  2 -m e th y lp ro p an o ic  a c id .33 We have employed (2S)-2-  
m e thy l -3 -benzy loxy - l -p ropano l , derived from a d iastereose l e c t i v e  imide 
a l k y l a t i o n ,  in  the  t o t a l  s yn th e s is  o f  ionomycin.34 A l k y l a t i o n  o f  3- 
phenylpropanoate imides with  benzyl bromomethyl s u l f i d e  a f fo rds  c h i ra l  
d e r i v a t i v e s  o f  2-benzy l th iomethyl -3-phenylpropanoic  acid, which we have 
employed as precursors fo r  the synthesis o f both enantiomers o f  t h i o r -
oc
phan (see Appendix 4). 3
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The diastereomeric imide a l k y l a t i o n  products are e a s i l y  separated 
by l i q u i d  chromatography on s i l i c a  g e l .  This pe rm i ts  th e  majo r  d i a ­
stereomer to  be i so la te d  in  a sta te o f high diastereomeric p u r i t y  (D1:D2 
_> 99:1).  The c a p a c i t y  f a c t o r  k' (de f ined  as ( t ^  - t o ) / t o  where t \  i s  
the re ten t ion  time o f  diastereomer 1 and tg  i s  the re ten t ion  t ime o f  an 
u n re ta in e d  compound) and th e  se p a ra t io n  f a c t o r  a (d e f in e d  as k 12 / k *i  
where k ' j  and k *2 are the  c a p a c i t y  f a c t o r s  f o r  d ias te reom ers  1 and 2 
re sp ec t ive ly )  f o r  several pa irs of diastereomers are recorded in  Table
11. From the data in  Table 11 several in te re s t in g  trends are observed. 
The amount o f separat ion depends on the d i f fe rence  in  size between R and 
R1. Even when R = methyl and R' = e t h y l ,  a reasonab le  d ia s te re o m e r  
s e p a ra t io n  can be ob ta ined .  A ls o ,  the  o rd e r  o f  e l u t i o n  i s  r e g u l a r .  
With a lk y la te d  (4R,5S)-norephedrine 2-oxazol id inone imides the (2R)-dia- 
stereomer e lu tes  f i r s t .  This informat ion permits the minor diastereomer 
to  be removed, in a p red ic tab le  manner, by discard ing or re cyc l in g  the 
head or the  t a i l  o f  th e  chromatograph ic  peak. General l y ,  we observed 
t h a t  d ias te reomers  w i t h  an a >1.3 are r e a d i l y  se parab le  by e i t h e r  
" f la s h "  chromatography or by MPLC (see Experimental Section).
Recent ly,  P i r k l e  has reported tha t  c h i ra l  2-oxazol id inones can be 
used to  reso lve  racemic primary amines v ia  diastereomeric a l lophanate  
d e r i v a t i v e s  (27 and 28).36 jh e  d ias te reomers  are separa ted by 1 i q u id  
chromatography on s i l i c a  ge l.  Diastereomer 27 e lu tes  before d ias te reo ­
mer 28. The observed order o f  e lu t io n  is  ra t io n a l iz e d  in the fo l l o w in g  
manner. The two diastereomers adopt the conformations shown in  Figure 
7. D ipo le -d ipo le  repu ls ion  causes the two carbonyls to  choose an a n t i -  
p e r i p l a n e r  arrangement .3? Hydrogen bonding between the  NH and the  2- 
oxazol idinone carbonyl provides add i t iona l  s t a b i l i z a t i o n  f o r  t h i s  con-
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Me
Ph’
(2R)- I7  <2S)'iZ
Figure 6. A lky la ted  N-Acyl 2-Oxazolidinone Diastereomers.
T a b l e  11.
Diastereomers
HPLC S e p a ra t io n  o f  
(Figure 6 ) .—
A 1 ky la te d N-Acyl 2 -0xazo l  i d i  nom
Entry RS r L k ’ 2R k'  2S a
A Me Et 1.04 1.39 1.34
B Me PhCH2 1.34 2.11 1.57
C Me CH2=CHCH2 0.96 1.53 1.59
0 Me j - P r 0.81 1.34 1.65
E Me t-Bu 0.53 1.05 1.94
F Me H-C8Hi7 0.39 1.05 2.69
a) HPLC cond i t ions :  88:12 isooctane/ethyl  acetate, 2.0 mL/min, 10 cm x 
8mm, Waters Associates Radial Pak 5 pm s i l i c a  gel column.
fo rm a t io n .  Th i s arrangement p l a c e s t h e R  and Rj_ s u b s t i t u e n t s  o f d i a -  
s te reomer 27 on o p p o s i te  faces o f  the m o le c u le ,  and thus 27 i s  b e t t e r  
ab le  to  “ fend o f f "  p o la r  associat ions with s i l i c a  gel than 28. There­
fo re ,  diastereomer 27 is  the f i r s t  to  e lu te .
Figure 7. Diastereomeric Al lophanate Der ivat ives
A s i m i l a r  argument can be used to  exp la in  the order of e lu t io n  f o r  
a l k y l a t e d  N-acy l  2 - o x a z o l id in o n e s .  The two d ias te reom ers  adopt the  
conformation shown in  Figure 6. D ipo le -d ip o le  repuls ion maintains the 
two carbonyls in  an a n t i - p e r ip la n e r  arrangement.^ The (2R)-diastereo- 
mer places the subst i tuent ant i  to  the res ident c h i r a l i t y  on the 2- 
o x a z o l i d in o n e  r i n g .  T h e re fo re ,  t h e  (2R) -d ias te reom er ,  l e s s  a b le  to  
associate with s i l i c a  g e l ,  e lu tes  f i r s t .
In summary, N-acyl 2-oxazol idinones are c le a n ly  deprotonated with 
LDA or  NaHMDS in  THF at -78°C t o  a f f o r d  the  l i t h i u m  o r  sodium e n o la te .  
Chi ra l  2-oxazol idinone imide enolates react with  methyl iod ide, a l l y l i c  
h a l id es ,  benzyl bromide, and other reac t ive  e le c t r o p h i1es in  a h ig h ly  
d ia s te re o se le c t i ve  manner. The C-4 subs t i tuent  o f the 2-oxazol idinone 
r ing  provides the asymmetric bias. A methyl group in  t h i s  pos i t ion  is  
s u f f i c i e n t  to  provide a high l e v e l  o f  d ias tereose lec t ion .  E i ther  sense 
o f  asymmetr ic i n d u c t i o n  can be ach ieved by use o f  c h i r a l  2 - o x a z o l i -  
dinones der ived from ( lS,2R)-norephedrine o r  (2 S ) -va l  i n o l .  The sodium 
enol a te  i s  more r e a c t i  ve, and when a l  ky l  ated w i t h  methyl io d id e  more 
d ia s te re o se le c t i ve ,  than the corresponding l i t h iu m  enolate. The r e s u l ­
ta n t  diastereomeric products can, in  a p red ic tab le  manner, be p u r i f ie d
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t o  a h igh degree o f  d ia s te r e o m e r ic  p u r i t y  by l i q u i d  chromatography on 
si 1 ica g e l .
F. Removal o f t h e  C hira l A u x i l ia ry .  We have demonstrated t h a t  
c h i r a l  N-acyl 2-oxazol id inones are a lk y la te d  in  a h ig h ly  d ias tereose lec-  
t i v e  fa s h io n ,  and t h a t  the  r e s u l t a n t  p roducts  can be ob ta ined  in  a 
d ia s te re o m e r ic a l  l y  pure s ta te .  The remain ing c r i t e r i o n  t o  be demon­
s t ra ted is  the s e le c t i v e  removal o f the c h i ra l  a u x i l i a r y  from the a l k y l ­
ated product in  a manner preserving the newly formed stereocenter. In 
terms o f c h i ra l  economy, i t  a lso is  useful i f  the c h i ra l  a u x i l i a r y  can 
be recovered and recycled.
We have deve loped  s e ve ra l  conven ien t  procedures f o r  the  non­
d e s t ru c t i ve  cleavage o f the c h i ra l  a u x i l i a r y  from a lk y la te d  N-acyl 2- 
o x a z o l id in o n e s .  The c h i r a l  p roduc t  can be ob ta ined  in  h igh y i e l d  in  
s e v e ra l  d i f f e r e n t  o x id a t i o n  s ta te s .  The amount o f  ra ce m iz a t io n  i s  
minimal. The various transformations fo r  removing the c h i r a l  a u x i l i a r y  
are i l l u s t r a t e d  in  Scheme 8.
The removal o f  2 - o x a z o l id in o n e s  from a l k y l a t e d  imides re q u i re s  
n u c le o p h i l i c  attack at the exocyc l ic  imide carbonyl (Scheme 9, path A). 
Nuc leoph i l ic  attack a t the endocyc l ic  2-oxazol id inone carbonyl a ffo rds 
th e  r i n g  opened p roduc t  (Scheme 9, path B). Path A must be fa vo re d  to  
o b ta in  a high y i e l d  o f  the  c h i r a l  p roduct .  In c re a s in g  the s ize  o f  R1 
and r2, however, can hinder n u c le o p h i l i c  attack at the exocyc l ic  car­
bonyl ,  and thereby fa vo r  r ing  opening. Therefore, removal of the ch i ra l  
a u x i l i a r y  from the a lk y la te d  product i s  system dependent. We have found 
by careful  choice o f  react ion condit ions tha t  r ing  opening can be m in i ­
mized. The various methods o f  c h i ra l  a u x i l i a r y  removal are described 
below.








A) LiOBn, THF, 0 °C  B) H2l 5 % P d /C ,  EtOH or 6 M  HBr in HOAc. C) KOH, MeOH/ 
HjO, 0 ° C .  D) (C O C D j,  CH2CI2 , 0 ° C  E) Cp2Ti = CH2, CH2CI2. F) MeMflBr, CH2CI2. 
6) D IB A L ,  CHjCIj . H) L i A IH 4 o r  L iB H , , THF. I ) (C 0 C I )2. DMSO, E t,N , CH2Cl2.
J) HjNNHj , EtOH
Scheme 8
® 0x
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The f i r s t  removal technique invest iga ted  was base-catalyzed h yd ro l ­
ys is .  Treatment o f  a l k y la te d  imide (2R)-21g w ith  potassium hydroxide in  
methanol/water at 0°C a f fo rds  (2R)-2-methyl -3-phenyl propanoic acid 26g
v a l i n o l  amide. The hyd ro lys is  o f  other a lk y la te d  imides a f fo rds  s im i l a r  
m ix tu re s .  Only  im ides  ( 2 S ) -1 7 f  and (2R ) -2 1 f  are h yd ro lyze d  to  a f f o r d  
the re s u l t a n t  c h i r a l  acids in  >90% y i e l d  (eqs 24 and 25). Presumably, 
the s e l e c t i v i t y  in  t h i s  example is  assisted by in t ra m o le cu la r  formation 
o f  a c y c l i c  anhydride, which then opens to  a f fo rd  the c h i r a l  2-methyl- 
succ in ic  acid 26f.
in  71% y i e l d  (eq 23).29 The remainder of the product i s  the r ing  opened
KOH, MeOH/HjO




( 2 R ) -2 1 f ( 2 R ) - 2 6 f  (91% )
H 1)(- -1 5 .0 °  (c 4.21, EtOH)
n  n 0
K O H ,M e 0 H /H ,0
(25)
(2 S ) -1 ? f ( 2 S ) - 2 6 f  (9 5 % )
H l l l = • 15.7° (c 4  25 , EtOH)
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T r a n s e s t e r i f i c a t i o n  was i n v e s t i g a t e d  as an a l t e r n a t e  method f o r  
removing th e  c h i r a l  a u x i l i a r y  from a l k y l a t e d  im ides. The r e s u l t a n t  
c h i r a l  es te r  a lso  is  in  the ca rboxy l ic  acid ox ida t ion  state. Methanol- 
y s i s  o f  im ide (2R)-21g (MeOH, NaOMe, 0°C) proceeds r a p i d l y  to  a f f o r d  
methyl (2R)-2-methyl-3-phenyl propanoate 30g in 60% y i e l d  (eq 26).29 Un­
fo r tu n a te l y ,  as with  base-catalyzed hyd ro lys is ,  r ing  opening a lso  com­
petes w i t h  t h i s  process. S i m i l a r  m ix tu res  are  ob ta ined  w i t h  o th e r  
a l k y l a t e d  imides.  Other bases (LiOMe, KOMe, Mg(0Me)2) do not s i g n i f ­
i c a n t l y  improve the re su l ts .
0 0 0
A l l  M M e O N o ,  MeOH \ \N> ^ M e  ---------------;--------------- ^  Me0> V Me <2 6 >
| | : 0 °C , 0.5h
V  v 'Ph N ’ h
(2R)-21g (2R)-30g (60%)
We found a t r a n s e s te r i f i c a t io n  react ion th a t  co n s is te n t ly  a ffords 
c h i r a l  esters in >90% y ie ld .  Treatment of the a lk y la te d  imide (ca. 0.3 
M in  THF, 0°C) w ith  1.5 equiv o f  l i t h iu m  benzyl oxide c le a n ly  a ffords the 
corresponding benzyl ester (eq 27). The reac t ion  condi t ions are r e l a ­
t i v e l y  s p e c i f i c ,  and the r e a c t i o n  i s  o n l y  su cce ss fu l  f o r  p re pa r ing  
benzyl esters. But the process is  successful  w i th  most a lk y la te d  imides 
and i t  causes minimal racemization ( vide i n f r a ). The t r a n s e s te r i f i c a ­
t i o n  r e s u l t s  f o r  c le a va g e  o f  v a r io u s  a l k y l a t e d  imides w i th  l i t h i u m  
benzyl oxide are summarized in  Table 12.
- 5 4 -
M 0II r 2  BnOLi,  T H F ,  0 ° C ,  1~4 h II .
x / V *     B n O - V * '  ( 2 7 )
R1 R.
17 or 21 31
o o 
0 ' ^ sn ' ^ s^ rJ
 ‘‘" M e  Rl
17 21
T a b le  12- T ra n s e s te r i f ic a t io n  of A lky la ted  2-0xazolidinone Imides to Afford Benzyl Esters 
(eq 2 7 ) 4
Entry Imide R1 r2 2R:ZS^ Ester Yie ld^ CONFIG £“ ^589 (c, ch2c 12)
A 17a He Et <1:99 31a 90% S +12.8° 2.16
21b Me Et <1:99 31a 92% S +12.5° 5.55
C 17h Et Me >99:1 31a 93% H
OC
M1 2 .85
[4 21a Et Me >99:1 31a 89% R -12 .6° 6.38
E 17b Me ch2=chch2 <1:99 31b 86% S +2.3° 14.7
F< 17c Me CH2=C(CH3 )CH2 3:97 31c 93% S -3 .7 ° 6.33
21c Me ch2=c ( ch3 )ch2 >99:1 31c 93% R +3-9° 5.86
H 21e Me BnOCH2 >99:1 31e 96% R -3 .5 ° 4.78
I 179 Me PhCH2 <1:99 31g 92% 5 +26.8° 5.93
J i 219 Me PhCH2 >99:1 319 92% R -26 .8° 2.33
K 17k PhCHz BnSCH2 98:2 31k 83% R +36.2° 0.86
L 21k PhCHz BnSCH2 2:98 31k 82% S -34 .6° 2.46
a) T ra n s es ter i f ica t ion  reaction performed with 1.5 equiv of l i th ium  benzyloxide in THF (ca. 0.3 
M) at 0°C for 1 h. b) Diastereomer ra t io  of a lk y la te d  imide p r io r  to t ra n s e s te r i f ic a t io n .  c) 
Iso la ted  y ie ld  of benzyl ester ,  d) We thank Dr. K. D. Ennis for  these re s u l ts ,  re f .  29.
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The s p e c i f i c  ro ta t io n  f o r  enant iomeric benzyl esters der ived from 
a lk y la te d  imides is  equal in  magnitude and opposite in  sign (Table 12). 
Since we already have shown th a t  both norephedrine and v a l i n o l - d e r i v e d  
c h i r a l  a u x i l i a r i e s  have e q u a l ly  high enant iomeric p u r i t i e s ,  the o p t ica l  
ro ta t io n  re s u l t s  suggest--but do not p rove - - tha t  n e g l i g i b l e  racemizat ion 
occurs during t ra n s e s te r i f i c a t io n .
An experiment was designed to  assay the maximum amount o f  racemiza­
t i o n  th a t  occurs during t r a n s e s te r i f i c a t io n .  The experiment, o u t l in e d  
in  Scheme 10, consis ts  of fou r  separate react ions: 1) t r a n s e s t e r i f i c a ­
t i o n  (1.5 e qu iv  o f  LiOBn, THF, 0°C, 1 h) o f  an a l k y l a t e d  im ide o f  known 
d ia s te re o m e r ic  p u r i t y  t o  a f f o r d  the  c h i r a l  benzyl e s te r  ( s te p  A); 2) 
h y d ro g e n o ly s i  s (5% Pd on C, H2> E t0H o r  THF) o f  th e  benzyl e s t e r  t o  
a f f o r d  the  c h i r a l  ca rboxy l  ic  ac id  (s tep  B); 3) t re a tm e n t  o f  t h i s  ac id  
w ith  e thy l  ch ioroformate (THF, Et3N, -10°C, 0.5 h) or o x a l l y l  c h lo r id e  
(CH2C12 , 0°C, 4 h) (s tep  C); and f i n a l l y  4) t re a tm e n t  o f  the r e s u l t a n t  
carboethoxy mixed anhydride or ac id  c h l o r i d e  w i t h  the  metal ated (4S)- 
v a l i n o l  2 - o x a z o l id in o n e  (THF, -78°C, 0.5 h) to  a f f o r d  the s t a r t i n g  
a lk y la te d  imide (step D). The re s u l t s  are summarized in  Table 13.
Pe r fo rm ing  the ra ce m iz a t io n  assay on im ide (2R)-21g (R = PhCH2 ) 
w i t h  an i n i t i a l  d ias te reom er  r a t i o  [ ( 2 R ) -2 1 g : (2 S ) -2 1 g ]  o f  >99.9:0.1 
a f fo rds  the a lk y la te d  imide with  a f i n a l  diastereomer r a t i o  o f  99.8:0.2 
(Table 13, entry  A). Thus, w ith  t h i s  imide, less than 0.2% racemization 
occurs. This places an upper l i m i t  on the amount o f racemization tha t  
occurs during t r a n s e s te r i f i c a t io n .  The same assay repeated with imide 
(2R)-21e (R = BnOCH2 ) [ (2R)-21e:(2S)-21e = 99.2 :0 .8 ] r e s u l t e d  in  1.8% 
and 1.6% ra ce m iz a t io n  (Tab le  13, e n t r i e s  B and C). Thus, even w i t h  a 
system more prone to  racemizat ion, less than 2% o f  the stereochemistry
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R! CH208n 
2 lg ,  R= CHgPh
Me
©







A) L iOBn,  T H F , 0 ° C , 1 h .  B) H2, 5 % P d /C ,  EtOH or THF. 
Cl)  EtOjCCI,  Et3N, THF, -10°C. C2) (C OCI^ , CH,CI?1 0 &C. 
D> 8.* n-BuLi ,  THF, - 7 8 ° C .
Scheme 10
Table 13. T ra n s e s te r i f i c a t io n  Racemization Assay (Scheme 10).
Entry Imide R
Diastereomer R a t io i  




A^ 219 PhCH2 99.9:0.1 99.8:0.2 0.2%
B Zle BnOCH2 99.2:0 .8 98.3:1.7 1. 8 %
21e BnOCH2 99.2:0.8 98.4:1. 1. 6 %
a) Diastereomer r a t i o  determined by c a p i l l a r y  GC analys is ,  b) We thank 
Dr. M. D. Ennis f o r  t h i s  r e s u l t ,  r e f .  29. c) We thank Mr. J. R. S t i  1 1 e 
f o r  t h i s  r e s u l t ,  re f .  38. d) Acy la t ion  o f  the c h i r a l  acid ch lo r ide .
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i s  eroded. I n te r e s t i n g l y ,  the c h i ra l  acid ch lo r id e  racemizes less than 
the c h i ra l  carboethoxy mixed a n h y d r i d e . 38c
The racemizat ion assay a lso  demonstrates a h ig h -y ie ld  procedure fo r  
obta in ing c h i ra l  ca rboxy l ic  acids from a lk y la te d  imides: t ran se s te r ­
i f i c a t i o n  of the a lk y la te d  imide t o  g ive  the benzyl ester fo l low ed  by 
hydrogenolysis o f the benzyl es te r  to  a f fo rd  the c h i r a l  ca rboxy l ic  acid. 
This two-step sequence avoids the problem o f  2-oxazol id inone r ing  open­
ing encountered during base-catalyzed hydro lys is .  The benzyl ester can 
even be s e l e c t i v e l y  removed in  th e  presence o f  a benzyl  e th e r .  For 
example, h y d ro g e n o ly s is  o f  benzyl (2R)-2-methyl-3-benzyl oxypropanoate 
31e with 5% pal ladium on carbon in  THF c le a n ly  a ffo rds  (2R)-2-methyl 3- 




We were unab le  t o  remove the  benzyl e s t e r  from benzyl  (2R)- or 
(2S)-2-benzylth iomethyl -3-phenylpropanoate 31k by hydrogenolysis due to  
c a ta l y s t  poisoning. Benzyl es te rs ,  however, a lso  can be removed under 
a c id ic  condit ions. For example, Maclaren has reported tha t  the benzyl 
es te r  o f (S)-S-benzylcyste ine, benzyl es te r  i s  s e le c t i v e l y  removed by 
t re a tm e n t  w i t h  anhydrous hydrogen bromide in  g l a c i a l  a c e t i c  ac id  (eq 
2 9 ) . Applying t h i s  technique t o  (2R)-benzyl es te r  31k a ffords (2R)-2- 
benzyl  t h i o m e t h y l - 3 - p h e n y l  p ropano ic  ac id  26k ( [ 0 0 5 3 9  = +54.1° (c 1.54,
- 5 8 -
EtOH)) in  85% y i e l d  (eq 30). L ike w ise ,  (2S)-benzyl  e s te r  31k a f f o r d s  
(2R)-ac id  26k ( [ a ] 589 = -50.6°  (£ 1.57, EtOH)) i n  83% y i e l d .
0 0 
II 6M HBr in [I




6 M HBr in II




H . s= *54.1° (c 1.54, EtOH)
(2S)-26k (83%)
-50  6° (C1.57, EtOH)
The l i t h iu m  benzyloxide t r a n s e s t e r i f i c a t i o n  r e a c t i o n  i s  th e  o n l y  
i n te rmol  ecul a r  t r a n s e s t e r i f  i c a t io n  react ion that con s is ten t ly  a f fo rds 
high y ie ld s  o f  c h i ra l  esters. We, however, found that the in t ramolec­
u l a r  v a r i a n t  o f  th e  t r a n s e s t e r i f i c a t i o n  react ion is  qu ite  successful .  
The product  from t h i s  r e a c t i o n  i s  the c h i r a l  2 - s u b s t i t u t e d  l a c to n e .  
Removal o f  the c h i r a l  a u x i l i a r y  by in t ram o lecu la r  mediated t ranses te r ­
i f i c a t i o n  r e q u i r e s  th e  presence o f  a f r e e  hydroxy l  in  the  s u b s t ra te .  
The precursors we used to  demonstrate these cyc l iz a t io n s  are the a l l y l -  
ated imides (2S)-17b and (2R)-21b.
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Ozonolysis o f imide (2R)-21b [(2R)-21b:(2S)-21b >99:1] in  methanol 
a t  -78°C w i t h  Sudan Red I I I  as an i n d i c a t o r 4!  f o l l o w e d  by d im e thy l  
s u l f i d e  workup42 g iv e s  a m ix tu re  o f  the aldehyde and the  d im e thy l  
a c e t a l .  S u b je c t in g  t h i s  m ix tu re  to  h y d r o c h l o r i c  ac id  i n  aqueous THF 
c le a n l y  a f fo rds  the aldehyde in  97% y ie l d .  Reduction o f  the re su l ta n t  
aldehyde w ith  sodium borohydride on alumina43 in  d ie thy l  ether gives the 
hydroxy imide, which spontaneously lac ton izes upon d i s t i l l a t i o n  to  give 
(2R)-2-methy 1 b u t y r o l  ac tone 32 ( [a ]5 8 9  = +21*2° {£ 8.56, EtOH)) i n  70% 
y i e l d  (eq 31). The s p e c i f i c  r o t a t i o n  f o r  (2 R ) - la c to n e  32 is  in  good 
agreement w ith  the highest ro ta t io n  reported in the l i t e r a t u r e  fo r  t h i s  




H ydrobo ra t ion  o f  im ide (2S)-17b [ (2 R ) -17 b : (2 S ) -1 7 b  <1:99] w i th  
di  s i amyl borane (THF, 0°C f o r  1.5 h then 25°C f o r  0.5 h) f o l l o w e d  by 
ox ida t ion  o f  the re s u l ta n t  organoborane w i t h  t r i e t h y l  amine-N-oxide in  
r e f l u x in g  toluene gives a mix ture o f  the hydroxy imide and the lactone. 
Ref lux ing t h i s  mixture in  the presence o f  excess t r i e t h y l  amine a ffords 
a f t e r  chromatography (2S)-2-methyl val ero l  actone 33 ([a]ggg = +67.3° (c
6.6, MeOH)) in  68% y i e l d  (eq 32) .29 The s p e c i f i c  r o t a t i o n  f o r  (2S)- 
lac tone 33 exceeds the highest ro ta t io n  reported in the 1 i t e ra tu re  fo r  
t h i s  l a c to n e  ( [a ]5 8 9  = +64.4° ( £ 4 .4 ,  MeOH)).*^
0
i )  0 „  M e O H , - 7 8 - C
o X v ^ M e  (31)
2 )  Me2S, then H * j
3) NoBH4/AI20 3 ( 7 0 % )
32
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0 0 0
2) Me,NO,toluene, U
3)M e,N ,  CHCI), 11
I) (Sio)2BH, T H F
&
(32)
(2S)-17b (6 8 %)
33
In  a d d i t i o n  t o  t r a n s e s t e r i f i c a t i o n ,  the  c h i r a l  product c a n  b e  
removed from the a lk y la te d  imide by transaminat ion. Treatment o f  a l k y ­
la te d  imide {2S)-17g [(2R)-17g:(2S)-17g <1:99] w ith  anhydrous hydrazine 
i n  e th a n o l  at 25°C f o r  4 h a f f o r d s  ( 2 S ) -2 -m e th y l -3 -p ro p a n o ic  a c id ,  
hydrazide 43g in  76% y i e l d  (eq 33). Chiral  hydrazides are p o t e n t i a l l y  
transformed v ia  the acyl azide to  c h i r a l  amides, amines, isocyanates, 
and urethanes (Scheme 11). These transformations are known to  be free 
from ra c e m iz a t i o n . ^
Cherpeck and Tannis, in  our la b o ra to r ie s ,  have demonstrated tha t  
boron a ld o la te s  derived from N-acyl 2-oxazo l id inones react with methyl-
We were in te res ted  in apply ing t h i s  transformation to  the preparat ion of 
c h i r a l  ketones from a l k y l a t e d  imides. Treatment o f  a l k y l a t e d  imide 
(2S)-17g C(2R)-17g:(2S)-17g <1:99] w i t h  1.1 equ iv  o f  methylmagnesiurn 
bromide in  d ich l  oromethane a t 0°C f o r  3 h a ffords the ring-opened




magnesium bromide to  a f fo rd  the corresponding methyl ketone (eq 3 4 ).45
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A) HONO. B)  R3NH2. C) A  . D) H20. E) R3OH
Scheme 11
norephedrine amide acetate 35 in  97% y i e l d  (eq 35). The s t ruc tu re  of 35 
was in fe r red  by the presence o f  two carbonyl absorpt ions (1750 and 1685 
cm~l) i n  the  IR spectrum, and the  presence o f  two phenyl r in g s  ( 7.2
and 7.1 ppm) and a methyl s i n g le t  (2.1 ppm) in the NMR spectrum. The 
same react ion repeated with  excess methylmagnesiurn bromide in re f lu x in g  
d i c h l  oromethane a f f o r d s  the  r ing -opened  norephedr ine amide 36 in  99% 
y i e l d  (eq 36). Presumably , the  imide carbony l  i s  two h indered in  the 
case o f  a lk y la te d  imides f o r  the methyl magnesium bromide.to approach the
- 6 2 -
im ide  c a r b o n y l .  T h e re fo re ,  e x c l u s i v e  a t ta c k  at the  2 - o x a z o l id in o n e  
carbonyl c l e a n ly  a f fo rds  the ring-opened product.
MeMgBr
0 0 Me 0
A V 1 "-Jy |i’ 1 -  mv “v ^ n ' V * '  os)
I I  MeCI.,, 0 ° C  II s I I
p h**J ^ Me V Ph 0  Ph H
(2 S ) -1 7 g  35  (97%)
0  0  Me O
(36)0 X NX ^ « <  _ H O ^ T . nX
Ph*’"  ‘‘ •Me ^ P t i  Pn n ^ phA:I I I  M eC l,,“"  ^p n
( 2 S ) - 1 7 g  3 6  0 9% )
An a l t e rn a te  method is  a v a i l a b le  to  prepare c h i ra l  methyl ketones 
from the a lk y la te d  imides v ia  an in d i re c t  route. St i  11 e and Grubbs have 
demonstrated tha t  the t i tanocene methyl idene complex re a c ts  w i t h  ac id  
c h l o r i d e s  to  a f f o r d  methyl ketones (eq 3 7 ).38 we a l re a d y  have shown 
th a t  c h i r a l  acid ch lo r ides  can be prepared with less than 2% racemiza­
t io n .  Reaction o f (2R)-2-methyl -3-benzyloxypropanoic acid ch lo r id e  37g 
w i th  the t i tanocene methyl idene complex affords (3R)-3-methyl-4-benzyl - 
oxy-2-butanone 38 w ith  less than 0.5% addi t iona l  racemization (eq 3 8 ).38
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-  JJ. (37)
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(< 0 .5 %  racemization)
Mukaiyama has shown th a t  N-acy l  t h i a z o l i d i n e -2 - t h io n e s  undergo 
reduct ion with  d i i s o b u ty l  aluminum hydride (DIBAL) to  a f fo rd  the corres-
hedral intermedia te, and thus prevent over- reduct ion to  the a lcoho l .  We 
were in te res ted  in  apply ing t h i s  transformation to  the a lk y la te d  imides. 
U n fo r tuna te ly ,  t reatment o f the a lk y la te d  imides with 1.1 equiv o f  DIBAL 
a f fo rds  a mixture o f  s ta r t i n g  m a te r ia l ,  aldehyde, and the over-reduced 
a lcoho l .  Presumably, the 2 -o x a z o l id i n o n e  i s  i n s u f f i c i e n t l y  bas ic  to  
s t a b i l i z e  the te t rahed ra l  intermediate.
ponding a ldehyde  (eq 3 9 ) . C h e la t i o n  serves to  s t a b i l i z e  the te t r a -
DIBAL (39)
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We have prepared c h i ra l  aldehydes from a lk y la te d  imides v ia  a two- 
step reduc t ion -ox ida t ion  process (eq 40). Reduction o f a lk y la te d  imides 
w i th  e i t h e r  l i t h i u m  aluminum hydride (LAH) or l i t h iu m  borohydride gives 
the c h i ra l  a lcohol ( v ide i n f r a ). Oxidat ion o f the re su l ta n t  a lcohol by 
the Parikh m od i f ica t ion  o f  the M o f fe t  procedure (SO3 — p y t ' i d in e ,  DMSO, 
E t g N ) , ^  o r  the  Swern procedure  ((COClJg, DMSO, E t 3 N)^® a f f o r d s  the  
c h i r a l  aldehyde. Although c h i r a l  2 -subs t i tu ted  aldehydes are re l  a t i v e l y  
prone to  racemizat ion, we have shown tha t  these techniques usual l y  l i m i t  
the amount o f  racemization to  under 0.5%.^’
0  0
LI Q I) LAH or LiBH., THF ||
x / V " '   :------------------------------------------  h > L ^ R ,  ( 4 0 )
1 2) SOj-pyridi ne, DMSO,Et3N,MeCl, I
R, R.or 1
17 or 21 (COCI)2, DMSO,EtjN ,MeCI? 4 0
The a lk y la te d  imides are reduced with  e i t h e r  LAH or l i t h iu m  boro­
hydride in  THF to  g ive  the corresponding c h i ra l  primary alcohol 39 (eq 
41). The reduc t  i on re s u i t s  are summari zed in  Tab le  14. Th e y  i e l d  o f  
a lcoho l  ranges from 76-90%. Small amounts o f  the under-reduced a ld e ­
hyde 40 as w e l l  as the ring-opened methyl amine 41 are responsib le fo r  
the remainder o f the product. Reduction at the 2-oxazol idinone carbonyl 
i s  minimized by mainta in ing the LAH reduct ion below 0°C, or the l i t h i u m  
b o ro h yd r id e  re d u c t io n  below 25°C. Other re d u c ta n ts  such as borane, 
excess DIBAL, l i t h i u m  t r i e t h y l  borohydride, or sodium borohydride do not 
a f fo rd  s ig n i f i c a n t  y ie ld s  o f  the c h i ra l  a lcoho l .
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Table 14. Reduction of A lkylated  2-0xazolidinone Imides (eq 41).
Entry Imide ftl R2
R a t io i  
2ft: 2S ReductantJl Conditions Alcohol CONFIG Y ie ld t  [ a ] 58g (c, Ch2C l2.
A 17e He BnOCH2 <1:99 LiBHjj 0°C, 4 h 39e S 881 -4 .2 ° 2.50
B 21e He BnOCHj >99:1 LiAlH4 0°C, 4 h 39e R 76% +5.3°4 2.20
c£ 219 Me PhCH2 >99:1 L1BH4 25°C, 2 h 39g R 78% + 1 0 .7 ° I 0.94
[ £ 219 Me PhCH2 >99:1 L i A1H4 0°C, 0 .5  h 39g R 88% +10.3° 1.15
E i 219 Me PhCH2 >99:1 LiAl H4 25°C, 0 .5  h 39g R 86% +11.0° 0.65
F 171 Me £ ' C8H17 >99:1 LiBh4 0°C, 4 h 391 ft 84% +10.8° 4.37
G Zll Me n-caHi? <1:99 Li BH4 0°C, 4 h 391 S 90% -11.0°2 4.21
a) D ias tereom er r a t i o  of im ide p r i o r  to  re d u c t io n ,  b) One m olar e q u iv ,  thus fo u r  hydride  equ ivs .  
c) Is o la t e d  y i e l d  o f  a l c o h o l ,  d) L i t .  r o t a t i o n  +4.97° (0 .9 3 ) ,  r e f .  33b. e) We thank Dr. M. D. 
Ennis f o r  these r e s u l t s ,  r e f .  29. f )  L i t .  r o t a t i o n  +11.8° (4 .6 ) ,  r e f .  49. g) L i t .  r o t a t i o n  - 9 .8 °  
( n e a t ) ,  r e f .  50.
The sp e c i f i c  r o ta t io n s  f o r  the various ch i ra l  a lcoho ls  are s im i l a r  
to  the highest reported l i t e r a t u r e  values (Table 13). The enant iomeric 
p u r i t y  o f  (2R)- and (2S)-2-methy 1 -3 -benzyloxy- l-propanol 39e was con­
f i rm e d  by an a l t e r n a t e  method. The Mosher e s te r  o f  a l c o h o l  39e was 
prepared by the standard procedure (eq 42).22 Neither c a p i l l a r y  GC nor 
HPLC separates the diastereomers. The 500 MHz NMR spectra o f (2R)-42
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and (2S)-42, however, are s u f f i c i e n t l y  d i f f e r e n t  to  demonstrate tha t  
each e n a n t io m e r  o f  t h e  a l c o h o l  i s  >95% e n a n t io m e r ic a l  l y  pure. 
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Figure 8 500 MHz NMR Spectra o f ( 2R)-  and (2S)-42
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covered in ta c t  from each of these c h i ra l  a u x i l i a r y  removal procedures. 
U su a l l y ,  the c h i r a l  a u x i l i a r y  is  separated from the c h i r a l  product by 
l i q u i d  chromatography on s i l i c a  ge l.  Further e lu t io n  o f  the column with  
a more p o la r  s o l v e n t  removes the 2 - o x a z o l i d i n o n e .  A n a ly s i s  o f  the  
Mosher imide der ived from the recovered 2-oxazol id inone ind ica tes  th a t  
no ra ce m iz a t io n  o f  th e  c h i r a l  a u x i l i a r y  occurs d u r in g  t h i s  process. 
T h e re fo re ,  th e  c h i r a l  a u x i l i a r y  can be r e c y c le d ,  i n v o k in g  a form o f  
c h i r a l  economy.
4
IV. SUMMARY
We have demonstrated t h a t  N-acy l  2 -o x a z o l i d i n o n e s ,  d e r i v e d  from 
r e a d i l y  a v a i l a b le ,  enant iomerical l y  pure, c h i ra l  amino a lc o h o ls ,  are 
useful  c h i ra l  a c y c l i c  enolate synthons. E n o l iza t ion  o f the N-acyl 2- 
oxazo l id inone w ith  e i t h e r  LDA or  NaHMDS s te re o s e le c t i v e ly  a f fo rds  the 
six-membered chelated (Z) imide enolate. Chira l  s u b s t i tu t io n  at the C-4 
p o s i t i o n  o f  t h e  2 - o x a z o l i d i n o n e  r i n g  d i r e c t s  methyl i o d id e ,  a l l y l i c  
h a l id es ,  benzyl bromide, or other re a c t i v e  el e c t ro p h i 1 es to  approach the 
1 east h indered  d ia s t e r e o fa c e  o f  th e  e n o la te .  The k i n e t i c  a l k y l a t i o n  
d ias te reose lec t ion  i s  g ene ra l ly  >95:5. The major diastereomer can, in  a 
p re d ic ta b le  manner, be iso la te d  by l i q u i d  chromatography on s i l i c a  g e l ,  
w i t h  a di  as te reom er i  c p u r i t y o f _ > 9 9 : l .  N o n -d e s t r u c t i v e  methods are 
a v a i l a b le  to  remove the c h i r a l  a u x i l i a r y  from the a lk y la te d  imide, and 
e i t h e r  d i r e c t l y  or v ia  fu r th e r  transformations a f fo rd  ch i ra l  a lcoho ls ,  
aldehydes, amides, amines, ca rb oxy l ic  ac ids, ca rboxy l ic  acid c h lo r id e s ,  
es te rs ,  hydrazides, ketones, lac tones, or urethanes in  a s ta te  of high 
e n a n t io m e r ic  p u r i t y .  In each case, th e  2 - o x a z o l id in o n e  i s  recovered  
i n t a c t ,  pe rm i t t ing  the economical r e cyc l in g  o f  the ch i ra l  a u x i l i a r y .
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V. EXPERIMENTAL SECTION
G eneral. M elt ing  points were determined with  a Buchi SMP-20 m e l t ­
ing po int apparatus and are uncorrected. IR spectra were recorded on a 
Beckman 4210 spec t ropho tom ete r  and are re p o r ted  in  r e c ip r o c a l  c e n t i ­
meters (cm- *). Routine NMR spectra were recorded on a Varian Asso­
c ia te s  CFT-20 (80 MHz) or  EM-390 (90 MHz) spectrometer. High f i e l d  ! H 
NMR sp e c t ra  were recorded on a Va r ian  Assoc ia tes  XL-200 (200 MHz), a 
B ruke r  WM-300 (300 MHz), o r  a Bruker WM-500 (500 MHz)^  spectrometer .  
Chemical s h i f t s  are reported in  ppm from in te rna l  te t ram ethy ls i  1ane on 
the S scale. Data are reported as fo l lo w s :  chemical s h i f t ,  m u l t i p l i c i t y  
(s = s i n g l e t ,  d = d o u b le t ,  t  = t r i p l e t ,  q = q u a r t e t ,  qn = q u i n t e t ,  m = 
m u l t i p l e t  and br  = b road) ,  c o u p l i n g  cons tan t  (Hz), i n t e g r a t i o n  and 
i n t e r p r e t a t i o n .  NMR spec t ra  were recorded on a JE0L FX-90Q (22.5 
MHz) or a Varian Associates XL-200 (50 MHz) spectrometer and are rep o r t ­
ed in  ppm from in te rna l  te tramethyl  si 1ane on the 8  scale. M u l t i p l i c ­
i t i e s ,  when determined by off-resonance decoupl ing, are reported using 
the above format.
O p t i c a l  r o t a t i o n s  were determined w i t h  a Jasco DIP-181 d i g i t a l  
p o la r i m e t e r  a t  589, 577, 546, 435 and 365 nm. Data are re p o r te d  as 
f o l l o w s :  [ a ] 5 gg, [ <x]5 7 7 , [ 0 1 5 4 5 , [ 0 1 4 3 5 , [ a^365» c o n c e n t ra t io n  (_c 
g/100 mL) and so lvent .  When ch loroform was used as the so lve n t ,  i t  was 
f i l t e r e d  through a c t i v i t y  1 alumina immediately p r i o r  to  use.
Combustion analyses were performed by Ga lb ra i th  Laborator ies, Inc. 
(K n o x v i l l e ,  Tennessee), Mr. Lawrence Henl ing at the C a l i fo rn ia  I n s t i t u t e  
o f  Technology M i c r o a n a l y t i c a l  L a b o ra to ry ,  or Spang M i c r o a n a l y t i c a l  
Laboratory (Eagle Harbor, Michigan).
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A n a l y t i c a l  gas chromatography (GC) was c a r r i e d  out on a H e w le t t  
Packard 5880A gas chromatograph equipped w i t h  a sp l i t  mode capi 1 1 ary  
i n j e c t o r  and a f lame i o n i z a t i o n  d e te c to r .  Unless o th e rw ise  noted, 
hydrogen was used as th e  c a r r i e r  gas. The f o l  1 owing wal 1 coated open 
t u b u l a r  (WCOT) fused s i l i c a  c a p i l l a r y  columns were employed: 0.32 
mm x 15 m and 0.32 mm x 30 m Carbowax 20M (J and W A s s o c ia te s ) ,  0.32 mm 
x 30 m DB-1 (J and W A s s o c ia te s ) ,  0.32 mm x 30 m DB-5 (J and W Asso­
c i a t e s ) ,  0.31 mm x 25 m SE-54 (H e w le t t  Packard) and 0.21 mm x 25 m 
methyl s i l i c o n e  (Hewlett  Packard). Spec i f ic  GC condi t ions are reported 
i n  th e  f o l  1 owing fo rm a t :  co lumn, oven te m p e ra tu re ,  c a r r i e r  gas f l o w  
ra te ,  and re ten t ion  time. Unless otherwise ind icated, the i n je c to r  and 
detecto r  temperatures were 250°C.
Flash chromatography was performed according to  the general proce­
dure of Sti  11,^2 employing EM Reagents S i l i c a  Gel 60 (40-63 pm). Data 
are reported as fo l lo w s :  column dimensions (d x 1 ), e lu ta n t  composition 
and order of e lu t io n .  Medium pressure l i q u i d  chromatography (MPLC) was 
c a r r i e d  out on an MPLC apparatus c o n s i s t i n g  o f  a Chromatron ix  SV8031 
Sample In je c t io n  Va lve,  a F lu id  Metering Inc. model RP-SY Lab Pump and 
an ISC0 model UA-5 UV (254 nm) Detector using the fo l lo w in g  EM Reagents 
prepacked LoBar L iChroprep Si 60 co l  umns: co l  umn A (1.0 x 24 cm, 40-63 
pm s i l i c a  g e l ) ,  column B (2.5 x 31 cm, 40-63 pm s i l i c a  gel)  and column C 
(3.7 x 44 cm, 63-125 pm s i l i c a  ge l) .  Spec i f ic  MPLC condi t ions are re ­
ported as fo l lo w s :  column dimensions (d x 1 ) , e lu ta n t  composition, e l u ­
ta n t  f lo w  rate  and order o f e lu t io n .  A n a ly t i c a l  high performance l i q u i d  
chromatography (HPLC) was car r ied  out on a Waters Associates ALC 202/401 
HPLC equipped with a model 6000 high pressure so lven t  pump, a model U6 K 
i n j e c t o r  and a d i f f e r e n t i a l  UV d e te c to r  (254 nm), us ing the f o l  low ing
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columns: Waters Associates Radial Pak ( 8  mm x 10 cm, 5 nm s i l i c a  gel)  or 
( 8  mm x 10 cm, 10 ym s i l i c a  g e l ) ,  DuPont Zorbax (4.6 mm x 25 cm, 5 ym 
s i l i c a  g e l ) ,  and Regis (4.6 mm x 25 cm, P i r k l e ^  p h e n y lg l y c i n e  co ­
v a le n t l y  bound to  5 ym aminopropyl s i l i c a  ge l) .  Spec i f ic  HPLC condi ­
t io n s  are reported as fo l l o w s :  column, e lu ta n t  composition, e lu ta n t  f low  
ra te  and r e t e n t i o n  volume ( k ') .  P re p a ra t i v e  HPLC was performed on a 
Waters Associates PrepLC/System 500 l i q u i d  chromatograph, equipped with  
a r e f  r  ac t  i ve index d e t e c t o r  and using two PrepPak 500 s i l i c a  gel c a r -  
t r i d g e s  (5 x 30 cm, 30ym s i l i c a  g e l ) .  S p e c i f i c  HPLC c o n d i t i o n s  are 
reported using the above format. Unless otherwise noted, the substrate 
was in t ro d u c e d  onto  th e  HPLC as a concen t ra ted  s o l u t i o n  th rough  the 
s o l v e n t  i n l e t  p o r t .  A n a l y t i c a l  t h i n  l a y e r  chromatography (TLC) was 
performed using EM Reagents 0.25 mm s i l i c a  gel 60-F p la tes .  V i s u a l i z a ­
t i o n  o f  th e  deve loped  chromatogram was performed by UV absorbance, 
iod ine vapor, an aqueous cerium molybdate s p r a y o r  an aqueous potas­
sium permanganate spray.
When necessary ,  s o l v e n t s  and reagents were d r ie d  p r i o r  to  use. 
Die thy l  e ther ,  dimethoxyethane (DME) and te t rahydro furan (THF) were d is ­
t i l  1 ed from sodi um-potassium al loy/benzophenone k e t y l . Benzene and 
to luene were d i s t i l l e d  from sodium/benzophenone k e ty l .  Boron t r i f l u o r i d e  
etherate, chi  o ro t r im e th y ls i  1 ane, dichloromethane, d i isopropy l  amine, d i ­
isopropyl e thy l  ami ne, hexamethyl d is i  l y l  amine, and t r i e t h y l  ami ne were d i s ­
t i l  l e d  from c a lc iu m  hyd r ide .  A c e to n i t r i  1 e, dimethyl formamide (DMF), 
dimethyl s u l fo x id e  (DMS0) and hexamethylphosphoric t r iam ide  (HMPA) were 
d i s t i l  led  from c a lc iu m  h yd r id e  and s to red  o ve r  4A m o le c u la r  s ieve s .  
A lky l  bromides and iodides were passed through a column o f  a c t i v i t y  1
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alumina immediately p r io r  to  use. n -B u ty l1 i th ium (A ld r ich  Chemical Co.) 
was s tanda rd ized  by doub le  t i t r a t i o n  ( t o t a l  base - i n o r g a n ic  base = 
organic base).
Unless o the rw ise  noted, a l l  non-aqueous react ions were performed 
under an oxygen-free atmosphere of argon or nitrogen with  r i g i d  e x c lu ­
sion o f moisture from reagents and glassware.
{2S )-2-A m ino-3-m ethy l-1 -bu tano l [ ( S ) - V a l  i nol I n t o  an oven
dr ied ,  5-L, three-necked, round-bottomed f l a s k  equipped with a mechan­
i c a l  s t i r r e r ,  a d i s t i l l a t i o n  head / re f lux  condenser, and a 250 mL pres­
su re -equa l iz ing  add i t ion  funnel was introduced 234 g (2.00 mol) of (S)- 
v a l  ine  ( [ a ] 589 = -27.4 (c 3.4, 6 N. aqueous HCl), A1 d r i c h  Chemical Co.). 
The apparatus was f lushed with n i t rogen and the f l a s k  charged w ith  1-L 
o f  d ry  THF and 275 mL (318 g, 2.20 mol)  o f  boron t r i f l u o r i d e  d i e t h y l  
etherate. The mixture was heated at r e f l u x  u n t i l  the v a l in e  d isso lved  
(0.5-1 h). S t i r r i n g  was co n t inu e d  as 220 mL (10.0 M, 2.20 mol)  o f  
borane dimethyl s u l f i d e  was added dropwise over a 4 h period. External 
h e a t in g  was ad jus ted  to  a l  1 ow d im e th y l  s u 1 f i d e  and d i e t h y l  e th e r  to  
d i s t i l  from the react ion f l a s k .  Caution: a large quantity of hydrogen is  
evolved during the addition. A f te r  the add i t ion  was complete, the f l a s k  
was charged w i th  an a d d i t i o n a l  500 mL o f  dry THF. D i s t i l l a t i o n  was 
continued u n t i l  the temperature o f  the d i s t i l l a t e  rose to  64-65°C. The 
r e a c t i o n  m ix tu re  was then heated a t r e f l u x  f o r  4 h. Ex te rn a l  h e a t in g  
was con t inued  as the  r e a c t i o n  m ix tu re  was hyd ro lyzed  by the  cautious  
dropwise addi t ion  of 250 mL o f  a 1:1 ( v / v )  mixture of THF and water over 
a 0.5 h period, fo l lowed by the a d d i t io n  of 1.5 L o f a 5 M aqueous s o lu ­
t i o n  of sodium hydroxide over a 0.5 h period. A f te r  the addi t ions were
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complete, the two-phase react ion mixture was heated a t r e f l u x  f o r  an 8 -h 
p e r io d .  The r e a c t i o n  m ix tu re  was coo led  t o  room tempera tu re .  A smal 1 
amount o f  an amorphous so l  i d  was removed by f i  1 t r a t i o n  th rough  a 2 cm 
pad o f  c e l i t e .  The react ion mixture was t rans fe r red  to  a 6 -L separatory 
f u n n e l ,  and the  two l a y e r s  separated. The low er  aqueous l a y e r  was 
extracted w i th  four  1-L por t ions o f d ie th y l  ether. The etheral  ex t rac ts  
were combined w i t h  th e  THF s o l u t i o n  (upper phase). The wate r  t h a t  
separated at t h i s  po int was combined with  the aqueous phase. The organ­
ic  s o lu t io n  was dr ied over anhydrous potassium carbonate, f i l t e r e d ,  and 
the s o lv e n t  removed in vacuo. The residue was d i s t i l l e d  under reduced 
p ressure  to  a f f o r d  82-113 g (40-55%) o f  ( S ) - v a l i n o l  as a c o l o r l e s s  
l i q u i d ,  bp 97-98°C ( 8  mm), [ L i t . 18 bp 55-57°C (2 mm)], which may sol i d -  
i f y  upon standing, mp 27-29°C, [ L i t . 85 mp 31-32°C]. An add i t iona l  25-40 
g (12-19%) o f  ( S ) - v a l i n o l  was ob ta ined  by cont inuously  ex t rac t ing  the 
aqueous phase with  dichloromethane fo r  4 days. IR (CH2 C12^ 3600-3040, 
1580, 1460, 1220 cm“ l ;  XH NMR (CDC1 3/90  MHz) 8  3.60 (d o f  d, J = 4.5, 
11 Hz, 1 H, C i -H ) ,  3.26 (d o f  d, J = 9, 11 Hz, 1H, C1 -±L)> 2.6-2.4 (m, 1H, 
Cg-H), 2.35-2.15 (b r  s, 3H, OH, NH2 ) ,  1.85-1.3 (m, 1 H, C2 -CH), 1.90 (d, 
J = 6 Hz, 6 H, CH( CH_3 ) 2 ) ;  S p e c i f i c  r o t a t i o n :  [a ]589  = +17 *2° (£ 10.9, 
EtOH), [ L i t . 56 [ a ] 5 8 9  = +18.5° (c 7.83, EtOH)].
General Procedure fo r  the P reparatio n  o f 2 -0xa zo lid in o n es . A. 
Diethyl Carbonate Method.25 a magnet ica l ly  s t i r r e d  mixture of the i n d i ­
cated amino-alcohol (1 . 0  equiv ) ,  d ie thy l  carbonate ( 1.1 equiv) and anhy­
drous potassium carbonate (0.1 equiv) ,  in  a f l a s k  equipped fo r  d i s t i l ­
l a t i o n  through a 20-cm Vigreux column, is ,heated in  an o i l  bath ( i n te rn ­
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al react ion temperature 125-126°C) u n t i l  2.0 equiv o f  ethanol is  c o l ­
le c t e d .  The V igreux column i s  removed f o r  d i s t i l l a t i o n  o f  the  l a s t  
t r a c e s  o f  e th a n o l .  The r e a c t i o n  m ix tu re  i s  a l l o w e d  t o  cool to  room 
temperature, the product d isso lved  in  dichioromethane or d ie thy l  ether ,  
and the  s o l u t i o n  f i l t e r e d  th rough  a pad o f  c e l i t e .  The f i l t r a t e  i s  
concentrated j_n vacuo and the residue p u r i f ie d  by d i s t i l l a t i o n  or re ­
c r y s t a l l i z a t i o n  to  a f fo rd  the ind icated 2 -oxazol id inones.
B. Diphenyl Carbonate M ethod.26 A mechanical l y  s t i r r e d  mixture of 
the ind icated amino-al cohol (1 . 0  equiv) ,  diphenyl carbonate (1.1 equiv),  
and anhydrous potassium carbonate  (1.1 e q u iv )  i s  heated at 110°C ( i n ­
te rna l  react ion temperature) f o r  a 4-6 h period. The re s u l ta n t  mixture 
is al lowed to  cool to  < 60°C. Excess diphenyl carbonate i s  hydrolyzed 
by add i t ion  o f  methanol (4-6 mL/mmol o f  i n i t i a l  diphenyl carbonate) and 
heating the mixture a t r e f l u x  f o r  0.5 h. S u f f i c ie n t  water (4-6 mL/mmol 
o f  potassium carbonate) i s  added to  d isso lve  the potassium carbonate and 
methanol is  removed j_n vacuo. The product and phenol are extracted in to  
dichioromethane ( 3 x 1  mL/mmol of expected 2-oxazol id inone). The com­
bined e x t r a c t s  are washed w i th  2 M aqueous sodium h yd rox id e  ( 3 x 1  
mL/mmol o f i n i t i a l  diphenyl carbonate, to  remove the phenol),  1 M aque­
ous hydroch lor ic  acid (1 x 0.5 mL/mmol o f i n i t i a l  am ino-a lcoho l), b r ine ,  
d r ied  over anhydrous magnesium s u l f a te ,  and concentrated j_n vacuo. The 
re s id u e  i s  p u r i f i e d  by r e c r y s t a l l i z a t i o n  to  a f f o r d  the  i n d i c a te d  2 - 
oxazol idinone.
C. Phosgene M e th o d .2 ?  To a m e c h a n ic a l l y  s t i r r e d ,  coo led  (0°C) 
s o lu t io n  of the ind icated amino-al cohol ( 1 . 0  e q u iv )  and t r i  e th y l  ami ne 
(2 .2  equiv) in  toluene ( 1 - 2  mL/mmol o f amino-a lcohol) i s  added a toluene 
s o lu t io n  o f phosgene (1.0 equiv) dropwise. The th ic k  white mixture is
s t i r r e d  a t 0°C f o r  1 h. The m ix tu re  i s  f i l t e r e d  and th e  p r e c i p i t a t e  
washed with  warm ethyl  acetate (3x). The combined f i l t r a t e  and washings 
are concentrated in  vacuo and the residue p u r i f ie d  by r e c r y s t a l l i z a t i o n  
to  a f fo rd  the indicated 2 -oxazol idinone.
(+ )-4-M ethyl-2-oxazo l id inone [ (± ) -A l an ino l 2 -0xazo l id ino ne, (5 , 
Table  2, Entry A )]. D ie th y l Carbonate Method. A magnetical  l y  s t i r r e d  
m ix tu re  o f  4.85 g (64.6 mmol) o f  (± ) -a l  a n in o l  , 9.0 mL (8 . 8  g, 74 mmol ) 
o f  d i e t h y l  ca rbona te ,  and 0.2 g (0.14 mmol) o f  anhydrous potassium 
carbonate was heated at 125-126°C ( in te rn a l  reac t ion  temperature) u n t i l
7.5 g (5.9 g, 130 mmol) of ethanol d i s t i l l e d  (ca. 4 h). I s o la t i o n  ac­
cording to  the general d ie th y l  carbonate c y c l i z a t i o n  procedure gave
3.5 g (54% mass balance) o f  a pale y e l lo w  l i q u id .  D i s t i l l a t i o n  (Kugel- 
rohr ,  100 C, 12 mm) afforded 3.0 g (46%) o f  (± ) -a lan ino l  2-oxazol i d i  none 
5 as a mobile c o lo r le s s  l i q u i d :  IR (neat) 3600-3100, Z980, 1745, 1410, 
1245, 1030 c n r 1; ! H NMR (CDC1 3/90 MHz) £  6 . 8  <br s, 1H, N-H), 4.6-4.3 
(m, 1H, C4 -H),  4 .2 -3 . 8  (m, 2H, C5 -H2 ), 1.33 (d, J = 6 Hz, 3H, C4 -CH3 ); 
GC (30 m DB-5, 100 C, 94 cm/sec, t r  = 2.45 min) ;  TLC ( e th y l  a c e ta te ,  Rf 
= 0.45).
(4R ,5S )-4-M ethyl -5-phenyl-2-oxazol idinone [(4R,5S)-Norephedrine 2- 
O xazo lid inone, (6 , T ab le  2 , Entry B )]. D ie th y l Carbonate Method. A
m a g n e t i c a l l y  s t i r r e d  m ix tu re  o f  35.2 g (0.233 mol) o f  ( lS ,2 R ) -n o r -  
ephed r ine ,  30 mL (30.3 g, 0.256 mol) o f  d i e t h y l  ca rbona te ,  and 5 g o f  
anhydrous potassium carbonate was heated at 125-126°C ( in te rna l  react ion 
temperature) u n t i l  30 mL o f  ethanol d i s t i l l e d  (ca. 16 h). I s o la t i o n  ac­
cording to the general d ie thy l  carbonate c y c l i z a t i o n  procedure gave 41 g
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(99% mass balance) o f a pale y e l lo w  s o l i d .  The product was r e c r y s t a l ­
l i z e d  from t o l u e n e  t o  a f f o r d  35 g (87%) o f  6  as a w h i te  c r y s t a l l i n e  
s o l i d :  mp 121-122°C ( L i t . 57  117°C); 1R (CHC13 ) 3460, 3400-3200, 3020, 
2980, 1760, 1450, 1380, 1350, 1220, 1125, 1000, 960, 690 c m ' l ;  *H NMR 
( CDC1 3 /90 MHz) 8  7.33 (s ,  5H, a romat ic  H 's),  6 .3 -6.0 (b r  s, 1H, N-HJ, 
5.67 (d, J = 7.5 Hz, 1H, C5 -H) ,  4.17 (qn, J = 7.0 Hz, 1H, C4 -H) ,  0.80 
(d, 0 = 7.0 Hz, 3H, C4 -CH3 ) ;  13C NMR (CDC 1 3 /22-5 MHz) 8  159.9, 135.0, 
128.4, 125.9, 81.0, 52.4, 17.4; S p e c i f i c  R o ta t i o n  [ a ] 5 8 9  = +177.2°, 
t a 35 7 7  = +186.1° , [ a ] 5 4 5  = +212.0°, [ 0 1 1 4 3 5  = +368.6° , Lot 13 5 5  = +598.6° 
(c 2.21, CHC1 3 ). [ L i t . 5 7  [ a ] 5 8 9  = +158.4° (c 0.44, CHCl 3 >3 ; GC (30 m DB- 
1, 150°C, 81 cm/sec, t r  = 4 . 3 1  min) ;  TLC ( e th y l  a c e ta te ,  Rf = 0.45).
Ana l .  Calcd. f o r  C io H n N 0 2 : c > 67.78; H, 6.62; N, 7.90. Found: C, 
67.42; H, 6.19; N, 7.87.
{4R ,5S )-4-M ethyl -5-phenyl-2-oxazol idinone [(4R,5S)-Norephedrine 2- 
O xazo lid inone, (6 , Tab le  2 , Entry C )]. D iphenyl Carbonate Method. A
mechanical ly  s t i r r e d  mixture of 151 g (1.00 mol) o f (lS,2R)-norephedrine 
( [ a ] 5 gg = +33.4° ( c  7, water)  as the  hydroch l  o r i d e  sa l  t ,  A1 d r i c h  Chem­
i c a l  Co.), 236 g (1.10 mol) o f  di phenyl ca rb on a te ,  and 152 g (1.10 mol) 
o f  anhydrous potass ium carbona te ,  t r e a t e d  acco rd in g  to  th e  genera l 
diphenyl carbonate c y c l i z a t i o n  procedure to  g ive  195 g (110% mass b a l ­
ance) o f  a l i g h t - y e l l o w  so l id .  Recrystal  1 i z a t io n  from to luene (600 mL, 
3 crops) afforded 145-165 g (82-93%) of norephedrine 2-oxazol id inone 6 
as a white c r y s t a l l i n e  s o l i d ,  ide n t ica l  in  a l l  respects to  the p r e v i ­
ously prepared m a te r ia l .
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(4R,5S)-4-Methyl-5-phenyl-Z-oxazolidinone [{4R,5S)-Norephedrine 2- 
Oxazolidinone, (6, Table 2, Entry D)]. Phosgene Method. A mechanical ly  
s t i r r e d  s o lu t io n  of 82.0 g (0.542 mol) o f ( lS,2R)-norephedrine and 110 g 
(1.08 mol) of t r i e t h y l  amine in  400 mL of toluene was treated w ith  282 mL 
(1.92 M in  t o l u e n e ,  0.542 mol)  o f  phosgene acco rd ing  t o  th e  genera l 
phosgene c y c l i z a t i o n  procedure to  give 99.4 g (103% mass balance) of a 
pale y e l lo w  so l id .  R e c r y s ta l l i z a t io n  from ch lo ro fo rm /d ie thy l  ether 6 - 
a f f o r d e d  84.9 g ( 8 8 %) o f  (4R,5S)-norephedr ine  2 -o x a z o l id in o n e  6  as a 
white c r y s t a l l i n e  s o l i d ,  i d e n t ic a l  in  a l l  respects to  the p rev ious ly  
prepared ma te r ia l .
(± )-c is -4 -M e th y l -5 -pheny l -2 -o xazo l id inone [(±)-N orephedrine  2 - 
Oxazolidinone, (6 , Table 2, Entry E)]. Phosgene Method. A magnet ica l ly  
s t i r r e d  s o l u t i o n  o f  1.51 g (10.0 mmol) o f  (± ) -n o rephed r ine  and 2.80 mL 
(2.03 g, 20.1 mmol) o f  t r i  e t h y l  ami ne in  20 mL o f  t o lu e n e  was t r e a te d  
w i t h  8.3 mL (1.2 M in  t o l u e n e ,  10.0 mmol) o f  phosgene acco rd ing  t o  the 
general phosgene c y c l i z a t i o n  procedure to  g ive 1.89 g (99% mass balance) 
o f  a y e l l o w  s o l i d .  P u r i f i c a t i o n  by f l a s h  chromatography (3 x 30 cm 
co lumn,  d i e t h y l  e th e r )  a f f o r d e d  1.39 g (73%) o f  (± ) -n o rephed r ine  2- 
oxazol idinone 6 , as a whi te c r y s t a l l i n e  s o l i d :  mp 136°C, [ L i t ^ 5 .  mp 142- 
144°C] ;  IR (CHC1 3 ) 3460, 3030, 1765, 1230, 1210 cm"1; *H NMR (CDC13/90 
MHz) S 7.30 (s ,  5H, a ro m a t ic  H's),  5.67 (d, J = 7.8 Hz, 1H, C^-H), 4.17 
(qn, J = 6 . 8  Hz, 1H, C4 -H ) ,  0.82 (d, J = 6 . 8  Hz, 3H, 6 4 - 0113) ;  GO (30 m 
DB-5, 150°C, 94 cm/sec, t r  = 5 , 8 6  min) ;  TLC ( e th y l  a c e ta te ,  Rf = 0.45).
Ana l,  ca lc d .  f o r  Cx0H11 ^02 : C, 67.78; H, 6.62. Found: C, 67.64; H,
6. 40.
- 7 8 -
(4S,5S)-4-Methyl-5-phenyl-2-oxazol idinone [(4S,5S)-Norpseudoephed- 
rine  2-0xazolidinone, (7 , Table 2, Entry F )]. Diethyl Carbonate Method.
A magnet ica l  l y  s t i r r e d  m ix tu re  o f  6.92 g (45.8 mmol) o f  ( lR ,2 R ) -n o r -  
pseudoephedrine ([alggg = -41.7° (£ 7 , water) as the hydroch lor ide s a l t ,  
A ld r i c h  Chemical Co.), 6.2 mL (6.1 g, 51 mmol) of d ie th y l  carbonate, and 
0.70 g (5.1 mmol) o f  anhydrous potass ium carbonate  was heated a t  125- 
126°C ( i n t e r n a l  r e a c t i o n  tem pera tu re )  u n t i l  5.4 mL (4.2 g, 91 mmol ) o f  
ethanol d i s t i l l e d  (ca. 8 h). I s o la t i o n  according to  the general d ie thy l  
carbonate c y c l i z a t i o n  procedure gave 8.5 g (105% mass balance) o f a pale 
y e l l o w  s o l id .  Recrystal  1 iza t ion  from to luene (two crops) afforded 7.2 g 
(90% y ie l d )  o f  (4S,5S)-norpseudoephedrine 2-oxazol idinone 7 as a white 
c r y s t a l l i n e  s o l i d :  mp 119-120°C; IR (CH2 c i 2 ) 3460, 3320-3200, 3060, 
2990, 1770, 1450, 1420, 1400, 1320 c n r * ;  *H NMR (CDC1 3 / 8 O MHz) S 7.35 
(s ,  5H, a romat ic  H 's),  6.45-6.2 (b r  s ,  1H, NH), 5.02 (d, J = 7.8 Hz, 1H, 
C5 -H),  3.82 (qn, J = 7.2 Hz, 1H, C4 -H),  1.40 (d, J = 7.0 Hz, 3H, C4- 
CH3 ); Specif ic  ro ta t io n  [a]589 = +15.7°, [ a ] 5 7 7  = +17.1°, [ 0O5 4 6
= +19.0°, [ a ] 4 3 5  = +32.4°, [ o ] 3 6 5 = +50.9° (c 1.83, EtOH); GC (30 m DB- 
5, 175°C, 8 6  cm/sec, t r  = 2.71 m in) ;  TLC ( e th y l  a c e ta te ,  Rf = 0.52).
Ana l.  Calcd. f o r  C1 qh1 1 N0 2 : C, 67.78; H, 6.26. Found: C, 67.86; H,
6.35.
(4S)_4_(l_M ethyl ethyl )-2-oxazol idinone [(S )-V al inol 2-Oxazol id in ­
one, (8, Table 2, Entry G)]. D iethyl Carbonate Method. A m agne t ica l ly  
s t i r r e d  m ix tu re  o f  103 g ( 1 . 0 0  mol) o f  ( S ) -va l  i n o l , 133 mL (130 g, 1.10 
mol)  o f  d i e t h y l  ca rbona te ,  and 14 g (0.10 mol) o f  anhydrous potass ium 
carbonate was heated at 125-126°C ( in te rn a l  react ion temperature) u n t i l  
117 mL (92 g, 2.0 mol)  o f  e thano l  d i s t i l  l e d  (ca. 4-6 h). The r e s u l t a n t
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mix ture was cooled to  room temperature, d isso lved  in  d ie thy l  ether (3 
L), and the s o lu t io n  f i l t e r e d  through a 2 cm pad o f c e l i t e  to  remove the 
potassium carbonate. The etheral  s o lu t io n  was concentrated to  a volume 
o f  ca. 1 L, s l o w l y  co o le d  t o  0°C, and th e  p roduc t  a l  1 owed t o  c r y s t a l  - 
l i z e .  Concentration o f  the mother l iq u o rs  provided two add i t iona l  crops 
of c r y s ta ls .  The t o t a l  y i e l d  o f (S ) -v a l in o l  2-oxazol idinone 8 , was 110- 
123 g (85-95%), as a w h i te  need les :  mp 69-70°C, [ L i t . 58 mp 71.5°C] ;  IR 
(CH2 C1 2) 3480, 3340-3240, 3060, 2980, 1760, 1400, 1240 cm"1; NMR 
(CDC 1 3 / 9 0  MHz) S 6.7 (b r  s, 1H, N-H), 4.42 ( t ,  0 = 8 . 6  Hz, 1H, C5 -H),  
4.07 (d o f  d, J = 8.5, 6.5 Hz, 1H, C5 -H) ,  3.58 (d o f  t ,  J = 8 .6 , 6.5 Hz, 
1H, t 1 .9 -1 . 6  (m, 1H, C4 -CH), 0.95 ( o v e r l a p p in g  d 's ,  J = 6.0 Hz,
6 H, CH( Ch[3 ) 2 ) i S p e c i f i c  r o t a t i o n  [ 0O 5 8 9  = -1 6 .6 ° ,  [ a ] 5 7 7  = -17 .3° ,
^ “ ^546 = -2 0 .2 ° ,  [ 0O 4 3 5  = -37 .3° ,  [ a ]3 6 5  = -63.7° (^  5.81, EtOH); GC
(30 m DB-5, 100°C, 94 cm/sec, t r  = 5.55 min) ;  TLC (6:4 hexanes/e thy 1 
a c e ta te ,  Rf  = 0 .19).
Anal.  Calcd. f o r  C6 Hn N0 2 : C, 55.80; H, 8.58. Found: C, 55.63; H,
8.53.
(± )-4 -(l-M ethy le thy l)-2 -oxazo lid ino ne [(± )-V a lin o l 2-0xazolidinone, 
( 8 , Table 2 , Entry H )]. Phosgene Method. A magnetical l y  s t i r r e d  so lu ­
t i o n  o f  1.03 g (10.0 mmol) o f  ( ± ) - v a l i n o l  and 2.80 mL (2.03 g, 20.1 
mmol) o f  t r i e t h y l  amine in  20 mL o f  to luene was trea ted  with  8.3 mL (1.2 
M in  to luene ,  10.0 mmol) of phosgene according to  the general phosgene 
c y c l i z a t i o n  procedure  t o  g iv e  1.0 g (77% mass ba lance )  o f  a y e l l o w  
s o l i d .  P u r i f i c a t io n  by f l a s h  chromatography (2 x 20 cm column, d ie thy l  
ether)  afforded 0.75* g (58 %) o f  ( ± ) - v a l in o l  oxazol idinone 8 , as a white
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c rys ta l  l i n e  s o l i d :  mp 64-65 C; IR (CHC1 3 ) 3480, 3400-3200, 3020, 2970, 
1755, 1405, 1230 c u r l ;  lH NMR (CDCI3 / 9 0  MHz) 8  6.7 (b r  s, 1H, N-H), 4.42 
( t ,  J = 8 . 6  Hz, 1H, C5 -H),  4.07 (d o f  d, J = 8.5, 6.5 Hz, 1H, C5 -H),  
3.58 (d o f  t ,  J = 8 . 6 , 6.5 Hz, 1H, C4 -H),  1 .9 -1 . 6  (m, 1H, C4 -CH), 0.95 
( o v e r l a p p in g  d 's ,  J = 6.0 Hz, 6 H, CH( C_H3 ) 2^ ^  (^0 m OB-5, 100°C, 94 
cm/sec, t r = 5.52  min) ;  TLC ( e th y l  a ce ta te ,  Rf = 0.49).
Ana l .  Ca lcd .  f o r  C6HnN02: c » 55.80; H, 8.58. Found: C, 55.61; H,
8.46.
(4R)-4-Phenyl-2-oxazol idinone [(4R)-Phenyl g lycinol 2-0xazol idinone, 
(9 , Table 2,  Entry I ) ] .  D ie th y l Carbonate Method. A m a g n e t i c a l l y  
s t i r r e d  mixture o f  20.0 g (0.143 mol) of (R)-phenyl g ly c in o l  (W g g g  = 
-31.7°  (£ 0.76, 1 aqueous HC1), A l d r i c h  Chemical Co.), 17.4 ml (17.0 
g, 0.144 mol) o f  d i e t h y l  ca rbona te ,  and 2.1 g (15 mmol) o f  anhydrous 
potassium carbonate was heated at 125-126°C ( in te rna l  react ion tempera­
tu r e )  u n t i l  16 mL (13 g, 0.27 mol) o f  e thano l  d i s t i l l e d  (ca. 4h). 
I s o la t i o n  according to  the general d ie thy l  carbonate c y c l i z a t i o n  pro­
cedure gave 19.8 g (85% mass balance) o f a pink s o l id .  R e c ry s ta l l i z a ­
t i o n  from hexanes/chloroform afforded 18.5 g (79%) o f  (R)-phenylg lyc ino l 
oxazo1 id in o ne  9 as a w h i te  c r y s t a l l i n e  s o l i d :  mp 123.5-124.5°C; IR 
(CHC13 ) 3440, 3300-3180, 2990, 1750, 1390, 1210, 1135 cm" l ;  *H NMR 
(CDC 1 3 / 9 0  MHz) S 7 . 3 3  (s ,  5H, a romat ic  H's), 6.3 (b r  s, 1H, N-H), 4.92 
(d o f  d, J = 6.9, 8.9 Hz, 1H, C4 -H),  4.68 ( t ,  J = 8.7 Hz, 1H, C5 -±L)*
4.12 (d o f  d, J = 6.9, 8.3 Hz, 1H, C5 _h) ; 13C NMR (CDC 1 3 /-22.5 MHz) 8  
160.1, 139.8, 129.1, 128.6, 126.0, 72.5, 56.3; S p e c i f i c  r o t a t i o n  [a ]589  
.= -5 8 .6 ° ,  [ a ] 5 7 7  = -62 .0° ,  [ 0O 5 4 6  = -70 .7° ,  [ a ] 4 35  = -121.6° ,  [ a ] 3 g5 = 
-196.4° (£ 1.06, CH2 C12); GC (30 m DB-5, 150°C, 94 cm/sec, t r  = 5.05
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m in) ;  TLC (e th y l  a c e ta te ,  Rf = 0.46).
Ana l .  Calcd. f o r  CgHgNO?: C, 66.25; H, 5.56; N, 8.58. Found: C, 
66.20; H, 5.55; N, 8.56.
(4S)-4-Phenylmethyl-2-oxazolidinone [(S)-Phenylalaninol 2-O xazoli- 
dinone, (10 , Table 2 , Entry J ) ] .  D ie th y l Carbonate Method. A magnet­
i c a l l y  s t i r r e d  mixture o f 2.05 g (13.6 mmol) o f (S)-phenyl al ani n o l , 1.80 
mL (1.76 g, 14.9 mmol) o f  d i e t h y l  carbonate  and 0.2 g (0.14 mmol) o f  
anhydrous potassium carbona te  was heated in  an o i l  bath a t 120-125°C 
u n t i 1 no amino a l  cohol remained as de tec ted  by TLC (e th y l  a c e ta te ,  Rf 
phenyl al  aninol = 0.01, Rf 10 = 0.43). I s o la t i o n  according to  the general 
d ie th y l  carbonate c y c l i z a t i o n  procedure gave 2.3 g o f  a cloudy l i q u id .  
P u r i f i c a t io n  by f la s h  chromatography (3 x 30 cm column, d ie th y l  ether) 
a f f o r d e d  1.86 g (77 %)  o f  (S ) -pheny la  1a n in o l  2 -o x a z o l id in o n e  10, as a 
whi te c r y s t a l l i n e  s o l i d :  mp 82-83°C; IR (CHCl3 ) 3460, 3020, 1760, 1400, 
1220 cin~l; NMR (CDCI3 / 9 0  MHz) 3 7.4-7.1 (m, 5H, a romat ic  H's),  5.52 
(b r  s, 1H, N-H), 4.6-4.3 (m, 1 H, C5 -H),  4.2-3.9 (m, 2 H, C/j-H, C5 -H) .  
2.88 (d, J = 6 Hz, 2H, C4 -CH^>); S p e c i f i c  r o t a t i o n  [ a ] 5 3 g = +5.1°, [ < * 1 5 7 7  
= +5.5° , [ a ] 5 4 6  = +6.1°, [ a] 435 = +8-0°, [ a ] 365 = + 9 ’ 10  tc 0.76, EtOH); 
GC (30 m DB-1, 175°C, 100 cm/sec, 2.13 min).
Ana l .  Calcd. f o r  C i 0 ^ 1 1  NO2 : c > 67.78; H, 6.62. Found: C, 67.83; H,
6.55.
General Procedure to  Determine the Enantiomeric Purity of 4-Substi- 
tu te d -2 -0 x a zo l id inones. The ind icated 2-oxazol idinone is  acy la ted with  
(R )- ( - ) -2 -methoxy-2 -pheny l -3 ,3 ,3 - t r i f luoropropanoy l  c h lo r i d e  1 1 ^ 2  ac­
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cording to  the general acy la t ion  procedure ( vide i n f r a ) . The r a t i o  of 
imide diastereomers (12:13), which corresponds t o  the enantiomeric pur­
i t y  o f  the 2-oxazol id inone, is  determined by GC and HPLC ana lys is  o f  the 
unfract ionated product. An authent ic mixture o f diastereomers i s  pre­
pared from the ind icated racemic 2-oxazol id inone and (R)-acid ch lo r id e
11 or from the ind icated oxazol idinone and racemic acid ch lo r id e  11.
Enantiomeric Purity of (4R,5S)-4-Methy 1 -5 -phenyl -2 -o x azo l id i  none 
[(4R,5S)-Norephedrine 2-Oxazol idinone, (6, Table 3, Entry A)]. A so lu ­
t i o n  o f  44.6 mg (0.252 mmol) o f  (4R,5S)-norephedr i  ne 2 -o x a z o l id in o n e  6 
( [ a ] 58g = +172.2° (£ 2.21, CHC1 3 ) ) ,  (0.1 M in  THF) was m e ta la ted  w i th  
0.16 mL (1.55 M in  hexane, 0.248 mmol) o f  j i - b u t y l  1 i th iu rn  and acy l  ated 
w i t h  0.053 mL (70 mg, 0.28 mmol) o f  (R ) -ac id  c h l o r i d e  11 accord ing  to  
th e  genera l  acy l  a t  ion procedure t o  g i v e  105 mg (107% mass ba lance )  o f  
u n p u r i f i e d  p roduc t .  A n a ly s is  by GC (30 m Carbowax 20M, 225°C, 94 
cm/sec, t r 12 = 22.89 min) i n d ic a te d  the  presence o f  o n l y  d ia s t e r e o -  
isomer 12 (1 i m i t s  o f  d e te c t i o n  > 200:1). HPLC a n a l y s i s  ( 8  mm x 10 cm 
Radia l  Pak (10 pm s i l i c a  g e l ) ,  88:12 i s o o c t a n e / e t h y l  a c e ta te ,  2.0 
mL/min, k' 12 = 2.59) a lso  indicated the presence of on ly  one d iastereo- 
isomer. A s tandard  m ix tu re  o f  d ias te reomers  was prepared from (±)- 
norephedrine 2-oxazol idinone 6 and (R)-acid ch lo r id e  11 by the some pro­
cedure. Analys is  by GC (same condit ions as above: t r  13 = 21.97 min, t r
12 = 22.89 min). HPLC a n a l y s i s  (same c o n d i t i o n s  as above: k 1 13 = 2.32,
k ‘ 12 = 2.59, a = 1.12). TLC (8:2 hexanes /e thy l  a ce ta te  Rf 13 = 0.57, 
Rf 12 = 0.67).
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Enantlom eric P u r ity  o f (4S,5S)-4-Hethyl-5-phenyl-2-oxazol idinone 
[(4S,5S)-Norpseudoephedrine 2-Oxazolidinone, (7, Table 3, Entry B)]. A
s o l u t i o n  o f  177 mg (1.00 mmol) o f  (4S,5S)-norpseudoephedrine 2-oxazo l­
id in o n e  ( [ a ] 589 = + 15>7° (£ 1*83» EtOH)), (0.2 M in  THF) was m e ta la te d
w i t h  0.45 mL (2.23 M in  hexane, 1.00 mmol) o f  jn -b u ty l  1 i t h iu m  and acy l  -  
a ted w i t h  0.20 mL (0.27 g, 1.06 mmol) o f  (R ) -ac id  c h l o r i d e  11 acco rd ing  
to  the general a cy la t io n  procedure to  g ive 0.40 g (101% mass balance) o f
unpur i f ied  product. Analys is  by GC (30 m OB-5, 200°C, 83 cm/sec, tp 
= 8.23 min) ind icated the presence o f on ly  diastereoisomer 13 ( l i m i t s  of 
de tect ion > 200:1). HPLC ana lys is  ( 8  mm x 10 cm Radial Pak (5 pm s i l i c a  
g e l ) ,  88:12 i s o o c t a n e /e th y l  a c e ta te ,  2.0 mL/min, k 1 13 = 3.02) a l s o  
ind icated the presence o f  on ly  one diastereomer. A standard mixture o f  
di  astereomers was prepared from (4S,5S)-norpseudoephedri ne 2 -o x a z o l i ­
dinone 7 and (±)-acid ch lo r id e  11 by the same procedure. Analysis by GC 
(same c o n d i t i o n s  as above: t r  \ 2  = 7.59 min, t r  13 = 8.23 min). HPLC 
a n a l y s i s  (same c o n d i t i o n s  as above: k 1 13 = 3.02, k ‘ 12 = 3.95, a  = 
1.38). TLC (8:2 h e xan e s /e th y l  a c e ta te ,  Rf 13  = 0.29, Rf 12 = 0.23).
Enantiom eric P u rity  o f (4 S )-4 - ( l-M e th y le th y l )-2 -o x a zo lid in o n e  
[ ( 4 S ) - V a l  in o l 2-0xazo l id ino ne, ( 8 , Tabl e 3 , Entry C )]. A s o l u t i o n  o f  
42.9 mg (0.333 mmol) o f (4S ) -va l ino l  2-oxazol id inone 8  ([a]589 “ -16.6° 
(£ 5.81, CH2 CI 2^)» (0*1 Hi ^HF) was m e ta la ted  w i th  0.24 mL (1.55 M in  
hexane, 0.37 mmol) o f n -buty l  1 i thium and acyl ated with  0.069 mL (92 mg, 
0.37 mmol) o f  (R ) -ac id  c h l o r i d e  11 accord ing  t o  the  genera l  a c y l a t i o n  
procedure t o  g iv e  120 mg (104% mass ba lance)  o f  u n p u r i f i e d  p roduc t .  
A n a ly s i s  by GC (30 m Carbowax 20M, 200°C, 96 cm/sec, t r 13 = 9.04 min) 
ind icated the presence of on ly  diastereoisomer 13 ( l i m i t s  o f  detect ion
- 8 4 -
>200:1). HPLC a n a l y s i s  ( 8  mm x 10 cm Radia l  Pak (10 ym s i l i c a  g e l ) ,  
76:24 isooctane/ethyl  acetate, 2.0 mL/min, k1 13 = 1.72) a lso  ind icated 
the presence of on ly  one diastereoisomer 13. A standard mixture o f  d ia -  
stereomers was prepared from (± ) - v a l in o l  2-oxazol id inone 8  and (R)-acid 
c h lo r id e  11 by the same procedure. Analys is  by GC (same cond i t ions  as
above: t r  13  = 9 .04 min, t r  12 = 9.53 min). HPLC a n a l y s i s  (same c o n d i ­
t i o n s  as above: k' 13 = 1.72, k 1 12 = 2.44, a = 1.42). TLC (8:2 hexanes/ 
e th y l  a c e ta te ,  Rf  13  = o.43, Rf 12 = 0.32).
Enantiomeric Purity  o f (4R)-4-Phenyl-2-Oxazolidinone [{4R)-Phenyl -  
glyc ino l 2-Oxazol idinone, (9 , Table 3, Entry D)3- A s o lu t io n  o f 163 mg
(1.00 mmol) of (4R)-pheny lg lyc ino l  2-oxazol id inone 9 ([a]589 = “ 58.6° (£
1.06, C H g C ^) ) ,  (0.2 M i n  THF) was m e ta la te d  w i t h  0.45 mL (2.23 M in
hexane, 1.00 mmol) o f  n -buty l  1 i th ium and acyla ted with  0.20 mL (0.27 g,
1.06 mmol) o f  (R ) -ac id  c h l o r i d e  11 a cco rd in g  t o  the  genera l  a c y l a t i o n  
procedure to  g ive 0.40 (105% mass balance) o f unpur i f ied  product. Anal­
y s i s  by GC (30 m Carbowax 20M, 225°C, 93 cm/sec, t r  1 2  = 20.12 min; 30 m 
DB-5, 200°C, 83 cm/sec, t r  12 = 7.03 min) ind icated the presence o f  on ly  
one diastereoisomer 12 ( l i m i t s  of de tect ion > 200:1). HPLC ana lys is  ( 8  
mm x 10 cm Radial Pak (10 ym s i l i c a  g e l ) ,  76:24 isooctane/e thyl  acetate, 
2.0 mL/min, k 1 12 = 3.00) a l s o  i n d i c a te d  the  presence o f  o n l y  d i a ­
stereoisomer 12. A standard mixture o f  diastereomers was prepared from 
(4R)-phenylg lycinol 2-oxazol id inone 9 and racemic acid c h lo r id e  11 by 
the same procedure. GC (same cond i t ions as above: Carbowax 20M, t r  12 =
20.12 min, t r  13  = 21.18 min; DB-5, t r  12 = 7.03 min, t r  13 = 7.42 min). 
HPLC (same c o n d i t i o n s  as above: k 1 13 = 2.14, k' 12 = 3.00, a = 1.40). 
TLC (8:2 hexanes /e thy l  a c e ta te  Rf  13  = 0.32, Rf 12 = 0.25).
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Enantiomeric Purity  of (4S)-4-Phenylm ethyl-2-oxazol id inone t(4 S )-  
Phenylal aninol 2-0xazol idinone, (10, Table 3, Entry E)]. A s o lu t io n  of 
177 mg (1.00 mmol) o f (4S)-phenyl a lan ino l  2-oxazol id inone 10 (ta]589 = 
+ 5.1° (£ 0.76, e t h a n o l ) ) ,  (0.2 M in  THF) was m e ta la ted  w i th  0.45 mL 
(2.23 M in  hexane, 1.00 mmol) o f  j i - b u t y l  1 i t h iu m  and acy l  a ted w i t h  0.20 
mL (0.27 g, 1.06 mmol) o f  (R ) -a c id  c h l o r i d e  11 acco rd ing  t o  th e  general 
a c y l a t i o n  procedure t o  g i v e  0.40 g (101% mass ba lance )  o f  u n p u r i f i e d  
p ro du c t .  A n a ly s i s  by GC (30 m DB-5, 200°C, 83 cm/sec, t r  1 3  = 1 0 . 7 8  
min) ind ica ted  the presence o f on ly  one diastereoisomer 13. HPLC ana l­
y s is  ( 8  mm x 10 cm Radial Pak (10 pm s i l i c a  ge l ) ,  76:24 isooctane/ethy l  
a c e ta te ,  2.0 mL/min, k' 13 = 1.31) a ls o  i n d i c a te d  th e  presence o f  o n ly  
one diastereoisomer. A standard mixture o f  diastereomers was prepared 
from (4S)-phenyl al aninol 2-oxazol id inone 10 and racemic acid ch lo r id e  11 
by the same procedure. GC (same condit ions as above: t r  1 2  = 10.52 min, 
t r  13 = 10.78 min). HPLC (same c o n d i t i o n s  as above: k' 13 = 1.31, k 1 12 
= 1.78, a = 1.36). TLC (8:2 hexanes /e thy l  a c e ta te ,  Rf  13  = 0.39, Rf 12 
= 0.32).
General Procedure fo r  the N -A cy la tio n  of 2-0xazol id i nones. To a
m agne t ica l ly  or mechanica l ly  s t i r r e d ,  coo led  (-78°C) s o l u t i o n  o f  the 
ind ica ted  2-oxazol id inone, 0.1-1.0 M in  THF, i s  added a hexane so lu t ion  
o f  _n-butyl 1 i th ium (1.0-1.2 equiv) over a 10-20 min period. A f te r  s t i r ­
r ing  f o r  0 - 2 0  min, the ind icated acy la t ing  agent (acid c h lo r id e ,  anhy­
d r i d e  o r  mixed a n hyd r ide ;  1 . 0 - 1 . 2  e q u iv )  i s  added e i t h e r  neat o r  as a 
THF so lu t io n .  The react ion mixture is  al lowed to warm to  room tempera­
tu re  and s t i r r e d  fo r  0.5-1.0 h. Excess a cy la t in g  agent is  quenched by 
*
add i t ion  o f  1 M aqueous potassium bicarbonate and s t i r r i n g  the two-phase
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m ix tu re  f o r  0 .5-1.0 h. The THF is  removed j_n vacuo and the  p roduc t  
ex t rac ted  in to  d ich i  oromethane (3x). The combined organic ex t rac ts  are 
washed w i t h  b r i n e ,  d r ie d  o ve r  anhydrous magnesium s u l f a t e  o r  sodium 
s u l f a t e ,  and concentrated HI vacuo. The N-acyl 2-oxazol idinone imides 
are p u r i f i e d  by chromatography, molecu lar  d i s t i l l a t i o n  or r e c r y s t a l l i ­
za t ion.
S p e c ific  In fo rm atio n  fo r  the Acylation of (4R,5S)-Norephedrine 2- 
Oxazol idinone (6 ), (4S)-Phenyl a l aninol 2-0xazo l id i none (1 0 ), or (4R)- 
Phenyl g ly c in o l 2 -0xazo l id inone (9).  r i -Buty 1 1 i th iu m  i s  added t o  the  
2 -oxazol id inone s o lu t io n  u n t i l  the orange-red c o lo r  o f the dianion j u s t  
pe rs is ts .  The a c y la t in g  agent is added immediately t o  prevent epimer- 
i z a t i o n  a t  th e  benzyl  i c  carbon o f  norephedr ine and phenyl g l y c i n o l  2 - 
oxazol idinones.
(+ )-3 -(l-O x o b u ty l)-4 -m e th y l-2 -o x a z o lid in o n e  (14c, Table 4, Entry
A). A s o lu t io n  o f 0.841 g (8.32 mmol) o f (±)-a lan inol 2-oxazol idinone 5 
(0.42 M in  THF) was metal  ated w i t h  5.8 mL (1.57 M in  hexane, 9.11 mmol) 
o f  £ - b u t y l  1 i t h iu m  and a c y la te d  w i t h  1.50 mL (1.47 g, 9.17 mmol) o f  
butanoic anhydride according to  the general acy la t ion  procedure to  give 
1.4 g (99% mass balance) o f unpur i f ied  product. The t i t l e  compound was 
i s o l a t e d  by f l a s h  chromatography (3 x 30 cm column, 7:3 hexanes /e thy l  
acetate) fo l low ed  by molecu lar  d i s t i l l a t i o n  (Kugelrohr,  75°C, 0.005 mm) 
t o  a f f o r d  0.937 g ( 6 6 %) o f  14c as a c o l o r l e s s  l i q u i d :  IR (CCl^) 2980, 
2940, 2880, 1795, 1710, 1390, 1340, 1210, 1135 cm"1 ; *H NMR (CDC13 / ^ 0  
MHz) 8  4.7-4.3 (m, 2H, C5 - h 2) ,  4.1-3.9 (m, 1H, C4 -H),  2.87 ( t ,  J = 7.5 
Hz, 2H, C2'-H2)» 1.9-1.5 (m, 2H, C3 ' -H 2),  1.40 (d, J = 6.3 Hz, 3H, C4 -
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CH3 ) ,  1.00 ( t ,  J = 7.0 Hz, 3H, C4 *- ^ 3 ) ;  GC (30 m SE-54, 100°C, 54 
cm/sec, t r  = 8.97 m in) ;  TLC (7:3 hexanes /e thy l  a c e ta te ,  R f  = 0.29).
Ana l .  Ca lcd .  f o r  CQH1 3 NO3 : C, 55.13; H, 7.65. Found: C, 56.18; H,
7.68.
(4R,5S)-3-(l-0xoethyl)-4-m ethyl-5-phenyl-2-oxazol idinone (16a, Table 
4 , E ntry  B). A s o l u t i o n  o f  4.12 g (23.3 mmol) o f  (4R,5S)-norephedr ine 
2 -oxazo l  i d in o n e  6 (0.23 M in  THF) was m e ta la te d  w i t h  14.0 mL (1.57 M in  
hexane, 22.0 mmol) o f  j i - b u t y l  l i t h i u m  and a c y la te d  w i t h  1.88 g (23.9 
mmol) of acetyl  ch lo r id e  according to  the general a cy la t io n  procedure to 
g i v e  4.92 g (96% mass ba lance )  o f  u n p u r i f i e d  p roduct .  The t i t l e  com­
pound was i so la te d  by molecu lar  d i s t i l l a t i o n  (Kugelrohr, 140°C, 0.006 
mm) to  a f fo rd  4.75 g (93%) of 16a as a white c r y s t a l l i n e  s o l i d :  mp 65.5- 
66.0°C; IR (CC14 ) 2095, 1800, 1715, 1380, 1370, 1350, 1200, 1165 cm"1; 
1 ti NMR (CDC 1 3 / 9 0  MHz) S 7.3 (s ,  5H, a romat ic  H's), 5.61 (d, J = 7.2 Hz, 
1H, C5 -H) ,  4.70 (qn, J = 6 . 8  Hz, 1H, C4 -H),  2.48 (s ,  3H, C2 ' -H 3 ) .  0 . 8 8  
(d, J = 6 . 8  Hz, 3H, C4 _CH3 ); S p e c i f i c  r o t a t i o n  [a ]5 8 9  = +47.6°, [CO5 7 7  = 
+49.9°, [ a ] 5 4 6  = +57.0°, [a ]435  = +101.3°, [ 0O3 6 5  = + 172-80 (c 2.06, 
CH2 C1 2 ) ;  00 (30 m SE-54, 175°C, 49 cm/sec, t r  = 4.40 m in) ;  HPLC ( 8  mm x 
10 cm Radi a l  Pak (5 ym si  1 ica  g e l ) ,  88:12 i so o c ta n e /e th y l  a c e ta te ,  2.0 
mL/min, k' = 5.13); TLC (8:2 hexane /e thy l  a c e ta te ,  Rf = 0.39).
Ana l .  Calcd. f o r  C1 2 H1 3 NO3 : C, 65.74; H, 5.98. Found: C, 65.80; H,
6 .20.
- 8 8 -
(4 R ,5 S )-3 -(l-0 x o p ro p y l )-4 -m ethy l -5 -phenyl -2 -oxazo l idinone (16b, 
Table 4 ,  E n t ry  C). A mechanical l y  s t i r r e d  s o l u t i o n  o f  8 8 . 6  g (0.500 
mol) o f (4R,5S)-norephedrine 2-oxazol id inone 6  (0.5 M in  THF) was meta l ­
a ted w i t h  290 mL (1.74 M in  hexane, 0.505 mol)  o f  j i - b u t y l  1 i t h iu m  and 
acyl ated with  52 mL (55 g, 0.60 mol) of propanoyl ch lo r id e  according to  
th e  genera l  a c y l a t i o n  procedure t o  g iv e  124 g (106% mass ba lance)  o f  
u npur i f ied  product. The t i t l e  compound was iso la ted  by molecu lar  d i s t i l ­
l a t i o n  (K u g e l r o h r ,  135°C, 0.008 mm) to  a f f o r d  110 g (94%) o f  16b as a 
c o lo r le s s  viscous l i q u i d :  IR (CH2c i 2) 2990, 1785, 1710, 1370, 1350,
1245, 1220, 1200, 1150, 1125 cm"! ;  *H NMR (CDC 1 3/90  MHz) B 7.33 (s,  5H, 
a rom a t ic  H 's),  5.63 (d, J = 7.2 Hz, 1H, C5 -H) .  4.73 (qn, J = 6 . 8  Hz, 1 H, 
C4 -H),  2.93 (q, J = 7.5 Hz, 2H, C2 ' -H 2 ) ,  1.17 ( t ,  J = 7.2 Hz, 3H, C3 ' -  
H3 ) ,  0.88 (d, J = 6 . 8  Hz, 3H, C4 -CH3 ) ;  13c NMR (CDC1 3 /22-5 MHz) B 173.7,
153.0, 133.5, 128.6, 125.6, 79.0, 54.7, 29.2, 14.5, 8.3; S p e c i f i c  r o t a ­
t i o n  [a lg g g  = +43.4°, [ 0G 5 7 7  = +45.1°, [ a ] 5 4 g = +51.6°, [ 0O 4 3 5  = +92.3°, 
[a ]3 6 5  = +159.8° (c 3.61, CH2 C1 2 ) i Gc ( 3 0  m SE-54, 175°C, 49 cm/sec, t r 
= 5.75 m in) ;  HPLC ( 8  mm x 10 cm Radia l  Pak (5 ym s i l i c a  g e l ) ,  88:12 
isooctane/e thy l  acetate, 2.0 mL/min, k1 = 2.62).
Ana l .  Calcd. f o r  C1 3 h1 5 N0 3 : C, 66.94; H, 6.48. Found: C, 67.17; H,
6.64.
(4R,5S)-3-(l-0xobutyl )-4-methyl -5-phenyl -2-oxazol idinone (16c, Table 
4 , E n t r y  D). A mechanical l y  s t i r r e d  s o l u t i o n  o f  20.0 g (0.113 m o l ) o f  
(4R ,5S)-norephedr ine  2 - o x a z o l id in o n e  6  (0.28 M in  THF) was m e ta la ted  
w i th  80 mL (1.55 M in hexane, 0.124 mol) o f  j i -b u ty l  1 i t h i  urn and acyl ated 
w i t h  22.0 mL (21.3 g, 0.135 mol) o f  b u tano ic  anhydr ide accord ing  to  the  
general a c y la t io n  procedure to g ive 30 g (108% mass balance) of unpuri ­
- 8 9 -
f i e d  product. The t i t l e  compound was i so la te d  by r e c r y s t a l l i z a t i o n  from 
pentane/d ie thyl  ether to  a f fo rd  24.3 g (87%) o f 16c as a whi te c r y s t a l ­
l i n e  s o l i d :  mp 55.5-56°C; IR (CH2 C I 2 ) 2970, 2940, 2880, 1785, 1705, 
1385, 1370, 1350, 1235, 1220, 1200, 1125 cm-1; *H NMR (CDC 1 3/90  MHz) 8  
6.83 (s ,  5H, a romat ic  H 's),  5.62 (d, J = 7.2 Hz, 1H, C5 -H),  4.73 (qn, J 
= 6 . 8  Hz, 1H, C4 -H),  2.93 ( t ,  J = 7.5 Hz, 1H, C2 ' -H ) ,  2.90 ( t ,  J = 6.9 
Hz, 1H, C2 ' -H ) ,  1.68 (m, 2H, 0 3 --JI2 ) , 0.98 ( t ,  J = 7.0 Hz, 3H, C4 ' -H 3 )> 
0.88 (d, J = 6 . 8  Hz, 3H, C4 -CH3 ); 13C NMR (CDC 13 /22.5 MHz) 8  172.9,
153.0, 133.5, 128.7, 125.7, 79.0, 54.7, 37.4, 17.8, 14.6, 13.6; S p e c i f i c  
r o t a t i o n  [a lg g g  = +40.4°, [CO5 7 7  = +41.6°, [ 0 ^ 5 4 5  = +47.8°, [ 0O 4 3 5  = 
+86.0°, [ a ] 3 6 5  = +149.3° (c 4.9, CH2 C12 )  ̂ GC ( 3 0  m SE-54, 200°C, 47 
cm/sec, t p = 5 .O6 m in) ;  HPLC (8 mmx 10 cm Rad ia l  Pak (5 ym s i l i c a  g e l ) ,  
88:12 isooctane/ethyl  ace ta te , 2.0 mL/min, k' = 1.93); TLC (7:3 hexanes/ 
e th y l  a c e ta te ,  Rf  = 0.36).
Ana l.  Calcd. f o r  C1 4 h1 7 N03 : C, 68.00; H, 6.93. Found: C, 68.20; H,
7.12.
(4R, 5S) - 3 - ( l -0xo -3 -m e th y lb u ty l ) -4-methyl - 5-phenyl -2 -oxazo l id i  none 
(16d, T a b le  4, E n t ry  E). A s o l u t i o n  o f  8 . 8 6  g (50.0 mmol) o f  (4R,5S)- 
norephedrine 2-oxazol id inone 6 (0.20 M in  THF) was metalated w i th  22.4 
mL (2.23 M i n hexane, 50.0 mmol) o f n-butyl  1 i th ium and acylated with  6 . 6  
g (54.7 mmol) o f  3 -m e th y lb u ta n o y l  c h l o r i d e  acco rd ing  to  the  genera l  
a c y l a t i o n  procedure t o  g i v e  13.6 g (104% mass ba lance)  o f  u n p u r i f i e d  
p roduc t .  The t i t l e  compound was p u r i f i e d  by r e c r y s t a l l i z a t i o n  from 
pentane/d ie thyl  ether to  a f fo rd  11.8 g (90%) o f  16d as a white c r y s t a l -
1 ine  so l  i d :  mp 5 2 - 5 3 ° C ;  IR (CH2 C1 2 ) 3 0 6 0 ,  2 9 7 0 ,  1 7 8 0 ,  1 7 0 0 ,  1 3 7 0 ,
- 9 0 -
1350, 1305, 1215, 1200, 1160 cm"1; *H NMR (CDC 1 3/90 MHz) g 7.4 (s ,  5H, 
a romat ic  H's),  5.70 (d, J = 7.2 Hz, 1H, C5 -H),  4.80 (qn, J = 6 . 8  Hz, 1H, 
C4 -H),  2.97 (d o f  d, J = 16.5, 7.5 Hz, 1H, C2 ' -H ) ,  2.73 (d o f  d, J =
16.5, 7.5 Hz, 1H, C2 ' -H ) ,  2.5-1.9 (m, 1H, C3 ' -H ) ,  1-02 (d, J = 7.2 Hz, 
6 H, C31- CJI3 , C4 ' -H3 ) ,  0.92 (d, J = 6 . 8  Hz, 3H, C4 -CH3 ); S p e c i f i c  r o t a ­
t i o n  [ a ] 5 8 9  = +38.5° , [ 0 3 5 7 7  = +40.9°, [a3546 = +47.0°, [ 0 3 4 3 5  = +84.0°, 
£“ ^365 = +145.1° (c 2.36, CH2 C12 ); GC (30 m DB-1, 175°C, 78 cm/sec, t r  =
4.45 min) ;  HPLC ( 8  mm x 10 cm Radia l  Pak (5 ym s i l i c a  g e l ) ,  88:12 
isooctane/ethyl  acetate, 2.0 mL/min, k1 = 1.50); TLC (8:2 hexanes/ethyl  
a c e ta te ,  Rf = 0.69).
Ana l .  Calcd. f o r  C2 5 H1 9 NO3 : C, 68.94; H, 7.33. Found: C, 69.06; H,
7.30.
(4R,5S)-3-(l-0xo-4-pentenyl)-4-m ethyi-5-phenyl-2-oxazolidinone  
(16e, Tab le  4 , Entry F). A s o l u t i o n  o f  7.21 g (40.7 mmol) o f  (4R,5S)- 
norephedrine 2-oxazol id inone 6  (0.14 M in THF) was metalated with  25.0 
mL (1.55 M in  hexane, 38.8 mmol) o f  j v b u t y l l  i t h i  urn and acyl ated with  5.4 
g (45.5 mmol) o f 4-pentenoyl ch lo r id e  according to  the general a cy la t io n  
procedure to  g ive 10.8 g (107% mass balance) o f unpur i f ied  product. The 
t i t l e  compound was i so la te d  by f l a s h  chromatography (4 x 30 cm column, 
7:3 h e x a n e s /d ie th y l  e th e r )  to  a f f o r d  9.26 g (92%) o f  16e as a w h i te  
c r y s t a l l i n e  s o l i d  : mp 59-60°C; IR (CH2 C12) 3060, 2990, 1780, 1700, 
1370, 1350, 1200 c n r 1 ; *H NMR (CDC 1 3/90 MHz) S 7.35 (s ,  5H, a rom at ic  
H 's),  6 .1-5.7 (m, 1H, C4 <-H), 5.60 (d, J = 7.2 Hz, 1H, C5 -H),  5.2-4.9 
(m, 2H, C51 - H^),  4.73 (qn, J = 6 . 8  Hz, 1H, C4 -H),  3.2-3.0 (m, 2H, C2«- 
H^), 2.6-2.3 (m, 2H, C3 --H2), 0.90 (d, J = 6 . 8  Hz, 3H, C4 -H3 ); S p e c i f i c  
r o t a t i o n  = +34.6°, [ 0 3 5 7 7  = +36.4°, [ a ] 5 4g = +41.8°, [ a ] 4 3 5  =
- 9 1 -
+74.9°,  [ a ] 365 = +129.8° (c 1.35, CH2 C12); GC {30 m DB-5, 175°C, 85 
cm/sec, t r  = 6.08 mi n ) ; HPLC ( 8  mm x 10 cm Radi a 1 Pak (5 jjm s i l i c a  g e l ) ,  
88:12 isooctane/e thy l  acetate, 2.0 mL/min, k' = 1.99); TLC {8:2 hexanes/ 
e t h y l  a c e ta te ,  Rf  = 0.53).
Ana l .  Calcd. f o r  C1 5 H1 7 N0 3 : C, 69.48; H, 6.61. Found: C, 69.54; H,
6.51.
(4R, 5S)- 3 - ( l-0 x o -3 , 3-dimethylbutyl) -4 -m ethyl-5-phenyl-2-oxazolidi­
none ( 1 6 f ,  Tab le  4 , Entry G). A s o l u t i o n  o f 8 . 8 6  g (50.0 mmol) o f  
(4R,5S)-norephedrine 2-oxazol id inone 6  (0.2 M in  THF) was metalated with
22.4 mL (2.23 M in  hexane, 50.0 mmol) o f  j i - b u t y l  1 i t h iu m  and acy l  ated 
w i th  7.4 g (55.0 mmol) o f 3,3-dimethyl butanoyl c h lo r id e  according t o  the 
general a cy la t io n  procedure to  g ive 15.2 g (110% mass balance) o f  crude 
p roduc t .  The t i t l e  compound was p u r i f i e d  by r e c r y s t a l l i z a t i o n  from 
hexanes/ethyl  acetate to  a f fo rd  12.0 g (87%) o f  16 f  as a white c r y s t a l ­
l i n e  s o l i d :  mp 79-80°C; IR (CH2 c i 2) 3060, 2970, 1785, 1700, 1370, 1350, 
1250, 1190, 1170, 1120 cra-1; *H NMR (CDC13/90  MHz) 8  7.30 (s,  5H, 
a ro m a t ic  H's),  5.60 ( d ,  J = 7.2 Hz, 1H, Cs-H), 4.77 (qn, J = 6 . 8  Hz, 1H, 
C4 -H ) ,  3.07 ( d ,  J = 15 Hz, 1 H, C2 ' -H ) ,  2.82 ( d ,  J = 15 Hz, 1 H, C2 ' -H) ,
1.1 (s ,  9H, C3 1 - ( CJH3) 3) ,  0.90 (d, J = 6 . 8  Hz, 3H, C4 -CH3 ); S p e c i f i c  
r o t a t i o n  [ a ] 5 8 9  = +36.3°, [a ]577 = +38.8°, [ a ] 5 4 6  = +44.3°, [ a ] 435 = 
+78.4°, [ a ] 3 6 5  = +133.5° (c 2.63, CH2 C l 2 ) i  GC ( 3 0  m DB_1> 175°C, 78 
cm/sec, t r  = 5.14 mi n ) ; HPLC ( 8 mmx 10 cm Rad ia l  Pak (5 pm s i l i c a  g e l ) ,  
88:12 isooctane/e thy l  acetate, 2.0 mL/min, k' = 1.13); TLC (8:2 hexanes/ 
e th y l  a ce ta te ,  Rf  = 0.63).
Ana l .  Calcd. f o r  C1 6 H2 1 N03 : C, 69.79; H, 7.69. Found: C, 69.83;
7.57.
- 9 2 -
(4R ,5S )-3-(l-0xo-2-phenylethyl) -4-methyl-5-phenyl-2-oxazolidinone  
(16g, Table 4 , Entry H). A magnetica 1 1y s t i r r e d  s o l u t i o n  o f  8 . 8 6  g 
{50.0 mmol) of (4R,5S)-norephedrine 2-oxazol id inone 6 (0,2 M in  THF) was 
m e ta la te d  w i th  22.4 mL {2.23 M in  hexane, 50.0 mmol) o f  j i - b u t y l  1 i t h i  urn 
and acy la ted with 8.5 g (55 mmol) o f  phenyl acetyl  ch lo r id e  according to  
th e  genera l a c y l a t i o n  procedure t o  g i v e  15.1 g (105% mass ba la n ce )  o f  
crude product .  The t i t l e  compound was p u r i f i e d  by r e c r y s t a l  1 i z a t i o n  
from hexanes /e thy l  a ce ta te  t o  a f f o r d  13.4 g (90%) o f  16g as a w h i te  
c r y s t a l l i n e  s o l i d :  mp 101-102°C; IR (CH2 c i 2 ) 3060, 2990, 1780, 1710, 
1355 cm"1 ; !h NMR (CDC 1 3 / 8 O MHz) 8  7.3 (m, 10H, a romat ic  H's),  5.65 (d, 
J = 8  Hz, 1H, C5 -H),  4.75 (qn, J = 7 Hz, 1H, C4 -H),  4.3 (s ,  2H, C2 1 -1±2  ̂* 
0.90 (d, J = 7 Hz, 3H, C4 -CH3 ); S p e c i f i c  r o t a t i o n  [ a ] 5 8 9  = +0.5° , [ a ] 5 7 7  
= +0.5° ,  [a ]546  = +0.5° , [ a ] 4 3 5  = +0.6° , [a ]365  = +0.8° ( ^  0.97, 
CH2 C12); GC (30 m DB-5, 200°C, 83 cm/sec, t r  = 9.35 min),  HPLC ( 8  mm x 
10 cm Radia l  Pak (5 urn s i l i c a  g e l ), 88:12 i s o o c ta n e /e th y 1 a c e ta te ,  2.0 
mL/min, k' = 3.07); TLC (8:2 h e xan e s /e th y l  a c e ta te ,  Rf = 0.47).
Ana l .  Calcd. f o r  C igH^NOs: C, 73.20; H, 5.80. Found: C, 73.01; H,
5.77.
(4R ,5S )-3-(1-Oxo-3-phenyl propyl) -4-m ethyl-5-phenyl-2-oxazoli di none 
{16h, Tab le  4 , Entry I ) .  A m e c h a n ic a l l y  s t i r r e d ,  s o l u t i o n  o f  44.3 g 
(0.250 mol) o f (4R,5S)-norephedrine 2-oxazol id inone 6 (0.5 M in THF) was 
m e ta la te d  w i th  147 mL (1.70 ^  in  hexane, 0.250 mol) o f _ n - b u t y l l i t h i u m  
and a c y la te d  w i t h  39.0 mL (44.3 g, 0.263 mol) o f  3-pheny l  propanoyl  
c h l o r i d e  accord ing  to  th e  genera l  a c y l a t i o n  procedure t o  g i v e  83.2 g 
(107% mass ba lance)  o f  u n p u r i f i e d  p roduct .  The t i t l e  compound was 
p u r i f i e d  by r e c r y s t a l l i z a t i o n  from 9:1 hexanes/ethyl  acetate (2 crops)
- 9 3 -
to  a f fo rd  68.1 g (8 8 %) o f  16h as a white c r y s t a l l i n e  s o l i d :  mp 95-96°C; 
IR (CH2 C12) 3060, 3000, 1785, 1700, 1370, 1350, 1250 cm- 1 ; NMR 
( CDC 1 3 /500 MHz) 8  7.44-7.19 (m, 10H, a romat ic  H's), 5.63 (d, J = 7.5 Hz, 
1H, C5 -H) ,  4.75 (qn, J = 6.9 Hz, 1H, C4 -H) ,  3.34 (m, 2H, C g ' - j ^ ) .  3-06-
3.00 (m, 2H, C3 ._H2 ) ,  0.89 (d ,  J = 6 . 8 Hz, 3H, C4 -H 3 ) ;  13C NMR 
(CDC 13 / 2 2 - 5  MHz) 8  172.1, 152.9, 140.4, 133.4, 128.7, 126.2, 125.6,
79.0, 54.7, 37.2, 30.3, 14.5; S p e c i f i c  r o t a t i o n  [a3s89 = +28.7°, [ < * 1 5 7 7  
= +28.9°, [ a ] 5 4 5  = +32.9°, [ < * 3 4 3 5  = +60.1°, [ 0 3 3 5 5  = +106.7° (£ 0.45, 
CH2 C12); gc (30 m DB-1, 200°C, 86  cm/sec, t r  -  9.06 min) ;  HPLC ( 8  mm x 
10 cm Radia l  Pak (5 um s i l i c a  g e l ) ,  88:12 i s o o c t a n e /e th y l  a c e ta te ,  2.0 
mL/min, k ‘ = 2.76);  TLC (7:3 hexanes /e thy l  a c e ta te ,  Rf = 0.42).
Ana l .  Calcd. f o r  Cl g H1 9 N0 3 : C, 73.77,; H, 6.19. Found: C, 73.85; H,
6.28.
(4R,5S)-3-(l-0xodecyl )-4-methyl -5-phenyl -2-oxazol id i none (1 6 i, Tabl e 
4, Entry J ). A so l  u t i  on o f  8 . 8 6  g (50.0 mmol) o f  (4R,5S)-norephedr i  ne 
2 -o x a z o l id i n o n e  6 (0.2 M in  THF) was m e ta la te d  w i t h  32.3 mL (1.55 M in  
hexane, 50.1 mmol) of _n-butyl 1 i thiurn and acylated with  9.80 mL (9.54 g,
50.0 mmol) o f  decanoyl c h l o r i d e  a cco rd ing  t o  th e  genera l a c y l a t i o n  
procedure to  g ive  16.8 g (101% mass balance) o f  unpur i f ied  product. The 
t i t l e  compound was i so la te d  by molecu lar  d i s t i l l a t i o n  (Kugelrohr, 150°C, 
0.006 mm) t o  a f f o r d  14.8 g (89%) o f  1 6 i as a c o l o r l e s s  l i q u i d  which 
s o l i d i f i e d  on s ta n d in g :  mp 41-42°C; IR (CC14 ) 2940, 2870, 1790, 1705, 
1380, 1370, 1345, 1220, 1200 c i r r * ;  ^H NMR (CDCI3 / 9 0  MHz) 8  7.3 (s,  5H, 
a romat ic  H's), 5.62 (d, J = 7.2 Hz, 1H, C5 -H) ,  4.73 (qn, J = 6 . 8  Hz, 1H, 
C4 -HJ, 2.95 (m, 2H, C2 ' -H 2 ), 1-65 (m, 2H, C3 ' -H 2 ) ,  1.3 (br  s, 12H,
- 9 4 -
al  i p h a t i c  H's), 0.90 (m, 6 H, C4 -H3 , C io ' -H 3 ) i  13c NMR (CCl4 /22.5 MHz) 8
171.8, 151.9, 133.9, 128.3, 125.6, 78.2, 54.1 , 35.2, 31.7, 29.3, 29.1 ,
24.1, 22.5, 14.4, 14.0; S p e c i f i c  r o t a t i o n  CaJsgg = +27.4°, [ 0 3 5 7 7  = 
+28.9° , [a ]5 4 6  = +33.0° , [ a ] 4 3 5  = +59.5°, [a ]3 6 5  = +103.4° (£ 3.03, 
CH2 C1 2 ); GC (30 m DB-1, 200°C, 83 cm/sec, t r  = 10.38 min);  HPLC ( 8  mm x 
10 cm Rad ia l  Pak (5 ym s i l i c a  g e l ) ,  88:12 i so o c ta n e /e th y l  a c e ta te ,  2.0 
mL/tnin, k 1 = 1.08); TLC (85:15 h e xan e s /e th y l  a c e ta te ,  Rf = 0.36).
Ana l .  Calcd. f o r  C2 0 H2 9 N0 3 : C, 72.47; H, 8.82. Found: C, 72.75; H,
8.98.
(4R ,5S )-3 -(l-O xo-Z -(l-naph thy l) ethyl)-4-m ethyl-5-phenyl-2-oxazol- 
id inone ( 1 6 j ,  Table 4 , Entry K). A s o l u t i o n  o f  8 . 8 6  g (50.0 mmol) o f  
(4R,5S)-norephedrine 2-oxazo l id inone 6 (0.2 M in THF) was metalated with
27.0 mL (1.76 M in hexane, 50.0 mmol) o f  j i - b u t y l  1 i t h i  urn and acy l  ated 
w i t h  11.3 g (55.2 mmol) o f  2 - ( n a p h t h - l - y l ) a c e t y l  ch lo r id e  according to 
th e  genera l  a c y la t i o n  procedure to  g iv e  17.6 g (102% mass ba lance)  o f  
crude p roduc t .  The t i t l e  compound was p u r i f i e d  by r e c r y s t a l  1 i z a t i o n  
from hexanes /e thy l  a ce ta te  t o  a f f o r d  15.3 g (8 8 %) o f  16j  as a w h i te  
c r y s t a l  1 ine so l id :  mp 103-104°C; IR (CH2 C1 2 ) 3060, 2990, 1780, 1705, 
1420, 1350 cm"1; *H NMR (CDC1 3 /90 MHz) 8  8.2-7.2 (m, 12H, a romat ic  H's),
5.45 (d, J = 7.2 Hz, 1H, C5 -H),  4.9-4.7 (m, 3H, C4 -H, C2 <-H2), 0.90 (d, 
J = 7 Hz, 3H, C4 -CH3 ); Spec if ic  r o ta t io n  [<*3539  = -40.1°, [ 01)577 =
-4 2 .1 ° ,  [ c 3 546 = -4 8 .9 ° ,  [ a 3 435 = -9 3 .3 ° ,  [ a 3 365 = -174.7° (c 0.584,
CH2 C12 ); 8 C (30 m DB-5, 2 5 0 ° C , ( i n j e c t o r ,  d e t e c t o r  = 275°C), 78 cm/sec,
8.01 m in) ;  HPLC ( 8  mm x 10 cm Radia l  Pak (5 ym s i l i c a  g e l ) ,  88:12 
isooctane/e thy l  acetate, 2.0 mL/min, k' = 3.88); TLC (8:2 hexanes/ethyl 
a c e ta te ,  Rf = 0.40).
- 9 5 -
Ana l .  Ca lcd .  f o r  C2 2 HigN0 3 : C, 76.50; H, 5.54; N, 4.06. Found: C, 
76.28; H, 5.59; N, 3.97.
( 4R, 5S) - 3 - (l-Oxo-2-methyoxyeth y l) -4-methyl-5-phenyl-2-oxazoli di none 
(16k, Table 4 ,  Entry L). A s o l u t i o n  o f  8 . 8 6  g {50.0 mmol) o f  (4R,5S)- 
norephedrine 2-oxazol idinone 6 (0.2 M in THF) was metalated w i th  22.4 mL 
(2.23 M in  hexane, 50.0 mmol) o f r i -butyl  1 i thiurn and acylated with  5.0 mL 
(5.9 g, 55 mmol) o f  methoxyacety l  c h l o r i d e  acco rd ing  t o  th e  genera l 
a c y l a t i o n  procedure t o  g iv e  12.0 g (96% mass ba lance)  o f  u n p u r i f i e d  
p roduc t .  The t i t l e  compound was iso  1ated by mol ecu 1a r  di s t i 11 a t i o n  
(Kugel rohr,  150°C, 0.02 mm) fo l lowed by r e c r y s t a l l i z a t i o n  from pentane/ 
d i e t h y l  e th e r  t o  a f f o r d  1 0 . 0  g (80%) o f  16k as a w h i te  c r y s t a l l i n e
s o l i d :  mp 63-64°C; IR (CH2 C12 ) 3060» 2990> 2940» 2830> 1780» 1720> 1450> 
1405, 1380, 1370, 1350, 1215, 1200, 1150, 1130, 1120 cm” 1 ; *H NMR
(CDCI3 / 8 O MHz) S 7.35 (m, 5 H, a romat ic  H 's),  5.75 (d, J = 7.5 Hz, 1 H, 
C5 -H ) ,  4.80 (qn, J = 7.2 Hz, 1H, C4 -H) ,  4.65 (s ,  2H, C2*-jl2^ * 3 , 5 0  
3H, OCH^), 0.95 (d, J = 7.1 Hz, 3H, C4 -CH3 ); S p e c i f i c  r o t a t i o n  [a ]5 8 9  = 
+30.4° , [ 0O 5 7 7  = +31.6° , [ a ] 5 4 5  = +36.2°, [ 0 3 4 3 5  = +66.0°, [ 0 3 3 5 5  = 
+116.8° (c 1.07, CH2 C12); 6 C (30 m DB-5, 175°C, 85 cm/sec, t r  = 5.50 
min); HPLC ( 8  mm x 10 cm Radial Pak (5 ym s i l i c a  g e l ) ,  64:36 isooctane/ 
e th y l  a c e ta te ,  2 .0mL/m in ,  k' = 3.11); TLC (8:2 he xan e s /e th y l  a c e ta te ,  
Rf  = 0.19).
Ana l .  Ca lcd .  f o r  C ^ H ^ f ^ :  C, 62.64; H, 6.07. Found: C, 62.84; H,
6.08.
- 9 6 -
(4R,5S)-3-(l-0xo-2-phenylmethoxyethyl)-4-methyl-5-phenyl-2-oxazol- 
id inone ( 1 6 1 ,  Table 4 ,  Entry M). A s o l u t i o n  o f  2.90 g (16.4 mmol) o f  
(4R ,5S)-norephedr ine  2 - o x a z o l i d i n o n e  6 (0.25 M in  THF) was m e ta la te d  
w i t h  10.5 mL (1.57 M in  hexane, 16.5 mmol) o f  j i - b u t y l  1 i t h iu m  and acy l  - 
ated with  3.00 g (16.2 mmol) o f  phenylmethoxyacetyl c h lo r id e  according 
to  the general a c y la t io n  procedure to  g ive  5.72 g (109% mass balance) of 
crude product. The t i t l e  compound was i so la te d  by f l a s h  chromatography 
(3 x 30 cm column, 8:2 h e xan e s /e th y l  a c e ta te )  t o  a f f o r d  4.61 g (87%) o f  
161  as a w h i te  c r y s t a l  l i n e  so l id :  mp 99-100°C; IR (CD0 1 3 ) 3040, 3000, 
2930, 1785, 1725, 1380, 1350, 1260, 1220, 1205, 1150, 1125 cm"1 ; !h  NMR 
(CDC1 3 / 9 0  MHz) 8  7.33 (s ,  10H, a rom a t ic  H's), 5.68 (d, J = 7.2 Hz, 1 H, 
C5 -H ) ,  4.75 (qn, J = 6 . 8  Hz, 1H, C4 -H) ,  4.71 (s,  2H, C 2 ’ -H2 ̂  ’ 4 *6 6  
2H, 0CH2 Ph), 0.93 (d, J = 6 . 8  Hz, 3H, C4 -H3 ); 13C NMR (CDC 1 3 /22.5 MHz) 8
169.8, 152.9, 137.2, 133.0, 128.8, 128.7, 128.4, 128.0, 125.6, 79.9,
73.4, 69.7, 54.4, 14.5; S p e c i f i c  r o t a t i o n  [a l s g g  = +16.2°, [ 0 3 5 7 7  = 
+ 17.0° , [ o ] 546 = +19.7°,  [ a ] 4 3 5  = +35.8°, [ a ] 365 = +64*8° ^  2 A 1  > 
CH2C l 2 ); GC (30 m SE-54, 240°C, ( i n j e c to r ,  detector  = 275°C), 71 cm/sec, 
t r  = 5.58 min) ;  HPLC ( 8  mm x 10 cm Radia l  Pak (10 pm s i l i c a  g e l ) ,  64:36 
isooctane/e thy l  acetate, 2.0 mL/min, k' = 0.95); TLC (8:2 hexanes/ethyl  
a c e ta te ,  Rf = 0.29).
Ana l .  Ca lcd .  f o r  C1 9 h1 9 N0 4 : C, 70.14; H, 5.89. Found: C, 70.06; H,
5.97.
(4S,5S)-3-(l-0xobuty 1 )-4-methyl -5-phenyl -2-oxazol id i none (18c, Tabl e 
4, Entry N). A s o l u t i o n  o f  1.77 g (10.0 mmol) o f  (4S,5S)-norpseudo- 
ephedr ine  2 -oxazo l  i d i  none 7 (0.2 M in  THF) was metal ated w i t h  4.5 mL 
(2.23 M in hexane, 10.0 mmol) o f  _n-butyl 1 i th ium and acyl ated with  1.2 mL
- 9 7 -
( 1.2 g, 12  mmol) o f  butanoyl ch lo r id e  according to  the general acy la t ion  
procedure t o  g ive  2.5 g (100% mass balance) o f  unpur i f ied  product. The 
t i t l e  compound was iso la te d  by d i s t i l l a t i o n  (Kugelrohr,  140°C, 0.01 mm) 
t o  a f f o r d  2.35 g (95%) o f  18c as a c o l o r l e s s  l i q u i d :  IR (neat )  2970, 
2880, 1785, 1705, 1460, 1370, 1325, 1220, 1200 cm"1 ; l H NMR (CDCI3 / 8 O 
MHz) S 7.35 (m, 5H, a romat ic  H 's),  5.07 (d, J = 4.5 Hz, 1H, C5 -H},  4.42 
(d o f  q, J = 4.5 Hz, 6 . 8  Hz, 1H, C4 -H ) ,  2.93 ( t ,  J = 7.8 Hz, 2H, C2«- 
H2 ), 1.95-1.5 (m, 2H, C3 ' -H 2),  1.60 (d, J «= 6 . 8  Hz, 3H, C4 -CH3 ) ,  1.00 
( t ,  J = 7.5 Hz, 3H, C4 ' -H 3);  S p e c i f i c  r o t a t i o n  [cx]589 = +21.8°, [ a ] 5 7 7  = 
+23.1°, [ a ] 5 4 6  = +27.3°, [ a ] 4 3 5 = +56.3° , [ a ] 3 6 5  = +112.2° (c 2.95, 
CH2 C12); GC (30 m DB-5, 175°C, 8 6  cm/sec, t r  = 3.61 min) ;  HPLC ( 8  mm x 
10 cm Rad ia l  Pak (5 ym s i l i c a  g e l ,  88:12 i s o o c t a n e /e th y l  a c e ta te ,  2.0 
mL/min, k ‘ -  1.51);  TLC (8:2 h e xan e s /e th y l  a c e ta te ,  Rf = 0.37).
Ana l .  Calcd. f o r  C1 4 H1 7 N0 3 : C, 68.00; H, 6.93. Found: C, 68.23; H,
6.81.
(4S)-3-(l-0xopropyl )-4-(l-methyl ethyl )-2-oxazol tdinone (20b, Tabl e 
4 , Entry 0). A mechanical l y  s t i  r re d  s o l u t i o n  o f  115 g (0.891 mol)  o f  
(S ) - v a l in o l  2-oxazol id inone 8  (0.9 M in  THF) was metalated with 550 mL 
(1.76 M in hexane, 0.968 mol) o f  ^ -b u ty l  1 i thiuin and acyla ted with  100 mL 
(107 g, 1.18 mol) o f  propanoyl ch lo r id e  according to  the general acy la -  
t i o n  procedure to  g ive 180 g (109% mass balance) o f unpur i f ied  product. 
The t i t l e  compound was i so la te d  by molecu lar  d i s t i l l a t i o n  (Kugelrohr,  
100°C, 0.01 mm) to  a f f o r d  153 g (93%) o f  20b as a c o l o r l e s s  l i q u i d :  IR 
(neat) 2970, 2880, 1785, 1705, 1385, 1370, 1245, 1210, 1070 cm"1; NMR 
(CDC1 3 / 9 0  MHz) 8  4.6-4.1 (m, 3H, C4 -H, C5 -H2), 2.95 (q, J = 7.6 Hz, 2H,
- 9 8 -
C2 l - i i 2 ) ,  2.57-2.22 (m, 1 H, C4 -CHJ, 1.18 ( t ,  J = 7.6 Hz, 3H, C3 ' -H 3 ). 
0.92 (over lapping d's, 6 H, CH(CH3 )2 ); Spec if ic  ro ta t io n  [CO5 3 9  = +91.9°, 
[ a ] 5 7 7  = +96.0° , [ a ] 5 4 6 = + 1 0 9 . 5 ° , [ a ] 4 3 5  = + 1 8 6 . 2 ° , [ a ] 3 6 5  = +293.9° (c 
= 0.377, CH2 C1 2 ); GC (30 m DB-5, 100°C, 94 cm/sec, t r  = 7.16 min) ;  TLC 
(8:2 hexanes/ethyl  acetate, Rf = 0.49).
Ana l .  Ca lcd .  f o r  CgHx5 ^ 0 3 : C, 58.36; H, 8.16. Found: C, 58.38; H,
8.30.
(4S)-3-(l-Oxo-3-phenylpropyl)-4-(l-methylethyl)-2-oxazolidinone  
(20h, Table 4 ,  Entry Q). A m e c h a n ic a l l y  s t i r r e d  s o l u t i o n  o f  20.0 g 
(0.155 mol) o f (S ) - v a l in o l  2-oxazol id inone 8  (0.31 M in THF) was metal - 
ated w i t h  95.0 mL (1.70 M in  hexane, 0.162 m o l ) o f  ^ - b u t y l  1 i t h iu m  and 
acyl ated w ith  25.0 mL (28.4 g, 0.168 mol) o f  3-phenyl propanoyl ch lo r id e  
according to  the general a cy la t io n  procedure to  g ive  41.5 g (102% mass 
ba lance )  o f  u n p u r i f i e d  p roduc t .  The t i t l e  compound was p u r i f i e d  by 
r e c r y s t a l l i z a t i o n  from hexanes (750 mL, 2 crops) to a f fo rd  37.0 g (91%) 
of 20h as a white c r y s t a l l i n e  s o l id :  mp 63-64°C; IR (CH2 C12 ) 3060, 2970, 
1780, 1700, 1385, 1210 cm"1; *H NMR (CDC1 3/500 MHz) 8  7.3-7.17 (m, 5H, 
a rom a t ic  H’ s ) ,  4.41 (d o f  d o f  d, J = 8.5, 4.0, 3.2 Hz, 1H, C4 -HJ> 4*24 
(d o f  d, J = 9.3, 8.4 Hz, 1H, C5 -H),  4.19 (d o f  d, J = 9.3, 3.2 Hz, 1H, 
C5 -H) ,  3.30 (d o f  d o f  d, J = 17.5, 8.7, 6.9 Hz, 1H, C2 - H ) .  3.22 (d o f  
d o f  d, J = 17.5, 8.5, 7.2 Hz, 1H, C2 . -H),  3.1-2.9 (m, 2H, C3 ' -H 2 ), 2.4-
2.3 (m, 1H, C4 -CH), 0.90 (d, J = 7.4 Hz, 3H, CH(CH3) ) .  0-84 (d, J = 7.4 
Hz, 3H, CH( Cjig))■ 13c NMR (CDC 1 3 /22.5 MHz) § 172.3, 154.0, 140.5, 128.5,
126.1, 63.4, 58.4, 37.0, 30.4, 28.4, 17.9, 14.6; S p e c i f i c  r o t a t i o n  
[a ]5 8 9  = +71.0° , [ a ] g 77  = +74.1°, [ a ] 5 4 g = +84.2° , [CJ4 3 5  = +143.4°, 
ta l3 6 5  = +225.3° (c 4.61, CH2 C12 ); GC (30 m DB-1, 175°C, 83 cm/sec, t r  =
- 9 9 -
4.75 min) ;  HPLC ( 8  mm x 10 cm Radia l  Pak (5 pm s i l i c a  g e l ) ,  88:12 
isooctane/e thy l  acetate, 2.0 mL/min, k1 = 4.86); TLC (8:2 hexanes/ethyl  
a c e ta te ,  Rf = 0.47).
Ana l.  Calcd. f o r  C1 5 h 1 9 N0 3 : C, 68.94; H, 7.33. Found: C, 69.17; H,
7.42.
(4S)-3 -( l-0xod ecy l)-4 -( l-m eth y leth y l)-2 -oxazo lid in on e (20i, Table 
4 ,  Entry R). A mechanical l y  s t i r r e d  so l u t i o n  o f  3.10 g (24.0 mmol) o f  
(S ) - v a l in o l  2-oxazol idinone 8  (0.33 M in THF) was metal ated w ith  15.5 mL 
(1.61 M in hexane, 25.0 mmol) o f  jn-butyl  1 i th ium and acyl ated w ith  5.00 g 
(26.2 mmol) o f  decanoyl c h l o r i d e  accord ing  t o  the  genera l  a c y l a t i o n  
procedure to  g i v e . 8.3 g (122% mass balance) of unpur i f ied  product. The 
t i t l e  compound was i so la te d  by f l a s h  chromatography (3 x 30 cm column, 
7:3 hexanes/diethyl  ether) fo l lowed by molecular  d i s t i l l a t i o n  (Kugel­
r o h r ,  160°C, 0.008 min) t o  a f f o r d  3.83 g (56%) o f  20 i as a c o l o r l e s s  
l i q u i d :  IR (CH2C12) 3070, 2980, 2940, 2880, 1785, 1705, 1390, 1210 cm"1; 
l H NMR (CC14 / 9 0  MHz) 8  4.4-4.1 (m, 3H, C4 -H, C5 -H2) ,  3 .0 -2 . 8  (m, 2H, 
C2 *-H2) , 2.6-2.3 (m, 1H, C4 -CH), 1.6 (m, 2H, C3 ' -H2 )» 1-30 (b r  s, 12H, 
a l i p h a t i c  H's), 0.91 (m, 9H, CH(CH3)2 , C1 q ' - Jl3) i S p e c i f i c  r o t a t i o n  
Ca3589 = +63.7°, [ a ] 5 7 7  = +66.7°, [ a ] 5 46 = +75.7°, [ a ] 4 3 5 = +128.8°, 
^ 3 6 5  = +202.8° { c  2.07, CH2 C12); SC (25 m Carbowax 20M, 175°C, 50 
cm/sec, t r  = 13.09 min);  TLC (7:3 h e x a n e s /d ie th y l  e th e r ,  Rf = 0.17).
Anal.  Calcd. f o r  C1 6 h2 9 N03 : C, 67.81; H, 10.31. Found: C, 68.06; 
H, 10.35.
- 1 0 0 -
(4R)-3-(l-0xopropyl )-4-phenyl-2-oxazol idinone (22b, Table 4, Entry
S). A s o lu t io n  o f  2.00 g (12.3 mmol) o f  (R)-phenyl g ly c in o l  2-oxazol- 
id in o n e  9 (0.25 M in  THF) was m e ta la te d  w i t h  8.0 mL (1.53 M in  hexane, 
12-2 mmol) o f n-buty l  1 i th ium and acy la ted with 1.1 mL (1.2 g, 12.6 mmol) 
o f  propanoyl c h lo r id e  according to  the general a c y la t io n  procedure to  
g i v e  2.7 g (100% mass ba l  a nee) o f  u n p u r i f i e d  p roduc t .  The t i t l e  com­
pound was i so la te d  by molecu lar  d i s t i l l a t i o n  (Kugelrohr,  155°C, 0.01 mm) 
to  a f fo rd  2.30 g (85%) o f  22b as a c o lo r l e s s  l i q u i d  which c rys ta l  1 ized 
on s ta n d in g :  mp 76-77°C; IR (CCI4 ) 1795, 1720, 1380, 1200 cm“ l ;  *H NMR 
(CDC 1 3 / 9 0  MHz) 8  7.3 (s ,  5H, a romat ic  H 's),  5.38 (d o f  d, J = 9.0, 4.2 
Hz, 1H, C4 -H),  4.62 ( t ,  J = 9.0 Hz, 1H, C5 -H),  4.22 (d o f  d, J = 9.0,
3.7 Hz, 1H, C5 -H),  2.92 (q , J = 7.5 Hz, 2H, Cg ' -J^ ) ,  1.10 ( t ,  J = 7.5 
Hz, 3H, C3 *- i i 3 ) ;  S p e c i f i c  r o t a t i o n  [a ]5 8 9  = -84 .1 ° ,  [ 0O 5 7 7  = -8 9 .1 ° ,  
[ “ ]546 = -102.3° ,  [ a ] 4 3 5  = -185.8° ,  [ o ] 3 6 5 = -316.8° ,  (c 1.44, CH2 C12); 
GC (30 m DB-1, 175°C, 104 cm/sec, t r  = 1-63 min) ;  HPLC ( 8  mm x 10 cm 
Radial Pak (5 um s i l i c a  g e l ) ,  88:12 isooctane/e thyl  acetate, 2.0 mL/min, 
k' = 6.99) ;  TLC (8:2 h e x a n e s /e th y l  a c e ta te ,  Rf = 0.29).
Ana l .  Calcd. f o r  C1 2 h1 3 N03 : C, 65.74; H, 5.98; N, 6.39. Found: C, 
65.83; H, 6.03; N, 6.33.
(4R)-3-(l-0xobutyl)-4-phenyl-2-oxazolidinone (22c, Table 4, Entry
T). A s o lu t io n  o f 5.00 g (30.7 mmol) o f  (R)-phenyl g ly c i  nol 2-oxazol i d i ­
none 9 (0.3 M in  THF) was m e ta la te d  w i t h  20.0 mL (1.60 M in  hexane, 32.0 
mmol ) o f  j i - b u t y l  1 i t h iu m  and acy l  ated w i t h  5.2 mL (5.0 g, 32 mmol) o f  
butanoic anhydride according to  the general acy la t ion  procedure to  give
6.7 g (94% mass balance) o f unpur i f ied  product. The t i t l e  compound was 
i s o l a t e d  by m o le c u la r  d i s t i l l a t i o n  (K u g e l ro h r ,  150°C, 0.005 mm) to
- 1 0 1 -
a f fo rd  6 . 0  g (84%) o f  2 2 c as a c o lo r le s s  l i q u i d  which c r y s t a l l i z e d  upon 
s ta n d in g :  mp 50-51°C; IR (CH2 C12) 3050, 2970, 1780, 1705, 1380, 1330, 
1200 cm- 1 ; iH NMR (CCI4 / 9 0  MHz) B 7.28 (s ,  5H, a romat ic  H 's),  5.28 (d o f  
d, J = 9.0, 4.0 Hz, 1H, C4 -H) ,  4.57 ( t ,  J = 9.0 Hz, 1H C5 -H),  4.15 (d o f  
d, J = 9.0, 3.9 Hz, 1H, C5 -H),  2.82 ( t ,  J = 7.5 Hz, 2H, C2■ - H.2)* 1-60 
(m, 2H, C3 * —JH2 )» 0.90 ( t ,  J = 7.5 Hz, 3H, C4 ' -H 3);  S p e c i f i c  r o t a t i o n  
[<*]589 = -7 9 .5 ° ,  [ a ] 5 7 7  = -8 3 .6 ° ,  [ 0 3 5 4 5  = -8 7 .0 ° ,  [CO4 3 5  = -173.6° ,  
[ a ] 3 6 5  = -296.8°  (c 2.21, CH2 C12 ); GC (30 m DB-1, 175°C, 104 cm/sec, t r  
= 2.12 m in) ;  HPLC ( 8  mm x 10 cm Radia l  Pak (5 pm s i l i c a  g e l ) ,  88:12 
isooctane/e thy l  acetate, 2.0 mL/min, k' = 5.57); TLC (8:2 hexanes/ethyl  
a c e ta te ,  Rf  = 0.35).
Ana l .  Ca lcd .  f o r  C1 3 H i 5 N0 3 : C, 66.94; H, 6.48. Found: C, 67.19; H,
6.56.
(4S)-3-(l-0xopropyl )-4-phenyl methyl -2-oxazol idi none (24b, Tabl e 4, 
Entry U). A s o l u t i o n  o f  17.7 g (100 mmol) o f  (4S)-phenyl  a l  a n in o l  2- 
oxazol  i di none 10 (0.2 i n  THF) was m e ta la te d  w i t h  65 mL (1.69 M in  
hexane, 110 mmol) o f  n - b u t y l  1 i t h i  urn and acy l  ated w i th  9.6 mL (10.2 g, 
1 1 0  mmol) o f  propanoyl  c h l o r i d e  acco rd ing  t o  the  genera l  a c y l a t i o n  
procedure to  g ive  23.5 g (101% mass balance) o f  unpur i f ied  product. The 
t i t l e  compound was iso la te d  by molecular  d i s t i l l a t i o n  (Kugelrohr,  140°C, 
0.008 mm) t o  a f f o r d  23.0 g (99%) o f  24b as a c o l o r l e s s  l i q u i d  which 
c r y s t a l l i z e d  on standing: mp 44.5-45.5°C; IR (CH2 c i 2) 3050, 2980, 1780, 
1700, 1385, 1375, 1240, 1210, 1080 cnr*;  *H NMR (CDC13/90 MHz) 8  7.2 (m, 
5H, a romat ic  H's),  4.8-4.5 (m, 1H, C4 -H} ,  4.13 (d, J = 6 . 8  Hz, 2H, C4 -  
CH2 Ph), 3.27 (d o f  d, J -  14.1, 3.7 Hz, 1H, C5 -H),  2.93 (q, J = 7.8 Hz,
- 1 0 2 -
2H, C2 >-H2) , 2.77 ( d  o f  d ,  J = 13.9, 9.9 Hz, 1H, C5 -H ) ,  1.18 ( d ,  J = 3H, 
C3 »-H3); 13C NMR (CDC 1 3 /22.5 MHz) 8  173.9, 153.4, 135.4, 129.4, 128.9,
127.2, 66.2, 55.0, 37.8, 29.1, 8.3; S p e c i f i c  r o t a t i o n  [o3b89 = +80.7°, 
L a J 5 7 7 = +84.4°, [ a ]5 4 6  = +95.6°, [ 0 1 4 3 5  = +162.2°, [ 0 1 3 5 5  = +254.3° {£
1.00, CH2 C1 2 ) ;  (30 m OB-1, 175°C, 100 cm/sec, t r  *  2.44 m in) ;  HPLC ( 8
mm x 10 cm Radial Pak (5 ym s i l i c a  ge l ) ,  88:12 isooctane/e thy l  acetate,
2.0 mL/min, k' = 4.85);  TLC (8:2 h e xanes /e thy l  a c e ta te ,  Rf = 0.37).
Ana l.  Calcd. f o r  C1 3 h1 5 N0 3 : C, 66.94; H, 6.48. Found: C, 66.73; H,
6.51.
(4S )-3 -( l-0xob u ty1  )-4-phenyl methyl -2-oxazol idinone (24c, Table 4, 
E n try  V). A s o l u t i o n  o f  1.77 g (10.0 mmol) o f  (4S)-pheny 1 a 1 a n in o l  
2 - o x a z o l i d i n o n e  10 (0.2 M in  THF) was metal ated w i t h  4.5 mL (2.23 M_ in  
hexane, 10.0 mmol) o f  r i -buty l  1 i thium and acyl ated with  1.2 mL (1.2 g, 12 
mmol) o f butanoyl c h lo r id e  according to  the general a c y la t io n  procedure 
t o  g i v e  2.5 g (100% mass ba lance)  o f  u n p u r i f i e d  p roduc t .  The t i t l e  
compound was i s o l a t e d  by d i s t i l l a t i o n  (K u g e l ro h r ,  140°C, 0.01 mm) to  
a f f o r d  2.35 g (95%) o f  24c as a c o l o r l e s s  l i q u i d ;  IR (neat )  2980, 2950, 
2890, 1790, 1705, 1455, 1390, 1365, 1215, 1090 cm " l ;  *H NMR (CDCI3 / 8 O 
MHz) S 7.30 (m, 5H, a ro m a t ic  H's), 4.65 (m, 1H, C4 -H),  4 . 18 (d, J = 6.0 
Hz, 2H, C4 -CH2), 3.32 (d o f  d, J = 13.2, 4 Hz, 1H, C5 -H) ,  2.92 ( t ,  J = 8 
Hz, 2H, C2 . -H2 ),  2.77 (d o f  d, J = 13.2, 9.0 Hz, 1H, C5 -H),  1.75 (m, 2H, 
C3 1 —_H2)> 1-05 ( t ,  J = 8 z, 3H, C4 ‘ - Ji3 ) ;  S p e c i f i c  r o t a t i o n  [a3589 = 
+74.8°, [ a ] 5 7 7  = +78.1°,  [ 0 3 5 4 5  = +8 8 . 8 ° ,  [ 0 3 4 3 5  = +150.7°, [a3365 = 
+235.7° (c 1,34, CH2 C12); GC (30 m DB-5, 175°C, 8 6  cm/sec, t r  *  4.95 
min); HPLC ( 8  mm x 10 cm Radial  Pak (5 ym s i l i c a  g e l ) ,  88:12 isooctane/ 
e t h y l  a c e ta te ,  2.0 mL/min, k ‘ = 3.79);  TLC (8:2 he xan e s /e th y l  a c e ta te ,
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Rf  = 0.29).
Ana l .  Calcd. f o r  C1 4 H1 7 NO3 : C, 68.00; H, 6.93. Found: C, 68.13; H,
7.03.
(4R,5S)-3-((2E)-l-Oxo-Z-butenyl)-4-methyl-5-pheqyl-2-oxazol idinone 
(16m). A s o l u t i o n  o f  l.OOg (5.64 mmol) o f  (4R,5S)-norephedr ine  2- 
oxazol  i d in o n e  6  (0.38 M in  THF) was meta l ated w i t h  3.4 mL (1.61 M in  
hexane, 5.47 mmol) o f  _n-butyl 1 i th ium and acyl ated w ith  0.58 mL (0.63 g,
6 . 0  mmol) of crotonyl ch lo r id e  according to  the general a cy la t io n  pro­
cedure t o  g iv e  1.41 g (101% mass ba lance )  o f  u n p u r i f i e d  p roduc t .  The 
t i t l e  compound was i s o la te d  by f l a s h  chromatography (3 x 30 cm column, 
7:3 h e x a n e s /d ie th y l  e th e r )  t o  a f f o r d  1.21 g (87%) o f  16m as a w h i te  
c r y s t a l  1 ine  so l  i d :  mp 6 5 -66 °C; IR (CC14 ) 2990, 1790, 1690, 1645, 1350, 
1240, 1195, 1150, 1125, 1045 c n r * ;  *H NMR (CDC 1 3/500 MHz) 8  7.45-7.30 
(m, 5H, a ro m a t ic  H's),  7.28 (d o f  q, J = 15.5, 1.7 Hz, 1H, C2 *” Ji)» 7.17 
(d o f  q, J = 15.5, 6 . 8  Hz, 1H, C3 . -H},  5.68 (d, J = 7.2 Hz, 1H C5 -H),
4.81 (qn, J = 6 . 8  Hz, 1H C4 -H ) ,  1.96 (d o f  d, J = 6.9, 1.7 Hz, 3H, C4 *- 
H3),  0.92 (d, J = 6 . 8  Hz, 3H, C4 -CH3 ) ;  13C NMR (CDCl3 /22.5 MHz) 8  164.6,
153.0, 146.5, 133.5, 128.6, 125.7, 122.0, 79.0, 54.8, 18.5, 14.6; Spe­
c i f i c  ro ta t io n  [ a ] 5 8 9  = +32.4°, [ a ] 5 7 7  = +33.3°, [a ] 5 4 6  = +37.9°, [ a ] 4 3 5  
= +64.7°,  [ a] 3 6 5  = +110.4° (c 1.63, CH^Cl 2 )> 6C ( 3 0  m DB' 1 * 175° c » 1 0 4  
cm/sec, t r  = 3 . 5 5  m in);  HPLC ( 8  mm x 10 cm R ad ia l  Pak (5 ym s i l  ica g e l ) ,  
88:12 isooctane/e thy l  acetate, 2.0 mL/min, k 1 = 3.08); TLC (8:2 hexanes/ 
d i e t h y l  e th e r ,  Rf  = 0.26).
Ana l .  Calcd. f o r  C^HigNOs: C, 68.56; H, 6.16. Found: C, 68.82; H,
6.14.
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(4R, 5S) - 3 - ( ( 2R)-1-Oxo-2-bromopropyl)-4-met hyl-5-phenyl-2-oxazol-  
id inone (16n) and (4R ,5S)-3-((2S)-l-0xo-2-brom opropyl ) -4 -m e th y l-5 -  
p h en y l-2 -o x a zo l id inone (16o). A s o l u t i o n  o f  8 . 8 6  g (50.0 mmol) o f  
(4R,5S)-norephedrine 2-oxazo l id inone 6 (0.2 M in  THF) was metalated with 
27 mL (1.76 M in hexane, 50.0 mmol) o f  £ - b u t y l 1i thiurn and acyl ated with
9.4 g (55 mmol) o f (±)-2-bromopropanoyl ch lo r ide  according to  the gen­
e r a l  a c y l a t i o n  procedure t o  g i v e  17.2 g (110% mass ba la n ce )  o f  the  
u n p u r i f i e d  p roducts .  The two d ias te reom ers  were separa ted  by f l a s h  
chromatography ( 6  x 30 cm column, 9:1 hexanes/ethyl acetate, 16n e lu tes  
f i r s t )  to  a f fo rd  6 . 6  g (85%) o f  16n as a white c rys ta l  1 ine s o l i d  and 7.0 g 
(90%) o f 16o as a white c r y s t a l l i n e  so l id .
16n: mp 88-89°C; IR (CH2 C12 ) 3060, 2995, 1785, 1710, 1420, 1370
cm- l ;  NMR (CDCI3 / 8 O MHz) $ 7.35 (m, 5H, a romat ic  H's),  6.9-6.65 (m, 
2H, C5 -H, C2 ' -H ) ,  4.78 (qn, J = 7 Hz, 1H, C4 -H),  1.87 (d, J = 7.2 Hz, 
3H, C31 - 113) ,  0.95 (d, J = 7 Hz, 3H, C4 -CH3 ); S p e c i f i c  r o t a t i o n  [o3589 = 
+9.3° , [ a ] 5 7 7  = +10.0°, [ 0 3 5 4 5  = +11.2°, [a ]4 3 5  = +19.8°, [a3365 = 
+36.6° (c. 0.485, CH2 C12); GC (The d ias te reomers  ep im er ize  under the 
cond i t ions required f o r  GC a n a lys is ) ;  HPLC (8 mm x 10 cm Radial Pak (5 
ym s i  1 ica  g e l ) ,  88:12 i  s o o c ta n e /e th y l  a ce ta te ,  2.0 mL/min, k' = 0.96); 
TLC (8:2 hexanes/ethyl  acetate, Rf = 0.73).
16o: mp 99 -1 00°C; IR (CH2 c 1 2 ) 3060, 2990, 1785, 1710, 1420, 1370
c n r ^ ;  *H NMR (CDCI3 / 8 O MHz) $ 7.35 (m, 5H, a romat ic  H's), 5 .9 -5 . 6  (m, 
2H, C5 -H, C2 <-H), 4.83 (qn, J = 7 Hz, 1H, C4 -H),  1.85 (d, J = 6 . 8  Hz, 
3H, 0 3 1 - ^ 3 ) ,  0.91 (d, J = 7  Hz, 3H, C4 - 0^ 3 ) ; S p e c i f i c  r o t a t i o n  [aJsgg =
+ 8 .8 ° ,  [ a ] 5 7 7  = +9.0°, [a ]5 4 6  = +10.1°,  [a ]435  = +18.0°, [ 0 3 3 5 5  = +34>3°
(^ 0.714, CH2 C12); GC (The diastereomers epimerize under the condi t ions 
re q u i re d  f o r  GC a n a l y s i s ) ;  HPLC ( 8  mm x 10 cm Radia l  Pak (5 ym s i l i c a
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g e l ) ,  88:12 i s o o c t a n e / e t h y l  a c e ta te ,  2.0 mL/min, k' = 4.52);  TLC (8:2 
hexanes/ethyl  acetate, Rf = 0.46).
(4R ,5S )-3 -(l-0xo-2-( 2 ,5-dimethyl pyrro l-1-y l)ethyl) -4 -methyl-5-phen­
y l - 2 - o x a z o l  id inone (16p). To a m e c h a n ic a l l y  s t i r r e d ,  coo led  (-5°C) 
s o l u t i o n  o f  3.28 g (21.4 mmol) o f  (2,5-dimethyl p y r r o l - 1 - y l  )acet ic  acid 
(0.5 M in  THF) was added 3.00 mL (2.18 g, 21.5 mmol) o f  t r i  e th y l  ami ne 
and 2.05 ml (2.33 g, 21.4 mmol) o f  ethyl  chi  orofornate. The th ick -wh i te  
m ix tu r e  was s t i r r e d  a t -5°C f o r  0.5 h f o l l o w e d  by th e  a d d i t i o n  v ia  
cannula o f  a s o lu t io n  o f  the metalated 2 -oxazol id inone, prepared pre­
v io u s l y  from 3.79 g (21.4 mmol) o f  (4R,5S)-norephedrine 2-oxazol idinone 
6  (0.5 M in  THF) and 12.7 mL (1.69 M in  hexane, 21.5 mmoL) o f  j i - b u t y l  - 
l i t h iu m .  The react ion mixture was s t i r r e d  at 0°C f o r  4 h, then worked- 
up according to  the general a cy la t io n  procedure (under an atmosphere of 
n i t r o g e n )  t o  g iv e  7.2 g (108% mass ba lance)  o f  u n p u r i f i e d  p roduc t  con­
tam in a ted  w i t h  ( 4 R , 5 S ) -3 - ( l - e th o x y - l - o x o m e th y l  )-4-methyl -5-phenyl -2- 
oxazol idinone. The t i t l e  compound was i so la te d  by f l a s h  chromatography 
(5 x 20 cm column, 75:25 h exanes /e thy l  ace ta te )  to  a f f o r d  2.51 g (38%) 
o f  16p as a w h i te  c r y s t a l l i n e  s o l i d :  mp 154-155°C; IR (CHgC 1 2) 3060, 
2990, 1785, 1770, 1410, 1370, 1345, 1200 cm"1 ; *H NMR (CDC 1 3/90 MHz) § 
7.33 (m, 5H, a romat ic  H's), 5.73 (s ,  2H, a romat ic  H's),  5.68 (d, J = 7.2 
Hz, 1H, C5 -H),  5.06 (d, J = 2 Hz, 2H, C2 ' -H 2 ), 4.72 (qn, J = 6 . 8  Hz, 1H, 
C4 -H),  2.28 (s ,  6 H, C2 "-CH3, C5 "-CH3), 0.92 (d, J = 6 . 8  Hz, 3H, C4 -CH3h  
S p e c i f i c  r o t a t i o n  [ a ] 5 8 9 = -2 4 .8 ° ,  [ a ] 5 7 7  = -2 6 .2 ° ,  [ 0O 5 4 6  = -30 .2° ,  
[ a ] 4 3 5 = -54 .8 ° ,  [ a j 3 6 5  = -92.0° (c 1.36, CH2 C12); GC (30 m DB-1,-250°C, 
( i n j e c t o r ,  d e t e c t o r  = 275°C), 89 cm/sec, t r  = 1.93 min) ;  HPLC ( 8  mm x 10
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cm Rad ia l  Pak (5 um s i l i c a  g e l ) ,  88:12 i s o o c t a n e /e th y l  a c e ta te ,  2.0 
mL/min, k' = 4 .47);  TLC (7:3 hexanes /e thy l  a c e ta te ,  Rf = 0.43).
Ana l .  Calcd. f o r  C1 8 H2 0 N2 O3 : C, 69.21; H, 6.45. Found: C, 69.39;
H, 6.58.
Sodium Hexamethyldisilylamide.59 The fo l lo w in g  react ion and subse­
quent manipulat ions o f  the product were performed with care fu l  exclus ion 
o f  m o is tu re  and oxygen. A magnet ica l  l y  s t i r r e d  m ix tu re  o f  25 g (1.04 
m o l)  o f  o i l  f r e e  sodium h yd r ide  and 211 mL (161 g, 1.00 mol) o f  hexa- 
m e th y ld is i l y la m in e  in  800 mL o f  dry to luene was heated at r e f l u x  f o r  18 
h. The hot,  dark mixture was f i l t e r e d  through a 2 cm pad o f  c e l i t e .  The 
pa le  y e l l o w  f i l t r a t e  was concentrated in  vacuo to  a f fo rd  145-170 g (79- 
93%) o f  the  t i t l e  compound as a w h i te  c r y s t a l  1 ine  so l i d .  The product  
was t rans fe r red  and stored in  a dry box.
Potassium H exam ethyld isily lam ide.59  The fo l lo w in g  react ion and 
subsequent m a n ip u la t io n s  o f  the  p roduct  were performed w i th  c a r e fu l  
e x c lu s i o n  o f  m o is tu re  and oxygen. A m agnet ica l  l y  s t i r r e d  m ix tu re  o f
I .7  7 g (44.0 mmol) o f  o i l  f r e e  pot as si  um h yd r i  de and 7.11 g (44.0 mmol) 
o f  hexamethy ld is i ly lam ine  in  50 mL o f  dry toluene was heated at r e f l u x  
f o r  8  h. The h o t ,  dark m ix tu re  was f i l t e r e d  th rough  a 1 cm pad o f  
c e l i t e .  The pale y e l l o w  so lu t io n  was concentrated j_n vacuo to  a f fo rd
7.81 g ( 8 8 %) o f  the  t i t l e  compound as a w h i te  c r y s t a l  1 ine sol id.  The 
product was stored in  a dry box. Stock so lu t ions  were prepared in  THF, 
benzene or to luene and t i t r a t e d  p r io r  to  use.
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Benzyl Bromomethyl Ether (45). The t i t l e  compound was prepared by 
an a d a p ta t io n  o f  th e  procedure o f  Conner e t  a l . , 6 ° s u b s t i t u t i n g  anhy­
drous hydrogen bromide f o r  anhydrous c h l o r i d e .  The p roduc t  was d i s ­
t i l l e d  under reduced pressure through a 20-cm vacuum-jacketed Vigreux 
column. The forerun (bp 80-85°C, 0.6 mm), c o n s t i tu t in g  ca. 40-50% o f  the 
crude p ro d u c t ,  was shown to  be m a in ly  benzyl bromide. The p roduct  45 
(40-50%), was then c o l l e c t e d  as a c o l o r l e s s  l i q u i d  (bp 80-85°C, 0.01 
mm). Benzyl bromomethyl ether,  which fumes in  a i r ,  was stored at -10°C 
under an atmosphere o f  argon. 45: NMR (CDCI3 / 9 0  MHz) § 7 .4 0  (s ,  5H,
a romat ic  H's), 5.70 (s ,  2H, -0CH2 Br) ,  4.70 (s ,  2H, PhCH2 0 - ) .
Benzyl Chloromethyl Sulfide (46a). Anhydrous hydrogen c h io r id e  was 
bubbled through a magnet ica l ly  s t i r r e d ,c o o le d  (-10°C) s o lu t io n  o f  25.0 g 
(0.278 mol) o f s - t r i o x a n e  in  100 g (0.805 m o l ) o f  benzyl  t h i o l  u n t i 1 
saturated (ca. lh).  A f te r  an add i t iona l  period of 12 h at room tempera­
tu re ,  the reac t ion  mix ture was dr ied over anhydrous calcium ch lo r ide.  
The product was decanted from the calcium ch lo r id e  and d i s t i l l e d  through 
a 5-cm v ig re u x  column to  a f f o r d  101 g (73%) o f  46a as a c o l o r l e s s  
l i q u i d :  bp 74-76°C, 0.01 mm, ( L i t . 61  bp 102°C, 2 mm); NMR (CC14 /90 
MHz) 8  7.2 (s,  5H, a romat ic  H's),  4.40 (s ,  2H, SCH2 C1), 3.80 (s ,  2 H, 
PhCj^S).
Benzyl Bromomethyl Sul f id e  (46b). The t i t !  e compound was prepared 
f o l l o w in g  the procedure o f  Hollowood et. a l .^2  The product was p u r i f ie d  
by m o le c u la r  d i s t i l l a t i o n  (Kugel ro h r ,  140°C, 0.01 mm) t o  a f f o r d  46b 
(92%) as a c o l o r l e s s  l i q u i d ,  which s o l i d i f i e d  be low -10°C: *H NMR 
( CC 14 / 9 0  MHz) S 7.27 (s ,  5H, aromat ic  H's),  4.33 (s ,  2H, SCH2 B r) ,  3.82 
(s ,  2H, PhCH2 S).
- 1 0 8 -
General Procedure fo r the A lky la tio n  o f 2-0xazolidinone I*ride Enol- 
a tes . A lk y la t i o n  react ions are performed on scales ranging from 1 mmol 
to  0.5 mol at enolate concentrat ions o f  0.1-1.0 M in  THF. E le c t ro p h i le s  
are e i t h e r  f r e s h l y  d i s t i l l e d  o r  passed th rough  a column o f  n e u t r a l  
a c t i v i t y  1 alumina immediately p r i o r  t o  use.
E no la te  Generation. A. L ith ium  Enol a te . To a magnetical l y  s t i r r e d ,  
cooled (-5°C) s o lu t io n  o f  di isopropyl  amine (1.1 equiv, 0.5-1.0 M in  THF) 
is  added a hexane s o lu t io n  o f  n - b u t y l 1 i th ium (1.1 equiv). The c o lo r le s s  
s o lu t io n  o f  l i t h iu m  di isopropyl amide (LDA) i s  s t i r r e d  at -5°C f o r  0.5 h 
then cooled to  -78°C. The ind icated N-acyl 2-oxazol id inone (1.0 equiv, 
1-5 M in  THF) is  added dropwise. A f te r  s t i r r i n g  at -78°C fo r  0.5 h, the 
desired l i t h i u m  enolate i s  ready f o r  a l k y l a t i o n .
E n o la te  Generation. B. Sodium E no la te . To a magnetical l y  s t i r r e d ,  
c o o le d  (~78°C) s o l u t i o n  o f  sodium h e x a m e t h y l d i s i l y 1 amide (1.1 e q u iv ,  
weighed and t r a n s f e r r e d  i n  a dry  box, 0.5 M in  THF) i s  added th e  i n d i ­
cated N-acyl 2-oxazol idinone imide (1.0 equiv, 1-5 M in THF) dropwise. 
A f t e r  s t i r r i n g  a t -78°C f o r  0.5 h th e  d e s i re d  sodium e n o la te  i s  ready 
f o r  a l k y l a t i o n .
E no late  Generation. C. Potassium E no la te . To a m a g n e t i c a l l y  
s t i r r e d ,  cooled (-78°C) s o lu t io n  o f  the ind icated 3-acyl 2-oxazol id inone 
im ide (1.0 e q u iv ,  0.5-1 M i n  THF) i s  added a s o l u t i o n  o f  potassium 
hexamethyl d i s i  l y l  amide (1.1 equiv , 0.5-1 M in  benzene, THF or  toluene) 
dropwise. A f t e r  s t i r r i n g  a t -78°C f o r  0.5 h the  potassium e n o la te  i s  
ready f o r  a l k y la t i o n .
E nolate  Generation. D. Magnesium E no la te . To a s o lu t io n  o f the 
1 i t h iu m  enol a te  (prepared as d e sc r ib e d  above) i s  added a so l  u t i o n  o f  
anhydrous magnesium bromide (1.1 e q u i v ,  1.0 M in  1:1 b e n z e n e /d ie th y l
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ether).  A f t e r  s t i r r i n g  at -78°C fo r  0.5 h the desired magnesium enolate 
is  ready f o r  a l k y l a t i o n .
E n o la te  A lk y la t io n . To the m agne t ica l ly  s t i r r e d ,  cooled (-78°C) 
s o lu t io n  o f  the metal enola te , prepared as described above, is  added the 
i n d i c a t e d  e l e c t r o p h i l e  (1-10 e q u iv ,  neat or 2-5 M in  THF) dropwise. 
E l e c t r o p h i  1 e q u a n t i t y ,  as we 11 as r e a c t i o n  tempera tu re  and t im e ,  are 
va r ia b les  s p e c i f i c  to  each experiment. The react ion is  quenched by the 
a d d i t i o n  o f  3 M aqueous ammoni um c h l o r i d e .  V o l a t i l e s  are removed i n 
vacuo and the product extracted in to  dichloromethane (3x). The combined 
organic laye rs  are success ive ly  washed w ith  1 M aqueous sodium b i s u l f a te  
or  hyd roch lo r ic  acid (2 x), 1 M aqueous potassium bicarbonate (2 x), and 
b r i n e  ( l x ) ,  d r i e d  o v e r  anhydrous magnesium s u l f a t e  or sodium s u l f a t e ,  
and concentrated h i  vacuo. A l k y la t i o n  d ias te reose lec t ion ,  as w e l l  as 
the extent o f  reac t ion ,  is  determined by GC ana lys is  o f the u n f rac t ion ­
a ted p roduc t .  The product  i s  p u r i f i e d  by chromatography, m o le c u la r  
d i s t i l l a t i o n  o r  r e c r y s t a l l i z a t i o n  as i n d i c a te d  in  the  f o l l o w i n g  
examples.
(4R ,5S )-3 -((2S )-l-0xo-2 -m ethy lbuty l) -4-m ethyl-5-phenyl-2-oxazol-  
id inone (17a , T ab le  9 , Entry A). L ith ium  E no late  A lk y la t io n . A mag­
n e t i c a l l y  s t i r r e d ,  cooled (-78°C) s o lu t io n  o f IDA [prepared from 1.55 mL 
(1.12 g, 11.1 mmol) o f  d i  i sopropy l  ami ne and 6 . 8  mL (1.61 M in  hexane, 
10.9 mmol) o f  _n-buty 1 1 i t h i u m ]  (0.2 M in  THF) was used to  e n o l i z e  2.34 g 
(10.0 mmol ) o f  16b. The r e s u l t a n t  l i t h i u m  e n o la te  was a l k y l a t e d  w i th
2.4 mL (4.7 g, 30 mmol) of ethyl  iodide according to  the general a l k y l a ­
t i o n  procedure f o r  2 h a t 0°C t o  g i v e  2.39 g (92% mass ba lance)  o f
- 1 1 0 -
u n p u r i f i e d  p roduc t .  A n a ly s i s  by GC (30 m DB-1, 175°C, 91 cm/sec) a f ­
fo rd e d  a 9:91 r a t i o  o f  (2R)-17a ( t r = 4.44 min) t o  (2S)-17a ( t r  = 4.69 
m in) ,  and i n d i c a te d  the  presence o f  both 6  ( t r  = 2.59 min, ca. 34%) and 
unreacted 16b ( t r  = 3.74 min, ca. 10%). The t i t l e  compound was iso la te d  
by MPLC (column C, 8:2 hexanes/diethyl e ther ,  10 mL/min, (2S)-17a e lu tes  
second) to  a f fo rd  734 mg (28%) o f  (2S)-17a as a white c r y s t a l l i n e  s o l id  
[ (2R )-17a : (2S)-17a  < 1 :99 ] :  mp 71-72°C; IR (CH2 C12 ) 3060, 2980, 2950, 
1785, 1700, 1390, 1370, 1350, 1240, 1200 c n r * ;  *H NMR ( CC 14 /90 MHz)S
7.3 (s ,  5H, a romat ic  H 's),  5.53 (d, J = 7.2 Hz, 1H, C5 -H) ,  4.67 (qn, 0 =
6 . 8  Hz, 1H, C4 -H ) } 3.60 (q, J = 6 . 8  Hz, 1H, C2 ' -H ) ,  2.1-1.3 (m, 2H, C3«- 
H2 ) ,  1.13 (d, J = 7.5 Hz, 3H, C2 '-CH3), 0.93 ( t ,  J = 7.5 Hz, 3H, C4 ' -  
H3 ), 0.85 (d, J = 6 . 8  Hz, 3H, C4 -CH3 ); 13C NMR (CC1 4 /22.5 MHz) 8  175.5,
151.4, 133.8, 128.2, 125.4, 77.9, 54.1, 38.4, 26.6, 16.2, 14.4, 11.2; 
S p e c i f i c  r o t a t i o n  CoDsgg = +54.7°, [ 0 3 5 7 7  = +58.9°,  [ a ] 5 4g = +67.2°, 
[ 0 3 4 3 5  = +117.9°, [ o 3 3 6 5  = 197.7° (c 1.38, CH2 C12); HPLC ( 8  mm x 10 cm 
Radia l  Pak (5 um s i l i c a  g e l ) ,  88:12, 2 .0mL/m in, k 1 (2R)-17a = 1.05, k' 
(2S)-17a = 1.41, o = 1.34).
Anal.  Calcd. f o r  C1 5 Hi g N03: C, 68.94; H, 7.33. Found: C, 69.09; H,
7.36.
(4R,5S)-3-((2S)-l-Q xo-2-m ethylbutyl)-4-m ethyl-5-phenyl-2-oxazol- 
idinone (17a, Table 9, Entry B). Sodium Enolate A lky la tio n . A magneti­
c a l l y  s t i r r e d ,  cooled (-78°C) so lu t io n  of 0.243 g (1.33 mmol) o f  sodium 
hexamethyl di  si  l y l  amide (0.25 M in THF) was used to  e no l ize  0.261 g (1.12 
mmol) of 16b. The re s u l t a n t  sodium enolate was a lk y la te d  with 0.40 ml 
(0.78 g, 5.0 mmol) o f  e thy l  iodide according to the general a l k y l a t i o n  
procedure f o r  2 h at -20°C to  g ive  0.272 g (76% mass balance) of unpuri­
- 1 1 1 -
f ie d  product. Analysis by GC (30 m SE-54, 200°C, 48 cm/sec) afforded a 
6:94 r a t i o  o f  (2R)-17a ( t r  = 8.31 min) t o  (2S)-17a ( t r  = 8 . 6 6  m in ) ,  and 
in d i c a te d  the  presence o f  unreacted  16b ( t r  = 5.75 min, ca. 20%). The 
t i t l e  compound was iso la te d  by f l a s h  chromatography (2 x 30 cm column, 
9:1 hexanes /e thy l  a c e ta te ,  (2S)-17a e lu t e s  second) to  a f f o r d  194 mg 
(53%) o f  (2S)-17a [ (2R)-17a:(2S)-17a = 2 :98 ]  as a w h i te  c r y s t a l l i n e  
sol id .
(4R ,5S)-3-((2S)-l-O xo-2-m ethyl-4-pentenyl)-4-m ethyl-5-phenyl-2 -  
oxazol id inone (17b, Tabl e 9 , Entry C). L i t  hi um Enol a te  A1 kyl a tio n . A
m agne t ica l ly  s t i r r e d ,  cooled (-78°C) s o lu t io n  of LDA [prepared from 3.10 
mL (2.24 g, 22.1 mmol) o f  di i sop ropy l  ami ne and 14.2 mL (1.55 M in  
hexane, 22.0 mmol) o f  n-buty l  1 i th ium ]  (0.66 M in THF) was used to  eno l -  
ize 4.60 g (19.7 mmol) of 16b. The r e s u l t a n t  l i t h i u m  enola te  was a l k y l ­
ated w i t h  5.1 mL (7.1 g, 59 mmol) o f  a l l y l  bromide acco rd ing  to  the  
genera l  a l k y l a t i o n  procedure f o r  3 h a t 0°C to  g i v e  5.28 g (98% mass 
ba lance)  o f  u n p u r i f i e d  p roduc t .  A n a ly s i s  by GC (30 m DB-1, 175°C, 79 
cm/sec) a f fo rd e d  a 2:98 r a t i o  o f  (2R )-17b ( t r  = 5.04 min) to  (2S )-17b  
( t r  = 5 . 4 5  min) ,  and in d i c a te d  th e  presence o f  both 6  ( t r  = 2.18 min, 
ca. 11%) and unreacted 16b ( t r  = 4.42 min, ca. 2%). The t i t l e  compound 
was i so la te d  by MPLC (column C, 85:15 hexanes/ethyl  acetate, 10 mL/min, 
( 2S)- 17b e lu t e s  second) to  a f f o r d  4.06 g (75%) o f  (2S)-17b as a w h i te  
c r y s t a l l i n e  s o l i d  [ (2R )-17b:(2S )-17b < 200 :1 ] :  mp 69-70°C; IR (CC 1 4 ) 
3000, 2950, 1795, 1705,1385, 1370, 1345, 1245, 1200, 1125 cm’ 1; *H NMR 
(CDC 1 3 / 9 0  MHz) § 7 .3  (m, 5H, a ro m a t ic  H 's),  6 .0-5.7 (m', 1H, C4 1 -JH), 5.55 
(d, J = 7.6 Hz, 1H, C5 -H),  5 .2 -4 . 8  (m, 2H, 4.67 (qn, J = 6 . 8
- 1 1 2 -
Hz, 1 H, C4 -H),  3.73 ( s e p t e t , J = 6.7 Hz, 1H, Cz'-H)» 2.6-1.9 (m, 2H,
C3'-Jl2)» I - 15  (d > 0 = 7 * 2 H2» 3H* c 2’ - cii3)» ° - 8 3  ( d * d = 6 * 8 Hz» 3H» c4~ 
CH3); ISC NMR (CDCI3 / 2 2 . 5  MHz) 8  174.8, 151.4, 135.1, 133.7, 128.2,
125.4, 116.7, 77.9, 54.2, 37.8, 36.7, 16.3, 14.4; S p e c i f i c  r o t a t i o n
[ a l s g g  = +47.0° , [ 0 3 5 7 7  ~ +48.2°, [ 0 3 5 4 5  = +55.1°,  [ 0 3 4 3 5  = +96.7°, 
[ a3 3 6 5 = +162.3° (c 2.36, CH2 C1 2 ); HPLC ( 8  mm x 10 cm Radia l  Pak (5 um 
s i l i c a  g e l ) ,  88:12 i s o o c t a n e / e t h y l  a c e ta te ,  2 .0m L /m in ,  k 1 (2R)-17b = 
0.97, k' (2S)-17b = 1.55, o = 1.60).
Ana l.  Calcd. f o r  C1 6 Hi g N0 3 : C, 70.31; H, 7.01. Found: C, 70.55; H,
7.16.
(4R ,5S )-3-((2S )-l-0xo-2-m ethyl-4-pentenyl) -4-methyl-5-phenyl-2 -  
oxazol id inone (17b, Tabl e 9 , Entry D). Sodium Enol a te  A1 ky l a tio n . A
magnet ica l ly  s t i r r e d ,  cooled (-78°C) s o lu t io n  o f  12.3 g (67.1 mmol) o f 
sodium hexamethyl di  si l y l  amide (0.93 M in THF) was used to  eno l ize  14.1 g 
(60.6 mmol) o f  16b. The r e s u l t a n t  sodium e n o la te  was a l k y l a t e d  w i t h
11.0 mL (20.3 g, 121 mmol) o f  a l l y l  io d id e  accord ing  to  th e  genera l 
a l k y l a t i o n  procedure f o r  3 h at -78°C to  g ive 17.2 g (104% mass balance) 
o f  u n p u r i f i e d  p roduc t .  A n a ly s i s  by GC (25 m SE-54, 175°C, 37 cm/sec) 
a f fo rd e d  a 7:93 r a t i o  o f  (2R)-17b ( t p = 7.97 min) to  (2S)-17b ( t r  = 8 . 6 6  
min). The t i t l e  compound was p u r i f ie d  by r e c r y s t a l l i z a t i o n  from pentane 
{3x ) t o  a f f o r d  13.7 g (83%) o f  (2S)-17b as a w h i te  c r y s t a l l i n e  s o l i d  
[(2R)-17b:'(2S)-17b < 1:200], iden t ica l  in a l l  respects to  the p rev ious ly  
prepared ma te r ia l .
- 1 1 3 -
(4R,5S)-3-((2S)-l-0xo-2-methyl-3-phenylmethoxypropyl) -4-methyl-5 -  
phenyl-2-oxazolidinone (17e, Table 9, Entry G). Lithium Enolate A lky la ­
t io n . A magnet ica l ly  s t i r r e d ,  cooled (-78°C) s o lu t io n  o f  LDA [prepared 
f rom 2.1 mL (1.52 g, 15.0 mmol) o f  di  i sopropy l  ami ne and 9.3 mL (1.61 M 
in  hexane, 15.0 mmol) o f  j i - b u t y  1 1 i t h i u m ]  (0.5 M in  THF) was used to  
e n o l i z e  3.15 g (13.5 mmol) o f  16b. The r e s u l t a n t  1 i t h iu m  e n o la te  was 
al  k y l  ated w i th  3.8 mL (5.4 g, 27 mmol ) o f  benzyl  bromomethyl e th e r  45 
according to  the general a l k y l a t i o n  procedure f o r  2 h at -20°C to  g ive
6.1 g (124% mass ba lance)  o f  u n p u r i f i e d  p roduct .  A n a ly s is  by GC (30 m 
DB-1, 150°C f o r  10 min, 20°C/min to  225°C, 83 cm/sec) a f fo rd e d  a 4:96 
r a t i o  o f  (2R )-17e ( t r  = 18.31 min) t o  (2S )-17e  ( t r  = 19.08 min) ,  and 
i n d i c a t e d  the presence o f  unreacted  16b ( t r  = 5.99 min, ca. 5%). The 
t i t l e  compound was i s o l a t e d  by MPLC (column C, 8:1:1 h e x a n e s /d ie th y l  
ether /dichloromethane to  a f fo rd  3.42 g (72%) o f (2S)-17e as a c o lo r le s s  
o i l  [  (2R)-17e: (2S)-17e = 1 :9 9 ] :  IR (CC14 ) 2990, 2940, 2870, 1790, 1700, 
1385, 1370, 1340, 1235, 1200, 1120, 1090 cm '1 ; XH NMR ( CC 1 4 /90 MHz) 8 
7.13 (m, 10H, a romat ic  H's),  5.45 (d, J = 7.2 Hz, 1H, C5 “ H), 4.63 (qn, J 
= 6.9 Hz, 1H, C4 -H),  4.40 (s ,  2H, 0CH2 Ph), 4.07 (m, 1H, C2 ' -H ) ,  3.67 (d 
o f  d,  J = 9.0, 7.5 Hz, 1H, C3 ' -H ) ,  3.45 (d o f  d, J = 9.0, 6.0 Hz, 1H, 
C3 . -H) ,  1.12 (d, J = 6.9 Hz, 3H, C2 '-CH3), 0.92 (d, J = 6.9 Hz, 3H, C4- 
CjH3 ) ;  13C NMR (CC14 /22.5 MHz) 8  174.1, 151.9, 138.2, 133.7, 128.2, 
127.9, 127.1, 125.6, 78.0, 72.6, 72.1 , 54.1, 38.0, 14.4, 13.7; S p e c i f i c  
r o t a t i o n  [a ]g g g  = +37.0°, [ a ] 5 7 7  = +37.3°, [ a ] 5 4g = +42.6°, [ a ] 4 3 5  = 
+ 73 .6° ,  [ a ] 3 6 5 = +119.4° (£ 2.07, CH2 C1 2 )-
An a l .  Calcd. f o r  C2 1 H2 3 N04 : C, 70.36; H, 6.79. Found: C, 70.62; H,
6 . 78 .
- 1 1 4 -
(4R ,5S)-3-((2S)-l,4-D ioxo-2-m ethyl-4-ethoxy)-4-m ethyl-5-phenyl-2 -  
oxazol idinone (17f,  Table 9, Entry H). Lithium Enolate A lky la tion . A
m a g ne t ica l ly  s t i r r e d ,  cooled (-78°C) s o lu t io n  o f  LDA [prepared from 2.3 
mL (1.6 g, 16 mmol) o f  d i i s o p ro p y la m in e  and 10 mL (1.61 M in  hexane,
16.1 mmol) o f  j i - b u ty l  1 i th ium ]  (0.37 M in  THF) was used to enol ize  3.43 g 
(14.7 mmol) o f  16b. The r e s u l t a n t  l i t h i u m  e n o la te  was a l k y l a t e d  w i th
4.9 mL (7.4 g, 44 mmol) o f  ethyl  2-bromoacetate according to  the general 
a l k y l a t i o n  procedure f o r  2 h at 0°C to  g ive 3.95 g (84% mass balance) of 
u n p u r i f i e d  p roduc t .  A n a ly s i s  by GC (30 m DB-1, 200°C, 8 8  cm/sec) a f ­
fo rd e d  a 7:93 r a t i o  o f  (2R ) -17 f  ( t r  = 5.75 min) to  (2 S ) -1 7 f  ( t r  -  6*28 
m in ) ,  and i n d i c a t e d  the  presence o f  both unreacted  16b ( t r  = 1.70 min, 
ca. 8 %) and an u n i d e n t i f i e d  m a te r ia l  ( t r  = 3.42 min, ca. 17%). The 
t i t l e  compound was i s o l a t e d  by MPLC (column C, 8:2 h e xa n e s /d ie th y l  
e t h e r ,  10 mL/min) t o  a f f o r d  2.40 g (51%) o f  ( 2 S ) -1 7 f  as a c o l o r l e s s  
l i q u i d  [  ( 2 R ) - 1 7 f : ( 2 S ) -1 7 f  = 1 :99 ] :  IR (CC1 4 ) 2990, 1795, 1740, 1705, 
1370, 1345, 1250, 1190, 1120, 1030 cm'1; ^  NMR (CC14/90 MHz) $ 7.28 (s,
5H, a rom a t ic  H's),  5.57 (d, J = 7.2 Hz, 1H, C5 -H).  4.63 (qn, J = 6 . 8  Hz,
1H, C4 -H),  4.2-3.9 (m, 3H, C2 ' -H, 0CH2 CH3 ), 2.80 (d o f  d, J = 18, 10 Hz, 
1H, C3 ' -H ) ,  2.30 (d o f  d, J = 18, 5 Hz, 1H, C3 ' -H ) ,  1.23 ( t ,  J = 7.2 Hz,
3H, 0CH2 CH3) ,  0.98 (d, J = 7.0 Hz, 3H, C2 t-CJH3 ) 0.87 (d, J = 6 . 8  Hz, 3H,
c4 -CH3); 13C NMR (CC14 /22.5  MHz) S 174.8, 170.4, 152.9, 133.8, 128.2,
125.5, 78.0, 59.6, 54.3, 37.4, 33.9, 17.0, 14.1, 13.9; S p e c i f i c  r o t a t i o n  
Ea.H589 = +35.7°,  [ 0 3 5 7 7  = +36.8°, [ 0 3 5 4 5  = +41.9° , [ a ] 4 3 5 = +70.3°, 
[<*3365 = +1 1 0-7° (c 1.78, CH2 C12).
Ana l .  Calcd. f o r  C j 7 H2 ^N0 5 : C, 63.94; H, 6.63. Found: C, 64.03; H,
6.63.
- 1 1 5 -
(4R,5S}-3-((2S)-l-0xo-2-m ethyl-3-phenyl propyl )-4-aethyl-5-phenyl -2 -  
oxazolidinone (17g, Table 9, Entry I) .  Lithium Enolate A lky lation . A
m agnet ica l ly  s t i r r e d ,  cooled (-78°C) so lu t io n  of LDA [prepared from 1.9 
mL (1.4 g, 14 mmol) o f  d i i s o p r o p y 1 amine and 8 . 6  mL (1.57 M in  hexane,
13.5 mmol) o f  n -buty l  1 i th iu m ]  (0.11 M in THF) was used to  eno l ize  2.91 g 
(12.5 mmol) o f  imide 16b. The re su l tan t  l i t h iu m  enola te  was a lky la te d  
w i t h  1.6 mL (2.3 g, 13.5 mmol) o f  benzyl bromide accord ing  to  the  
genera l  a l k y l  a t i o n  procedure f o r  2 h a t  0°C t o  g i v e  4.07 g (101% mass 
ba lance )  o f  u n p u r i f i e d  p roduc t .  A n a ly s is  by GC (30 m DB-1, 225°C, 77 
cm/sec) a f fo rd e d  a 2:98 r a t i o  o f  (2R)-17g ( t r  = 4.33 min) to  ( 2S)- 1 7 g 
( t r  = 4.99 min). The t i t l e  compound was iso la te d  by f l a s h  chromatogra­
phy (3 x 30 cm column, 85:15 hexanes /e thy l  a c e ta te ,  (2S)-17g e lu t e d  
second) t o  a f f o r d  2.93 g (73%) o f  (2S)-17g as a v iscous  c o l o r l e s s  o i l  
L(2R)-17g:(2S)-17g < 1 :9 9 ] :  IR (CC14) 1790, 1705, 1340, 1190 cm"1; XH 
NMR (CCI4 / 9 O MHz) S 7.2 (s ,  5H, aromat ic  H's), 6.7 (s ,  5H, aromat ic  
H 's),  5.47 (d, J = 7.2 Hz, 1H, C5 -H), 4.63 (qn, J = 6 . 8  Hz, 1H, C4 -H),
4.0 (m, 1H, Cz .-H) , 3.05 (d o f  d, J = 13.5, 6.4 Hz, 1 H, C3 >-H), 2.58 (d 
o f  d, J = 13.5, 8.1 Hz, 1H, C3 *-H), 1.08 (d, J = 6.9 Hz, 3H, C2 >-CH3), 
0.65 (d, J = 6 . 8  Hz, 3H, C4 -CH3); 13C NMR (CCl4 /22.5 MHz) S 175.2,
151.8, 138.9, 133.7, 129.0, 128.3, 128.0, 125.9, 125.5, 78.1 , 54.1 , 
39.7, 39.1, 16.1 , 14.2; S p e c i f i c  r o t a t i o n  [ a ] 5 8 9  = +78.5° (c 1.68, 
CH2 C1 2 ); HPLC ( 8  mm x 10 cm Radia l  Pak (10 um s i l i c a  g e l ) ,  88:12 i s o ­
o c ta n e /e th y l  a c e ta te ,  2.0 mL/min, k' (2R)-17g = 1.27, k' (2S)-17g =
2.02, a = 1.59).
Anal.  Calcd. f o r  C2 qH2 jN 0 3 : C, 74.28; H, 6.55. Found: C, 74.50; H,
6. 55.
- 1 1 6 -
(4R ,5S)-3-{(2S)-l-0xo-2-m ethyl-3-phenyl propyl) -4-methyl -5-phenyl-2 - 
oxazol id inone (17g, Tabl e 9 , Entry J ). Sodium Enol ate A1 kyl a tio n . A
m agne t ica l ly  s t i r r e d ,  cooled (-78°C) s o lu t io n  o f 10.5 g (57.3 mmol) of 
sodium hexam ethy ld is i l y l  amide (0.85 M in  THF) was used to  eno l ize  12.0 g 
(51.4 mmol) o f  imide 16 b. The r e s u l t a n t  sodium enol ate was a l k y l a t e d  
w i t h  7.4 mL (10.6 g, 62.2 mmol) o f  benzyl bromide a cco rd ing  to  the 
general a l k y l a t i o n  procedure f o r  3 h at -78°C to  g ive 17.9 g (108% mass 
ba lance )  o f  u n p u r i f i e d  p roduct .  A n a ly s i s  by GC (30 m DB-1, 225°C, 77 
cm/sec) a f fo rd e d  a 2:98 r a t i o  o f  (2R)-17g ( t r  = 4.33 min) t o  (2S)-17g 
( t r  = 4.99 min).  The t i t l e  compound was i s o l a t e d  by MPLC (column C, 7:3 
h e x a n e s /d ie th y l  e t h e r ,  10 mL/min, (2S)-17g e lu t e d  second) in  two p o r ­
t i o n s  t o  a f f o r d  13.1 g (79%) o f  (2S)-17g as a v iscous  c o l o r l e s s  l i q u i d  
[(2R)-17g:(2S)-17g < 1:99],  i d e n t ica l  in a l l  respects to the p rev ious ly  
prepared m a te r ia l .
( 4R, 5S) - 3 - ( { 2R)-1-Oxo-2-methy1 butyl)-4-methy 1-5-phenyl-2-oxazol-  
id inone (17h, Tabl e 9 , Entry K). Lithiurn Enol ate A1 k y la t io n . A mag­
n e t ica l  l y  s t i r r e d ,  cooled (-78°C) s o lu t io n  o f LDA [prepared from 2.00 mL 
(1.44 g, 14.3 mmol) o f  di i sopropy l  ami ne and 8 . 8  mL (1.61 M in  hexane,
14.2 mmol) o f  j i -bu ty l  1 i t h i  um] (0.43 M in  THF) was used to  enol ize  3.19 g 
(12.9 mmol) o f  imide 16c. The re s u l t a n t  l i t h iu m  enolate was a lky la te d  
w i t h  2.4 mL (5.5 g, 39 mmol) o f  methy l io d id e  accord ing  to  the  general 
a l k y l a t i o n  procedure f o r  2 h at 0°C to  g ive  3.25 g (96% mass balance) of 
u n p u r i f i e d  p roduc t .  A n a ly s i s  by GC (30 m DB-1, 175°C, 93 cm/sec) a f ­
fo rd e d  an 87:13 r a t i o  o f  (2R) - 17h ( t r  = 4.54 min) to  (2S)-17h ( t r  = 4.67 
min). The t i t l e  compound was iso la te d  by MPLC (column C, 85:15 hexanes/ 
d ie th y l  e ther ,  11 mL/min, (2R)-17h elu ted  f i r s t )  to  a f fo rd  2.51 g (75%)
- 1 1 7 -
o f  (2R)-17h as a whi te c r y s t a l l i n e  s o l i d  [(2R)-17h:(2S)-17h >99:1]: mp 
65-66°C; IR (CH2 C12 ) 2980, 2950, 2880, 1780, 1700, 1385, 1370, 1345, 
1235, 1200, 1125 cm- 1 ; NMR (CCI4 / 9 O MHz) 7.3 (s,.5H, a romat ic  H's), 
5.55 {d, J = 7.2 Hz, 1H, C5 -H),  4.66 (qn, J = 6 . 8  Hz, 1H, C4 -H )» 3.56 
( s e p t e t ,  J = 6.9 Hz, 1H, C2«- H), 2.0-1.2 (m, 2H, C ^ - l ^ ) ,  1-13 (d, J =
7.5 Hz, 3H, C2 ' -CH3), 0.90 ( t ,  J = 7.5 Hz, 3H, C4 <-H3), 0.85 (d, J = 6 . 8  
Hz, 3H, C4 -CH3 ); 13C NMR (CDC 1 3 /22.5 MHz) S 176.0, 152.0, 133.1 , 128.0,
125.2, 78.1, 54.1, 38.6, 25.9, 16.0, 13.8, 11.0; S p e c i f i c  r o t a t i o n
^ 5 8 9  = +6 - l c » [ ° ] 577 = +7.3°, [ a ] g 4 g = +8.2°, [ a ] 4 3 5 = +18.1°, [ a ] 365 
= +42.6° (c 1.72, CH2 C1 2).
An a l .  Ca lcd .  f o r  CjgHjgN03: C, 68.94; H, 7.33. Found: C, 69.11; H,
7.24.
(4R ,5S )-3-((2R )-l-0xo-2-m ethylbuty l) -4-m ethyl-5-phenyl-2-oxazol-  
idinone (17h, Table 9, Entry L). Sodium Enolate A lky la tion . A magneti­
ca l  l y  s t i r  red, co o le d  (-78°C) sol ut ion o f  11.0 g (60.0 mmol) o f  sodium 
hexamethyl d i  s i  1 y l  amide (0.64 M in  THF) was used to  e n o l i z e  1.1 g (45.0 
mmol) o f  imide 16c. The re s u l ta n t  sodium enolate was a lk y la te d  with 16 
mL (36 g, 260 mmol) o f  methyl iodide according to  the general a l k y l a t i o n  
procedure  f o r  3 h a t  -78°C to  g iv e  11.5 g ( 9 7 %  mass ba lance)  o f  u n p u r i ­
f i e d  product. Ana lys is  by GC (30 m DB-1, 175°C, 106 cm/sec) afforded a 
94:6 r a t i o  o f  (2R)-17h ( t r  = 3.98 min) t o  (2S)-17h ( t r  = 4.07 min). The 
t i t l e  compound was i s o l a t e d  by MPLC (column C, 95:5 hexanes/THF, 10 
mL/min, (2R)-17h e lu t e d  f i r s t )  i n  th re e  p o r t i o n s  to  a f f o r d  9.7 g (82%) 
o f  (2R)-17h as a w h i te  c r y s t a l l i n e  s o l i d  [ (2R)-17h:(2S)-17h > 9 9 :1 ] ,  
i d e n t i c a l  in  a l l  respects to  the p rev ious ly  prepared m a te r ia l .
- 1 1 8 -
(4R,5S) - 3 - ( ( 2R)-1-Oxo-2-methylb u ty l) -4-m ethyl-5-phenyl-2-oxazoli-  
dinone (17h, Table 7, Entry C). Potassium Enolate A lky la tio n . A mag- 
n e t i c a l  l y  s t i r r e d ,  coo led  (-78°C) s o l u t i o n  o f  0.207 g (0.838 mmol) o f  
im ide 16c {0.1 M in  THF) was enol ized w i t h  2.0 mL (0.50 M in  THF, 1.0 
mmol) o f  potassium hexamethyl d i  s i  1 y l  amide and a l k y l a t e d  w i t h  0.24 mL 
(0.55 g, 3.9 mmol) of methyl iodide according to  the general a l k y l a t i o n  
procedure f o r  2 h a t -78°C to  g i v e  0.20 g (91% mass ba lance )  o f  u n p u r i ­
f i e d  product. Analysis by GC (30 m DB-1, 175°C, 93 cm/sec) afforded an 
81:19 r a t i o  o f  (2R)-17h ( t r  = 4.54 min) to  (2S)-17h ( t r  = 4.67 min).
(4R, 5S) - 3 - ( ( 2R)-1 -Ox o-2-methy1 bu ty l) -4-methyl-5-pheny1-2 -o xazo li-  
dinone {17h, Table 7, Entry D). Magnesium Enolate A lky la tion . A mag­
n e t i c a l l y  s t i r r e d ,  cooled (-78°C) s o lu t io n  o f  LDA [prepared from 0.15 mL 
(0.112 g, 1.10 mmol) o f  di i sopropy 1 ami ne and 0.72 ml (1.53 M in  hexane, 
1.11 mmol) o f  jn-butyl  1 i t h i  urn] (0.2 M in  THF) was used to eno l ize  0.250 g 
(1.00 mmol) o f  imide 16c. A f t e r  0.5 h at -78°C a s o l u t i o n  o f  anhydrous 
magnesium bromide (ca. 210 mg, 1.14 mmol) in  5 mL of 1:1 benzene/diethyl  
e ther  was added. The re su l ta n t  magnesium enolate was a lk y la te d  with 0.2 
mL (0.57 g, 4 mmol) of methyl iodide according to  the general a l k y l a t i o n  
procedure f o r  2 h at 0°C to  g ive  0.21 g (78% mass balance) of unpur i f ied  
p roduc t .  A n a ly s i s  by GC (30 m SE-54, 175°C, 48 cm/sec) a f fo rd e d  a 94:6 
r a t i o  o f  ( 2R) - 1 7 h ( t r  = 8.31 min) t o  (2S)-17h ( t r  = 8 . 6 6  min) and 
i n d i c a t e d  the  presence o f  unreacted 16c ( t r  = 5.75 min). No e n o la te  
decomposition products were observed.
- 1 1 9 -
(4R ,5S)-3-((2R )-l-0xo-2,3-d im ethylbutyl)-4-roethyl-5-phenyl-2-oxazol- 
id inone (171, Tabl e 9 , Entry M). L ithium  Enol a te  A1 kyl a tio n . A mag­
n e t i c a l l y  s t i r r e d ,  cooled (-78°C) s o lu t io n  of LDA [prepared from 0.175 
mL (0.125 g, 1.25 mmol) o f  di  i sopropy l  ami ne and 0.77 mL (1.61 M in  
hexane, 1.24 mmol) o f  n-butyl  1 i th iurn] (0.1 M in THF) was used to  eno l ize  
0.297 g (1.14 mmol) o f  imide 16d. The r e s u l t a n t  l i t h i u m  enol a te  was 
a lk y la te d  with  0.21 mL (0.48 g, 3.37 mmol) o f  methyl iodide according to  
th e  genera l  a l k y l a t i o n  procedure f o r  2 h a t  -10°C to  g iv e  0.33 g (105% 
mass balance) of unpur i f ied  product. Analys is  by GC (30 m DB-1, 175°C, 
83 cm/sec) a f fo rd e d  a 87:13 r a t i o  o f  (2R) -17 i  ( t r  = 4.98 min) t o  (2S)- 
17i ( t r  = 5.30 min) ,  and in d i c a te d  the  presence o f  both 6 ( t r  = 2.15 
min, ca. 6 %) and unreacted im ide 16d ( t r  = 4.33 min, ca. 11%). The 
t i t l e  compound was iso la te d  by MPLC (column B, 9:1 hexanes/ethyl  ace­
ta te ,  5 mL/min, (2R)-17i e lu ted f i r s t )  to  a f fo rd  0.173 g (54%) o f 17i  as 
a c o lo r l e s s  o i l  [ (2R)-17 i : (2S)-17i > 991): IR (CH2 C12) 3060, 2995, 1780, 
1 700, 1420, 1380, 1270, 890 cm” 1; l H NMR (CDCl3/90  MHz) 8  7.33 (m, 5H, 
a ro m a t ic  H 's),  5.62 (d, J = 7.2 Hz, 1H, C5 -H) ,  4.73 (qn, J = 6 . 8  Hz, 1H, 
C4 -H) ,  3.60 (qn, J = 7.0 Hz, 1H, C2 --H),  2.2-1.7 (m, 1H, C31-H) ,  1.13 
(d, J = 7.2 Hz, 3H, C2 «-CH3), 1.0-0.8 (m, 9H, C4 -CH3 , C3 ' -CH3 , C4 . -H3); 
13C NMR (CDCI3 / 2 2 . 5  MHz) 8  176.7, 152.7, 133.4, 128.6, 125.6, 78.7,
55.0, 43.7, 30.7, 21.2, 18.6, 14.3, 13.6; S p e c i f i c  r o t a t i o n  [a lg g g  = 
-8 .3 ° ,  [ a ] 5 7 7  = -8 .4 ° ,  [ 0 3 5 4 5  = "8*9°, [ a ] 4 3 5 = -13 .7° ,  [ o ] 3 5 5  = 14.5° 
(£ 2.42, CH2 C1 2); HPLC ( 8  mm x 10 cm Radia l  Pak (5 pm si  1 ica  g e l ), 88:12 
i s o o c t a n e / e t h y 1 a ce ta te ,  2.0 mL/min, k' (2R) -17 i  = 0.82, k' (2 S ) -1 7 i  =
1.53, a = 1.84).
- 1 2 0 -
(AR.SSj-S-UZRj- l -Oxo-Z.S.S-tr imethy l  b u t y l ) -4-methy l-5-pheny l -2 -  
oxazol id inone (17 j ,  Tab le  9, Entry N). Lith ium Enolate A l k y la t io n .  A
magneti  c a 1 l y  s t i  r r e d ,  coo led  {-78°C) s o l u t i o n  o f  LDA [p re p a re d  from 
0.165 mL (0.119 g, 1.18 mmol) o f  d i i s o p r o p y la m in e  and 0.73 mL (1.61 M in  
hexane, 1.18 mmol) o f  n-buty l  1 i t h ium ]  (0.1 M in  THF) was used to  eno l ize  
0.295 g (1.07 mmol) o f  im ide 16f.  The r e s u l t a n t  l i t h i u m  enol ate  was 
a lk y la te d  with 0.20 mL (0.46 g, 3.2 mmol) o f  methyl iod ide according to  
the general a lk y l  a t ion  procedure f o r  2 h at -10°C to  g ive  0.307 g (101% 
mass balance) of unpu r i f ied  product. Analys is  by GC (30 m DB-1, 175°C, 
83 cm/sec cm/sec) a f fo rd e d  a 94:6 r a t i o  o f  ( 2 R ) -1 7 j  ( t r  = 5.76 min) to  
(2 S ) -1 7 j  ( t r  = 6.33 m in ) ,  and i n d i c a te d  th e  presence o f  6  ( t r  = 2.15 
min, ca. 4%). The t i t l e  compound was i so la te d  by MPLC (column B, 85:15 
hexanes/diethyl  e t h e r , 5 mL/min, (2R)-17j e lu ted  f i r s t )  to  a f fo rd  0.172 g 
(56%) o f  (2R)-17 j  as a w h i te  c r y s t a l l i n e  s o l i d  [ { 2 R ) - 1 7 j : ( 2 S ) - 1 7 j  >
99:1]: mp 82-83°C; IR (CH2C12) 3050> 298o> 1775» 1695> 1380> 1365> 1340> 
1240, 1190 cm- 1 ; 1h NMR (CDCI3 / 9 O MHz) 8  7.5 (s,  5H, a romat i  c H 's ) , 5.60 
(d, J = 7.2 Hz, 1H, C5 -H) ,  4.75 (qn, J = 6 . 8  Hz, 1H, C4 -H ) ,  3 * 6 8  (q,  J =
7.0 Hz, 1H, C2 . -H) ,  1.13 (d, J = 7.5 Hz, 3H, C2 *-CH3 ) , 1.03 (s,  9H, C3 ' -  
( ci l 3 )3 )* 0.90 (d, J = 7.5 Hz, 3H, C4 -CH3 ); 13° NMR (CDC1 3 /22.5 MHz) §
176.4, 153.0, 133.4, 128.7, 125.6, 78.5, 55.1 , 44.9, 33.5, 27.4, 14.3, 
12.9; Spec if ic  ro ta t io n  [ a ] 5 8g = -13.1°, [CO577  = - l 3-3° i  [<*3546 =
-1 5 .0 ° ,  [ a ] 4 3 5  = -2 5 .8 ° ,  [ a ] 3 6 5  = -36.0° (c 3.60, CH2 C12); HPLC ( 8 mm x 
10 crn Radia l  Pak (5 pm s i l i c a  g e l ) ,  8 8 :12 i s o o c ta n e /e th y l  a c e ta te ,
2.0 mL/min, k' (2R) -17 j  = 0.55, k' (2 S ) -17 j  = 1.06, a = 1.93).
- 1 2 1 -
(4R, 5S) - 3 - ( ( 2R) -1 -Oxo-2-phenylmethy11h1omethy1 -3 -phenyl p ropy l ) -4 -  
m e thy l -5 -pheny l -2 -oxazo l id inone (17k, Table 9, Entry 0). Li th ium Enol-  
a te  A l k y l  a t i o n .  A magnetical  l y  s t i r r e d ,  cooled (-78°C) s o lu t io n  o f  LDA 
[p re p a re d  from 9.5 mL (6.9 g, 67.8 mmol) o f  d i i s o p r o p y la m in e  and 40 mL 
(1.69 M in hexane, 67.6 mmol) o f  jn-butyl  1 i th ium ]  (0.5 M in THF) was used 
to  e n o l i z e  20.0 g (64.6 mmol) o f  imide 16h. The r e s u l t a n t  l i t h i u m  
enol ate was a lk y la te d  with  10.6 mL (15.5 g, 71.3 mmol) o f  benzyl bromo- 
methyl s u l f i d e  46b according to  the general a l k y l a t i o n  procedure f o r  2 h 
at -25°C and 2 h at 0°C to g ive  31.3 g (108% mass balance) of unpur i f ied 
p roduc t .  A n a ly s i s  by GC (30 m DB-1, 200°C f o r  10 min, 25°C/min to  
275°C, ( i n je c to r  and de tec tor  = 300°C), 90 cm/sec) afforded a 98:2 r a t i o  
o f  (2R)-17k ( t p = 17.92 min) t o  (2S)-17k ( t r  = 18.12 min) ,  and i n d i c a te d  
th e  presence o f  both 6  ( t r  = 1.19 min, ca. 5%) and unreacted 16h ( t r  =
8.60 min, ca. 8 %). The t i t l e  compound was i s o l a t e d  by chromatography 
(Waters Prep-500, two 5 x 30 cm columns, hexanes/ethyl  acetate (adjusted 
t o  TLC Rf = 0.09) ,  250 mL/min) in  th re e  p o r t i o n s  to  a f f o r d  21.8 g (76%) 
o f  (2R)-17k as a c o l o r l e s s ,  v iscou s  o i l  [ (2R ) -17k : (2S ) -17k  = 98 :2 ] :  IR 
(nea t )  3030, 2920, 1780, 1700, 1490, 1450, 1380, 1340, 1190, 1120 cm '1 ; 
XH NMR (CDCl 3/500 MHz) S 7.42-7.20 (m, 15H, a romat ic  H 's),  5.18 (d, J =
7.0 Hz, 1H, C5 -H),  4.61-4.52 (m, 2H, C4 -H, C2 ' -H ) ,  3.77 (d, J = 13.5 Hz, 
1H, SCH(H)Ph), 3.72 (d, J = 13.5 Hz, 1 H, SCH(H)Ph), 2.91 (d o f  d, J =
13.0, 8 . 8  Hz, 1H, C3 ' -H ) ,  2.86 (d o f  d, J = 13.0, 7.3 Hz, 1H, C3 '-H)> 
2.83 (d o f  d, J = 13.8, 9.9 Hz, 1H, CZ--CH(H)S), 2.53 (d o f  d, 0 = 13.7,
5.0 Hz, 1H, C2 ' -CH(H)S), 0.89 (d, J = 6.5 Hz, 3H, C4 -CH3 ) ; 13C NMR 
(CDC13 / 2 2 . 5  MHz) S 174.5, 152.6, 138.2, 138.0, 133.1 , 129.1, 128.9,
128.6, 128.4, 126.9, 126.6, 125.5, 78.7, 55.0, 44.6, 39.0, 35.9, 32.2, 
14.4; S p e c i f i c  r o t a t i o n  [ 0O 5 3 9  = +70.6°, [ 0 ^ 5 7 7  = +74.2°, [ 0 3 5 4 5  =
- 1 2 2 -
+84.5°, [a ]4 3 5  = +150.0°, [a ]3 6 5  = +253.1° (c 1.42, CHgClg); HPLC ( 8  mm 
x 10 cm Radial Pak (5 pm s i l i c a  g e l ) ,  88:12 isooctane/e thy l  acetate, 2.0 
mL/min, k' (2R)-17k = 1.98, k' (2S)-17k = 1.69, a = 1.17);  TLC (7:3 
hexanes/ethyl  acetate, = 0 .4 4 ).
Ana l .  Ca 1 cd. f o r  C2 7 H2 7 N0 3 S: C, 72.78; H, 6.11. Found: C, 73.03; 
H, 6.07.
(4R ,5S)-3-((2R)-l-0xo-2-m ethyldecyl)-4-m ethyl-5-phenyl-2-oxazoli- 
dinone (171, Table 9, Entry P). Lithium Enol ate A lky la tion . A magneti­
c a l l y  s t i r r e d ,  coo led  ( - 7 8 ° C) s o l u t i o n  o f  LDA [p repared  from 1.60 ml 
(1.16 g, 11.4 mmol) o f  di  i sopropy l  ami ne and 7.0 ml (1.61 M in  hexane,
11.3 mmol) o f  _n-butyl  1 i t h i u m ]  (0.2 M in  THF) was used to  enol ize 3.39 g 
(10.2 mmol) o f imide 16 i. The re su l ta n t  l i t h i u m  enolate was a lk y la te d  
w i t h  2.6 mL (5.9 g, 42 mmol) o f  methyl i o d id e  accord ing  to  the  genera l 
a l k y l a t i o n  procedure  f o r  2 h a t 0°C to  g i v e  3.67 g (104% mass ba lance)  
o f  u n p u r i f i e d  p roduct.  A n a ly s i s  by GC (30 m SE-54, 200°C, 75 cm/sec) 
a f fo r d e d  a 89:11 r a t i o  o f  (2R)-171 ( t r  = 14.19 min) t o  (2SJ-171 ( t r  = 
14.55 min). The t i t l e  compound was i s o l a t e d  by MPLC (column C, 7:3 
hexanes/diethyl  e th e r ,10 mL/min, (2R)-171 e lu ted  f i r s t )  to  a f fo rd  2.45 g 
(70%) o f  ( 2R)-171 as a w h i te  c r y s t a l l i n e  s o l i d  [ (2R)-171: (2S)-171 > 
200:1]: mp 42-43°C; IR (CH2C12 ) 3060> 2990> 294°* 2860» 1780> 170°*
1340, 1200 cm“ l ;  NMR (CCI4 / 9 0  MHz) § 7.3 (s ,  5H, aromat ic  H's), 5.53 
(d, J = 7.2 Hz, 1H, C5 -H) ,  4.63 (qn, J = 6.9 Hz, 1H, C4 -H),  3.60 (q, 0 =
7.0 Hz, 1H, C2 ' -H ) ,  1.27 (b r  s, 14H, a l i p h a t i c  H's),  1.13 (d, J = 7.0 
Hz, 3H, C2 --CH3),  0.87 (m, 6 H, C4 -CH3 , C io '-H/} ) ;  S p e c i f i c  r o t a t i o n  
[ a ] 5 3 9 = -1 .4 ° ,  [a ]577  = -0 .4 ° ,  [ 0 ^ 5 4 6  = -0 .6 ° ,  [ 0 3 4 3 5  = +1*9°* [a^365 =
- 1 2 3 -
+13.6° (c 1.6, CHgC 1 2 ) i HPLC (8mm x 10  cmRadia l  Pak {5 pm s i l i c a  g e l ) ,  
88:12, 2.0 mL/min, k' (2R)-171 = 0.40, k' (2S)-171 = 1.06, a = 2.65).
Ana l .  Calcd. f o r  C2 1 H3 1 NO3 : C, 73.01; H, 9.04. Found: C, 73.18; H,
9.25.
(4R,5S)-3-((ZR)-l-Oxo-2-m ethy1decyl)-4-m ethyl-5-phenyl-2-oxazol- 
idinone (171, Table 9, Entry Q). Sodium Enolate A lky la tion . A magneti- 
ca 1 1 y s t  i r r e d ,  coo led  (-78°C) s o l u t i o n  o f  0.25 g (1.37 mmol) o f  sod i um 
h e xam e th y ld is i l y l  amide (0.1 M in THF) was used to  eno l ize  0.406 g (1.23 
mmol) o f  im ide 1 6 i . The r e s u l t a n t  sodium e n o la te  was a l k y l a t e d  w i th  
0.31 mL (0.71 g, 5.0 mmol) o f  methy l io d id e  accord ing  to  th e  genera l 
a l k y l a t i o n  procedure f o r  2 h at -78°C to  g ive 0.421 g (99% mass balance) 
o f  u n p u r i f i e d  p roduc t .  A n a ly s i s  by GC (30 m SE-54, 200°C, 75 cm/sec) 
a f fo rd e d  a 94:6 r a t i o  o f  (2R)-171 ( t r  = 14.17 min) to  ( 2S)-171 ( t r  = 
14.53 min). The t i t l e  compound was i so la te d  by f la sh  chromatography (2 
x 30 cm column, 85:15 hexanes/ethyl  acetate, (2R)-171 e lu ted  f i r s t )  to 
a f f o r d  0.361 g (85%) o f  ( 2R)-17 1 as a w h i te  c r y s t a l l i n e  s o l i d  [ ( 2R)- 
1 7 1 : (2S ) -1 7 1  > 200 :1 ] ,  i d e n t i c a l  in  a l l  respec ts  to  the  p r e v i o u s l y  
prepared ma te r ia l .
(4S )-3-((2R )-l-0xo -2-m ethyl-4 -pentenyl)-4 -(2 -m ethylethyl)-2 -oxazo l- 
idinone (21b, Table 10, Entry B). t ith iu n  Enolate A lky la tion . A mag­
n e t i c a l l y  s t i r r e d ,  cooled (-78°C) s o lu t io n  o f LDA [prepared from 4.4 mL 
(3.2 g, 31 mmol) o f  di i so p ropy l  ami ne and 20.0 mL (1.55 M in  hexane, 31.0 
mmol) o f  _n-butyl 1 i t h i  um] (1.0 M in THF) was used to  eno l ize  5.21 g (28.1 
mmol) o f  imide 20b. The re s u l ta n t  l i t h iu m  enolate was a lk y la te d  with
7.3 mL (10 g, 84 mmol) of a l l y l  bromide according to the general a l k y l a ­
t i o n  procedure f o r  2 h a t  -10°C t o  g i v e  6.04 g (95% mass ba lance )  o f
- 1 2 4 -
u n p u r i f i e d  p roduc t .  A n a ly s i s  by GC (30 m DB-1, 125°C, 85 cm/sec) a f ­
fo rd e d  a 98:2 r a t i o  o f  (2R)-21b ( t r  = 5.71 min) t o  (2S)-21b ( t r  = 5.12 
min). The t i t l e  compound was i so la te d  by MPLC (column C, 9:1 hexanes/ 
d ie th y l  e ther ,  10 mL/min, (2R)-21b elu ted  second) to  a f fo rd  4.52 g (75%) 
o f  (2R)-21b as a c o l o r l e s s  l i q u i d  [ (2R)-21b:(2S)-21b > 9 9 :1 ] :  1R 
(CH2 c 1 2 ) 3060. 2970, 2940, 2880, 1780, 1700, 1385, 1300, 1240, 1 2 2 0 , 
1210 cm-1; lH NMR (CDCI3 / 9 O MHz) § 6.0-5.5 (m, 1H, C4 ' -H ) ,  5.2-4.9 (m, 
2 H, C5 1 - H2 ) ,  4.5-4.1 (m, 3H, C4 -H, C5 -H2 ) ,  3.85 (m, J = 7.0 Hz, 1H, C z ' ~  
H), 2.7-2.0 (m, 3H, C4 -CH, C3 ■ - ^ 2 ) ,  1.13 (d, J = 7.0 Hz, 3H, C2 '-CH3 ), 
0.95 (d, J = 6 . 8  Hz, 3H, CH(CH3 ) , 0.89 (d, J = 6 . 8  Hz, 3H, CH(CH3 ); 13C 
NMR (CDCI3 / 2 2 . 5  MHz) S 176.2, 153.7, 135.3, 117.0, 63.2, 58.4, 38.3,
37.2, 28.5, 17.9, 16.2, 14.7; S p e c i f i c  r o t a t i o n  [a ]589  = +62.9°, C0(^577  
= +65.2°, [ a ] 5 4 6  = +73.9°, [ ^ 4 3 5  = +126.3°, [ a ] 3 6 5 = +199.1° (c 3.48, 
CH2 C12 )•
Ana l .  Calcd. f o r  C1 2 Hi g N0 3 : C, 63.98; H, 8.50. Found: C, 64.17; H,
8.60.
(4S)-3-((2R)-l-0xo-2-m ethyl-3-phenylm ethoxypropyl)-4-{2-m ethyl- 
ethyl)-2-oxazolid inone (21e, Table 10, Entry E). Lithium Enolate Alky­
la t io n .  A m agne t ica l ly  s t i r r e d ,  cooled (-78°C) s o lu t io n  o f LDA [p re ­
pared from 15.4 mL (11.1 g, 110 mmol) o f  d i i s o p r o p y l  amine and 65 mL 
(1.70 M_ in  hexane, 110 mmol) o f  _n-butyl 1 i t h i  um] (1 M in  THF) was used to 
e n o l i  ze 18.5 g (100 mmol) o f  20b. The r e s u l t a n t  1 i t h i  um e n o la te  was 
a l k y l a t e d  w i t h  28 mL (40 g, 200 mmol) o f  benzyl bromomethyl e th e r  45 
according to  the general a l k y l a t i o n  procedure fo r  4 h a t -45°C, then 1 h 
at 0°C. To the react ion mix ture was added 24 mL (24 g, 300 mmol) o f  dry
- 1 2 5 -
p y r i d i n e  and 19 mL (20.5 g, 200 mmol) o f  a c e t i c  anhydr ide.  The m ix tu re  
was s t i r r e d  fo r  4 h at room temperature. The mixture was t rans fe r red  to  
a 1-L f l a s k ,  c a u t i o u s l y  d i l u t e d  w i t h  250 mL o f  2 M aqueous potassium 
b ic a rb o n a te ,  and s t i r r e d  a t room tem pera tu re  u n t i l  the  e v o l u t i o n  o f  
carbon d iox ide ceased (ca. 2 h). The mixture was concentrated j_n vacuo 
and th e  product  e x t r a c te d  i n t o  d i c h l  oromethane (3 x 200 mL). The com­
bined organic ex t rac ts  were washed with  water (2 x), 1 M aqueous hydro­
c h lo r i c  acid (2 x), 1 M aqueous potassium bicarbonate, and br ine, dr ied 
over anhydrous magnesium s u l f a te  and concentrated i_n vacuo. Analysis by 
GC (30 m DB-1, 100°C fo r  2 min, 20°C/min to  200°C, 8 8  cm/sec) afforded a 
98:2 r a t i o  o f  (2R)-21e ( t r  = 9.85 min) to  (2S)-21e ( t r  = 9.63 min). The 
t i t l e  compound was iso la ted  in  two port ions by f la sh  chromatography (7 x 
70 cm column, 95:5 h e x a n e s / t e t r a h y d ro fu ra n )  to  a f f o r d  18.9-22.6 g (62- 
74%) o f  2 1 e as a c o l o r l e s s  o i l  [ ( 2 R )- 2 1 e : ( 2 S )-2 1 e = 9 9 :1 ] :  IR (CH2 C12) 
3060, 2980, 1780, 1705, 1390, 1235, 1210 cm’ 1; NMR (CDC13/90 MHz) 8  
7.2 (s ,  5H, a romat ic  H's),  4.45 (s ,  2H, OC^Ph),  4.5-4.0 (m, 4H, C4 -H, 
C5 -H2 , C2 ' -H ) ,  3.70 (d o f  d, J = 8.4, 7.5 Hz, 1H, C3 ' -H ) ,  3.50 (d o f  d, 
J = 8.4, 5.7 Hz, 1H, C3 *-H), 2.32 (m, 1H, C4 -CH), 1.13 (d, J = 6 . 8  Hz, 
3H, C2 .-CH3), 0.87 (d, J = 6.5 Hz, 3H, CH(Cjj3),  0.82 (d,  J = 6.9 Hz, 3H, 
CH(CH3)) ;  13C NMR (CDC 1 3 /22.5 MHz) S 175.3, 153.8, 138.2, 128.2, 127.5,
73.0, 72.7, 63.2, 58.4, 38.3, 28.3, 17.8, 14.6, 13.7; S p e c i f i c  r o t a t i o n  
[ a ] 589 = +35.4°, [ a35 7 7  = +36.6°, [ 0 3 5 4 5  = +41*9°> £aJ435 = +73.0°, 
[ a ] 3 6 5  = +120.7° (c 2.88, CH2 C12 ); TLC (7:3 hexan e s /e th y1 a c e ta te ,  Rf = 
0 .33) .
Ana l .  Calcd. f o r  C j 7 H2 3 N0 4 : C, 6 6 . 8 6 ; H, 7.59. Found: C, 66.72; H,
7.64.
- 1 2 6 -
(4S)-3-{(2R)-1,4-Dioxo-2-methyl-4-ethoxybutyl) - 4 - (2-methyl e thyl) -2-  
oxazolidinone (21f,  Table 10, Entry F). Lithium Enolate Alkylation. A
m agne t ica l ly  s t i r r e d ,  cooled (-78°C) s o lu t io n  o f  LDA [prepared from 2.3 
mL (1.7 g, 16 mmol) o f  di  i sop ropy 1 ami ne and 10.1 mL (1.61 M in  hexane,
16.3 mmol) o f  j i - b u t y l  1 i t h iu m ]  (0.3 M in  THF) was used t o  e n o l i z e  2.67 g 
(14.5 mmol) o f imide 20b. The re s u l ta n t  l i t h iu m  enola te  was a lk y la te d  
w i th  3.4 mL (6.2 g, 29 mmol) o f  e th y l  2 - io d o a c e ta te  acco rd ing  to  the  
genera l  a l k y l a t i o n  procedure f o r  2 h a t -20°C then 2 h a t  0°C to  g iv e  
4.42 g (112% mass balance) of unpur i f ied  product. Analys is  by GC (30 m 
DB-1, 175°C, 78 cm/sec) a f fo rd e d  a 95:5 r a t i o  o f  ( 2 R ) - 2 1 f  ( t r  = 2.81 
min) t o  ( 2 S ) - 2 1 f  ( t r  = 2.69 min). The t i t l e  compound was i s o l a t e d  by 
MPLC (column C, 7:3 h e x a n e s /d ie th y l  e th e r ,  10 mL/min, ( 2 R ) - 2 1 f  e lu t e d  
second) to  a f f o r d  2.0 g (51%) o f  ( 2 R ) - 2 1 f  as a c o l o r l e s s  l i q u i d  [ (2 R ) -  
2 1 f : ( 2 S ) - 2 1 f  > 100:1 ] :  IR (CC1 4 ) 2980, 1795, 1735, 1700, 1380, 1255, 
1190 cm- 1 ; ! H NMR (CDC 1 3/90  MHz) 8  4.45 (d o f  d o f  d, J = 9.0, 4.0, 3.0 
Hz, 1H, C4 -H),  4.28 (d o f  d, J = 9.8, 9.5 Hz, 1H, C5 -H),  4.24 (d o f  d, J 
= 9.8, 3.0 Hz, 1H, C5 -H) ,  4.16 (d o f  d o f  q, J = 10.0, 4.7, 7.0 Hz, 1H, 
C2 ' -H ) ,  4.10 (q, J = 6.9 Hz, 2H, 0CH2 CH3), 2.89 (d o f  d, J = 17, 1.0 Hz, 
1H, C3 . -H) ,  2.42 (d o f  d, J = 17.0, 4.7 Hz, 1H, C3 *-H), 2.38 (m, 1H, C4- 
CH), 1.23 ( t ,  J = 6.9 Hz, 3H, 0CH2 CH3) ,  1.18 (d, J = 7.0 Hz, 3H, C2«- 
CJH3 ) ,  0.94 (d, J = 7.0 Hz, 3H, CHCCJLj)), 0.91 (d, J = 7.0 Hz, 3H, 
CH{CH3)} ;  13C NMR (CDC 13 / 2 2 -5 MHz) 8  175.9, 171.6, 153.6, 63.2, 60.4,
58.6, 37.8, 34.4, 28.2, 17.9, 17.1, 14.5, 14.2; S p e c i f i c  r o t a t i o n  [ 0O 5 8 9  
= +48.7°, [ a ] 5 7 7  = +51.2°, [a ]5 4 6  = +59.3°, [ a ] 4 3 5 = +102.2°, [ a ] 3 g 5 = 
+ 169.3° (c 1.64, CH2 C12).
Ana l .  Calcd. f o r  C ^ H ^ N O g :  C, 57.55; H, 7.80. Found: C, 57.67; H,
7. 93.
- 1 2 7 -
(4S)-3-((2S)-l-Oxo-2-phenylmethylthiomethyl-3-phenyl propyl)-4-(2-  
methylethyl}-2-oxazolidinone (21k, Table 10, Entry I) .  Lithium Enolate 
A1 kyl a t i o n .  A m a g n e t i c a l l y  s t i r r e d ,  coo led  (-78°C) so 1ut i on o f  LDA 
[prepared from 15.4 mL (11.1 g, 110 mmol) o f d i isopropy l  amine and 65 mL 
(1.69 M in hexane, 110 mmol} o f  £ -bu ty l  1 i t h i  um] (0.75 M in  THF) was used 
to  enol ize  26.1 g (100 mmol) o f  imide 20b. The re s u l t a n t  l i t h iu m  eno l ­
ate was a lk y la te d  with 23.9 g (110 mmol) o f benzyl bromomethyl s u l f i d e  
46b acco rd ing  to  the genera l  a l k y l a t i o n  procedure f o r  2 h a t  -20°C to  
g i v e  53.0 g (133% mass bal ance) o f  u n p u r i f i e d  p roduc t .  A n a ly s i s  by GC 
(30 m DB-1, 175°C f o r  5 min, 20°C/min to  250°C, 60 cm/sec) a f fo rd e d  a 
3:97 r a t i o  o f  (2R)-21k ( t r  = 11.74 min) to  (2S)-21k ( t r  = 11.53 min),  
and i n d i c a te d  the  presence o f  unreacted 20b ( t r  = 4.17 min, ca. 1 0 %). 
The t i t l e  compound was is o la te d  by chromatography (Waters Prep-500, two 
5 x 30 cm s i l i c a  gel columns, 87:13 hexanes/ethyl acetate, 250 mL/min) 
in  two p o r t i o n s  to  a f f o r d  33.1 g (83%) o f  (2S)-21k as a v is co u s  c o l o r ­
le s s  l i q u i d  [ (2 R ) -2 1 k : (2S)-21k = 2 :98 ] :  IR (neat) 3040, 2980, 2940, 
1780, 1700, 1495, 1455, 1390, 1300, 1250, 1200, 1100, 760, 700 cm"1; l H 
NMR (CDC 1 3 / 5 O O  MHz) 8  7.30-7.16 (m, 10H, a romat ic  H 's),  4.60 (m, 1H, 
C2 >-H), 4.27 (d o f  d o f  d, J = 8.5, 3.8, 2.5, 1H, C4 -H) ,  4.09 (d o f  d, J
= 9.3, 2.7 Hz, 1H, C5 -H), 3.92 (d o f  d, J = 9.3, 8.7 Hz, 1H, C5 -H),  3.76
(d, J = 14.0 Hz, 1H, SCH(H)Ph), 3.70 (d, J = 14.0 Hz, 1H, SCH(H)Ph), 
2.90 (d o f  d, J = 13.0, 8.0 Hz, 1H, C3 . -H) ,  2.80 (d o f  d, J = 13.5, 10.0 
Hz, 1H, C2 ' -CH(H)S), 2.78 (d o f  d, J = 13.0, 7.5 Hz, 1H, C3 ' -H ) ,  2.50 (d 
Of d, J = 13.5, 4.5 Hz, 1H, C2 .-CH(H)S), 2.37 (d o f  s e p te t ,  J = 3.8, 7.’1
Hz, 1H, C4 -CH(CH3 )2 ),  0.91 (d, J = 7.1 Hz, 3H, CH(CH3) ) ,  0.89 (d, J =
7.1 Hz, 3H, CH(CH3) ) ; 13C NMR (CDC13 /22.5 MHz) 8  174.6, 153.7, 138.2,
138.0, 129.1 , 128.9, 128.4, 126.8, 126.5, 63.2, 58.7, 44.4, 38.7, 35.7,
- 1 2 8 -
32.3, 28.5, 17.9, 14.8; S p e c i f i c  r o t a t i o n  [ a ] 5 8 9  = -29.1°  (£ 2.34, 
CH2 C I 2 ); MPLC (8 mm x 10 cm Radia l  Pak (5 pm s i l i c a  g e l ) ,  88:12 i s o ­
octane/ethyl  acetate, 2.0 mL/min, k1 (2S)-21k = 3.26; TLC (7:3 hexanes/ 
e th y l  a ce ta te ,  Rf = 0.54).
Ana l .  Calcd. f o r  C2 3 H2 7 NO3 S: C, 69.49; H, 6.85. Found: C, 69.62;
H, 6.85.
(4S)-3-((2S)-l-0xo-2-methyldecyl)-4-(2-methylethyl)-2-oxazolidinone  
(211, Table 10, Entry J). Lithium Enolate Alkylation. A magnet ica l ly  
s t i r r e d ,  cooled (-78°C) s o lu t io n  of LDA [prepared from 0.16 mL (0.116 g,
I.14 mmol) o f di isopropyl amine and 0.71 mL (1.61 in  hexane, 1.14 mmol) 
o f  j i - b u t y l  1 i t h i  um] (0.1 M in  THF) was used to  e n o l i z e  0.289 g (1.02 
mmol) o f  imide 20i.  The re s u l ta n t  l i t h iu m  enola te  was a lk y la te d  with 
0.25 mL (0.57 g, 4.0 mmol) o f  methyl io d id e  acco rd ing  t o  the  general  
a l k y l a t i o n  procedure f o r  2 h at 0°C to  give 0.324 g (107% mass balance) 
o f  u n p u r i f i e d  p roduc t .  A n a ly s i s  by GC (20 m Carbowax 20M, 175°C, 40 
cm/sec) a f fo rd e d  a 9:91 r a t i o  o f  (2RJ-211 ( t r  = 10.58 min) t o  (2S)-211 
( t p = 10.26 min) ,  and i n d i c a te d  the presence o f  unreacted  20i  ( t r  =
13.09 min, ca. 4%). The t i t l e  compound was i s o l a t e d  by f l a s h  chroma­
tography (3 x 30 cm column, 8:2 hexanes/diethyl  ether) to  a f fo rd  0.251 g 
(83%) o f  (2S)-211 as a c o l o r l e s s  l i q u i d  [(2RJ-211 :(2S)-211 < 1 :99 ] :  IR 
(CH2 C12) 3060, 2970, 2940, 2860, 1780, 1700, 1385, 1 2 1 0  cm"1; XH NMR 
(CCl4/90 MHz) 8  4.4-4.1 (m, 3H, C4 -H, C5 -H2 ) ,  3.6-3.4 (m, 1 H, C2 ' -H ) ,  
2.5-2.3 (m, 1H, C4 -CH), 1.3 (s ,  14H, a l i p h a t i c  H's), 1.12 (d, J = 7.0 
Hz, 3H, C2 ' - CJH3 ) ,  0.90 (m, 9H, CH(CFH3 )2 » ^1 O'-H3)» S p e c i f i c  r o t a t i o n
[a ]5 8 9  = +83.3°, [ a ] g 77  = +87.0°, [ a ] 5 40 = +98.6°, [ a ] 4 3 5  = +166.2°,
- 1 2 9 -
[ a3365 = +258.1° (c 2.03, CH2 C12).
Anal.  Calcd. f o r  C, 68.65; H, 10.51. Found: C, 68.67;
H, 10.37.
(4S)-3-((2S)~l-0xo-2-methyldecyl) -4 -(2-methylethyl )-2-oxazol l'dinone 
(211,  Tabl e 10, Entry K). Sodium Enol a te  A1 kyl a t ion .  A m agnet ica l  l y  
s t i r r e d ,  coo led  (-78°C) s o l u t i o n  o f  2.0 g (11 mmol) o f  sodium hexa- 
methyl d is i  l y l  amide (0.2 M in  THF) was used to  eno l ize  2.85 g (10.0 mmol) 
o f  imide 2 0 i .  The r e s u l t a n t  sodium e n o la te  was a l k y l a t e d  w i t h  2.5 mL 
( 5 . 7  g, 40 mmol ) o f  methy l io d id e  accord i  ng t o  the  genera l  a l k y l a t i o n  
procedure f o r  2 h a t  -78°C to  g i v e  2.64 g ( 8 8 % mass ba lance)  o f  u n p u r i ­
f i e d  p roduct.  A n a ly s i s  by GC (20 m Carbowax 20M, 175°C, 40 cm/sec) 
a f fo rd e d  a 7:93 r a t i o  o f ( 2R) -211 ( t r  = 10.56 min) to  (2S)~211 ( t r  = 
10.23 min), and ind icated the presence of unreacted 2Qi ( t r  = 13.05 min, 
ca. 2%). The t i t l  e compound was i s o l a t e d  by f l a s h  chromatography (4 x 
30 cm column, 8:2 hexanes/diethyl  ether) to  a f fo rd  2.29 g (77%) o f  (2S)-  
211 as a c o lo r le s s  l i q u i d  [(2R)-211 :(2S)-211 < 2 0 0 : 1 ] ,  i d e n t ic a l  in  a l l  
respects to  the p re v io u s ly  prepared mate r ia l .
(4R)-3-((2R)- l -0xo-2-methyl  butyl )-4-phenyl-2-oxazol idinone (23h, 
Table 8, Entry H). Lithium Enolate Alkylation. A magnet ica l ly  s t i r r e d ,  
coo led  (-78°C) s o l u t i o n  o f  LDA [p re p a re d  from 0.13 mL (0.095 g, 0.94 
mmol) o f d i i s o p r o p y la m in e  and 0.62 mL (1.52 M_ in  hexane, 0.94 mmol ) o f  
j i -bu ty l  1 i th ium ] (0.1 M in  THF) was used to  eno l ize  0.199 g (0.908 mmol) 
of imide 22c. The re su l ta n t  l i t h iu m  enolate  was a lk y la te d  with 0.24 mL 
(0.55 g, 3.9 mmol) o f methyl iodide according to  the general a l k y l a t i o n  
procedure fo r  2 h at 0°C to  g ive 0.19 g (85% mass balance) o f unpur i f ied
- 1 3 0 -
p roduc t .  A n a ly s i s  by GC (25 m Carbowax 20M, 200°C, 30 cm/sec Hel ium) 
a f fo rd e d  an 81:19 r a t i o  o f  (2R)-23h ( t r  = 9.42 min) t o  (2S)-23h ( t r  = 
9.58 min) ,  and i n d i c a te d  th e  presence o f  unreacted  22c ( t r  = 10.56 min, 
ca. 14%). An a n a l y t i c a l  sample was p u r i f i e d  by MPLC (co lumn B, 7:3 
hexanes/diethyl  ether) to  a f fo rd  (2R)-23h as a white c r y s t a l l i n e  s o l i d  
[ (2R) -23h : (2S) -23h  > 9 9 :1 ] :  mp 80-81°C; IR (CC1 4 ) 2980, 2940, 1795, 
1715, 1380, 1325, 1230, 1200, 1050 cm"1; *H NMR (CDCI3 / 9 O MHz) $ 7.3 (s, 
5H, a romat ic  H's),  5.40 (d o f  d, J = 9.0, 4.0 Hz, 1H, C4 -H) .  4.62 ( t ,  J 
= 9.0 Hz, 1H, C5 -H), 4.18 (d o f  d, J = 9.0, 4.0, 1H, C5 -H),  3.65 (q, J =
6.9 Hz, 1H, C2 ' -H ) ,  1.9-1.2 (m, 2H, C3 ' -H 2U 1*12 (d, J = 7.1 Hz, 3H,
C2 .-CH3 ), 0.90 ( t ,  J = 7.5 Hz, 3H, C ^ - l ^ ) ;  13C NMR (CDC 1 3 /22.5  MHz) S
176.4, 153.4, 139.4, 129.1 , 128.6, 125.7, 69.8, 57.7, 39.3, 26.1, 16.8, 
11.6.
Ana l .  Calcd. f o r  C1 4 h 1 7 N0 3 : C, 68.00; H, 6.93. Found: C, 68.29; H,
6.97.
General Procedure f o r  T r a n s e s t e r i f i c a t i o n  (Benzyl E s te r ) .  To a
m agne t ica l  l y  s t i r r e d ,  coo led  s o l u t i o n  o f  benzyl  a l c o h o l  ( 2 .0 e q u iv ,  
d i s t i l l e d )  in  anhydrous THF (ca. 0.3 M) i s  added a hexane s o lu t io n  o f  n- 
b u t y l l i t h i u m  (1.5 equiv).  To t h i s  s o lu t io n  is  added a s o lu t io n  o f  the 
i n d i c a te d  im ide (1.0 e q u iv ,  ca. 1 M in  THF). The r e a c t i o n  m ix tu re  i s
s t i r r e d  at 0°C u n t i l  no imide remains as de tec ted  by TLC (ca. 1-4 h).
The reac t ion  is  quenched by the a d d i t io n  o f  3 M aqueous ammonium c h lo r ­
ide. V o l a t i l e s  are removed in  vacuo and the product (along with benzyl 
a l c o h o l  and the  2-oxazo l  i d i  none) ex t rac ted  in to  di chi oromethane. The 
combined organic ex t rac ts  are dr ied over anhydrous magnesium s u l f a te  and
- 1 3 1 -
concentrated j n  vacuo. The benzyl es te r  i s  i so la te d  by l i q u i d  chroma­
tography as ind icated in  the fo l l o w in g  examples. Fur ther e lu t i o n  with  a 
more po la r  so lve n t  (e thy l  acetate or  d ie th y l  ether) a l low s  recovery of 
the 2 -oxazol idinone.
Benzyl (2R)-Z-Hethyl butanoate (31a, Table 12, Entry C). To a
magnetical  l y  s t i r r e d ,  cooled (0°C) s o lu t io n  o f  l i t h i u m  benzyloxide in  40 
mL o f  THF [p repared  from 0.65 mL (0.68 g, 6.3 mmol) o f  benzyl  a lc o h o l  
and 2.9 mL (1.61 M in  hexane, 4.7 mmol) o f  j i - b u t y l  1 i t h iu m )  was added 
0.824 g (3.15 mmol) o f  17h [ { 2 R) - 1 7h: ( 2S) - 1 7 h > 99 :1 ]  i n  10 mL o f  THF. 
A f t e r  s t i r r i n g  at 0°C f o r  2 h, th e  r e a c t i o n  p roduc ts  were i s o l a t e d  
according to  the general t r a n s e s t e r i f i c a t i o n  procedure. The t i t l e  com­
pound was iso la te d  by MPLC (column B, 9:1 hexanes/d iethyl  e ther ,  5 mL/ 
min) t o  a f f o r d  0.561 g (93%) o f  (2R)-benzy l  e s te r  31a as a c o l o r l e s s  
l i q u i d :  IR (CH2 C1 2 ) 3070, 2990, 1730, 1420, 1265, 900 cm"1; l W NMR
(CDC 13 / 9 0  MHz) 8  7.3 (s,  5H, a rom a t ic  H's), 5.0 (s ,  2H, OC^Ph) ,  2.3 
( s e x t e t ,  J = 7 Hz, 1H, C2 -J±), 1.9-1.3 (m, 2 H, C3 -H2 ) .  1-1 (d, J = 7 Hz, 
3H, C2 -CH3 ) ,  0.85 ( t , J = 8  Hz, 3H, C4 -H3 ); [cOssg = -1 2 .6 ' ,  [ 0 3 5 7 7  = 
-1 3 .0 ' ,  [ a ] 5 4 5  = -1 5 .1 ' ,  [ a ] 4 3 5  = -23.4*,  [ 0 3 3 5 5  = " 5 0 , 4 1  2<85>
CH2 C I 2 ); TLC (8:2 hexanes/ethyl  acetate, Rf = 0.65).
Ana l ,  c a lc d .  f o r  C i 2 H i 5 0 2 : ^4.97; H, 8.39. Found: C, 74.78; H,
8.23.
Benzyl (2S)-2-Methylbutanoate (31a, Table 12, Entry A). To a
m agne t ica l ly  s t i r r e d ,  cooled (0°C) s o lu t io n  o f  l i t h i u m  benzyloxide in  10 
mL o f  THF [p repared  from 0.21 mL (0.22 g, 2.0 mmol) o f  benzyl a l c o h o l  
and 0.93 mL (1.61 M in  hexane, 1.5 mmol) o f j n - b u t y l l i t h i u m )  was added
- 1 3 2 -
0.259 g (0.992 mmol) o f  17a [  (2R)-17a: (2S)-17a < 1 :99 ]  i n  3 mL o f  THF. 
A f t e r  s t i r r i n g  f o r  2 h a t  0°C, the  r e a c t i o n  p roduc ts  were i s o l a t e d  
according to the general t r a n s e s te r i f i c a t i o n  procedure. The t i t l e  com­
pound was i s o l a t e d  by MPLC (column B, 9:1 h e x a n e s /d ie th y l  e th e r ,  5
mL/min) to  a f fo rd  0.171 g (90%) o f  (2S)-benzyl es te r  31a as a c o lo r le s s
l i q u i d :  IR (CH2 C1 2 ) 3070, 2990, 1730, 1420, 1265, 900 cm '1 ; NMR 
(CDC 1 3/90 MHz) 8  7.3 (s,  5H, a romat ic  H's), 5.0 (s ,  2H, OC^Ph) ,  2.3
( s e x t e t ,  J = 7 Hz, 1H, C2 -H),  1.9-1.3 (m, 2H, C3 -H2 ) , 1.1 (d, J = 8 Hz,
3H, C2 -CH3 ) ,  0.85 ( t ,  J = 7 Hz, 3H, 0 4 - ^ 3 ); S p e c i f i c  r o t a t i o n  [ a ] 5 gg = 
+12.8°, [ a ] 5 7 7  = +13.2°,  [a ]&46 = +15.1°,  [ a ] 4 3 5  = +24.8°, [a ]3 6 5  = 
+40.4°, (_c 2.16, CH2 C1 2 ); TLC (8:2 hexanes /e thy l  a c e ta te ,  Rf = 0.61).
Anal.  Calcd. f o r  C i 2 Hi602 : C, 74.97; H, 8.39. Found: C, 74.91; H,
8.32.
Benzyl (2R)-2-Methyl -3 -benzyl  oxypropanoate (31e, Table 12, Entry
H). To a m agnet ica l ly  s t i r r e d ,  cooled (0°C) s o lu t io n  o f  l i t h iu m  benzy l ­
ox ide  in  80 mL o f  THF [p repared  from 8.2 mL (8 . 6  g, 79 mmol) o f  benzyl 
a l c o h o l  and 35 mL (1.70 M in  hexane, 60 mmol) o f  n - b u t y l  1 i t h i  um] was 
added 12.2 g (39.7 mmol) o f  21e  [ ( 2 R ) - 2 1 e : ( 2 S ) - 2 1 e  99.2:0.8) in  20 mL o f  
THF. A f te r  s t i r r i n g  at 0°C fo r  1 h the react ion products were i so la te d  
according to  the general t r a n s e s te r i f i c a t i o n  procedure. The t i t l e  com­
pound was iso la te d  by f la sh  chromatography (5 x 45 cm column, 9:1 hex- 
anes/THF) to  a f fo rd  10.9 g (96%) o f  (2R)-benzyl ester  31e as a c o lo r le s s  
l i q u i d .  Further e lu t io n  of the column w ith  d ie thy l  ether a fforded 4.3 g 
(84%) of (4 S ) -va l in o l  2-oxazol idinone.
- 1 3 3 -
(2R)-31e: IR (CC14 ) 2960, 1740, 1450, 1245, 1170 cm '1; *H NMR 
( CDC 1 3 / 9 0  MHz) 7.31, 7.29 (2s, 10H, a rom a t ic  H 's) ,  5.1 (s ,  2H, 
C O C ^ P h ) ,  4.5 (s,  2H, CH2 0CH2 Ph), 3.4 (m, 2H, C3 -H2), 2.8 (q,  J = 7 Hz, 
1H, C2 -HJ, 1.2 (d, J = 7 Hz, C2 -C]i3 ); S p e c i f i c  r o t a t i o n  [a ]5 8 9  = -3 .46° ,  
Cc* ] 5 7 7  = -3 .5 6 ° ,  [ a ] 5 4 6  = -4 .0 6 ° ,  [ 0 3 4 3 5  = “ 6 .51°,  [ a ] 3 5 5  = -8 .6 7 ° ,  (c 
4.78, EtOH); GC (30 m DB-1, 200°C, 78 cm/sec, t r  = 3.43 min);  TLC (8:2 
hexanes/ethyl  acetate, Rf = 0.42).
(2R)-2~Methyl-3-benzyloxypropanoic acid (26e). A mixture of 9.48 g 
(33.3 mmol) o f  (2R)-benzyl es te r  31e and 200 mg o f  5% Pd on carbon in  90 
mL o f  THF at 25°C under an atmosphere o f hydrogen was s t i r r e d  u n t i l  750 
mL (ca. 1 equiv)  o f  hydrogen had been absorbed (ca. 10 h). The so lu t io n  
was f i l t e r e d  through a pad o f  c e l i t e ,  and the c e l i t e  washed w ith  d ie thy l  
ether. The combined f i l t r a t e s  were concentrated in  vacuo to  a f fo rd  
6.34 g (98%) o f  (2 R ) -a c id  26e as a c o l o r l e s s  l i q u i d :  IR (neat )  3400- 
2400, 1715, 1450, 1100 c m '1; *H NMR (CDC13/90 MHz) 8  10.3 (b r  s, 1H, 
C02 H), 7.3 (s ,  5H, a rom a t ic  H's), 4.5 (s,  2H, 0CH2 Ph), 3.6 (m, 2H, C3- 
_H2) ,  2.8 (m, 1H, C2 — JzL)> (d , J = 7 Hz, 3H, C j j - C ^ ) ;  S p e c i f i c  r o t a t i o n
[oc] 5 8 9  = -1 0 .5 ° ,  [ a ] 5 7 7  = -11 .5 ° ,  [ 0 3 5 4 5  = -1 2 .9 ° ,  [ 0 3 4 3 5  = "22 .6° ,  
[ a 3 365 = -35.7°  (n e a t ,  d = 1.095 g/mL).
Determination of  the Extent of Racemization During Transesterifica-  
t i o n  and Hydrogenolysis .  Method 1. (2R)-Acid 26e was prepared in  two 
steps from im ide 21e [ (2R)-21e:(2S)-21e = 99.2:0.8) as desc r ibed  in  the 
previous two experiments. To a magnet ica l ly  s t i r r e d  s o lu t io n  o f  89.9 mg 
(0.463 mmol) o f  (2R ) -a c id  26e in  1.0 mL o f  d ich  1 oromethane was added
- 1 3 4 -
0.20 mL (0.29 g, 2.3 mmol) o f  o x a l l y l  ch lo r id e .  The mixture was s t i r r e d  
at 25°C f o r  6 h, then concentrated j n  vacuo to  a f fo rd  98.5 mg (100% mass 
balance) o f  (2R)-acid ch lo r id e  37e as a c o lo r le s s  o i l .  The acid c h lo r ­
ide was immediately used in the next part  o f  the experiment.
To a m a g n e t i c a l l y  s t i r r e d ,  co o le d  (-78°C) s o l u t i o n  o f  0.104 g 
(0.789 mmol) o f (4S ) -va l ino l  2-oxazol id inone 8  in 10 mL o f  THF was added 
0.40 mL (1.70 M, in  hexane, 0.68 mmol) o f  n - b u t y l  1 i t h iu m .  The m ix tu re  
was s t i r r e d  f o r  0.5 h f o l  1 owed by th e  a d d i t i o n  o f  (2R ) -a c id  c h l o r i d e  
37e. The m ix tu re  was s t i r r e d  f o r  0.5 h a t  -78°C then quenched by the  
add i t ion  o f  3 M aqueous ammonium ch lo r ide .  The mix ture was concentrated 
in  vacuo and the product extracted in to  dichioromethane. The combined 
o rg an ic  e x t r a c t s  were washed w i t h  aqueous potassium b ica rb o n a te  and 
b r ine ,  dr ied over anhydrous magnesium s u l f a t e ,  and concentrated j_n vacuo 
t o  a f f o r d  0.20 g o f  a c o l o r l e s s  o i l .  A n a ly s i s  o f  th e  u n f r a c t i o n a te d  
r e a c t i o n  m ix tu re  by c a p i l  1 a ry  GC (30 m DB-1, 100°C f o r  2 min, 20°C/inin 
to  200°C, 89 cm/sec) a f fo rd e d  a 97.5:2.5 r a t i o  o f  (2R)-21e ( t r  = 9.87 
min) t o  (2S)-21e ( t r  = 9.66 min).
In two separate experiments®® the acid ch lo r id e  was prepared at 0°C 
f o r  4 h and 5 h. The ac id  c h l o r i d e  was a c y la te d  as above to  a f f o r d  a 
98.4:1.6 and 98.1:1.9 r a t i o  o f (2R)-21e to  (2S)-21e, resp ec t ive ly .
Determination o f  the Extent o f  Racemization During T ra n se s te r i f i ca -  
t i o n  and H ydro g e n o lys is .  Method 2. (2R)-Ac id  26e was prepared from 
imide 21e [ (2R)-21e:(2S)-21e = 99.2:0.8) as d esc r ibed  in  th e  p re v io u s  
experiments. To a magnet ica l ly  s t i r r e d ,  cooled (0°C) s o lu t io n  o f  0.101 g 
(0.520 mmol) o f  (2R)-ac id  26e and 55 uL (58 mg, 0.57 mmol) o f  t r i ­
e th y l  amine in  10 mL o f  THF was added 55 wL (62 mg, 0.58 mmol) o f  e th y l
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chl oroformate. A white p re c ip i ta te  immediately formed. The mixture was 
s t i r r e d  f o r  0.5 h at 0°C then cooled to -78°C.
In a separa te  f l a s k ,  0.59 mL (1.70 M in  hexane, 1.00 mmol) o f  j i -  
b u t y l - 1 i th iu m  was added t o  a m a g n e t i c a l l y  s t i r r e d ,  co o le d  (-78°C) 
so lu t io n  o f  0.130 g (1.00 mmol) o f  (4S ) -va l ino l  2-oxazol id inone 8  in 10 
ml o f  THF. A f te r  0.5 h, the s o lu t io n  o f  the metalated 2-oxazo l id inone 
was added dropwise v ia  cannula to  the s o lu t io n  o f the mixed anhydride. 
The react ion mixture was s t i r r e d  f o r  0.5 h at -78°C then al lowed to warm 
to  0°C o ve r  a 1-h pe r io d .  The r e a c t i o n  was quenched by a d d i t i o n  o f  
h a l f - s a tu ra te d  aqueous ammonium ch lo r ide .  The mixture was concentrated 
in  vacuo and the product extracted in to  dichloromethane. The combined 
o rg a n ic  e x t r a c t s  were washed w i t h  aqueous sodium b i s u l f a t e ,  aqueous 
potassium bicarbonate, and br ine, dr ied over anhydrous magnesium s u l f a te  
and concentrated _i_n vacuo t o .a f fo rd  0.25 g o f  a c o lo r le s s  o i l .  Analys is  
o f  the unfract ionated react ion m ix tu re  by c a p i l l a r y  GC (same c o n d i ­
t io n s  as the previous experiment) afforded a 98.3:1.7 r a t i o  o f  (2R)-21e 
to  (2S)-21e.
(4S)-3-((2R)-l,4-Dioxo-2-methylbutyl) - 4 - (2-methyl ethyl) -2-oxazol i -  
dinone {21m). Ozone was bubbled through a m agne t ica l ly  s t i r r e d ,  cooled 
(-78°C) s o lu t io n  o f  2.51 g (11.1 mmol) o f  imide 21b [(2R)-21b:(2S)-21b = 
99.8:0.2) and ca. 10 mg o f  Sudan Red I I I  i n  50 mL o f  methanol u n t i l  the  
red col o r  o f  the  i n d i c a t o r  changed to  ye l  1 ow. The s o l u t i o n  was purged 
w i t h  argon then quenched by the a d d i t i o n  o f  5 mL (4.3 g, 6 8  mmol, 
excess) dimethyl s u l f id e .  The mixture was al lowed to  warm to  25°C and 
s t i r r e d  overnight.  The react ion mixture was concentrated j[n vacuo to  
a f f o r d  a m ix tu re  o f  the product  and the  corresponding dimethyl a c e ta l .
- 1 3 6 -
The m ix tu re  was d i s s o l v e d  in  50 mL of THF and 20 mL o f  1 M aqueous 
hydroch i  o r i c  ac id .  A f t e r  0.5 h the  m ix tu re  was concen t ra ted  vn vacuo 
and the product d i s t i l l e d  (Kugelrohr,  15Q°C, 0.005 mm) to  a f fo rd  2.45 g 
(97%) o f  imide 21m as a c o l o r l e s s  o i l :  IR (CDC 13 ) 3170, 2980, 2840, 
2740, 1780, 1725, 1700, 1390, 1300, 1250, 1205 cm"1; XH NMR (CDCl3/90 
MHz) § 9.72 (s ,  1H, CH0), 4.6-4.0 (m, 4H, C4 -H, C5 -H2 , C2 --H),  3.08 (d 
o f  d, J = 18.0, 9.0 Hz, 1H, C3 ' -H ) ,  2.55 (d o f  d, J = 18.0, 5.0 Hz, 1H, 
C3 . -H) ,  2.5-2.2 (m, 1H, C4 -CH), 1.20 {d, J = 7.0 Hz, 3H, C2 '-CH3), 0.95, 
0.90 ( o v e r l a p p in g  d 's ,  J = 6 . 8  Hz, 6 H, CH(CH3) 2); 13C NMR (CDC 1 3 / 22.5 
MHz) 8  199.9, 175.7, 153.6, 63.2, 58.6, 47.8, 32.3, 28-1, 17.9, 16.9,
14.4.
(2R)-2-Methyl-4-hydroxybutanoic  acid, lactone (2-Methylbutyro- 
l a c t o n e ,  32). A m ix tu re  o f  1.47 g (6.49 mmol) o f  imide 21m and 6.5 g
(conta in ing ca. 6.5 mmol o f  BH4") of sodium borohydride on alumina^ 3 in 
40 mL o f  anhydrous d i e t h y l  e th e r  was s t i r r e d  a t  25°C f o r  0.5 h. The 
m ix tu r e  was f i l t e r e d ,  and the  a lumina washed w i th  anhydrous d ie t h y l  
ether.  The combined f i l t r a t e  and washings were concentrated j_n vacuo to 
a f fo rd  1.35 g of a pale y e l l o w  o i l .  D i s t i l l a t i o n  (Kugelrohr,  170°C, 60 
mm) afforded 0.455 g (70%) o f  (2R)- lactone 32 as a c o lo r le s s  l i q u id :  IR
(neat)  2980, 2950, 2920, 2890, 1780, 1455, 1380, 1370, 1170, 1025, 910 
cm-1; lH NMR (CDCI3 / 9 O MHz) 8  4 .5-4.0 (m, 2H, C4 -H2), 2.8-2.3 (m, 2H, 
C2 -H, C3 -H),  2 .2 -1 . 8  (m, 1H, C3 -H),  1.3 (d, J = 6 Hz, 3H, C2 -CH3); 
S p e c i f i c  r o t a t i o n  [ a ] 589 = +21.2° ( c 8.5, EtOH), L i t . 3 0  s p e c i f i c  r o t a ­
t i o n  o f  (2S)-32 [ ot] 5 gg -  -21.5° (£ 5.5, EtOH).
Ana l .  Calcd. f o r  C5 Hg02 : C, 47.60; H, 6.55. Found: C, 47.44; H,
6. 47.
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(2R )-2 -M ethy lsucc in ic  acid (26f) .  To a m a g n e t i c a l l y  s t i r r e d ,  
cooled (0°C) s o lu t io n  o f  1.39 g (5.13 mmol) o f  imide 21f  [ (2R ) -2 l f : (2S )-  
2 1 f  > 99 :1 ]  i n  50 mL o f  methanol was added 10 mL o f  6 M aqueous p o ta s ­
sium hydrox ide .  A f t e r  2 h no imide 2 1 f  remained as de tec ted  by TLC. 
The methanol was removed in  vacuo and the aqueous s o lu t io n  washed with 
dichloromethane. Concentration of the dichloromethane washings afforded 
0.64 g (96%) o f  ( 4 S ) - v a l i n o l  2 - o x a z o l id in o n e  8 . The aqueous s o l u t i o n  
was a c id i f i e d  w ith  6 M aqueous hydroch lo r ic  acid and the water removed 
lH  vacuo. The s o l i d  residue was washed with  d ie thy l  ether  to  d is so lve  
the product. Concentration of the d ie thy l  ether so lu t io n  afforded 0.62 g 
(91%) o f  (2R ) -a c id  26f  as a w h i te  c r y s t a l  l i n e  sol id :  mp 112-113°C;
NMR (CDC 1 3/90 MHz) & 9.6-9.0 (b r  s, 2H, C02 H), 3.1-2.4 (m, 3H, C2 -H, C3 - 
H^),  1.3 (d, J = 7 Hz, 3H, C2 -JH); S p e c i f i c  r o t a t i o n  [ a ] 5 8 9  "  +15.7° ( c
4.25, EtOH).
Anal.  Ca lcd .  f o r  0 5 8 3 0 4 : C, 45.46; H, 6.10. Found: C, 45.64; H,
6.19.
(2S )-2 -M eth y lsu cc in ic  acid (26f) .  To a m a g n e t i c a l l y  s t i r r e d ,  
cooled (0°C) s o lu t io n  o f  1.83 g (5.71 mmol) o f  imide 17f [ (2R)-17f :(2S)-  
1 7 f  < 1 :99 ]  i n  50 mL o f  methanol was added 10 mL o f  aqueous po tas-  
sium hyd rox ide .  A f t e r  2 h no imide 17f  remained as de tec ted  by TLC. 
The methanol was removed jui vacuo and the aqueous s o lu t io n  washed with  
dichloromethane. Concentration o f the dichloromethane washings afforded 
0.95 g (94%) o f  (4R,5S)-norephedr ine 2 -o x a z o l id in o n e  6 . The aqueous 
s o lu t io n  was a c id i f i e d  with 6 M aqueous hydroch lo r ic  acid and the water 
removed in  vacuo. The sol id res idue  was washed w i th  d i e t h y l  e th e r  to  
d i s s o l v e  the  p roduc t .  C on ce n t ra t io n  o f  the  d i e t h y l  e th e r  s o l u t i o n
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afforded 0.72 g (95%) o f  (2S)-acid 26 f as a white c r y s t a l l i n e  s o l i d :  mp 
109-110°C; iNMR (CDCI3 / 9 0  MHz) 8  9.6-9.0 (b r  s, 2 H, C02 H), 3.1-2.4 (m, 
3H, C2 -H, C3 -H2 ) ,  1.3 (d, J = 7 Hz, 3H, C2 -H);  S p e c i f i c  r o t a t i o n  [a ]5 8 9  
= -15.0°  (c 4.21, EtOH).
Ana l.  Calcd. f o r  C5 H8 0 4 : C, 45.46; H, 6.10. Found: C, 45.64; H,
6.19.
(2R )-2 -M ethy l -3 -b en zy l oxy-l-p ro p an o l (39e). Lithium Borohydride 
Reduction. To a magnet ica l ly  s t i r r e d ,  cooled (0°C) s o lu t io n  of 0.788 g 
(2.23 mmol) o f  im ide 17e [ (2R)-17e :(2S)-17e  < 1 :99 ]  i n  5 mL o f  THF was 
added 2.3 ml (1 M in  THF, 2.3 mmol) o f  l i t h i u m  bo rohyd r ide .  A f t e r  2 h 
no imide 17e remained as detected by TLC. The react ion was cau t ious ly  
quenched by the add i t ion  o f 1 M aqueous hydroch lo r ic  acid. The mixture 
was concentrated vacuo and extracted with dichloromethane. The com­
bined organic ex trac ts  were washed with  1 M aqueous hydroch lo r ic  acid 
and br ine, dr ied over anhydrous magnesium s u l f a te ,  and concentrated in 
vacuo to  a f f o r d  0.73 g o f  a c o l o r l e s s  o i l .  The t i t l e  compound was 
i s o la te d  by f l a s h  chromatography (3 x 30 cm column, 75:25 hexanes/ethyl  
a c e ta te )  t o  a f f o r d  0.346 g (8 8 %) o f  ( 2 R ) -a lco h o l  39e as a c o l o r l e s s  
l i q u i d :  IR (CH2 C12) 3640, 3540, 3060, 2970, 1265, 1090 cm '1 ; ! H NMR 
(CC1 4 /90 MHz) 8  7.2 (s ,  5H, a romat ic  H's),  4.4 (s ,  2H, 0CH2 Ph), 3.7-3.3 
(m, 4H, Ci-Hg, C3 -H2), 2.47 (b r  s, 1H, OH), 2.1 (m, 1H, C2 -H),  0.9 (d, J 
= 8 Hz, 3H, C2 -CF[3 ) ; S p e c i f i c  r o t a t i o n  [ a l s s g  = -4 .2° ( £ 2 . 5 ,  EtOH); GC 
(30 m DB-1, 120°C, 8 6  cm/sec, t r  = 4.07 min);  TLC (85:15 d i c h l o r o -  
methane/diethyl  ether,  Rf = 0.32).
!
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(2 S )-2 -K e th y l-3 -b e n zy lo x y -l-p ro p a n o l (39e). L ith ium  A1uninum 
Hydride Reduction. To a magnet ica l ly  s t i r r e d ,  cooled (-78°C) s o lu t io n  
o f  15.3 g (50.0 mmol) o f  imide 21e [(2 R )-21 e :(2S )-21e  > 99 :1 ]  i n  100 mL 
of THF was added 50 mL (1 M in THF, 50 mmol) of l i t h iu m  aluminum hydride 
d ropw ise  o v e r  a 15-min per iod .  A f t e r  0.5 h th e  m ix tu re  was a l l  owed t o  
warm to  25°C then s t i r r e d  f o r  2 h. The m ix tu re  was re co o le d  t o  -78°C 
then c a u t i o u s l y  quenched w i th  1.9 mL o f  w a te r ,  1.9 mL o f  2 M aqueous 
sodium hydroxide, and 5.7 mL of water. The mixture was a l lowed to  warm 
to  25°C and s t i r r e d  f o r  1 h. The m ix tu re  was f i l t e r e d  th rough  a s i n ­
tered glass f i l t e r  and the p re c ip i ta te  washed with  d ie thy l  ether. The 
f i l t r a t e  and washings were co n cen t ra ted  i_n vacuo. The p roduc t  was 
i s o l a t e d  by f l a s h  chromatography (7 x 70 cm co lumn, 85:15 d i c h l o r o -  
methane/diethyl  ether) to  a f fo rd  a f t e r  d i s t i l l a t i o n  (K u g e l r o h r ,  90°C, 
0.01 mm) 6 . 8  g (76%) of (2S)-alcohol 39e as a c o lo r l e s s  l i q u id .  Further 
e l u t i o n  w i t h  d i e t h y l  e the r  a f fo rd e d  4.8 g (74%) o f  ( 4 S ) - v a l i n o l  2- 
oxazo l id inone 8 .
(2S)-39e: IR (CH2 C12) 3640, 3540, 3060, 2970, 1265, 1090 cm- 1 ; l H
NMR (CC1 4 / 9 0  MHz) 8  7.2 (s ,  5H, a romat ic  H's),  4.4 (s ,  2H, 0CH2 Ph), 3.7-
3.3 (m, 4H, C !-H2 , C3 -H2), 2.47 (b r  s, 1H, OH), 2.1 (m, 1H, C2 -H),  0.9 
(d, J = 8 Hz, 3H, C^- CH3 ) ;  S p e c i f i c  r o t a t i o n  [ 0 0 5 3 9  = +5*3° { c  2.2, 
EtOH), L i t . 6 4  [ a ] 5 8 9  = +4.97° (c 0.9, EtOH); GC (30 m DB-1, 120°C, 86  
cm/sec, t r  = 4.07 min) ;  TLC (85:15 di ch i  oro inethane/d i  e th y l  e th e r ,  R f  =
0 .32) .
Determination of the Enantiomeric Purity  o f (2R)-2-M ethyl-3-benzyl-  
oxy-l-p ro p an o l (39e). To a m agnet ica l ly  s t i r r e d ,  cooled (0°C) so lu t io n  
o f  41 mg (0.228 mmol) o f (2 R ) -a lco h o l  39e i n  0.5 ml o f  p y r i d i n e  was
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added 54 uL (72 mg, 0.286 mmol) o f  (2R)-ac id  c h l o r i d e  11. The m ix tu re  
was s t i r r e d  at 25°C f o r  1 h. The r e a c t i o n  m ix tu re  was d i l u t e d  w i th  
water  and the p roduc t  e x t r a c te d  i n t o  d ich lo rom e thane .  The combined 
organic ex t rac ts  were washed with  1 M aqueous hydroch lo r ic  acid, sa tu r ­
ated aqueous potass ium b ic a rb o n a te ,  and b r in e ,  d r i e d  o ve r  anhydrous 
magnesium s u l f a t e ,  and co n cen t ra ted  j_n vacuo t o  a f f o r d  1 1 0  mg o f  a 
c o lo r l e s s  o i l .  Ana lys is  o f  the unfract ionated product by c a p i l l a r y  GC 
(DB-1, DB-5, or Carbowax 20M) did not separate the diastereomers. Anal­
y s i s  o f  the u n f r a c t i o n a t e d  p roduct  by 500 MHz NMR in d i c a te d  the
absence o f the (2S) diastereomer [(2R)-39e:(2S)-39e > 97:3) (Figure 8 ).
Determination o f the Enantiomeric Purity  o f (2S)-2-M ethyl-3-benzyl-  
oxy-l-p ro p an o l (39e). To a m agnet ica l ly  s t i r r e d ,  cooled (0°C) s o lu t io n  
o f  58 mg (0.322 mmol) o f  ( 2 S ) -a lc o h o l  39e i n  0.5 mL o f  p y r i d i n e  was 
added 76 uL (102 mg, 0.403 mmol ) o f  (2R)-ac id  c h l o r i d e  11. The m ix tu re  
was s t i r r e d  a t 25°C f o r  1 h. The re a c t i o n  m ix tu re  was d i l u t e d  w i th  
w a te r  and the  product  e x t r a c te d  i n t o  d ich lo rom ethane .  The combined 
organic ex t rac ts  were washed with 1 M aqueous hydroch lo r ic  ac id , sa tu r ­
ated aqueous potassium b ic a rb o n a te ,  and b r in e ,  d r ie d  o v e r  anhydrous 
magnesium s u l f a t e ,  and concen t ra ted  jjn vacuo to  a f f o r d  135 mg o f  a 
c o lo r le s s  o i l .  Analys is  of the unfract ionated product by c a p i l l a r y  GC 
(DB-1, DB-5, or Carbowax 20M) did not separate the diastereomers. Anal­
y s i s  o f  the  u n f r a c t i o n a t e d  product  by 500 MHz NMR in d i c a t e d  the
absence of the (2R) diastereomer [(2R)-39e:(2S)-39e < 3:97) (Figure 8 ).
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(2R)-2-Methyl-l-decanol (391) .  Lithium Borohydride Reduction. To
a m agne t ica l  l y  s t i r r e d ,  co o le d  (0°C) s o l u t i o n  o f  1.57 g (4.54 mmol) o f  
171 [(2R)-171 :(2S)-171 > 9 9 :1 ]  i n  20 mL o f  THF was added 0.12 g (5.5 
mmol) o f  l i t h i u m  b o rohyd r ide .  A f t e r  3 h no imide 171 was de tec ted  by 
TLC. The react ion was c a u t io u s ly  quenched by the add i t ion  o f 1 M aque­
ous h y d r o c h l o r i c  ac id .  The m ix tu re  was concen t ra ted  j_n vacuo then 
e x t r a c te d  w i t h  d ich lo rom e thane .  The combined o rgan ic  e x t r a c t s  were 
washed w i th  sa tu ra te d  aqueous potass ium b ica rbona te  and b r i n e ,  d r ie d  
over anhydrous magnesium s u l f a te ,  and concentrated J_n vacuo to  a f fo rd  
1.56 g o f  a c o l o r l e s s  o i l .  The p roduc t  was i s o l a t e d  by f l a s h  chroma­
to g ra ph y  (3 x 30 cm column, 8:2 h e x a n e s /d ie th y l  e th e r )  f o l l o w e d  by 
d i s t i l l a t i o n  (Kugelrohr, 160°C, 15 mm) to  a f fo rd  0.653 g (84%) of (2R)- 
a lcoho l  391 as a c o lo r le s s  l i q u i d .  Further e lu t io n  of the column with 
d i e t h y l  e th e r  a f fo rd e d  0.80 g (99%) o f  (4R,5S)-norephedrine 2 -o xazo l i -  
di  none 6 .
( 2 R ) - 3 9 1 :  IR (CH2 C1 2 ) 3630, 2960, 2940, 2860, 1465, 1030 cm- 1 ;
NMR ( CDC 1 3/90 MHz) 8  3.5-3.3 (m, 2H, C i -H ) ,  2.2 (b r  s, 1H, 0_H) s 1.7-1.2 
(b r ,  15H, a l i p h a t i c  H's),  1 .0 -0 . 8  (m, 6 H, C2 -CH3, C1 0 -H3 ) ;  S p e c i f i c  
r o t a t i o n  [oOsgg = +10.8°, [ 0 3 5 7 7  = +11.4°, [ 0 3 5 4 5  = +12.9°, [ 0 O 4 3 5  =  
+21.3°, [ a ] 3 6 5  = +32.3° (c 4.37, CH2 C12) ;  TLC (8:2 he xan e s /e th y l  ace­
t a t e ,  Rf  = 0.32).
Ana l .  Calcd. f o r  C ^ H ^ O :  C, 76.74 ; H, 13.95. Found: C, 76.77; H, 
14.08.
(2S)-2-Methyl-l-decanol (391) .  Lithium Borohydride Reduction. To
a m a g n e t i c a l l y  s t i r r e d ,  coo led  ( 0 °C) s o l u t i o n  o f  1.23 g (4.15 mmol) o f  
211 [ (2RJ-211 : (2S)-211 < 1 :99 ]  in  20 mL o f  THF was added 0.12 g (5.5
- 1 4 2 -
mmol) o f  1 i t h iu m  bo roh yd r id e .  A f t e r  3 h no imide 211 was de tec ted  by 
TLC. The react ion was cau t iou s ly  quenched by the add i t ion  of 1 M aque­
ous h y d r o c h l o r i c  ac id .  The m ix tu re  was concen t ra ted  i_n vacuo then 
e x t r a c te d  w i th  d i c h i  oromethane. The combined o rg a n ic  e x t r a c t s  were 
washed w i t h  sa tu ra te d  aqueous potassium b ica rbona te  and b r i n e ,  d r ie d  
over anhydrous magnesium s u l fa te ,  and concentrated j_n vacuo to  a f fo rd  
1.13 g o f  a c o l o r l e s s  o i l .  The product was i s o l a t e d  by f l a s h  chroma­
to g ra ph y  (3 x 30 cm column, 8:2 h e xa n e s /d ie th y l  e th e r )  f o l l o w e d  by 
d i s t i l l a t i o n  (Kugelrohr, 160°C, 15 mm) to  a f fo rd  0.643 g (90%) o f  (2S)- 
a lcoho l  391 as a c o lo r le s s  l i q u id .  Further e lu t io n  of the column w ith  
d ie th y l  ether afforded 0.72 g (85%) o f  (4S )-va l ino l  2-oxazol id inone 8 .
(2R)-391:  IR (CH2 C12) 3630, 2960, 2940, 2860, 1465, 1030 cm- 1 ; *H
NMR (CDC 1 3/90 MHz) 8  3.5-3.3 (m, 2H, C^-H), 2.2 (b r  s, 1H, OH), 1.7-1.2 
( b r ,  15H, a l i p h a t i c  H's), 1 .0 -0 . 8  (m, 6 H, C2 -CH3, C1 0 -H3); S p e c i f i c  
r o t a t i o n  [a ]ggg  = - 1 0 . 0 ° ,  [ 0 3 5 7 7  = CciD5 4 5  = - 1 2 . 6 ° ,  [ 0 3 4 3 5  =
-2 1 .1 ° ,  [ a ] 3 6 5  = -32.2° (c 4.21, CH2 C12); TLC (8:2 h exanes /e thy l  ace­
t a t e ,  Rf  = 0.32).
Ana l .  Calcd. f o r  C ^ H ^ O :  C, 76.74; H, 13.95. Found: C, 76.67; H,
13.97.
(2S)-2-Methyl-3-phenylpropanoic acid, hydrazide (34g). A magneti- 
c a l l y  s t i r r e d  s o l u t i o n  o f  1.92 g (5.94 mmol) o f imide 17g [ ( 2R) - 
17g : (2S )-17g  < 1 :99] and 0.5 mL (0.5 g, 15.6 mmol) o f anhydrous h yd ra ­
z in e  in  10 mL o f  anhydrous e thano l  was s t i r r e d  at 25°C f o r  4 h. The 
m ix tu re  was concen t ra ted  j_n vacuo (30°C at 30 mm then 30°C at 0.1 mm) 
and the residue d isso lved in  anhydrous d ie thy l  ether. The s o lu t io n  was
- 1 4  3 -
saturated w ith  anhydrous h yd roch lo r ic  ac id .  The m ix tu re  was f i l t e r e d  
and the p re c ip i ta te  washed with  d ie thy l  ether. (The combined f i l t r a t e  
and washings were concentrated jm vacuo to  a f fo rd  a f t e r  r e c r y s t a l l i z a ­
t i o n  from t o lu e n e  0.72 g (69%) o f  (4R,5S)-norephedrine 2-oxazol idinone 
6 ). The p r e c i p i t a t e  was t r e a te d  w i t h  s a tu ra te d  aqueous potass ium b i ­
ca rbona te  then e x t ra c te d  w i t h  d i c h l  oromethane. The combined o rgan ic  
e x t ra c ts  were washed with  br ine ,  dr ied over anhydrous magnesium s u l f a te  
and concentrated j_n vacuo to  a f fo rd  0.810 g (76%) of (2S)-hydrazide 34g 
as a w h i te  so l i d :  *H NMR ( CDC 1 3 /500 MHz)S 7.20 (m, 5H, a romat ic  H's),
6.60 (b r  s,  1H, H2 NN(H)C0), 3.76 (b r  s, 2H, H2 NN(H)C0), 2.95 (d o f  d, J 
= 14, 8 Hz, 1H, C3 -H),  2.70 (d o f  d, J = 14, 6 Hz', 1H, C3 -H),  2.40 (m, 
1H, C2 -H ) ,  1.20 (d, J = 7 Hz, 3H, C2 -CH3); GC (30 m DB-1, 200°C f o r  10 
min, 20°C/min t o  275°C, 89 cm/sec, t r  = 18.51 min).
Ana l .  Calcd. f o r  C ^ H ^ N ^ :  C, 67.36; H, 7.86. Found: C, 67.31; H,
7.83.
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CHAPTER 2
EFFORTS DIRECTED TOWARD THE ENANTIOSELECTIVE TOTAL SYNTHESIS OF
FERENSIMYCIN B
- 1 5 1 -
I. INTRODUCTION.
In 1982, Kusakabe and co-workers reported the i s o la t i o n  and char­
a c te r iz a t io n  o f two new po lye ther  ionophore a n t i b io t i c s ,  ferensimycin A 
(1) and fe re n s im y c in  B (2 ) . l  Since 1951, more than 75 members o f  t h i s  
important fa m i ly  o f natura l  p roduc ts  have been i s o l a t e d . ^  P o ly e th e r  
ionophores are character ized as r e l a t i v e l y  la rge ,  stereochemical l y  com­
p lex ca rboxy l ic  acids th a t  possess m u l t i p l e  ether l inkages,  u s u a l l y  as 
te t rahydro furan  and tetrahydropyran r ings (Figure 1).® E sp e c ia l ly  noted 
fo r  t h e i r  a b i l i t y  to  ex t rac t  inorganic cat ions in to  non-pol ar organic 
s o l v e n t s ,  p o l y e t h e r  ionophores are im po r ta n t  t o o l s  in  th e  s tudy o f  
c a t i o n  t r a n s p o r t . ^  As a n t i b i o t i c s ,  p o ly e th e r  ionophores i n h i b i t  the  
growth o f  G ra m -p o s i t i v e  b a c t e r i a ,  are e f f e c t i v e  in  the  t re a tm e n t  o f  
p o u l t r y  c o c c id o s i s ,  and im p ro v e  th e  u t i l i z a t i o n  o f  fe e d  among 
ruminants.^ Ever since the s t ruc tu re  o f monensin was e luc idated  by X- 
ray c r y s t a l l o g r a p h y , ®  s y n t h e t i c  chemis ts  have been i n t r i g u e d  by the 
a rc h i te c tu ra l  complexity of po lye ther  ionophores. Not on ly  do po lyether  
ionophores present cha l leng ing  ta rg e ts  f o r  t o t a l  s y n th e s is , ^  but they  
a l s o  p ro v id e  the  i n c e n t i v e  f o r  d e v e lo p in g  new s te r e o - ,  r e g i o - ,  and 
chemosel e c t i v e  r e a c t i o n s .  In c o n ju n c t io n  w i th  our i n t e r e s t  in  the  
development o f methodology f o r  asymmetric synthesis,® and the construc­
t i o n  o f  both macrol ide and po lyether  ionophore an t ib io t ics ,®  we under­
took the e n an t io se le c t ive  t o ta l  synthesis o f ferensimycin B (2).
The fe re n s im y c in s  were i s o l a t e d  from th e  fe r m e n ta t io n  b ro th  o f  
Streptomyces sp. No. 5057.* T h e i r  r e l a t i v e  s t r u c tu r e s  ( e x c lu d i  ng C-2 
and C-21 stereochemistry) were e luc idated by mass, NMR, and NMR
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Figure 1. Various Polyether Ionophore A n t ib io t i c s .
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spectroscopy. Westley (unpubl ished) has estab l ished, by X-ray c r y s t a l ­
l o g ra p h y ,  the  s te re o c h e m is t r y  o f  1 a t  C - l  and C-21 to  both  be ( S ) . 1 ^  
Struc tu ra l  l y ,  the ferensimycins are c lo s e ly  re la ted  to  l y s o c e l l i n  (3), 2 
d i f f e r i n g  from 3 o n ly  i n  the s u b s t i t u t i o n  at C-2. Both th e  r e l a t i v e  
stereochemistry and the absolute conf igura t ion  o f  3 have been determined 
by X-ray c rys ta l  1 ography. 11 By analogy, ferensimycin B (2) i s  presumed 
to  possess th e  same a b s o lu te  c o n f i g u r a t i o n  as fe re n s im y c in  A (1) and 
l y s o c e l l i n  (3). The s te re o c h e m is t r y  o f  2 a t  C-2 i s  ass igned as (S) 
based on the near ly  ide n t ica l  chemical s h i f t s  in the NMR spectra o f 
1 and 2 f o r  the carbon s igna ls  at and around C-2. Likewise, the s tereo­
ch e m is t ry  o f  2 a t C-21 i s  assigned as (S) by comparison o f  th e  ^ C  NMR 
spec t ra  o f  2 and 3. The e n a n t i o s e l e c t i v e  t o t a l  s y n th e s is  o f  f e r e n ­
simycin B would te s t  the v a l i d i t y  o f  these assignments.
The s t ru c tu ra l  homology of the ferensimycins and l y s o c e l l i n  sug­
gests  t h a t  they  a r i s e  v ia  s i m i l a r  b iochemica l  pathways. The carbon 
framework o f  p o l y e th e r  ionophores i s  constructed from simple acetate, 
propanoate, and butanoate b u i l d in g  b l o c k s . 12 For example, by fe e d in g  
Streptom.yces cacaoi var. asoensis labeled R^Ct^H precursors, Otake has 
demonstrated tha t  l y s o c e l l i n  i s  assembled from one acetate, e igh t  pro­
panoate, and two butanoate un its  (Scheme 1).13 Less is  known, however, 
about how the  s te re o c h e m is t r y  i s  generated du r in g  p o l y e t h e r  b i o ­
synthesis.
Westley has proposed a biochemical pathway tha t  accounts f o r  the 
stereochemistry o f  the two ether r ings in la sa lo c id  A (4) and i so la sa -  
l o c i d  A ( 5 ).14 Accord ing  to  h is  h yp o th es is ,  4 and 5 are both  d e r i v e d  
from diene 6. As i l l u s t r a t e d  in  Scheme 2, s te reose lec t ive  d iepox idat ion












of diene 6  fo l low ed  by acid catalyzed c y c l i z a t i o n  can a f fo rd  e i t h e r  4 or 
5. Support f o r  t h i s  biochemical pathway is  provided by Hutchinson, who, 
by fe e d in g  doub le  l a b e l e d  R ^C ^O g H  precursors to  Streptomyces 1 asa- 
1 i ensi  s , has shown t h a t  i s  in t ro d u c e d  i n t o  4 a t  C - l ,  C-3, C - l l ,  C- 
13, and C - l 5, but not at C-19 and C -22 .^  The absence o f labe led  oxygen 
at C-19 and C-22 would be expected i f  d iene 6 i s  an in te rm e d ia te .  
Presumably, the oxygen at these two pos it ions  is  obtained from molecu lar  
o x y g e n . 1 ^  The same d iene--diepoxide or  the analogous t r i e n e - - t r i e p o x id e
pathway has been proposed by Cane et a l .  as the f i n a l  s tep in  the
12rbiosynthesis  o f over 30 po lyether ionophores.
We envisioned employing a s im i l a r  d iene--stereosel e c t i v e  epoxida- 
t i o n - - a c i d  c a ta ly z e d  c yc l  i z a t i o n  ro u te  as a key r e a c t i o n  sequence to  
c o n s t r u c t  the B and C r i n g s  o f  f e re n s im y c in  B (2). A r e t r o s y n t h e t i c  
a n a l y s i s  o f  2, t h a t  r e v e a l s  the  r e q u i s i t e  diene in te rm e d ia te  (7 ) ,  i s  
i 1 1 u s t ra te d  in  Scheme 3. Since t h i s  approach c l o s e l y  resembles the
- 1 5 5 -
Scheme 2
Scheme 3
proposed b io s y n t h e t i c  pathway, d iene 7 o r  r e l a t e d  m o le cu les  c o u ld  be 
used to  study the f i n a l  stages of po lye ther  biosynthesis.
The s y n t h e t i c  s t r a te g y  we chose f o r  the  c o n s t r u c t i  on o f  f e r e n s i ­
mycin B (2) is  s u f f i c i e n t l y  f l e x i b l e  to  accommodate both ferensimycin A
( 1 ) and l y s o c e l l i n  (3). This chapter w i l l  describe our e f f o r t s  d irec ted 
toward the enan t iose lec t ive  to ta l  synthesis of 2 : 1 ) the preparat ion of
a C-11 t o  C-23 d iene in te rm e d ia te ;  2) a study o f  the s t e r e o s e l e c t i v e  
epoxidat ion o f bishomoal l y l i c  a lco h o ls ;  and 3) the preparat ion of the B 
te t rahydro furan  r ing o f  ferensimycin B v ia  a s te reose lec t ive  epoxida­
t i o n —acid catalyzed c y c l i z a t i o n  sequence.
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I I .  SYNTHETIC DESIGN.
An exam ina t ion  o f  the  s t r u c t u r e  o f  fe re n s im y c in  B (F igu re  1) 
revea ls  tha t  i t  possesses 16 ch i ra l  centers and three ether r ings (two 
of which are hemiketals).  Although l i t t l e  is  known about the chemistry 
o f ferensimycins A and B, i t  presumably is  s i m i l a r  to  th a t  o f  l y s o c e l l i n  
(3).  Koenuma has re p o r te d  th a t  3 is  degraded by both a c id i c  and 
s t ro n g ly  basic conditions.-*-? Under ac id ic  condi t ions (cat. HOAc, MeOH), 
the  f i  ve-meinbered hem ike ta l  C r i n g  o f  3 i n i t i a l  l y  isom er izes  t o  the 
corresponding six-membered hemiketal 8  (Scheme 4). This is  fo l lowed by 
the gradual decarboxy la t ion o f  C-I and methy la t ion o f  the C-3 hydroxyl 
group to  a f fo rd  9. Acetyl  a t ion  o f the C-21 hydroxyl group of 3, how-
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ever, prevents acid ca ta lyzed isomerization. Therefore, in  our synthe­
s is  of ferensimycin B, we w i l l  need to e i th e r  avoid ac id ic  condit ions, 
or pro tect the C-21 hydroxyl group when the five-membered hemiketal C 
r ing  is  present.
As the sodium or s i l v e r  s a l t ,  however, l y s o c e l l i n  is  s tab le. This 
suggests tha t  metal complexat ion impar ts  s t a b i l i t y  to  l y s o c e l l i n ,  as 
w e l l  as to  ferensimycins A and B. Shown in Figure 2 is  the s i l v e r  s a l t  
o f  l y s o c e l l i n .  Six o f  the oxygen atoms are coordinated to  the s i l v e r .  
Presumably, coord ina t ion  between 0(8) and Ag as w e l l  as a hydrogen bond 
between 0(1) and 0(9) prevent isomerizat ion of the five-membered hemi­









Figure 2. The S i lv e r  Salt of  Lysoce l l in .
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The r e v e r s i b i l i t y  o f the f i v e -  to  six-membered hemiketal r ingisom- 
e r iz a t io n  w i l l  be an important aspect of our synthet ic  plan. Present ly ,  
we do not know whether the s t a b i l i t y  of the metal complex i s  s u f f i c i e n t  
t o  re ve rse  the  e q u i l i b r i u m  in  f a v o r  o f  the  f ive-membered hemike ta l  
(Scheme 5). We intend to  examine t h i s  point with an authent ic  sample of 
l y s o c e l l i n  or  ferensimycin B. A l t e r n a t i v e l y ,  we may be able to  employ a 
mixed t h i o k e t a l  , such as 1 1 , and use s i l v e r  ion  comp! ex a t i o n  t o  d r i v e  
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Scheme 5
An i n i t i a l  re t ro syn th e t ic  ana lys is  of ferensimycin B revea ls  two 
a c y c l i c  t a r g e t s  14 ( l e f t - h a n d  segment) and 16 ( r ig h t - h a n d  segment) o f  
s im i l a r  stereochemical complex i ty  (Scheme 7). The major C-9/C-10 bond 
disconnection is  predicated on the to ta l  synthesis of l a s a lo c id  A by
Me Me
Scheme 6
both I r e l a n d l S  and K i s h i . ^  Unfor tunate ly ,  the le v e l  of d iastereose1ec- 
t i o n  they  observed f o r  t h i s  mixed a l d o l  condensat ion is  f a r  from 
o p t im a l .  For example, condensat ion o f  the  z inc  e n o la te  d e r iv e d  from 
ketone 18 w i t h  a ldehyde 17 a f f o r d s  a 61:20:11:7 m ix tu re  o f  the fo u r  
p o s s ib l e  e n an t io -1  a s a lo c id  A d ias te reom ers  19a, 19b, 19c, and 19d 
(Scheme 8).^0 C u r r e n t l y ,  we are i n v e s t i g a t i n g  methods to  improve the 
d ias te reose lec t ion  fo r  t h i s  c ruc ia l  bond c o n s t ru c t io n . ^
Shown in  Scheme 9 is  a re t rosyn the t ic  plan fo r  the construct ion of 
the le f t -hand  segment of ferensimycin B.21 This ta rge t  can be stereo- 
s e le c t i v e l y  prepared by the app l ica t io n  o f two asymmetric a ldo l  conden­
sa t io n s  (Steps A and C), one asymmetr ic a l k y l  a t i o n  (Step D), and one 
d irec ted  hydroborat ion (Step B). The c h i r a l i t y  f o r  the asymmetric a ldo l  
condensations and the asymmetric a lk y l a t i o n  w i l l  be derived from ch i ra l  
2 -oxazol idinone imides 2 0 a and 2 1 a.
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The d ia s te re o se le c t ive  a l k y l a t i o n  o f  ch i ra l  2-oxazol id inone imide 
eno la tes , described in  Chapter 1, provides an e f f i c i e n t  method of gener-
developed a h igh ly  stereoregul ar a ldo l  condensation using the same 2 - 
oxazol id inone c h i ra l  a u x i l i a r i e s . ^ a  I l l u s t r a t e d  in  Scheme 10 are the 
re le va n t  a ldo l  condensations required f o r  the construct ion o f the C-2/C- 
3 and C-7/C-8 bonds in  the l e f t - h a n d  segment o f fe re n s im y c in  B. The 
boron enolates derived from imides 20a and 21a (.n-BugBOTF, Et3 N, CH^CHg) 
react with aldehydes to a f fo rd  one o f the four possib le  diastereomers 
w ith  greater  than 99% s te r e o s e le c t i v i t y .  Depending on the c h i r a l i t y  of 
the C-4 2-oxazol idinone subs t i tuen t ,  e i t h e r  e ry th ro  diastereomer can be 
obtained. The proposed t r a n s i t i o n  s ta te  leading to  the observed major 
diastereomer is i l l u s t r a t e d  in  Figure 3 fo r  ch i ra l  imide 20a.
a t ing  ch i ra l  2 -subs t i tu ted  ca rboxy l ic  acid d e r i v a t i v e s . ^  We a lso  have
o o 0  0  OH
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Figure 3. Chiral  2 - 0 xa2ol id inone Imide Boron Aldol T rans i t ion  State.
The stereocheni i  s t y  at C-4 (Scheme 9, Step B) wi 1 1 be induced by a 
d i r e c t e d  hyd robora t  i on. B a r t r o l l i ,  i n  our l a b o r a t o r i e s ,  has demon­
s tra ted 1,3 asymmetric induct ion f o r  the hydroborat ion of ch i ra l  te rm i ­
nal o l e f i n s  (Eq l ) . 2 2  The l e v e l  o f  c h i r a l i t y  t r a n s f e r  ( rang ing  from 
60:40 to 91:9) depends main ly  on the s te r i c  d i f fe rence  between Rjv| and R|_ 
(R|_ i s  l a r g e r  than R^). A proposed t r a n s i t i o n  s t a t e ,  le a d in g  to  the  
major diastereomer, is i l l u s t r a t e d  in Scheme 11.
As prev ious ly  noted, we envisioned employing a d ia s te re o se le c t i ve  
e p o x id a t i o n - - e c id  c a ta l y z e d  c y c l i z a t i o r i  sequence to  e s t a b l i s h  the 
stereocherri i s ty  o f  the  B and C r in g s  o f  fe re n s im y c in  B. Th is  approach, 
i l l u s t r a t e d  in  Scheme 12 f o r  the synthesis o f 13 from diene 16, in v o lv e s  
two d irected epoxidat ions (Steps A and C), two acid cata lyzed c y c l i z a -  
t i o n s  (Steps B arid E), and one 2° a l c o h o l  t o  ketone o x id a t i o n  (Step D). 
The two d i r e c te d  e p o x id a t io n s  w i l l  be r e s p o n s ib le  f o r  g e n e ra t in g  the
nw OH
2) H,0;
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s te re o c h e m is t ry  a t  C-16, C-20, and C-21, and thus  are c r u c i a l  t o  the  
outcome of t h i s  synthet ic  plan.
The r ight-hand segment o f ferensimycin B, 13, has been obtained as 
the  n e u t ra l  p roduct  from the  bas ic  (NaOH, d ioxane /H 2 ®) d e g ra d a t io n  o f  
l y s o c e l l i n  (3) (Scheme 1 3 ).17 As p r e v io u s l y  noted f o r  3, th e  f i v e -  
membered hemiketal C r ing  of 13 undergoes acid cata lyzed isomer izat ion 
to  the six-membered hemiketal 26. Therefore, we w i l l  need to  c a r e f u l l y  
monitor the transfo rmation from epoxy-ketone 25 to  13 (Scheme 12, Step 
E) in  order to prevent isomerizat ion to 26. Otherwise, regenerat ion of 
the f ive-membered hem ike ta l  r i n g  at a l a t e r  stage would be necessary 
( v id e  sup ra ). A l t e r n a t i v e l y ,  the  second e p o x id a t io n  sequence (see 
Scheme 12, Steps C, D, and E) could be postponed u n t i l  a f t e r  the r i g h t -  
and le f t -hand  segments are coupled. This would permit metal ion com- 
p lexa t ion  to p ro tec t the desired five-membered hemiketal r ing  as i t  i s  
formed.
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K is h i23 ^as demonstrated th a t  the Sharp less  procedure (V0(acac)2> 
t^-BuOOH) f o r  the d i r e c t e d  e p o x id a t io n  o f  a l l y l i c  and h o m o a l l y l i c  
a l c o h o l s ^  can be extended to  bishomoa 1 1 y 1 i c  a l c o h o ls .  Fur thermore ,  
w i th  ch i ra l  bishomoal l y l  ic  a lcoho ls ,  he observed s ig n i f i c a n t  l e v e l s  of 
d i a s t e r e o s e l e c t i o n  (Scheme 14). Treatment o f  th e  r e s u l t a n t  epoxy­
a lco h o ls  w ith  acet ic  acid e x c lu s i v e ly  a ffords the diastereomeric t e t r a -  
hydrofurans. Summarized in  Table 1 are the data Kishi reported f o r  the 
e p o x i d a t i o n - - a c i d  c a ta l y z e d  c y c l i z a t i o n  o f  v a r io u s  bishomoa1 1 y l  ic  
a l c o h o l s . ^  The le v e l  o f  d ias te reose lec t ion  fo r  the vanadium catalyzed 
e p o x id a t io n s  ranges from 86:14 (Tab le  1, E n t ry  C) to  95:5 (T a b le  1, 
E n t ry  D). The sense o f  d i a s t e r e o s e l e c t i o n ,  which depends on the  c h i ­
r a l i t y  of the d i re c t in g  hydroxyl group, is  the same as th a t  required f o r  
the  construc t ion  of the B and C r ings  of ferensimycin B (compare Schemes 
12 and 14).
K ish i  has a p p l i e d  the  vanadium catalyzed epox idat ion--ac id  cata­
lyzed c y c l i z a t i o n  sequence to  stereosel e c t i v e l y  prepare a te t rahydro -  
furan r ing  in  his  synthesis o f  l a s a lo c id  A. 19 The re levan t  react ion is  
i 1 1 u s t r a te d  in  Eq 2. In t h i s  exampl e, he ob ta ined  an 89:11 r a t i o  o f  
t e t r a h y d r o f u r a n  d ia s te re o m e rs  from diene 30. S ig n i f i c a n t l y ,  the iso ­
la ted  o l e f i n  does not undergo epoxidat ion. The close s i m i l a r i t y  between 
d iene  16 and d iene 30 gave us co n f idence  t h a t  we would be a b le  to  
p repare  the  B and C r i n g s  o f  fe re n s im y c in  B, as i l l u s t r a t e d  in  Scheme 
12.
>
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Table 1. Epoxidation o f B ishomoal ly l ic  Alcohols (Scheme 14).
En t ry Substra te R1 R2 R3 [ 0 ]
Ratio
28:29
A 27a j_-Pr H H MCPBA 50:50
B 27a i -P r H H V0{acac)2> t-BuOOH 90:10
C 27b j_-Pr Me H V0 (acac)2 » l-^uOOH 86:14
D 27c J_-Pr H Me V0(acac)2j  t-BuOOH 95:5
E 27d 2 -MeOPh H H V0 (acac)2 > t-BuOOH 89:11
F 27e £-MeOPh Me H V0(acac)2i  t-BuOOH 89:11










31 (7 5 % ) 89  11
Shown In Scheme 15 is a re t rosyn the t ic  plan fo r  the construc t ion of 
diene 16. This ta rge t  can be s te re o s e le c t i v e ly  prepared by the a pp l ica ­
t i o n  o f  one asymmetr ic a 1 d o 1 condensat ion  (Step B), two asymmetr ic 
a lk y l a t i o n s  (Steps C and E), and one s te re o se le c t ive  W i t t ig  condensation 
(Step D). The c h i r a l i t y  fo r  the asymmetric a ldo l  condensation and the 
as.ymmet r i c a l k y l a t i o n s  w i l l  be d e r iv e d  from c h i r a l  2 -oxazo l  id inone 
imides 20a, 20b, and 21a. The s te re o se le c t ive  generat ion of the a(16- 
17) ( E ) - t r i  s u b s t i t u t e d  o l e f i n  (Step D) i s  precedented by the  work o f  
K i s h i ,  who has demonstra ted c o n d i t i o n s  f o r  p re p a r in g  e i t h e r  o l e f i n  
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I I I .  RESULTS AND DISCUSSION.
A. C o n s t r u c t io n  o f  Diene {32, see Scheme 15). The s y n th e s is  o f  
(E )-3 -bromomethy1-3-hexene (36),  the  t r i s u b s t i t u t e d  al l y l i c  bromide 
needed f o r  the  f i r s t  asymmetr ic a l k y l a t i o n ,  i s  shown in  Scheme 17.26 
The re q u is i te  a l l y l i c  a l c o h o l ,  (E } -3 -hydroxym ethy1-3-hexene ( 3 7 ) ,  i s  
prepared by m o d i f i c a t i o n  o f  the  Zwe i fe l  hydroaluminat ion procedure. ^ 7 
Thus, hydroa 1 um ina t ion  o f  3-hexyne w i th  d i i s o b u t y la l u m in u m  h y d r id e  
(DIBAL), metal a t ion  o f the r e s u l t a n t  c i s - v i n y la la n e  with  n-buty l  1 i th ium, 
and subsequent t re a tm e n t  o f  the  v i n y l a l a n a t e  complex w i t h  para form-  
aldehyde a ffords al  l y l i c  a lcohol 37 in  6 8 % y i e l d  as a col o r1 ess 1 iquid . 
Ana lys is  o f  the product by c a p i l l a r y  GC revea ls  a 99:1 r a t i o  o f (20E)-37 
t o  (20Z)-37. A l though  th e  y i e l d  i s  o n l y  moderate, the  r e a c t i o n  i s  
r e a d i l y  performed on a la rge  scale (> 1 mol), the reagents are inexpen­
s iv e ,  and the react ion a ffords a product o f high stereochemical pu r i t y .
1) i-Bu,AIH
Et — EEEE— Et ----------------------------------  H O ^ f ^ E t
2 )n -B u L i £
3) (HCHO)n , ,
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Scheme 17
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I n i t i a l l y ,  we attempted to  transform a l l y l i c  a lcohol 37 to  a l l y l i c  
bromide 36 by treatment w ith  phosphorus t r ib romide in  the presence of 
calcium hydride (eq 3).28 U nfo r tuna te ly ,  these condi t ions a f fo rd  a 2:1 
m ix tu re  o f  th e  d e s i re d  a l l y l i c  bromide to  the  iso m e r ic  SN2' d e r iv e d  
a l l y l i c  bromide. Corey has reported tha t  the complex obtained from N- 
bromosuccinimide (NBS) and dimethyl s u l f i d e  c le a n ly  transforms a l l y l i c  
a lcoho ls  to  t h e i r  respect ive  a l l y l i c  b r o m i d e s . 29 Accord ing ly ,  t reatment 
o f  a l l y l i c  a lcohol 37 w i th  the NBS— dimethyl s u l f i d e  complex a f fo rds ,  
a f t e r  simple f i l t r a t i o n  through s i l i c a  g e l ,  a l l y l i c  bromide 36 in  81% 
y i e l d  as a c o lo r l e s s  l i q u i d .  Analys is  o f  the product by c a p i l l a r y  GC 
revea ls  less than 1% of the isomeric a l l y l i c  bromide. Although r e l a ­
t i v e l y  s tab le  at room temperature, a l l y l i c  bromide 36 undergoes isomer i ­
zat ion and decomposition upon d i s t i l l a t i o n ,  even at reduced pressures.
Et
The f i r s t  o f  the two asymmetric a lk y la t io n s  constructs  the C-18/C- 
19 bond and es tab l ishes  the C-18 stereochemistry (Scheme 18). Eno l iza-  
t i o n  of imide 21a w ith  l i t h i u m  di isopropylamide (LDA, 1.1 equiv , -78°C, 
0.5 h) and subsequent t re a tm e n t  o f  the  r e s u l t a n t  l i t h i u m  e n o la te  w i t h  
a l l y l i c  bromide 36 (2 equiv , -35°C, 18 h) a ffords a lk y la te d  imide (18R)- 
35 along with  a minor amount o f  ( 1 8 S ) - 3 5 . ® b  Analysis o f  the u n f ra c t io n ­
ated p roduct  by c a p i l l a r y  GC r e v e a l s  a 98.5:1.5 r a t i o  o f  (18R) -3 5  to  
(18S)-35. Product i s o l a t i o n  by l i q u i d  chromatography (Waters Prep-500)
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a f fo rds a lk y la te d  imide (18R)-35 in 6 8 % y i e l d  as a c o lo r le s s  o i l  [(18R)- 
35:(18S)-35 > 99:1 ] .
Previous attempts to  reduce a lk y la te d  imides to  the aldehyde oxida­
t i o n  s ta te  w i t h  DIBAL (1 e q u iv ,  CH2 C12 » have proven unsuc­
c e s s f u l .  30 T h e re fo re ,  we chose the tw o -s te p  r e d u c t i o n - o x id a t i o n  se­
quence to  transform a lky la te d  imide (18R)-35 to  aldehyde 3 9 . Reduc­
t i v e  cleavage o f  the ch i ra l  a u x i l i a r y  from a lk y la te d  imide (18R)-35 with 
l i t h iu m  aluminum hydride (LAH, 4 hydride equiv , THF, 0°C, 3 h) a ffo rds, 
a f t e r  product  i s o l a t i o n  by l i q u i d  chromatography, a l c o h o l  38 in  95“. 
y i e l d  as a c o lo r le s s  l iq u id .  A f te r  eva lua t ing  several ox idat ion proce­
dures, 22b, 30 we found tha t  the modif ied Swern procedure is  the method
31best sui ted f o r  preparing ch i ra l  aldehydes se n s i t ive  to  racemization. 
Thus, treatment of alcohol 38 with o x a l l y l  c h lo r id e ,  dimethyl su l fox ide 
(DMSO), and t r i e t h y l  amine (CHgC12 * "60°C to  -30°C, 0.75 h) a f fo rd s  
aldehyde 39 in  94% y i e l d  as a c o lo r le ss  l i q u id .
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The second t r i s u b s t i t u t e d  o l e f i n  [a(16,17)3 i s  s te re o s e l  e c t i v e l  y 
constructed v ia  a W i t t ig  react ion as i l l u s t r a t e d  in  Scheme 19. Carbo- 
e th o x y e th y l i d e n e  t r i p h e n y lp h o s p h o ra n e  has been shown to  re a c t  w i th  
c h i r a l  2 -subs t i tu ted  aldehydes with a n e g l i g ib le  amount of racemization 
and with  a high degree of s t e r e o s e le c t i v i t y  to a f fo rd  (E ) - t r i s u b s t i t u te d  
o le f ins .22b,  23, 32, 33 Accord ing ly ,  treatment of aldehyde 39 with  the 
s t a b i l i z e d  phosphorane (1.2 e q u iv ,  40°C, 12 h) a f f o r d s  e s te r
(16E)-34 and a minor amount o f the diastereomeric product (16Z)-34 in a 
combined y i e l d  of 93%. Analysis of the unfract ionated product by c a p i l ­
l a r y  GC revea ls  a 97:3 r a t i o  of {16E)-34 to (16Z)—34- The same react ion 
performed in  r e f l u x in g  benzene (4 h) a ffords a 95:5 r a t i o  o f  (16E)-34 to
o






(16Z)-34. Although the diastereomers are separable by ca re fu l  l i q u i d  
ch romatography , we chose to  remove the m inor  o l  e f  i n i somer a t a 1 a t e r  
stage ( vide i n f r a ).
Reduct ion  o f  e s t e r  34 [ (16E) -34 : (16Z )-34  = 97 :3 ]  w i t h  DIBAL (2.2 
equiv , CH2 C l 2 > -78°C to  -20°C, 2 h) fo l lowed by an aqueous sodium potas­
sium t a r t r a t e  workup a f fo rds  al l y l i c  alcohol 40 in  99% y i e l d  as a c o lo r -  
1 ess 1 iqu id . I n i t i a l  l y ,  we attempted to transform al l y l  i c  al cohol 40 to  
a l l y l i c  bromide 41a by the p re v io u s ly  described NBS--dimethyl s u l f id e  
p r o c e d u r e . ^  U nfo r tuna te ly ,  with t h i s  a l l y l i c  a lc o h o l ,  these condi t ions 
a f f o r d  an i n t r a c t a b l e  m ix tu re  o f  s e v e ra l  i someri  c a 1 l y l i c  bromi des. 
A f t e r  e v a l u a t i n g  s e v e ra l  o th e r  procedures ,  we found the  t r i p h e n y l -  
phosphine--carbon tetrabromide method to  be w e l l  sui ted f o r  t h i s  t ra n s ­
formation. 36 Thus, treatment o f  a l l y l i c  a lcohol 40 with t r ipheny lphos-  
phine and carbon tetrabromide in a c e t o n i t r i l e  ra p id l y  a f fo rds  a l l y l i c  
bromide 41a in  94% y i e l d .  A n a ly s i s  o f  the  p roduc t  by c a p i l l a r y  GC 
revea ls  less than 1% of the isomeric SN2' derived a l l y l i c  bromide.
The second asymmetric a l k y l a t i o n  constructs the C-14/C-15 bond and 
es tab l ishes  the C-14 stereochemistry.  Un fo r tuna te ly ,  t reatment o f  the 
l i t h i u m  e n o la te  d e r i v e d  from imide 20a w i t h  a l l y l i c  bromide 41a (2 
equiv , -78°C to  0°C, 4 h) a f fo rds  a lk y la te d  imide 33 in  a mere 6 % y i e l d  
(eq 4). Even t re a tm e n t  o f  th e  more r e a c t i v e  s o d iu m e n o la te ,  prepared 
from imide 20a and sodium hexamethyl d is i  ly lam ide  (NaHMDS, 1.1 equiv,  
-78°C to  -40°C, 4 h) a f f o r d s  the  d e s i re d  p roduc t  i n  o n l y  28% y i e l d .  
Although the a l l y l i c  bromide could be recovered and recyc led, we desired 
a more r e a c t i v e  e l  e c t r o p h i 1 e, and t h e r e f o r e  decided t o  prepare the  
corresponding a l l y l i c  iod ide 41b.
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Rydon has reported tha t  methyl triphenoxyphosphonium iodide t rans ­
forms a l c o h o l s ,  i n c l u d i n g  a l l y l i c  a l c o h o l s ,  to  t h e i r  r e s p e c t i v e  
i o d i d e s . A l t h o u g h  the o r ig in a l  procedure c a l l e d  fo r  the alcohol and 
phosphonium io d id e  t o  be heated in  r e f l u x i n g  benzene, M o f fe t  has r e ­
po r te d  t h a t  the  r e a c t i o n  proceeds at room tem pera tu re  i f  performed in  
dimethylformamide ( D M F ).38 Accord ing ly ,  treatment o f a l l y l i c  alcohol 40 
L(16E)-40:(16Z)-40 = 97:3] with  f r e s h l y  prepared methyl t r iphenoxyphos- 
phonium i o d i d e ^  ( i . i  equiv ,  DMF, 20°C, 20 min) a ffords a l l y l i c  iodide 
41b along with a minor amount o f diphenyl methylphosphonate (112% mass 
balance). Analys is  of the product by NMR spectroscopy reveals  a 96:5 
r a t i o  o f (16E)-41b to  (16Z)-41 b and ca. 10% o f  the phosphonate. Whi le  
th e  phosphonate can be removed by s im p le  f i l t r a t i o n  o f  the  m ix tu re  
th rough  a lum ina ,  t h i s  r e s u l t s  i n  a c o n s id e ra b le  amount (10-40%) o f 
o l e f i n  isomer izat ion. A l l y l i c  iodide 41b undergoes f a c i l e  ac id, heat, 
iod ine, and l i g h t  ca ta lyzed isomerizat ion. Therefore, i t  i s  imperat ive 
t o  use the product immediately,  without fu r th e r  p u r i f i c a t io n .
Al l y l i c  io d id e  41b fu n c t i o n s  adm irab ly  in  the  second asymmetr ic 
a l k y l a t i o n  (Scheme 20). E n o l i z a t i o n  o f  imide 20a w i th  NaHMDS (1,1 
e q u i v ,  -7 8 ° ,  0.5 h) and subsequent t rea tm en t  o f  the  r e s u l t a n t  sodium 
enolate  with a l l y l i c  iod ide 41b (0.33 equiv, -30°C, 4 h) a ffords a l k y l ­
ated imide (14S,16E)-33 along with minor amounts of two diastereomeric 
products. The large excess of enolate (3 equiv) r e l a t i v e  to  e le c t ro -
7 8 %
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Scheme 20
p h i l e  is  necessary to  obtain a reasonable product y ie ld .  Analys is  of 
the unfract ionated product by c a p i l l a r y  GC reveals  a 93:7 r a t i o  of the 
major diastereomer (14S,16E)-33 to  the minor diastereomers (14R,16E)-33 
and (14S,16Z)-33. Product i s o l a t i o n  by l i q u i d  chromatography (Waters 
P re p -500) a f f o r d s  a l k y l a t e d  im ide 33 in  78% y i e l d  (based on a l l y l i c  
alcohol 40). The product, however, s t i l l  contains the minor d iastereo- 
mers. These are removed at a l a t e r  stage.
The two-step reduc t ion-ox ida t ion  sequence is repeated to transform 
a l k y l a t e d  imide 33 to  aldehyde 43. Thus, r e d u c t i v e  c leavage  o f  the 
c h i ra l  a u x i l i a r y  from a lk y la te d  imide 33 with  LAH (4 hydride equiv, THF, 
0°C, 3 h) a f f o r d s ,  a f t e r  product  i s o l a t i o n  by l i q u i d  chromatography, 
a l c o h o l  42 in  9 4 % y ie ld  as a c o l o r l e s s  l i q u i d .  One o f the  minor d i a -  
s te reomers, presumably (14R)-42 i s  removed du r in g  product i s o l a t i o n .
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Analys is  o f  the re su l ta n t  product by c a p i l l a r y  GC reveals  a 97:3 r a t i o  
o f diastereomers. Treatment of alcohol 42 with o x a l l y l  c h lo r id e ,  DMSO, 
and t r i e t h y l  ami ne (CHgCT 2 » _60° c t 0  - 30° c > ° - 5 h) affords aldehyde 43 in 
98% y ie l d .  Analys is  of the product by c a p i l l a r y  GC revea ls  a 97:3 r a t i o  
of d iastereomers.3^
An asymmetric a ldo l  condensation constructs the C-12/C-13 bond and 
e s t a b l i s h e s  the  s te re o c h e m is t r y  a t C-12 and C-13.3a E n o l i z a t i o n  o f  
imide 20b with  d i- jn-buty l  boryl  t r i f l a t e  and t r ie thy lam ine  (CHgC 12 » -78°C 
f o r  0.5 h then 0°C f o r  1 h) and subsequent t rea tm en t  o f the  r e s u l t a n t  
boron e n o la te  w i th  a ldehyde 43 (-78°C to  0°C, 2.5 h) a f f o r d s ,  a f t e r  * 
o x i d a t i v e  workup, diene 32 a long  w i t h  minor amounts o f  s e v e ra l  d ia -  
stereomers (eq 5). A n a ly s i s  o f  the  u n f r a c t i o n a te d  p ro du c t ,  as i t s  
t r im e th y l  s i l y l  d e r i v a t i v e  (Et2 NSiMe3 , DMAP, CH2 C12 > ^ by c a p i l l a r y  
GC r e v e a l s  a 2.6:4.2:92.8:0.4 m ix tu re  of di astereomers. Product i s o l a ­
t i o n  by l i q u i d  chromatography (MPLC) a f fo rds  diene 32 in 82% y i e l d  as a 
viscous c o lo r le s s  o i l  (0:4:96:0). The i d e n t i t y  of the remaining minor 
diastereomer is  unknown.
1) (n-Bu)jBOTf, Et,N
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B. The Stereoselective Epoxidation of Bishomoallylic Alcohols: A
Model Study. We prepared bishonioal l y l  ic alcohol 44 as a model substrate 
f o r  the eva lua t ion  of the epoxidat ion--ac id  catalyzed c y c l i z a t i o n  se­
quence. Thus, e n o l iza t io n  of imide 21a with d i - n -b u ty lb o ry l  t r i f l a t e  
and t r i e t h y l  amine (CHzCl^ -78°C fo r  0.5 h then 0°C fo r  1 h) and subse­
quent treatment of the re su l ta n t  boron enolate with  aldehyde 39 (-78°C 
to  0°C, 4 h) a f fo rds ,  a f t e r  ox ida t ive  workup, bishomoal l y l i c  alcohol 44 
i n 8 8 % y i e l d  (eq 6 ). A n a ly s i s  o f  the t r i m e t h y l s i l y l a t e d  d e r i v a t i v e  
( E t 2 NSiMe3 , DMAP, CH2 C12 * 4 *0 r e v e a ls  the  presence o f  o n l y  one d ia -  
s te reomer ( l i m i t s  o f  d e t e c t i o n ^  100:1). Bishomoal l y l i c  a lc o h o l  44 
possesses the same r e l a t i v e  (al though opposite absolute) stereochemistry 




K ish i  has repor ted  t h a t  m-ch lo roperbenzo ic  acid (MCPBA) exh ib i ts  
n e g l i g i b l e  d ias te reose lec t ion  f o r  the e p o x id a t io n  o f  c h i r a l  bishomo­
al l y l i c  a lcoho ls  (see Table 1, Entry A).25 Therefore, f o r  i d e n t i f i c a ­
t i o n  purposes, we employed MCPBA to  prepare a standard mixture of ce t ra -  
h y d ro fu ra n  d ias te reom ers  45 and 46 from bishomoal l y l  i c  a lc o h o l  44 
(Scheme 21). Accordingly,  treatment o f bishomoal l y l i c  a lcohol 44 with 
MCPBA (1.2 equiv, CH2C I2 , -20°C to  25°C, 4 h) fo l lowed by acet ic  acid (3 
e q u iv ,  0.5 h) a f f o r d s  te t r a h y d r o fu r a n s  45 and 46. A n a ly s i s  o f  the 
u n f r a c U o n a te d  product  by c a p i l l a r y  GC re v e a l  s a 23:77 r a t i o  o f  45 t o  
46. The diastereomers are re a d i l y  separable by l i q u i d  chromatography to
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a f f o r d  45 in  19% y i e l d  (45 :46  > 99:1) and 46 in  72% y i e l d  (45:46 < 
1:99). Presumably, the C-4 methyl group is  responsible fo r  the observed 
d ias te reose lec t ion  in a manner analogous to  the t r a n s i t i o n  s ta te  shown 
in Scheme 1 1 .2 2 b
Me Me E1
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( o )  = 1-BuOOH, VOCococlj 9 2  : 8
(o) = MCPBA 23 : 77
Scheme 21
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The id e n t i t y  o f  the two t e t r a h y d r o f u r a n  d ias te reom ers  was d e t e r ­
mined by n u c le a r  Overhauser enhancement (NOE) d i f fe rence  spectroscopy. 
I r r a d ia t io n  o f  the C-3 proton of te trahydro furan  45 a f fo rds  a p o s i t i v e  
enhancement o f  the signal f o r  the C-7 proton. This ind icates th a t  these 
two groups res ide on the same side o f  the te trahydrofu ran r ing. In the 
case o f  t e t r a h y d r o f u r a n  46 ,  i r r a d i a t i o n  o f  the  C-3 p ro to n  does not 
r e s u l t  i n  a s ig n a l  enhancement f o r  the  C-7 pro ton .  T h e re fo re ,  t e t r a -  
hydrofurans 45 and 46 are assigned the s t ruc tu res  i l l u s t r a t e d  in  Scheme 
21.
In contrast to  the above MCPBA epoxidat ion r e s u l t s ,  the vanadium 
cata lyzed t -bu ty lhydroperox ide  epox ida t ion- -ac id  catalyzed c y c l i z a t i o n  
sequence favors  te t rahydro fu ran  45. For example, treatment o f  bishomo- 
a l l y l i c  a lcohol  44 with  anhydrous j t -buty lhydroperox ide^^ (1.2 equiv) in  
the presence o f  a c a t a l y t i c  amount o f  vanadyl a c e ty la c e to n a te  ( 0 . 1  
equiv , 25°C, 2 h) fo l lowed by ace t ic  acid (3 equiv)  and dimethyl s u l f i d e  
(excess, t o  decompose the  remain ing peroxide) a f fo rds  te trahydrofurans 
45 and 46. A n a ly s i s  o f  th e  u n f r a c t i o n a te d  p roduc t  by c a p i l l a r y  GC 
revea ls  a 92:8 r a t i o  of 45 to  46. Product i s o la t i o n  by l i q u i d  chroma­
tography a f fo rds  te t rahydro furan  45 in  74% y i e l d  (45:46 >99:1).
C. S te reose lec t ive  Preparat ion o f  the B Tetrahydrofuran Ring. The
f i r s t  s te re o se le c t ive  epox ida t ion - -ac id  cata lyzed c y c l i z a t i o n  sequence 
constructs what w i l l  become the B te trahydro furan  r ing  o f ferensimycin B 
(Scheme 22). The presence o f  th e  a(20,21) doub le  bond in  d iene 32 
d i c t a t e s  t h a t  c a r e fu l  1 y c o n t r o l  led  c o n d i t i o n s  be employed f o r  t h i s  
transformation in  order to  prevent over-ox idat ion .  Accord ingly,  t r e a t ­
ment o f  d iene 32 w i t h  anhydrous t , - b u ty l  hyd roperox ide  (1.1 e q u iv ) ,
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vanadyl a c e ty l  acetonate ( 0 . 1  e q u i v ) ,  and anhydrous sodium acetate ( 10  
equiv)  in  benzene fo r  1.5 h at 25°C, fo l low ed  by c h io ro t r im e th y ls i  1 ane 
(10 e q u i v ) ,  t r i  e th y l  ami ne (10 e q u i v ) ,  and DMAP (1 e q u iv )  f o r  0.5 h at 
25°C a f f o r d s ,  a f t e r  i s o l a t i o n  by l i q u i d  chromatography,  t r i m e t h y l  - 
s i l y l a t e d  diene 47 in  45% y i e l d  and t r im e th y l  si l y l  ated epoxide 48 in  45%. 
y i e l d .  Treatment of t r im e thy l  s i l y l a t e d  epoxide 48 with acet ic  acid in 
THF/water  (1 :5 :3)  f o r  4 h a t  25°C a f f o r d s  t e t r a h y d r o f u r a n  49 in  85% 
y i e l d .  A n a ly s i s  o f  the p roduct  by c a p i l  l a r y  GC, HPLC, and h igh  f i e l d  
NMR spectroscopy reveals the presence o f on ly  one diastereomer. Presum­
ab ly ,  any minor diastereomers are removed during l i q u i d  chromatographic 
product i s o la t io n .  Treatment of t r im e th y l  si l y l  ated diene 47 with acet ic
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acid in THF/water (1:5:3) f o r  4 h at 25°C a f fo rds  diene 32 in  91% y ie l d .  
Therefore, based on recovered diene 32, te trahydro fu ran  49 i s  obtained 
in an o v e r a l l  y i e l d  o f  55%. Attempts to  improve the y i e l d  by increasing 
the amount o f  e i t h e r  the j t -bu ty lhydroperox ide  or the vanadium c a ta l y s t  
have proven u n s u c c e s s fu l .  Rather ,  s e v e ra l  u n i d e n t i f i e d  b yp rod u c ts ,  
presumably a r e s u l t  of  d iepox ida t ion ,  are formed.
The stereochemistry o f  te t rahydro furan 49 was inves t iga ted  by NOE 
d i f f e r e n c e  spec t roscopy .  I r r a d i a t i o n  o f  the  C-13 p ro to n  a f f o r d s  a 
p o s i t i v e  enhancement o f  the  s ig n a l  f o r  th e  C-17 p ro ton .  In  a d d i t i o n ,  
i r r a d ia t i o n  o f the C-16 methyl protons a f fo rds  a smaTl p o s i t i v e  enhance­
ment o f  the signal f o r  the C-12 protons. These re s u l t s  are in  agreement 
w ith  the s t ru c tu re  proposed f o r  te t rahydro furan  49.
D. Construction of the Left-Hand H a lf  o f Ferensimycin B. Recently,  
P o ln ia sze k  in  our l a b o r a t o r i e s  has c o n s t ru c te d  an i n t e r m e d ia t e  (50) 
co r respond ing  to  the  l e f t - h a l f  o f  f e re n s im y c in  B.^ l  The s y n th e s is  
b a s ic a l l y  f o l l o w s  the plan p rev ious ly  o u t l in e d  in  Scheme 9. The re s u l t s  
are shown in Scheme 23.

















O '^ N H  :  Xn
J___ Ik* v  k.
'M e
,x NH i  X v
V
Scheme 23
- 1 8 5 -
IV. SUMMARY
Our e f f o r t s ,  d irec ted toward the enan t iose lec t ive  t o ta l  synthesis 
o f  ferensimycin B, have culminated in  the preparat ion o f  two advanced 
intermediates 49 and 50. The synthesis o f  both 49 and 50 demonstrates 
the u t i l i t y  o f  c h i r a l  2 -oxazol idinones as synthons fo r  the construc t ion 
o f  a c y c l i c  stereochemistry. Furthermore, we have shown th a t  the vanad­
ium cata lyzed d irected epox ida t ion--ac id  catalyzed c y c l i z a t i o n  sequence 
i s  successful  fo r  the preparat ion of the B te t rahydrofuran r ing. I n t e r ­
mediate 49 ,  corresponding to  the r ight-hand h a l f  o f  ferensimycin B, is  
prepared in  ten steps i n  an o v e r a l l  y i e l d  o f  18%. L ike w ise ,  i n t e r ­
med ia te  5 0 ,  co rrespond ing  to  the  l e f t - h a n d  h a l f  o f  fe re n s im y c in  B, i s 
prepared in  ten steps in  an o v e r a l l  y i e l d  o f  5 %.21 E f f o r t s  co n t in u e  
toward the u l t im a te  completion o f  t h i s  synthesis:  1 ) the s te reose lec t ive  
preparat ion of the five-membered hemiketal C r ing ;  2) the preparat ion of 
e thy l  ketone 13; and 3) the s te re o se le c t ive  coupl ing of the l e f t -  and 
r ig h t -h a n d  segments.
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V. EXPERIMENTAL SECTION
General. M e l t in g  points were determined w ith  a Buchi SMP-20 m e l t ­
ing point apparatus and are uncorrected. IR spectra were recorded on a 
Beckman 4210 sp e c t ro ph o to m e te r  and are r e p o r te d  in  r e c ip r o c a l  c e n t i ­
meters (cm-1 ). Routine ^  NMR spectra were recorded on a Varian Asso­
c ia tes  CFT-20 (80 MHz) or EM-390 (90 MHz) spectrometer. High f i e l d  iH 
NMR sp e c t ra  were recorded on a Va r ian  Assoc ia tes  XL-200 (200 MHz), a 
Bruker  WM-300 (300 MHz), o r  a Bruker  WM-500 (500 MHz) ^ 1 spec t romete r .  
Chemical s h i f t s  are reported in  ppm from in te rn a l  te t ram e thy ls i  1ane on 
the 8  scale. Data are reported as fo l lo w s :  chemical s h i f t ,  m u l t i p l i c i t y  
(s = s i n g l e t ,  d = d o u b l e t ,  t  = t r i p l e t ,  q = q u a r t e t ,  qn = q u i n t e t ,  m = 
m u l t i p l e t  and b r  = b road) ,  c o u p l i n g  c o n s ta n t  (Hz),  i n t e g r a t i o n  and 
i n t e r p r e t a t  i on. 13C NMR spec t ra  were recorded on a JE0L FX-90Q (22.5 
MHz) or a Varian Associates XL-200 (50 MHz) spectrometer and are repor t ­
ed in ppm from in te rna l  tetramethy l si  1 ane on the S scale. M u l t i p l i c ­
i t i e s ,  when determined by off-resonance decoupl ing, are reported using 
the above format.
O p t i c a l  r o t a t i o n s  were determined w i t h  a Jasco DIP-181 d i g i t a l  
p o la r i m e t e r  a t  589, 577, 546, 435 and 365 nm. Data are re po r ted  as
f o l l o w s :  [ a ] 5 8 g, [ a ] 5 7 7 , [a ]5 4 6 .  M 4 3 5 * [a ]365» c o n c e n t ra t io n  (£ = 
g/100 mL) and so lven t .  When chloroform was used as the so lve n t ,  i t  was 
f i l t e r e d  through a c t i v i t y  1 alumina immediately p r i o r  to  use.
Combustion analyses were performed by Ga lb ra i th  Laborator ies, Inc., 
(K n o x v i l l e ,  Tennessee) or Mr. Lawrence Henl ing at the C a l i f o rn ia  I n s t i ­
tu te  o f Technology M ic roa n a ly t ica l  Laboratory.
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A n a l y t i c a l  gas chromatography (GC) was c a r r i e d  out on a H ew le t t  
Packard 5880A gas chromatograph equipped w i t h  a s p l i t  mode c a p i l  l a r y  
i n j e c t o r  and a f lame i o n i z a t i o n  d e te c to r .  Hydrogen was used as the 
c a r r i e r  gas. The f o l l o w in g  w a l l  coated open tu b u la r  (WCQT) fused s i l i c a  
c a p i l l a r y  columns were employed: 0.32 mm x 15 m and 0.32 mm x 30 m 
Carbowax 20M (J and W A s s o c ia te s ) ,  0.32 mm x 30 m DB-1 (J and W Asso­
c i a t e s ) ,  0.32 mm x 30 m DB-5 (J and W A s s o c ia te s ) ,  0.31 mm x 25 m SE-54 
(Hewlett  Packard) and 0.21 mm x 25 m methyl s i l i c o n e  (Hewlett Packard). 
S p e c i f i c  GC c o n d i t i o n s  are repo r ted  in  the f o l l o w i n g  f o r m a t : column, 
oven tem pera tu re ,  c a r r i e r  gas f l o w  r a te ,  and r e t e n t i o n  t ime. Unless 
otherwise ind ica ted ,  the i n je c to r  and detector  temperatures were 250°C.
Flash chromatography was performed according to  the general proce­
dure of S t i l l , ^  employing EM Reagents S i l i c a  Gel 60 (40-63 wm). Data 
are reported as f o l l o w s :  column dimensions (d x 1 ), e lu tan t  composition 
and order of e lu t io n .  Medium pressure l i q u i d  chromatography (MPLC) was 
c a r r i e d  out on an MPLC apparatus c o n s i s t i n g  o f  a Chromatronix  SV8Q31 
Sample In je c t io n  v a lv e ,  a F lu id  Metering Inc. model RP-SY Lab Pump and 
an ISC0 model UA-5 UV (254 nm) detector  using the fo l lo w in g  EM Reagents 
prepacked LoBar L iC hroprep  Si 60 columns: column A (1.0 x 24 cm, 40-63 
pm s i l i c a  ge l ) ,  column B (2.5 x 31 cm, 40-63 pm s i l i c a  gel)  and column C 
(3.7  x 44 cm, 63-125 pm s i l i c a  ge l) .  Specif ic  MPLC condit ions are re­
ported as fo l lo w s :  column dimensions (d x 1 ), e lu ta n t  composition, e l u ­
ta n t  f lo w  rate and order o f  e lu t io n .  A na ly t ica l  high performance l i q u id  
chromatography (HPLC) was carr ied  out on a Waters Associates ALC 202/401 
HPLC equipped with a model 6000 high pressure so lven t  pump, a model U6K 
i n j e c t o r  and a d i f f e r e n t i a l  UV d e te c to r  (254 nm), using the  f o l l o w i n g  
columns: Waters Associates Radial Pak ( 8  mm x 10 cm, 5 pm s i l i c a  ge l)  or
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( 8  mm x 10 cm, 10 nm s i l i c a  ge l)  and DuPont Zorbax (4.6 mm x 25 cm, 5 um 
s i l i c a  ge l) .  Specif ic  HPLC condi t ions are reported as fo l lo w s :  column, 
e l u t a n t  co m p o s i t io n ,  e l u t a n t  f l o w  r a te  and r e t e n t i o n  volume ( k 1). 
Preparat ive HPLC was performed on a Waters Associates PrepLC/System 500 
l i q u i d  chromatograph, equipped w i th  a r e f r a c t i v e  index d e te c to r  and 
using two PrepPak 500 s i l i c a  gel car t r idges (5 x 30 cm). Spec if ic  HPLC 
condit ions are reported using the above format. Unless otherwise noted, 
the s u b s t r a te  was in t roduced  onto the HPLC as a concen t ra ted  s o l u t i o n  
through the so lven t  i n l e t  port. A n a ly t ica l  th in  layer  chromatography 
(TLC) was performed using EM Reagents 0.25 mm s i l i c a  gel 60-F p la t e s .  
V i s u a l i z a t io n  of the developed chromatogram was performed by UV absor­
bance, i o d in e  vapor ,  an aqueous cerium mo 1 ybdate  sp ray ,  or an aqueous 
potassium permanganate spray.
When necessary , s o l v e n t s  and reagents were d r ie d  p r i o r  to  use. 
D ie th y l  e th e r  and t e t r a h y d r o fu r a n  (THF) were d i s t i l  led  from sodium--  
potassium al 1oy/benzophenone ke ty l .  Benzene and toluene were d i s t i l l e d  
from sodium/benzophenone k e t y l .  Boron t r i f  1 u o r i d e - - d i e t h y l  e t h e r a t e ,  
ch i  o r o t r im e t h y l  s i  1 ane, dichloromethane, d i isopropy l  amine, hexamethyl- 
d is i  l y l  amine, and t r i e t h y l  ami ne were d i s t i l l e d  from ca lc iu m  hyd r ide .  
A c e t o n i t r i 1e, d imethy l fo rmamide  (DMF), and dimethyl su l fox ide  (DMSU) 
were d i s t i l l e d  from calcium hydride and stored over 4A molecu lar sieves. 
Unless otherwise noted, a lk y l  bromides and iodides were passed tnrough a 
column of a c t i v i t y  1 alumina immediately p r io r  to  use. jn-Butyl 1 i thium 
(A ld r ich  Chemical Co.) was standardized by double t i t r a t i o n  ( to ta l  base 
-  inorganic base = organic base).
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Unless otherwise noted, a l l  non-aqueous r e a c t i o n s  were performed 
under an oxygen-free atmosphere o f  argon or  ni t rogen with r i g i d  exc lu ­
s ion o f moisture from reagents and glassware.
(3E)-3-Hydroxymethyl-3-hexene (37). A mechanical l y  s t i r r e d  so lu ­
t i o n  of 182 mL (132 g, 1.60 mol) of 3-hexyne (Farchan Chemical) and 1.60 
L (1.0 M in  hexane, 1.60 mol) o f  d i i  sobu ty l  a l  umi num h yd r id e  was heated 
at 50-60°C fo r  a 4 h period. The c o lo r le s s  s o lu t io n  was cooled to  room 
te m p e ra tu re ,  f o l  1 owed by the a d d i t i o n  o f  1.00 L (1.60 M i n  hexane, 1.60 
m o l )  o f  j i - b u t y l  1 i t h iu m  over  a 40 min p e r io d  ( s l i g h t l y  exo the rm ic ,  
te m p e ra tu re ro se to 3 0 -3 5 °C ) .  The t h i c k , p a l e  y e l  1owmixturewas s t i r r e d  
a t  room tem pera tu re  f o r  0.5 h. The p r e c i p i t a t e  was d i s s o l v e d  by the  
dropw ise  a d d i t i o n  o f  130 mL (ca. 1.6 mol) o f  THF ( s i  i g h t l y  exo the rm ic ,  
temperature rose to  30-35°C). To the pale y e l lo w  s o lu t io n  was added 53 g 
(1.76 mol) o f  para fo rmal  dehyde (d r ie d  j_n vacuo o ve r  phosphorus pent-  
oxide) in por t ions over a 2 h period (at a ra te  to  maintain the tempera­
t u r e  be low 30°C). Caution: Do not add a l l  o f  the para forma 1 dehyde in  
one portion; the reaction may become uncontrollable a f te r  an induction 
period. The react ion  mixture was s t i r r e d  at room temperature fo r  16 h. 
The m ix tu re  i s  coo led  to  0°C and quenched by th e  c a u t io u s  a d d i t i o n  o f  
1.5 L o f  6 N aqueous s u l f u r i c  ac id  ove r  a 2 h p e r iod .  Dur ing the 
i n i t i a l  phase o f the add i t ion ,  a large quant i ty  o f gas i s  evolved. The 
two phases were separated and the  lower  aqueous phase e x t r a c te d  w i th  
th ree  500 mL port ions o f  dichloromethane. The combined organic ex trac ts  
were dr ied  over anhydrous sodium s u l fa te  and concentrated J_n vacuo to 
a f fo rd  250 g o f  a pale yel 1 ow o i l .  D i s t i l  1at ion through a 20-cm Vigreux 
column afforded a 50 g forerun (bp 45-60°C, 10 mm) which consisted of 37
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(ca. 50%) contaminated w ith  3-methyl butanol and r^-pentanol, fo l lowed by 
125 g (58%) o f  the t i t l e  compound as a c o lo r le s s  l i q u i d  (bp 63-64°C, 10 
mm. A n a ly s is  by GC (30 m DB-5, 50°C, 32 cm/sec) a f fo rd e d  a 99:1 r a t i o  
o f  ( 3E)-37  ( t r  = 9 .O6 mi n) t o  (3Z)-37 ( t r  = 9.33 min).
(3E)-37: IR (neat )  3500-3100, 2960, 2940, 2880, 1460, 1360, 1075, 
1030, 1005, 850 cm-1; *H NMR (CDC1 3 /90  MHz) 8  5.37 (b r  t ,  J = 7.2 Hz, 
1H, C4 -H),  4.00 (s ,  2H, C3 -CH2 OH), 2.2-1.9 (m, 5H, OH, C2 -H2 , C5 -H2 )> 
0.99, 0.97 ( o v e r l a p p in g  t ' s ,  J = 7.5, 7.5 Hz, 6 H, C6 -.H3 ); 13c NMR
(CDC 1 3 / 2 2 . 5  MHz) 8  140.2, 128.0, 6 6 . 8 , 21.1, 20.7, 14.4, 13.4.
0
(3E)-3-bromomethyl-3-hexene (36). To a m e c h a n ic a l l y  s t i r r e d ,  
coo led  (0°C) suspension o f  39.2 g (0.220 mol) o f  N-brornosuccinimide 
( r e c r y s ta l l i z e d  from water, d r ied in  vacuo over phosphorus pentoxide) in 
500 mL o f  d ich io rom e th a n e  was added 16.2 mL (13.7 g, 0.221 mol) o f  
dimethyl s u l f i d e  dropwise over a 15 min period. The re s u l ta n t  ye l lo w  
p re c ip i ta te  was s t i r r e d  at 0°C f o r  15 min, cooled to  -SO^C, and fo l lowed 
by the  a d d i t i o n  o f  22.8 g (0.200 mol) o f  a l l y l i c  a l c o h o l  37 dropwise 
o v e r  a 15 min pe r iod .  A f t e r  an a d d i t i o n a l  15 min at -30°C and 3 h at 
0°C, the m ix tu re  was s e q u e n t ia l  l y  washed w i th  c o ld  wate r  (3 x 300 mL) 
and b r in e  (300 mL), d r ie d  o v e r  anhydrous magnesium s u l f a t e ,  and 
concen t ra ted  j_n vacuo to  a f f o r d  37 g o f  a ye l  low o i l .  The u n p u r i f i e d  
product was d i l u te d  with  pentane, f i l t e r e d  through 40 g of s i l i c a  g e l ,  
and co ncen t ra ted  i n  vacuo to  a f f o r d  28.7 g (81%) o f  36 as a c o l o r l e s s  
l i q u i d .  A n a ly s i s  by GC (30 m DB-5, 75°C, 37 cm/sec) a f fo rd e d  a 99:1 
r a t i o  o f  (3E)-36 ( t r  = 4.61 min) to  (3Z) -36 ( t r  = 4.81 min) and 
i n d i c a te d  the presence o f  l e s s  than 1 % o f  the SN2 1 p roduct  ( t r  = 3.52 
min) .
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(3E)-36: 1R (neat )  2980, 2945, 2880, 1460, 1440, 1380, 1215, 1200 
c m '1 ; l H NMR (CDC 1 3/90 MHz) 8  5.58 (b r  t ,  J = 7.2 Hz, 1H, C4 -H) ,  3.96 
(s ,  2H, CHgBr), 2.4-1.9 (m, 4H, C2~U2> c 5~h2^> 1*03» 1 , 0 0  ( o v e r l a p p in g  
t ' s ,  J = 7.2, 7.8 Hz, 6 H, C1 -H3 , C6 -H3 ); 13C NMR (CDCl3 /22.5 MHz) 8
137.1, 133.2, 39.3, 21.3, 21.3, 13.9, 13.0.
(4S)-3-((2R ,4E)-l-0xo-2-m ethyl-4-ethylhept-4-enyl) - 4 - (1-methyl-  
e th y l ) -2 -o x a zo l id inone (35).  A m agne t ica l ly  s t i r r e d ,  cooled (-78°C) 
s o lu t io n  of l i t h i u m  d i isopropylamide [LDA, prepared from 14.0 mL (10.1 
g, 100 mmol) o f di isopropylamine and 57 mL (1.76 M in  hexane, 100 mmol) 
o f  n-buty l  1 i th ium ]  (0.5 M in  THF) was used to  eno l ize  18.5 g (100 mmol) 
of imide 21a. A f te r  s t i r r i n g  f o r  0.5 h at -78°C, the re s u l ta n t  l i t h iu m  
eno la te  was trea ted  w ith  35 g (198 mmol) o f  a l l y l i c  bromide 36 f o r  18 h 
a t  -35°C. The r e a c t i o n  was quenched by a d d i t i o n  o f  ha 1f - s a t u r a t e d  
aqueous ammoni um c h l o r i d e .  V o l a t i l e s  were removed j_n vacuo and the 
product extracted in to  dichloromethane (3x). The combined organic ex­
t r a c t s  were success ive ly  washed with  1 M aqueous sodium b i s u l f a t e ,  1 M 
aqueous potassium b is u l f a t e  (2 x), and b r ine ,  dr ied over anhydrous mag­
nesium s u l f a te ,  and concentrated in vacuo to  g ive  55 g o f  a y e l lo w  o i l .  
A n a ly s i s  by GC (30 m DB-1, 150°C, 104 cm/sec) a f fo rd e d  a 98.5:1.5 r a t i o  
o f  (2R)-35 ( t r  = 6.80 min) t o  (2S) -3 5  ( t r  = 5.98 min). The t i t l e  
compound was i s o la te d  by l i q u i d  chromatography (Waters Prep-500, two 5 x 
30 cm s i l i c a  gel columns, 9:1 hexanes/ethyl  acetate, 250 mL/min, minor 
isomer e lu t e d  f i r s t )  in  two p o r t i o n s  t o  a f f o r d  18.3 g (65%) o f  (2R)-35 
as a c o l o r l e s s  l i q u i d  [(2RJ-35: (2S)-35 > 9 9 :1 ] :  IR (neat)  2970, 2940, 
2880, 1780, 1700, 1455, 1385, 1300, 1240, 1200 cm- 1 ; *H NMR (CDCl3/200 
MHz) S 5.13 (b r  t ,  J = 7.2 Hz, 1H, C5 --H),  4.50-4.42 (m, 1H, C4 -H),
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4.31-4.15 (m, 2 H, C5 -H2), 4.01 ( s e p te t ,  J = 7.0 Hz, C2 ' -H)» 2.53 (d of 
d, J = 13.4, 7.1 Hz, 1H, C3 . -H),  2.34-2.26 (m, 1H, C4 -CH), 2.12-1.92 (m, 
5H, C3 <-H, C4 '-CH2 , Cg' -Ji2) , 1.10 {d, J = 6.7 Hz, 3H, C2 >-CH3) ,  1.00- 
0.83 (m, 12H, CH(CH3)2 , CH2 CH3 , C7 -H3 ); 13C NMR (CDC13 /22.5 MHz) 8
177.1, 153.7, 137.6, 128.7, 63.1 , 58.4, 40.8, 35.9, 28.5, 22.7, 20.9, 
17.9, 16.6, 14.7, 14.5, 13.2; S p e c i f i c  r o t a t i o n  [a lg g g  = +60.8°, [ 0O 5 7 7  
= +63.4°, [ a ] 5 4 6  = +72.4°, [ a ] 4 3 5  = +123.5°, [ a ] 365 = +195.2°, (c 1.68, 
CH2C12); HPLC (8  mm x 10 cm Radial Pak (5 um s i l i c a  g e l ) ,  9:1 isooctane/ 
e thy l  acetate, 4.0 mL/min) k l = 2.48; TLC (8:2 hexanes/ethyl  acetate) Rf 
= 0.54.
Anal.  Calcd. f o r  C1 6 H2 7 N03 : C, 68.28; H, 9.67; N, 5.00. found: C, 
68.37; H, 9.59; N, 4.99.
Mixed f ra c t io n s  from the previous chromatography were p u r i f ie d  by 
MPLC (column B, 9:1 h e xanes /e thy l  a c e ta te ,  4 mL/min) to  a f f o r d  150 mg 
(0.5%) o f  (2S)-35 as a c o l o r l e s s  l i q u i d  L (2R)-35: (2S)-35 = 1 :99 ] :  IK 
(neat )  2970, 2940, 2880, 1780, 1700, 1460, 1385, 1300, 1240, 1205 cm '1; 
*H NMR (CDC 1 3 / 9 0  MHz) 8  5.1 (b r  t ,  J = 7.2 Hz, 1H, C5 >-H), 4.5-4.3 (m, 
1H, C4 -H),  4.3-4.1 (m, 2H, C5 -H2),  3.95 ( s e p te t ,  J = 7.0 Hz, 1H, C2 ' -H ) ,  
2.6-2.2 (m, 2H, C4 -CH, C3 ' -H ) ,  2 .1 -1 . 8  (m, 5H, C3 ‘ -H, C4 '-CH2 , C6 ' -H 2 ), 
1.17 (d, J = 7.2 Hz, 3H, C2 ' -CH3), 1.0-0.8 (m, 12H, CH(CH3) 2 , CH2 CH3> 
c 7 ,_H3); 13c NMR (CDC 1 3 /22.5 MHz) 8  177.2, 153.7, 137.6, 128.5, 63.2,
58.5, 39.9, 35.9, 28.5, 22.9, 20.9, 17.9, 17.4, 14.6, 14.6, 13.3; Spe­
c i f i c  ro ta t io n  [ 0O5 8 9  = +84.0°,' [C1D577  = +37.1°, [ a ] 5 4 6 = +99.4°, [ a ] 4 3 5 
= +169.0°, [ a ] 3 6 5 = +268.7°, (c 1.80, CH2 C12)-
Ana i.  Calcd. f o r  C1 6 H2 7 N0 3 : C, 68.28; H, 9.67; N, 5.00. Found: C, 
68.37; H, 9.59; N, 4.92.
- 1 9 3 -
(2 R ,4 E )-2 -m e th y l-4 -e th y lh e p t -4 -e n - l -o l  (38). To a magnet ica l ly  
s t i r r e d ,  cooled (0°C) suspension o f  1.90 g (50.1 mmol) of l i t h iu m  a lumi­
num h yd r id e  in  60 mL o f  THF was added a s o l u t i o n  o f  12.3 g (43.7 mmol) 
of a lk y la te d  imide (2R)-35 in  40 mL of THF dropwise over a 0.5 h period. 
The m ix tu re  was s t i r r e d  f o r  3 h a t  0°C. Excess hyd r ide  was decomposed 
by the caut ious addit ion o f  10 mL of ethyl  acetate. The aluminum s a l t s  
were d is s o l v e d  in  100 mL o f  6 M aqueous h y d r o c h lo r i c  ac id  and the  
p roduc t  e x t r a c te d  i n t o  d ich io rom ethane  (3x). The combined o rgan ic  
e x t rac ts  were se q ue n t ia l l y  washed with 1 M aqueous hydroch lor ic  acid and 
b r ine ,  dr ied over anhydrous magnesium s u l f a te ,  and concentrated in vacuo 
to  g i v e  16 g o f  a p a le  y e l l o w  o i l .  F lash chromatography ( 6  x 25 cm 
column, 85:15 hexanes/ethyl  acetate) fo l low ed  by d i s t i l l a t i o n  (Kugel- 
r o h r ,  95°C, 3 mm) a f fo rd e d  6.45 g (95%) o f  38 as a c o l o r l e s s  l i q u i d .  
Further e lu t io n  of the column w ith  ethyl  acetate afforded 4.8 g (85%) of 
(4 S ) -va l in o l  derived 2-oxazol idinone.
38: 1R (neat)  3500-3200, 2970, 2940, 2880, 1460, 1375, 1030 cm” 1 ;
NMR (CCT 4/90 MHz) 8  5*06 (b r  t ,  J = 7.2 Hz, 1 H, C5 -H),  3.4 (b r  s, 2H, 
C! - H £ , (w i th  D2 0, d, J = 6 Hz}),  2.2-1.5 (m, 8 H, OH, C2 -H, C3 -H2 , C4 - 
CHg, C6 -H2 ), I * 1-0.8 (m, 9H, C2 -CH3 , CH2 CH3 , C7 -H3 ); 13C NMR (CDC13 /22.5 
MHz) 8  138.9, 128.1, 6 8 . 6 , 41.1 , 33.9, 22.9, 20.9, 16.8, 14.8, 13.3; 
S p e c i f i c  r o t a t i o n  [ 0 3 5 3 9  = -1*22°, [ 0 3 5 7 7  = -1*55°,  [ 0 3 5 4 5  = "2*13°> 
[ 0 3 4 3 5  = - 4 .4 1 ° ,  [ a ] 3 5 5  = -8 .9 0 ° ,  (neat ,  d = 0.84 g/mL); GC (30 m DB-5, 
75°C, 33 cm/sec) t r  = 15.69 min; TLC (8:2 hexanes/e thy l  a ce ta te )  Rf = 
0.41.
Ana l.  Calcd. f o r  C1 0 H2 0 0: C, 76.86; H, 12.90. Found: C, 76.82; H, 
12.77.
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(2 R ,4 E ) -2 -M e th y l -4 -e th y lhep t-4 -ena l (39). To a m a g n e t i c a l l y  
s t i r r e d ,  coo led  (-60°C) s o l u t i o n  o f  3.0 mL (3.03 g, 38.8 mmol) o f  d i ­
methyl s u l f o x i d e  in  30 mL o f  d i c h l  oromethane was added 1.9 ml (2.76 g,
2 1 . 8  mmol) o f  o x a l y l  c h l o r i d e  dropwise v ia  s y r in g e  (exo th e rm ic ,  gas 
evo lved) fo l low ed  a f te r  5 min by 2.78 g (17.8 mmol) o f  alcohol 38. The 
re s u l ta n t  white mixture was s t i r r e d  f o r  15 min at -60°C fo l lowed by the 
a d d i t i o n  o f  7.5 mL (5.45 g, 53.8 mmol) o f  t r i  e th y l  ami ne. The t h i c k  
white mixture was warmed to  -30°C and s t i r r e d  f o r  45 min. The react ion 
mixture was p a r t i t i o n e d  between pentane and water. The pentane so lu t io n  
was s e q u e n t ia l  l y  washed w i t h  1 M aqueous sodium b i s u l f a t e  (2x ) ,  water  
(2 x) ,  and b r i n e ,  d r ie d  o ve r  anhydrous magnesium s u l f a t e ,  and concen­
t ra te d  _i_n vacuo to  g ive 2.9 g o f a col or 1 ess 1 i quid. The t i t l e  compound 
was p u r i f ie d  by f l a s h  chromatography (4 x 25 cm column, 98:2 hexanes/ 
e th y l  a ce ta te )  f o l  1 owed by d i s t i l l a t i o n  ( K u g e l r o h r , ’ l l 0 ° C ,  10 mm) to  
a f f o r d  2.58 g (94%) o f  39 as a c o l o r l e s s  l i q u i d :  1R (neat) 2980, 2940, 
2880, 2720, 1730, 1460, 1440, 1375, 785 cm"1; *H NMR (CC14/90 MHz) 8  9.6 
(d, J = 2 Hz, 1H, CH0), 5.13 (b r  t ,  J = 7.2 Hz, 1H, C5 -H),  2.6-2.3 (m, 
2H, C2 -H, C3 -H),  2 .2 -1 . 8  (m, 5H, C3 -H, C4 CH2 , Cg-H2 ) ,  1.2-0.8 (m, 9H, 
C2-CH3 , CH2 CH3 , C7 -H3); 13C NMR (CDC1 3 /22.5 MHz) 8  204.9, 136.7, 129.1,
44.5, 37.8, 22.9, 21.0, 14.6, 13.4, 13.1; S p e c i f i c  r o t a t i o n  [ a l s s g  = 
-16.2°, CotD577  = -18.5°, [a]546 = -22.5°, [ a ] 4 3g = -59.8°, [ a ] 3 g5 =
-190 .9° ,  (neat ,  d = 0.84 g/mL); GC (30 m DB-5, 75°C, 32 cm/sec) t r  =
10.72 min; TLC (98:2 hexanes/ethyl  acetate) Rf = 0.18.
Ethyl 2-(Triphenyl phosphoranyl idene)propanoate (Carboethoxyethyl -  
idene t r ip h e n y l phosphorane). A m agne t ica l ly  s t i r r e d  mixture of 65.6 g 
(0.250 mol) o f  t r i  phenyl phosphi ne and 32.5 mL (45.3 g, 0.250 mol) o f
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e th y l  2-bromopropanoate was heated a t 85°C f o r  20-30 min ( u n t i l  the  
mixture began to  tu rn  dark red). A f te r  coo l ing to  room temperature, the 
reac t ion  mixture was d isso lved  in  500 ml of dichloromethane. The so lu ­
t i o n  was s e q u e n t ia l l y  washed with 2.5 M aqueous potassium hydroxide (3 x 
100 mL) and water, d r ied over anhydrous magnesium s u l f a te ,  and concen­
t r a t e d  in  vacuo. The res idue  was d i s s o l v e d  in  250 mL o f  hot e th y l  
acetate, s low ly  cooled to  room temperature and the product allowed to 
c r y s t a l l i z e ,  a f fo rd ing  66 g (73%) o f  the phosphorane as a y e l lo w  c rys­
t a l  1 i ne so l  i d: l ti NMR (CDC3 / 9 0  MHz) 8  7.8-7-3 (m, 15H, a romat ic  H's),
3.8 (b r  q, J = 7 Hz, 2H, OCH2 CH3 ) ,  1.2 (d, J = 14 Hz, 3H, CCH3 ) , 0.8-0.5 
(b r  s, 3H, OCH2 CH3 ).
Ethyl (2E,4R,6E}-2,4-Dimethyl -6-ethyl non-2,6-dienoate (34). A mag­
n e t i c a l l y  s t i r r e d  s o lu t io n  of 30 g (83 mmol) o f carboethoxyethylidene 
t r i  phenyl phosphorane and 10.4 g (67.7 mmol) o f  a 1 dehyde 39 in  50 ml o f 
dichloromethane was heated at 40°C fo r  12 h. The mixture was cooled to  
room temperature and added d i r e c t l y  to  the top o f  a 6 x 25 cm column of 
s i l i c a  ge l.  The column was e lu ted  with 95:5 hexanes/ethyl  acetate to  
a f fo rd  14.9 g (93% mass balance) o f 34 as a c o lo r le s s  l i q u id .  Analysis 
by GO (30 m DB-5, 100°C f o r  5 min, 25°C/min to  200°C, 33 cm/sec) a f ­
fo rded  a 97:3 r a t i o  o f  (2E)-34 ( t r  = 9.78 min) to  (2Z)-34 ( t r  = 9.14 
m in ) .
In a separate experiment, run in r e f lu x in g  benzene, a 95:5 r a t i o  of 
(2E)-34 to  (2Z)-34 was obtained. The two isomers were separated by MPLC 
(1.55 g sample, column C, 98:2 hexanes/ethyl acetate, 10 mL/min, (2E)-34 
e lu tes  second) fo l low ed  by d i s t i l l a t i o n  (Kugelrohr,  100°C, 0.008 mm) to
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a f f o r d  1.26 g (81%) o f  (2E)-34  as a c o l o r l e s s  l i q u i d  [ (2E ) -34 : (2Z ) -34  > 
99:1] and 25 mg o f  {2Z) -34  as a c o l o r l e s s  l i q u i d  [ ( 2 E ) -3 4 : (2Z)-34  = 
2 :98 ] .
(2E)-34: IR (neat)  2970, 2940, 2880, 1715, 1650, 1460, 1365, 1270,
1250, 1210, 1 125, 1105, 785 cm '1; !h  NMR (CDC1 3/200 MHz) 8  6.54 (b r  d,
J = 9.9 Hz, 1H, C3 -H) ,  5.07 (br  t ,  J = 7.0 Hz, 1H, C7 -H),  4.22 (q, J =
7.1 Hz, 2H, 0CH2 CH3), 2.66 (d o f  q, J = 10, 7 Hz, 1H, C4 -HJ, 2.06-1.92
(m, 6 H, C5 -H2 , C6 -CH2 , C8 -H2), 1.82 (s ,  3H, C2 -CH3), 1.29 ( t ,  J = 7.1
Hz, 3H, 0CH2 CH3), 0.99-0.88 (m, 9H, C4 -CH3, C6 -CH2 CH3 , C9 -H3 ) ; 13C NMR
(CDC 1 3 / 2 2 . 5  MHz) S 168.3, 147.9, 137.8, 128.6, 126.1, 60.3, 43.6, 32.0,
♦
23.0, 21.0, 19.6, 14.6, 14.4, 13.3, 12.5; S p e c i f i c  r o t a t i o n  [ a ] g 8g = 
-18 .6 ° ,  [ a ] 5 7  7 = -20 .6 ° ,  [ 0O 5 4 5  = -23 .1 ° ,  [ a ] 4 3 5 = -40 .7° ,  [ a ] 3 g5
= -66 .0 ° ,  ( n e a t ,  d = 0.884 g/mL); TLC (95:5 hexanes /e thy l  ace ta te )  Rf = 
0.29.
Anal.  Calcd. f o r  C1 5 H2 6 02 : C, 75.58; H, 10.99. Found: C, 75.80; H, 
10.92.
(2Z)-34: lH NMR (CDC 1 3 /200 MHz) 8  5.63 (b r  d, J = 9.6 Hz, 1H, C3 -H),
5.03 (b r  t ,  J = 7.2 Hz, 1H, C7 -H),  4.17 (q, J = 7.0 Hz, 2H, 0CH2 CH3), 
3.4-3.1 (m, 1H, C4 -H) ,  2.1-1.9 (m, 6 H, C5 -H2 , C g-C j^ , C8 - H ^ ,  1.85 (s, 
3H, C2 -CH3), 1.28 ( t ,  J = 7.0 Hz, 0CH2 CH3 ), 1.0-0.8 (m, 9H, C4 -CH3 , Cg-
CH2cJl3» c9“Jl3)•
(2 E ,4 R ,6 E ) -2 ,4 -D im e th y l - 6 - e t h y l  n o n - 2 , 6 - d i e n - l - o l  (40).  To a me­
c h a n ic a l l y  s t i r r e d ,  cooled (-78°C) s o lu t io n  o f  11.8 g (49.5 mmol) o f  34 
[ (2 E ) -3 4 : (2 Z ) -3 4  = 97:3 ]  in  100 mL o f  d i c h l  oromethane was added 110 mL 
(1.0 M in hexane, 110 mmol) o f d i iso b u ty l  aluminum hydride dropwise over
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a 1 h pe r io d .  A f t e r  0.5 h a t -78°C and 1 h at -20°C the  r e a c t i o n  was 
quenched by the caut ious add i t ion  of 20 mL of methanol fo l low ed  by 240 
ml o f  0.5 M aqueous sodium potassium t a r t r a t e .  The r e s u l t a n t  t h i c k  
whi te  mixture was s t i r r e d  at room temperature u n t i l  two c le a r  homogen­
eous phases were obtained {ca. 6 h). The layers were separated, and the 
aqueous phase e x t r a c te d  w i th  d i c h i  oromethane. The combined o rgan ic  
ex t rac ts  were washed with  br ine, dr ied over anhydrous magnesium s u l f a te ,  
and concentrated vacuo to  g ive  9.9 g (102% mass balance) o f  a c o lo r ­
l e s s  l i q u i d .  M o le c u l a r  d i s t i l  l a t i o n  ( K u g e l r o h r ,  110°C, 0.08 mm) a f ­
fo rd e d  9.6 g (99%) o f  a l  l y l i c  a l c o h o l  40. A n a ly s i s  by GC (30 m DB-5, 
150°C, 31 cm/sec) a f fo rd e d  a 97:3 r a t i o  o f  ( 2E} -4 0  ( t r  = 4.29 min) to  
(2Z)-40  ( t r  = 3.98 min).  An a n a l y t i c a l  sample was ob ta ined  a f t e r  
p u r i f i c a t i o n  by MPLC (column B, 9:1 h exanes /e thy l  a c e ta te ,  3 mL/min, 
(2Z) -4 0  e lu t e d  f i r s t )  t o  a f f o r d  (2E)-40 as c o l o r l e s s  l i q u i d  [ (2 E ) -  
40 : (2Z ) -40  > 99 :1 ] :  IR (neat)  3500-3200, 2980, 2880, 1460, 1375, 1070, 
1010 cm"1; 1h NMR (CDC 1 3/90  MHz) 8  5.17 ( b r  d, 0 = 9 Hz, 1H, C3 -H),  5.03 
( b r  t ,  J = 7 Hz, 1H, C7 -H),  3.93 ( b r  d, J = 5 Hz, 2H, C2 -H2) . 2.52 (d o f  
q, 0 = 10, 7 Hz, 1H, C4 -H),  2 .2 -1 . 8  (m, 7H, OH, C5 -H2 , C6 -CH2, C8 -H2), 
1.63 (s ,  3H, C2 -CH3), 1.1-0.8 (m, 9H, C4 -CH3 , C6 -CH2 CH3 , C9 -H3 ) ;  13C NMk 
(CDC 1 3 / 5 0  MHz) 8  138.53 (s,  C2), 133.03 (s ,  C6),  132.98 (d, C8), 127.96 
(d, C3), 60.03 ( t ,  C i ) ,  44.36 ( t ,  C5) ,  30.51 (d, C4 ) ,  22.9 ( t ,  Cg-CH2),
20.9 ( t ,  Cg), 20.4 (q, C2 -CH3), 14.7, 13.8, 13.3 (q, q, q, C4 -CH3 , C6- 
CH2 CH3 , C9 ); Specif ic  ro ta t io n  [otDggg = +4.61°, [ 0 3 5 7 7  = +4-73°, [a]546 
= +5.52°, [& J 4 3 5  -  +14.0° , [ a ] 3 5 5  = +32.0°, (nea t ,  d = 0.841 g/mL); TLC 
(8:2 hexanes/ethyl  acetate) Kf = 0.46.
Ana l .  Calcd. f o r  C1 3 H2 4 0: C, 79.53; H, 12.32. Found: C, 79.68; H, 
12.30.
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(2E,4R»6E)-l-Bromo-2,4-dimethyl-6-ethyl non-2,6-diene (41a). To a
magne t ica l ly  s t i r r e d  mixture o f 1.96 g (10.0 mmol) o f  a l l y l i c  alcohol 40 
[(2E)-40:(2Z)-40 = 97:3] and 5.25 g (20.0 mmol) o f  t r iphenylphosphine in 
20 mL of a c e t o n i t r i l e  was added 6.63 g (20.0 mmol) o f carbon tetrabrom- 
ide (sublimed p r io r  to  use). The tr iphenylphosphine d isso lved and the 
m ix tu re  tu rned  orange in  an exothermic r e a c t i o n .  A f t e r  15 min the 
react ion  was quenched by add i t ion  of 1 mL of methanol. The mixture was 
s t i r r e d  f o r  0.5 h then p a r t i t i o n e d  between pentane and water.  The 
aqueous phase was e x t r a c te d  w i th  pentane (3x).  The combined organ ic  
ex t rac ts  were s e q u e n t ia l l y  washed with water and br ine ,  f i l t e r e d  through 
15 g o f  s i l i c a  g e l ,  and co ncen t ra ted  j_n vacuo (< 1 mm, 30CC, u n t i  1 no 
brornoform is  detected by GC or NMR) to  a f fo rd  2.32 g (90%) o f  a l l y l i c  
bromide 41a as a c o lo r le s s  l i q u id :  *H NMR (CDC 1 3 / 9 0  MHz) § 5.35 (br d, J 
= 9 Hz, 1H, C3 -H),  5.02 (b r  t ,  J = 7.2 Hz, 1H, C7 -H) ,  3.92 (s,  2H, C2- 
H2), 2.47 (d o f  q, J = 10, 7 Hz, 1H, C4 -H), 2 .2 -1 . 8  (m, 6 H, C5 -H2 , C6- 
CH2, C8 -H2), 1.72 (s ,  3H, C2 -CH3) ,  1.0-0.8 (m, 9H, C4 -CH3 , C6 -CH2 CH3> 
C9 -H3 ); GC (30 m DB-1, 150°C, 35 cm/sec) t r = 4.47 min; TLC (9:1 
hexanes/ethyl  acetate) Rf = 0.80.
Methyltriphenoxyphosphonium i o d i d e . 3 8  a magnet ica l ly  s t i r r e d  mix­
t u r e  o f 9.2 ml (21.0 g, 148 mmol) o f  methyl i o d id e  and 26 mL (30.8 g,
99.3 mmol) of t r ipheny l  phosphite was heated at r e f l u x  in  an o i l  bath at 
120°C. The pot tem pera tu re  rose from 65 to  115°C ove r  a 24 h per iod .  
A f te r  coo l ing  to  room temperature, 100 mL o f  d ie th y l  ether was added and 
the  two-phase m ix tu re  s t i r r e d  u n t i 1 the 1 ower phase s o l i d i f i e d .  The 
e thera l  s o lu t io n  was discarded and the s o l i d  exhaust ive ly  washed with 
hot,  anhydrous ethy l  acetate. Excess ethyl  acetate was removed i_n vacuo
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to  a f f o r d  34 g (75%) o f  the  t i t l e  compound as a y e l l o w  c r y s t a l l i n e  
sol id :  1h NMR (Dry CDC 1 3 /90 MHz) 8  7.45 (s,  10H, a rom at ic  H's),  3.15 (d, 
J = 17 Hz, 3H, CH^)- The product  was handled and s to re d  w i th  r i g o ro u s  
p r o t e c t i o n  from m o is tu re  and 1 i g h t  in  a d ry  box. I f  p r i o r  to  use, the  
phosphonium iod ide turned brown or ^H NMR analys is  ind icated the pres­
ence o f  (Ph0 ) 2 p (0 )CH3 [ 8  1.8 (d, J = 18 H z ) ] ,  i t  was washed w i th  ho t ,  
anhydrous e thy l  acetate.
(2 E ,4 R ,6 E ) - l - Io d o -2 ,4 -d im e th y l-6 -e th y l  non-2,6-diene (41b). To a
m a g n e t i c a l l y  s t i r r e d ,  coo led  (20°C) s o l u t i o n  o f  18.4 g (40.7 mmol)of 
methyl t r i  phenoxyphosphonium io d id e  in  40 mL o f  dimethylformamide was 
added 8.00 g (40.7 mmol) o f  a l l y l i c  alcohol 40 [(2E)-40:(2Z)-40 = 97:3] 
d ropwise o v e r  a 5 min pe r iod .  A f t e r  20 min at room tempera tu re  the 
m ix tu r e  was p a r t i t i o n e d  between pentane (100 mL) and c o ld  1 M aqueous 
sodium h yd rox id e  (100 mL). The aqueous l a y e r  was e x t ra c te d  w i th  two 
por t ions of pentane. The combined o rg an ic  e x t r a c t s  were s e q u e n t i a l l y  
washed w i t h  c o ld  1 M aqueous sodium hydrox i  de (1 x 100 mL), c o ld  water  
(1 x 100 mL), and b r in e ,  d r ie d  over  anhydrous sodium s u l f a t e ,  and con­
centrated j_n vacuo to  a f fo rd  14.0 g (112% mass balance) o f  a pale ye l lo w  
l i q u i d .  *H NMR a n a l y s i s  a f fo rd e d  a 95:5 r a t i o  o f  (2E)-41b to  (2Z)-41b 
and i n d i c a t e d  the  presence o f  ca. 10% o f  (Ph0 ) 2 P(0 )CH3 . ^H NMR 
( CDC 1 3 / 9 0  MHz) 8  5.43 (b r  d, J = 9 Hz, 1H, C3 -H) ,  5.03 (b r  t ,  J = 7.2
Hz, 1H, C7 -H),  3.89 (s,  2H, C2 -H2) t 2.47 (d o f  q, J = 10, 7 Hz, 1H, C4 -
H), 2 . 2 -1 . 8  (m, 6 H, Cg-Hg, C6 -CH2 , C8 -H2 ) ,  1-72 (s ,  3H, C2 -CH3 ), 1.0-0.8
(m, 9H, C4 -CH3 , C6 -CH2 CH3 , C9 -H3 ). In  a separa te  exper iment i t  was
observed tha t  the (Ph0 )2P(0 )CH3 could be removed from the a l l y l i c  a lco ­
- 2 0 0 -
hol by pass ing a pentane s o l u t i o n  o f  the  m ix tu re  th rough  a s i l i c a  gel 
column. However, between 5 and 40% o l e f i n  isomer izat ion occurred. The 
unpur i f ied  product i s  the re fo re  used immediately in the next experiment, 
without f u r th e r  p u r i f i c a t i o n ,  in  order to  avoid excessive o l e f i n  isom­
e r iz a t io n .
(4R ,5S)-3-((2S ,4E,6R ,8E)-l-0xo-2,4 ,6-trimethyl-8-ethylundec-4,8- 
dienyl )-4-methyl-5-phenyl-2-oxazolidinone (33). A magnet ica l ly  s t i r r e d ,  
coo led  (-78°C) s o l u t i o n  o f  22.4 g {122 mmol) o f  sodium h e x a m e th y ld i - 
s i l y l a m i d e  (0.75 M in  THF) was used to  e n o l i z e  28.5 g (122 mmol) o f  
im ide  20a. A f t e r  s t i r r i n g  f o r  0.5 h a t  -78°C , the  r e s u l t a n t  sodium 
enola te  was a lk y la te d  w ith  ca. 12.5 g (40.7 mmol) o f  a l l y l i c  iod ide 41a 
f o r  0.5 h a t  -78°C then  4 h a t  -30°C. The r e a c t i o n  was quenched by the 
add i t ion  o f  h a l f - s a tu ra te d  aqueous ammonium ch lo r ide .  V o l a t i l e s  were 
removed j_n vacuo and th e  p roduc t  e x t r a c te d  i n t o  d i c h l  oromethane (3x ). 
The combined organic ex t rac ts  were se q u e n t ia l l y  washed with 1 M aqueous 
sodium b i s u l f a t e ,  1 M aqueous potassium b ica rb o n a te  and b r in e ,  d r ie d  
over anhydrous magnesium s u l f a te ,  and concentrated j_n vacuo to  g ive  41 g 
of a y e l lo w  o i l .  This mater ia l  was p repur i f ied  by f l a s h  chromatography 
( 8  x 25 cm s i l i c a  gel column, 9:1 hexanes/ethyl  acetate) to  a f fo rd  28 g 
o f  a c o lo r le s s  o i l .  The t i t l e  compound was iso la ted  by chromatography 
(Waters Prep-500, two 5 x 30 cm s i l i c a  gel columns, 95:5 hexanes/ethyl  
a c e ta te ,  250 mL/min) in  two p o r t i o n s  to  a f f o r d  26 g (78% based on 
a l l y l i c  a lcohol 40) o f  a c o lo r l e s s  l i q u id .  Analysis by GC (30 m DB-5, 
250°C, 78 cm/sec) ind icated the product to  be ca. 93% a lk y la te d  imide 33 
( t r  = 5.69 min) ,  and c o n ta in  ca. 7% o f  two u n i d e n t i f i e d  minor isomers 
( t r  = 4.90 min, 5.45 min).  An a n a l y t i c a l  sample was prepared by MPLC
- 2 0 1  -
(co l  umn C, 95:5 h e xa n e s /e th y l  a c e ta te ,  10 mL/min, minor  isomers e l  ute  
f i r s t )  to  a f fo rd  a lk y la te d  imide 33 as a c o lo r le s s  l i q u id  (>99% 33): IR 
(CH2 C12) 3060, 2979, 2940, 2880, 1780, 1700, 1450, 1385, 1370, 1340, 
1240, 1200, 1120 cm-1; l H NMR (CDCI3 / 5 0 0  MHz) § 7.4-7.2 (m, 5H, aromatic
H's) ,  5.658 (d, J = 7.2 Hz, 1H, C5 -H),  5-034 (br t ,  J = 7.2 Hz, 1 H, Cg>-
H), 4.952 (b r  d, J = 9.4 Hz, 1H, C51-H),  4.779 (qn, J = 6 . 8  Hz, 1H, C4- 
H), 3.98-3.91 (m, 1H, C2 «-H), 2.53-2.45 (m, 1H, C6 <-H), 2.03-1.85 (m,
8 H, C ̂  * -JH 2 » C 7 1 ” H2» C 8 ' ~ ̂ JH.2» 10 1 - ilL2)» 1*656 (d, J = 1.5 Hz, 3H, C4 1-
CH3), 1.092 (d, J = 6 . 8  Hz, C2 <-CH3), 0.942, 0.926 ( o v e r l a p p in g  t ‘ s, J =
8.0, 8.2 Hz, 6 H, Cg.-CH2 CH3 , C ̂  j  * -  H3 ) , 0.865, 0.856 ( o v e r l a p p in g  d 's ,  J 
* 6 .8 , 7.0 Hz, C4 -CH3 , C6 --CH3); 13C NMR (CDCl3 /22.5 MHz) 8  176.9, 
152.7 , 138.7, 134.6, 133.7, 130.1, 128.7 , 127.7, 125.8, 78.7, 54.8, 
44.7, 43.9, 35.9, 30.9, 22.9, 20.9, 16.2, 15.7, 14.8, 13.3; S p e c i f i c  
r o t a t i o n  [ 0O 5 3 9  = +22.9°, [ a ] 3 77  = +23.8°, = +27.6° , [ a ] 4 3 5 =
+ 50.9° , [ a ] 3 6 5  = +92.1°, (c 5.7 7, CH2 C1 2 ); HPLC ( 8  mm x 10 cm Radia l  Pak 
(5 m s i l i c a  g e l ) ,  96:4 i sooc tane/e thy  1 a c e ta te ,  2 .0mL/min) k' = 5.01, 
note :  k ‘ m inor  isomers = 2.28, 4.48; TLC (8:2 hexanes /e thy l  a ce ta te )  Rf 
= 0.64.
Ana l .  Calcd. f o r  C2 gH3 7 N0 3 : C, 75.87; H, 9.06; N, 3.40. Found: C, 
75.80; H, 8.91; N, 3.40.
(2S ,4E ,6R ,8E) -2 ,4 ,6 -T r im e thy l  - 8 - e th y  1 u n d e c - 4 ,8 - d ie n y l - l - o l  (42).
To a m a g n e t i c a l l y  s t i r r e d ,  coo led  (-30°C) s o l u t i o n  o f  75 mL (1.0 M in  
THF, 75 mmol) of l i t h i u m  aluminum hydride was added a s o lu t io n  o f  21.5 g 
(52.4 mmol) o f a l  k y l  ated imide 33 (93% by GC) in  50 mL o f  THF dropwise 
o ve r  a 0.5 h pe r io d .  The re a c t io n  m ix tu re  was a l l  owed to  warm to  room
-  2 0 2 -
te m p e ra tu re  o ve r  a 2 h p e r io d .  A f t e r  r e c o o l i n g  t o  -10°C, the  excess 
l i t h i u m  aluminum hydride was quenched by the caut ious dropwise add i t ion  
o f  10 mL of e thy l  acetate fo l lo w e d  by 150 mL o f  2 M aqueous hydroch lor ic  
a c id .  The p roduc t  was e x t r a c te d  i n t o  d i c h i  oromethane. The combined 
organic ex t rac ts  were s e q u e n t ia l l y  washed with 1 M aqueous hydroch lor ic  
acid and br ine ,  dr ied over anhydrous sodium s u l f a te ,  and concentrated in 
vacuo to  g ive  23.0 g o f  a mixture o f  norephedrine oxazol idinone and the 
product as a white s o l i d  and a c o lo r le s s  l i q u id .  The l i q u i d  was p u r i ­
f i e d  by f l a s h  chromatography (6 x 25 cm s i l i c a  gel column, 9:1 hexanes/ 
e t h y l  a ce ta te )  f o l l o w e d  by m o le c u la r  d i s t i l l a t i o n  (Kugel rohr,  110°C, 
0.01 mm) to  a f f o r d )  11.8 g (94%) o f  a l c o h o l  42 as a c o l o r l e s s  l i q u i d .  
Ana lys is  by GC (30 m DB-5, 150°C, 30 cm/sec) indicated the product to  be 
ca. 9 7% 42 ( t r  = 10.34 min) and c o n ta in  ca. 3% o f  an u n i d e n t i f i e d  minor 
i somer. The so l  id, when combined w i t h  m a te r ia l  ob ta ined  by e l  u t ing the  
column w ith  d ie th y l  e th e r ,  af forded 7.4 g (80%) o f  norephedrinederived 
2-oxazo l id inone. An a n a ly t i c a l  sample o f  42 was obtained a f te r  p u r i ­
f i c a t i o n  by MPLC (column B, 9:1 hexanes /e thy l  a c e ta te ,  4 mL/min) f o l ­
lowed by molecu lar  d i s t i l l a t i o n  (Kugel rohr,  110°C, 0.01 mm) to  a f fo rd  a
c o lo r l e s s  l i q u i d  (>99% major isomer by GC): IR (neat) 3500-3200, 2970,
2940, 2880, 1450, 1380, 1040 cirT1; NMR (CDC 1 3/90 MHz) 8  5.03 (b r  t ,  J 
= 7.2 Hz, 1H, Cg-H), 4.92 (d, J = 9.2 Hz, 1H, C5 -H),  3.5 (b r  s, 2H, C ^  
Hg), 2.5 (d o f  q, J = 10, 7 Hz, 1H C6 -H),  2.2-1.7 (m, 10H, OH, Cg-H, C3-
H.2 > C7~Ĥ 2> Cft-CHp, C] p -H g ) , 1.58 (s,  3H, C4 -CH3 ) ,  1.1-0.8 (m, 12H, Cg" 
c H.3 , C5 - CJH3 , Cg-CH2 CH3 , C1 1 -H3 ); 13C NMR (CDCI3 / 5 O MHz) 138.77 (s ) ,  
133.45 (d) ,  131.60 ( s ) ,  127.63 (d) ,  6 8 . 6 8  ( t ) ,  44.90 ( t ) ,  44.60 ( t ) ,  
33.60 (d) ,  30.73 (d ) ,  22.82 ( t ) ,  20.84 (q, t ) ,  16.59 (q),  16.04 (q) ,
14.72 (q) ,  13.26 (q ) ;  S p e c i f i c  r o t a t i o n  [ 0 3 5 3 9  = +13.6°, [ 0 3 5 7 7  =
- 2 0 3 -
+15.2° , [a ]g 4 6  = +17*4°, [ 0 3 4 3 5  = +37.3°, [ 0 3 3 5 5  = +75.0°, (n e a t ,  d - 
0.847 g/mL); TLC (8:2 hexanes/ethyl  acetate) = 0.47.
Ana l .  Calcd. f o r  CigH3 oO: C, 80.61; H, 12.68. Found: C, 80.52; H, 
12.60.
(2S,4E,6R,8E)-2,4 , 6-Trim ethy l -8 -e th y l undec-4 ,8 -d ien- l -a l  (43). To
a magnet ica l ly  s t i r r e d ,  cooled (-60°C) s o lu t io n  o f 0.86 mL (0.95 g, 12.1 
mmol) of dimethyl s u l fo x id e  in  12 mL of di chi oromethane was added 0.53 
mL (0.77 g, 6.1 mmol) o f  o x a l y l  c h l o r i d e  dropwise v i a  s y r in g e  (exo­
thermic, gas evolved) fo l lo w e d  a f t e r  5 mL by 1.31 mL of a lcohol 42. The 
re s u l t a n t  white mixture was s t i r r e d  fo r  15 min at -60°C fo l lo w e d  by the 
a d d i t i o n  o f  2.3 mL (1.65 g, 16.5 mmol) o f  t r i e t h y 1 amine. The t h i c k  
w h i te  m ix tu re  was warrned to  -30°C and s t i r r e d  f o r  0.5 h. The r e a c t i o n  
mix ture was p a r t i t i o n e d  between pentane and water. The pentane s o lu t io n  
was se q u e n t ia l  l y  washed w i t h  1 K aqueous sodium b i s u l f a t e  ( 2 x) ,  water  
(2 x),  and br ine, dr ied over anhydrous sodium s u l fa te ,  and concentrated 
i n vacuo to  a f f o r d  1.28 g (98%) o f  a ldehyde 43 as a c o l o r l e s s  l i q u i d .  
Ana lys is  by GC (30 m DB-5, 150°C, 30 cm/sec) ind icated the product to  be 
ca. 97% 43 ( t r  = 8.09 min) and con ta ined  ca. 3% o f  an u n i d e n t i f i e d  minor 
isomer ( t r  = 7.17 min). The a ldehyde was used im m ed ia te ly  w i t h o u t  
p u r i f i c a t i o n  to  avoid epimerizat ion. 3H NMR {CDCI3 / 9 0  MHz) 8 9.53 (d, J 
= 2 Hz, 1H, CH0), 4.97 (b r  t ,  J = 7.2 Hz, 1H, Cg-H), 4.87 (d, 0 = 9.2 
Hz, 1H, C5-H), 2.6-2.2 (m, 2H, C2-H, C6-H), 2.1-1.7 (m, 8H, C3-H2 , C7- 
H2 , C8-CH2» C10-H.2)> U57 ( s » 3h> C 4 “ ci l 3 )» 1 -1 -0.8 (m, 12H, C2 -CH3 , C6- 
cil3> Cg-CH2CH3, C1 1 -H3 ).
- 2 0 4 -
(4R,5S)-3-((2R,3S,4S,6E,8R,10E)-l-0xo-2,10-diethyl-3-hydroxy- 4 ,6 ,8 -  
trimethyl tridec-8,10-dienyl )-4-methyl -5-phenyl-2-oxazol idinone (32). To
a magne t ica l ly  s t i r r e d ,  cooled (-78°C) s o lu t io n  of 2.55 g (10.3 mmol) of 
im ide 20b (0.8 M i n  di  ch i  oromethane) was added 2.86 ml (3.12 g, 11,4 
mmol) o f di- jn-buty 1 boryl  t r i f l a t e  dropwise over a 5 min period. A f te r  5 
in i n ,  1.72 mL (1.25 g, 12.3 mmol) o f  t r i e t h y l a m i n e  was added. The m ix ­
t u r e  was s t i r r e d  a t 0°C f o r  1 h then re co o le d  to  -78°C. To the  b o ry l  
enolate  s o lu t io n  was added 1.95 g (8.25 mmol) o f aldehyde 43 (97:3 r a t i o  
by GC) dropwise o ve r  a 5 min pe r iod .  A f t e r  0.5 h at -78°C and 2 h at 
0°C the  r e a c t i o n  was quenched by the  a d d i t i o n  o f  10 mL o f  aqueous pH 7 
phosphate bu f fe r  in  30 mL o f  methanol fo l low ed  by 10 mL o f  30% aqueous 
hydrogen peroxide in  30 mL of methanol. The mixture was s t i r r e d  at 0 °C 
f o r  2 h. The mixture was concentrated i_n vacuo and the product extracted 
i n t o  di  ch i  oromethane. The combined organics were se q u e n t ia l l y  washed 
w ith  1 M aqueous potassium bicarbonate and br ine, dr ied over anhydrous 
sodium s u l f a t e ,  and concen t ra ted  _i_n vacuo to  a f f o r d  4.9 5 g (124% mass 
balance) of a co lo r le ss  viscous o i l .  Analysis by GC ( t r im ethy l  s i l y l a t e d  
sample ( E t 2 NSiMe3 > DMAP, CH2 C13 , 4 h)> 30 m DB-5, 250°C, 71 cm/sec, 
( i n j e c t o r ,  d e te c to r  = 275°C)) a f fo rd e d  a 2.6:4.2:92.9:0.4 m ix tu re  o f  
d ias te reom ers  ( t r = 10.94, 12.47, 12.86, 15.93 min r e s p e c t i v e l y )  and 
ind ica ted  the presence of ca. 25% of imide 20b ( t r  = 1*04 min). Analysis 
by HPLC ( 8  mm x 10 cm Waters Radia l  Pak (5 urn s i l i c a  g e l ) ,  85:15 i s o ­
octane/ethyl  acetate, 1.0 mL/min) afforded the fo l lo w in g  order of e l u ­
t i o n :  k 1 20b = 1.20, k1 minor isomer = 1.53, k ‘ minor isomer = 2.06, k' 
m inor  isoiner = 2.33, k' 32 = 2.76. MPLC se p a ra t io n  o f the crude m ix tu re  
(column C, 85:15 hexanes /e thy l  a c e ta te ,  10 mL/min) a f fo rd e d  0.19 g 
(9.7%) of recovered aldehyde 43 (mixture of di astereomers at C2, GC (30
- 2 0 5 -
m DB-5, 150°C, 31 cm/sec, t r  (2R)-43 = 7.87 min, ca. 39%; t r  (2S)-43 =
8.00 min, ca. 61%)), 0.85 g o f  a m ix tu re  o f  im ide  20b and the minor  
i somers, and 3.27 g (82%) o f  32 as a c o l o r l e s s  o i l  (GC, same c o n d i t i o n s  
as above, 4:96 r a t i o  o f  t r  = 12.47 min to  t r  = 12.86 min):  IR (CH2 C1 2 ) 
3540 (b r ) ,  3060, 2980, 2940, 2880, 1785, 1690, 1460, 1385, 1370, 1340, 
1235, 1200 cm " l ;  *H NMR (CDC 1 3 /500 MHz) 8  7.4-7.2 (m, 5H, a rom a t ic
H 's) ,  5.658 (d, J = 7.2 Hz, 1H, C5 -H).  5.074 (br  t ,  J = 7.1 Hz, 1 H,
CH ‘ -H), 4.950 (b r  d, J = 9.0 Hz, C7 ' -H ) ,  4.779 (qn, J = 7.1 Hz, 1H, C4 -
H), 3.98-3.91 (m, 1H, C2 ' -H ) ,  2.52-2.45 (m, 2H, C3 *-H, C8 ' -H ) ,  2.03-1.85
(m, 1 2 H, 0]H, C2 > - C H C 4 1 - H., C5 1 “ H2 » C9 ' -Jd.2 * ClO'"CJi2 > ^ 1 2 ' " l i 2 »̂ 1*660 
(s,  3H, Cg1 - C_H3 ) ,  1.090 (d, J = 7.1 Hz, 3H, C4 -CH3 ) , 0.95-0.84 (m, 15H,
C2 '-CH2 CH3  , C4 '-CH3 , Cs1 - C 3 , Cio'-CH2 CH3 , C i 3 ' - j i 3 ) ; 13C NMR (CDCl3/50 
MHz) 8  176,65 (s ) ,  152.72 (s ) ,  138.82 (s ) ,  133.91 (d ) ,  133.15 (s ) ,
131.59 ( s ), 128.84 (d ) ,  128.77 (d ) ,  127.59 (d) ,  125.64 (d ) ,  78.74 (d) ,  
76.74 (d) ,  55.08 (d) ,  46.44 (d),  43.53 ( t ) ,  34.36 (d) ,  30.78 (d ) ,  22.83
( t ) ,  20.92 (q) ,  20.87 ( t ) ,  19.14 ( t ) ,  15.94 (q ) ,  15.33 (q) ,  14.75 (q ) ,
14.50 (q) ,  13.27 (q ) ,  11.73 (q) ;  S p e c i f i c  r o t a t i o n  [ 0O 5 3 9  = +3.33°,
[ a ] 5 7 7 = +3.49°, [ a ] 5 4 6  -  +4.33°, [ a ] 4 3 5  = +9.67°,  [ a ] 3 6 5  = +21.9° (c
3.90, CH2 C12 ) i TLC (7:3 hexanes/ethyl  acetate) Rf = 0.59.
Anal.  Calcd. f o r  C3 QH4 5 NO4 : C, 74.50; H, 9.38; N, 2.90. Found: C, 
74.30; H, 9.13; N, 2.86.
(4S)-3-( (2S,3R,4R,6E)- l-0xo-2 ,4-d imethy l -3-hydroxy-6-e thy lnon-6 -  
e n y l ) -4 - ( l -m e th y le th y l ) -2 -o x a z o l ld in o n e  (44). To a magnet ica l ly  s t i r r ­
ed, cooled (-78°C) s o lu t io n  o f 0.932 g (5.03 mmol) of imide 21a in ‘10 mL 
o f  d ich  1 oromethane was added 1.30 mL (1.42 g, 5.17 mmol) o f  d i - jn -
- 2 0 6 -
b u t y l b o r y l  t r i f l a t e .  A f t e r  10 min, 0.84 mL (0.61 g, 6.0 mmol) o f  
t r i e t h y l  amine was added and the mix ture warmed to 0°C. The s o lu t io n  was 
s t i r r e d  f o r  0.5 h and cooled to  -78°C, fo l  1 owed by the add i t ion  of 0.92 g 
(6.0 mmol) o f  a ldehyde 39. A f t e r  0.5 h a t  -78°C and 1.5 h a t  0CC the 
reac t ion  was quenched by the add i t ion  o f 5 mL o f  pH 7 aqueous phosphate 
b u f f e r  in  15 mL o f  methanol f o l  1 owed by 5 mL o f  30% aqueous hydrogen 
pe rox ide  in  15 mL o f  methanol .  The m ix tu re  was s t i r r e d  f o r  2 h a t 0°C, 
co n ce n t ra te d  j_n vacuo and the  p roduc t  extracted in to  d ich l  oromethane. 
The combined organic ex t rac ts  were s e q u e n t ia l l y  washed with 1 M aqueous 
potassium bicarbonate and br ine ,  dr ied over anhydrous magnesium s u l f a te ,  
and concentrated j_n vacuo to  g ive  1.85 g (108% mass balance) o f  a white 
so l  id .  A n a ly s i s  o f  th e  u n f r a c t i o n a t e d  product  by GC ( t r i m e t h y l s i l y l  
d e r i v a t i v e  (E t 2 NSiMe3, DMAP, CHgC 12 »̂ 3 0  m DB" 5» 175° c > 8 3  cm/sec) 
i n d i c a t e d  the presence o f  o n l y  one d ia s te re o is o m e r  ( t r  = 17.57 min, > 
99%). R e c ry s ta l l i z a t io n  from pentane/ethyl  acetate (3 crops) afforded
1.51 g (8 8 %) of 44 as a white c r y s t a l l i n e  s o l id :  *H NMR (CDCI3 / 9 0  MHz) 8  
5.10 (b r  t ,  J = 7.0 Hz, 1H, C7 --H), 4.5-4.1 (m, 3H, C4 -H, C5 -Ji2 )» 3.9 (d 
o f  q, J = 2.5, 7.0 Hz, 1H, C ^ - H ) ,  3.5 (m, 1H, C3 >-H), 3.0 (d, J = 3 Hz, 
1H, OH), 2.5-1.4 (m, 8 H, C4 -CH2 , C4 ' -H ,  C5 *-H2, C6 -CH2, C8 '-H.2^» 1 , 1  <d ’
J = 7.0 Hz, 3H, C2 .-CH3), 1 .1 -0.8  (m, 12H, C H tC H ^ ,  C6 '-CH2 CH3 , C9 <- 
H3 ); 13C NMR (CDC 1 3 / 2 2 . 5  MHz) 8  177.9, 153.6, 139.1, 1 2 8 . 2 , 75.7, 63.4, 
58.4, 40.3, 39.9, 34.0, 28.5, 22.9, 21.0, 17.9, 15.3, 14.8, 13.4; TLC 
(7:3 hexanes/ethyl  acetate) Rf  = 0.55.
A n a l .  Ca 1 cd. f o r  C1 9 h3 3 N0 4 : C, 67.21; H, 9.80; N, 4.14. Found: C, 
67.28; H, 9.70; N, 4.02.
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( 2S) - 3 - { ( 2S)-1-Oxo-2-methy1-2-((3R,5R) -3-methyl-5-ethy1 -5 - ( (1 S) -1 -  
hydroxypropyl)tetrahydrofuran-2-yl) -4 - {1 -methyl ethyl)-2-oxazolidinone  
(45) and (2 S )-3 -( (2 S )- l-O x o -2 -m e th y l -2 -{(3R ,5S )-3 -m ethy l -5 -e th y l  -5 -  
((lR)-l-hydroxypropyl)tetrahydrofuran-2-yl)-4-(1-methyl ethyl)-2 -oxazol-  
idinone (46). Vanadyl acetyl acetonate--t>buty l hydroperoxide epoxida-  
t io n .  To a magnet ica l  l y  s t i r r e d  s o l u t i o n  o f  260 mg (0.766 mmol) o f  44 
and 20 mg (0.075 mmol) o f  vanadyl acetyl  acetonate ( r e c r y s ta l l i z e d ,  A l fa )  
i n  5 mL o f  benzene was added 0.22 mL (4.5 M in  benzene, 0.99 mmol) o f  _t- 
buty l  hydroperoxide. The blue-green s o lu t io n  turned dark red, then slow­
l y  faded to  yel low-orange. A f te r  2 h the react ion was quenched by the 
a d d i t i o n  o f  0.1 mL o f  a c e t i c  ac id  and 0.05 mL o f  d im e thy l  su l  f i d e .  The 
m ix tu r e  was s t i r r e d  at room tem pera tu re  f o r  0.5 h. The p roduc t  was 
extracted in to  dichioromethane, s e q u e n t i a l l y  washed w i th  1 M aqueous 
hyd roch lo r ic  acid, 1 M aqueous potassium bicarbonate, and br ine , dr ied 
over anhydrous magnesium s u l f a te  and concentrated in v a c u o  t o  g ive  
0.21 g (80%) mass ba lance o f  a c o l o r l e s s  o i l .  A n a ly s is  o f  the  un­
f rac t iona ted  product by GC (30 m DB-5, 200°C, 82 cm/sec) afforded a 92:8 
r a t i o  o f  45 ( t r  = 6 . 8 8  min) to  46 ( t r  = 6.44 min). The p ro du c t  was 
i s o l a t e d  by f 1 ash chromatography (2 x 25 cm column, 7:3 he xan e s /e th y l  
a c e ta te )  t o  a f f o r d  0.194 g (74%) o f  45 as a c o l o r l e s s  l i q u i d  (45 :46  > 
99:1 ) :  ! H NMR (CDC 1 3/90 MHz) 8  4.6-4.2 (m, 3H, C4 -H, C5 -H2), 4.0 (d o f
q, J = 2.5, 7.0 Hz, 1H, C2 ' -H ) ,  3 .8 -3 . 6  (m, 2H, C3 <-H, C7 ' -H ) ,  2.6-1.3 
(m, 9H, C4 -CH., C4 1 — JH, Cc,'-Hp , Cg'-CH^, 6 7 *-0JH, C8 1 ~H2 )» 1*2 (d» J = 7.0 
Hz, 3H, C2■ - CJH3 ) ,  1.1-0.8 (m, 12H, CH(CH3)2 , Cg'-CH2 CH3 , C9 «-H3); TLC 
(7:3 hexanes/ethyl acetate) Rf = 0.22.
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(2S )-3 -((2S )-l-0xo-2 -m ethy l-2 -{(3R ,5R )-3 -m ethy l-5 -e thy l-5 -{(lS )-  
1-hydroxypropyl)tetrahydrofuran-2-yl)-4 -(l-m ethylethyl)-2 -oxazo lid i none 
(45) and (2 S )-3 - ( (2 S )- l -0 x o -2 -m e th y l -2 -((3R ,5S )-3 -m ethy l -5 -e th y l  -5 -  
((lR)-l-hydroxypropyl)tetrahydrofuran-2-yl)-4-(1-m ethyl ethyl)-2-oxazol-  
idinone (45). m-Chloroperbenzoic Acid Epoxidation. To a m a g n e t i c a l l y  
s t i r r e d ,  cooled (-20°C) s o lu t io n  o f  252 mg (0.741 mmol) o f  44 was added 
200 mg (ca. 80%, 0.93 mmol) o f  m-chl o roperbenzo ic  ac id  i n  4 p o r t i o n s  
o ve r  a 0.5 h pe r iod .  The r e a c t i o n  m ix tu re  was s t i r r e d  at -20°C f o r  0.5 
h then  al 1 owed to  warm to  room tempera tu re .  A f t e r  4 h, the  re su l  t a n t  
mixture of epoxides were converted to  the corresponding tetrahydrofurans 
by add i t ion  of 0.1 mL o f  acet ic  acid and s t i r r i n g  the mixture fo r  0.5 h. 
The s o lu t io n  was d i lu te d  with  dichloromethane, washed with 1 M aqueous 
potassium carbonate to  remove the excess acid, washed with  br ine ,  dr ied 
over anhydrous magnesium s u l f a te ,  and concentrated j_n vacuo to  a f fo rd  
0.24 g o f a c o lo r le s s  l i q u id .  Analysis  o f  the unfract ionated product by 
GC (30 m DB-5, 200°C, 82 cm/sec) a f fo rd e d  a 23:77 r a t i o  o f  45 ( t r  = 6 . 8 8  
min) t o  46 ( t r  = 6.44 min). The product  was i s o l a t e d  by f l a s h  chroma­
tography (2 x 25 cm column, 7:3 hexanes/ethyl  acetate) to  a f fo rd  0.192 g 
(72%) o f  46 as a c o l o r l e s s  l i q u i d  (45:46 < 1:99) and 0.051 g (19%) o f  45 
as a c o lo r l e s s  l i q u i d  (45:46 > 99:1).
46: lH NMR (CDCl3/90 MHz) 8  4.6-4.2 (m, 3H, C4 -H, C5 -H2 ) , 4.1 (d 
o f  q, J = 2.5, 7.0 Hz, 1H, C2 ' -H ) ,  3.8-3.4 (m, 2H, C3 ' -H, C y i ) .  2.5-
2.1 (m, 5H, C4 -CH, Cq'-H, C5 ' -H2 , C7'-0H), 1.8-1.1 (m, 7H, C2 ' -CH3 , Cg1- 
CH.2 , C8'-H2). 1-0-0 . 8  (m, 12H, CH(CH3) 2, C6 ' -CH2 CH3 , Cg'-H3)i  TLC (7:3 
hexanes/ethyl  acetate) Rf = 0.31.
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(4R ,5S )-3 -((2R )-l-0xo -2 -e thy l-2 -((2R ,3S »5$)-3 ,5 -d im ethy1-5 -((IR , 
2R ,4E)-l-hydroxy-2-m ethyl-4-ethyl-hept-4-enyl)tetrahydrofuran-2-y l)-4- 
m ethyl-5-phenyl-2-oxazolidinone (49). Vanadyl acetyl acetonate--_t-butyl- 
hydroperoxide epoxidation . To a magnetical l y  s t i r r e d  mix ture o f 0.520 g 
(1.08 mmol) o f  g t ,  28.5 mg (0.108 mmol) o f  vanadyl a c e ty l  ace tonate  and 
0.25 g o f  anhydrous sodium acetate in  5 mL of anhydrous benzene at 25°C 
was added 0.27 mL (4.5 M in  benzene, 1.22 mmol) o f  anhydrous j t - b u t y l -  
hydroperoxide. The mix ture turned dark red. A f te r  1 h (pale y e l lo w ) ,  
th e  r e a c t i o n  was quenched by the  a d d i t i o n  o f  2 mL o f  a 1:1 m ix tu re  o f  
t r i e t h y l  amine and chi o ro t r im e th y ls i  1ane. The mixture was s t i r r e d  fo r  13 
h a t  25°C, d i l u t e d  w i t h  d ic h io rom e th a n e ,  washed w i t h  c o ld  water  and 
b r ine ,  d r ied  over anhydrous sodium s u l fa te  and concentrated in  vacuo to 
a f f o r d  0.77 g o f  a y e l l o w  o i l .  Th is  m a te r ia l  was p u r i f i e d  by f l a s h  
chromatography (3 x 25 cm, 95:5 hexanes/ethyl  acetate) to  a f fo rd  0.26 g 
(45%) o f  t r im e th y l  si l y l  ated diene 47 [ t reatment with  5:3:1 THF/water/ 
a c e t i c  ac id  a f fo rd e d  0.215 g (91%) o f 32] f o l l o w e d  by 0.26 g (45%) o f  
t r im e th y l  s i l y l a t e d  epoxide 4 8  [ t r e a tm e n t  w i th  5:3:1 T H F /w a te r /a c e t i c  
acid afforded 0.208 g (85%) of 49 as a c o lo r le s s  o i l ] .
49: *H NMR ( CDC 1 3 + D20/500 MHz) 8  7.3-7.5 (m, 5H, a romat ic  H's),
5.61 (d, J = 7.2 Hz, 1H, Cg-H), 5.11 ( t ,  J = 7.2 Hz, 1H, C5 ' " - H ) ,  4.79 
(qn, J = 7.0 Hz, C4 _h), 4.17 (m, 1H, C2 --H), 3.66 (d o f  d, J = 9.5, 6.0 
Hz, 1H, C2 “ -H),  3.39 (b r  d, J = 4 Hz, 1H, 2.4-1.3 (m, 12H,
C2 1- C > C3"~U» C^'-Hj?, C2 ' " -F [ ,  C3 1 • 1 -H^ » C4 IM-CH? , Cg111- ^ ) ,  1.19 
(s ,  3H, C5 " - CH3 ) , 1.05 (d, J = 6.2 Hz, 3H, C3 " -CH3), 0.97-0.89 (m, 
15H, C4 -CH3 , C2 ' -CH2 CH3 , C2 ' " -C H 3 , C4 <"-CH2 CH3 , C7 ‘ " - H 3); 13C NMR 
(CDCI3 / 5 O MHz) $ 174.37 (s ) ,  152.89 (s ) ,  138.95 (s ) ,  133.26 (s ) ,  128.72 
(d ) ,  128.17 (d ) ,  125.64 (d ) ,  86.11 (d ) ,  85.17 (s ) ,  80.99 (d) ,  78.61 (d ) ,
- 2 1 0 -
55.22 (d ) ,  48.37 (d ) ,  41.88 ( t ) ,  38.73 ( t ) ,  36.98 (d),  32.73 (d ) ,  24.79 
(q ) ,  22.59 ( t ) ,  22.06 ( t ) ,  20.89 ( t ) ,  17.89 (q) ,  17.03 ( q ) , 14.73 (q ) ,  
14.52 (q ) ,  13.37 (q) ,  11.82 (q);  TLC (8:2 hexanes /e thy l  a c e ta te )  Rf = 
0.30.
Ana l ,  ca 1 cd. f o r  C3 0 h4 5 N0 4 : C, 72.11; H, 9.08; N, 2.80. Found: C, 
72.12; H, 8.99; N, 2.78.
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APPENDIX 1
THE DIASTEREOSELECTIVE ALKYLATION OF CHIRAL ESTER AND CARBOXAMIDE 
ENOLATES. A TABULATION OF LITERATURE EXAMPLES.9
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Table 1. D ias te reose lec t ive  A lky la t ion  of (-)-Ephedrine Anride Enolates.
Entry Y R Base R1X
A lky la t io n
Conditions
Rati o i  
D1:D2 Yield Ref.
A H Me LDA Etl 10°C, 2 h 76:24 95% 1
B Me Me LDA EtI -40°C, 2 h 65:35 98% 1
C H Me LDA, MgBr2 Etl 25°C, 12 h 90:10 .75% 1
D H Me LDA j_-hexl 10°C, 2 h 80:20^ — 1
E H Me LDA, MgBr2 j_-hexl 25°C, 12 h 8 8 : 12— 90% 1
F H Me LDA, MgBr2 j i-BuI 25°C, 12 h >95:5 95% 1
G H Et LDA, MgBr2 _n-Bul 25°C, 12 h >90:10 93% 1
H H Et LDA, MgBr2 BnCl 25°C, 12 h >99:1 95% 1
I H H-c8h17 l>BuLi Mel -100°C, 0.5 h 81:19— — 2
J Me —-C8h17 t-BuLi Mel -100°C, 0.5 h 16:84^ 2
a) Unless otherwise noted, the diastereomer r a t i o  (D1:D2) was determined 
by NMR. b) The d ias te reom er  r a t i o  was i n f e r r e d  f romthe s p e c i f i c  
r o t a t i o n  o f  th e  c h i r a l  ac id  obta ined by h y d r o l y s i s  o f  the  a l k y l a t e d  
amide, c) The diastereomer r a t i o  was determined by c a p i l l a r y  GC analysis 
o f  the a lk y la te d  amide.
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Table 2. Diastereoselect ive A lk y la t io n  of (S ) -P ro l ino l  Amide Enolates.
A lky la t ion  Ratio®.
Entry Y R Base R1X Conditions D1:D2 Yield Ref.
A H Me LDA Etl 25°C 92:8 98% 3
B H Me LDA _n-BuI 25°C 94:6 99% 3
C H Me jt-BuL i n-CgHi/ I -100°C 83:17 — 2
D H Me LDA, KH n-C8 Hi7I -78°t£ 94:6 78% 3
E H Me LDA 1-BuI - ioo°cb 97:3 89% 3
F H Me LDA 'CH2 =CHCH2Br -100°C& 96:4 98% 3
G H Me LDA BnBr -100°C 8 8 : 1 2 75% 3
H H Me LDA 1 - 1 0 0 °C^ 97:3 59% 3
1 H Me LDA, KH 2 -78°0b 98:2 78% 3
J H Me LDA, KH 3 -78°cb 97:3 52% 3
K H Me LDA, KH 4 -78°Cb 99:1 83% 4
L H Et LDA Mel - ioo°c£ 94:6 98% 3
M H H-c8h17 i>BuLi Mel -120°C 90:10 — 2
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Table 2. Continued
Entry Y R Base R1X
A lky la t io n
Conditions
R a t io !
D1:D2 Yield Ref.
N H n-CgHi7 t -BuLi EtI -100°C 84:16 — 2
0 H H“ C8h17 1 -BuLi n-BuI -100°C 76:24 — 2
P H CH2 =CH(CH2 ) 7 LDA EtI - i o o ° c ! 90:10 ---------- 5
Q Me Me LDA EtI -78°C 22:78 — 3
R Et Me IDA EtI -78°C 19:81 — 3
S tbs£ Me LDA EtI -78°C 23:77 — 3
T TBS£ Me LDA CH2 =CHCH2Br -78°C 38:62 — 3
U MEM! Me LDA EtI -78°C 22:78 — 3
V mem! ' Me LDA CH2 =CHCH2Br -78°C 29:71 — 3
W mem! ch2 =ch(ch2 ) 7 LDA EtI -7 8 °c ! 13:87 — 5
X mem! ch2=ch(ch2 ) 7 LDA Me -7 8 °c ! 21:79 — 5
a) D ias te reomer  r a t i o  (D1:D2) determined by c a p i l  l a r y  GC. b) HMPA (2 
equiv )  added to  the preformed enolate p r io r  to  add i t ion  of the e le c t r o -  
phi le .  c) TBS = t-Bu(Me)2 Si. d) MEM = Me0CH2 CH20CH2.
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\ ^ , O Y  Y 0 ^  YO
U a ~ Y  0- y   N  0 ^ 0  Me 0
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\ J  \A m , V^--Me
8
Tabl e 3. Diastereosel ec t i  ve A1 kyl a t ion  of Subst i tuted Pyrrol  id i  ne Amide 
Enolates.
Entry Amide Y R R'X




A 5 H Me EtI 25°C 89:11 3
B 5 TBSk Me EtI -78°C 8:92 3
C 6 H Me EtI 25°C 95:5 3
D 6 TBS^ Me EtI -78°C 39:61 3
E 7 H Me EtI 25°C 76:24 3
F 7 TBS^ Me EtI -78°C 1:99 3
G 8 — Me EtI -78°C 95:5£ 6
H 8 — Et Mel -78°C 8 8 : 12^ 6
a) Unless otherwise noted, the diastereomer r a t i o  (D1:D2) was determined 
by capi  1 l a r y  GC. b) TBS = t -Bu(Me)?Si.  c) Diastereomer r a t i o  d e t e r ­
mined by NMR. '
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T a b le  4. D ia s te re o s e l  e c t i v e  A l k y l a t i o n  o f  ( 2 R ,5 R ) -D is u b s t i tu te d  
P y r ro l i d in e  Amide Enolates.
Entry R R'X




A Me Et 1 -78°C >95:5 87% 6
B Me jvBuI -78°C >95:5 81% 6
C Me CH2 =CHCH2Br -78°C >95:5 81% 6
D Me BnBr -78°C >95:5 80% 6
E Me BnOCH2Cl -78°C >95:5 74% 6
F Me TBS0(CH2) 3BrA -78°C >95:5 78% 6
6 Et Mel -78°C >95:5 91% 6
H jn-Bu Mel -78°C >95:5 81% 6
I PhCH2 Mel -78°C >95:5 76% 6
J J2"C16H33 Mel -78°C >95:5 61% 6
a) Diastereomer r a t i o  determined by NMR. b) TBS = t_-Bu(Me)2Si •





T a b le  5. D ia s t e r e o s e l e c t i v e  A l k y l a t i o n  o f (2 S ,5 S ) -D is u b s t i tu te d  
P y r ro l id in e  Amide Enolates.
Entry R R'X
A lk y la t io n
Conditions
R a t io i
D1:D2 Yield Ref.
A Me EtI -78°C >99:1 79% 6
B Me jn-Bu I -78°C >99:1 79% 6
C Me n-C8 Hi 7 I -20°C >99:1 75% 6
D Me BnBr -78°C 98:2
CO 6
E Et Mel -78°C >99:1 77% 6
F jn-Bu Mel -78°C >99:1 70% 6
G n-C8 Hi7 Mel -78°C >99:1 73% 6
H PhCH2 Mel -78°C 99:1 83% 6
a) Diastereomer r a t i o  determined by NMR.
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I) LDA, THF
2) Mel
T a b le  6. Diastereosel ec t i  ve A lk u y la t io n  of Chi ra l  4-Subst i tu ted 
2-0xazol id inone Imide Enolates.
Entry R
A lky la t io n  
Condit i  ons
Ratio^-
D1:D2 Ref.
A Me -30°C, 12 h 8 8 : 1 2 7
B Et -30°C, 12 h 90:1.0 7
C 2 ~Pr -30°C, 12 h 91:9 7
D Ph -30°C, 12 h 81:19 7
E c-hex -30°C, 12 h 86:14 7
F PhCH2 -30°C, 12 h 94:6 7
G £-MeOPhCH2 -30°C, 12 h 94:6 7
H £-ClPhCH2 -30°C, 12 h 94:6 7
I £-hexCH2 -30°C, 12 h 95:5 7
(a) Diastereomer r a t i o  (D1:D2) determined by c a p i l l a r y  6 C.
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0) y.= O jCNIMelPh
b) X= NiSOjPhlS.S-Me.Ph








Table 7. D ias te reose lec t ive  A lky la t io n  of Chiral Ester Enolates.
A l k y l a t i o n i  Rat io^
Entry Ester R R'X Conditions D1:D2 Ref.
A 9a Me n - ci 6 H33J A 93:7 8 b
B 9a Me 1-BuI A 93:7 8 b
C 9a Me 2 -BuI B 28:72 8 b
D 9a Me CH2 =CHCH2Br A 93:7 8 b
E 9a Me BnBr A 94:6£ 8 b
F 9a Me BnBr B 30:7 0 £ 8 b
G 9a _n-Bu BnBr A 93:7 8 b
H 9a —“ C16h33 Mel A 90:10 8 a
I 9a ch2 =chch2 Mel A 90:10 8 b
J 9a ch2=chch2 BnBr A 93:7 8 b
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Table 7. Continued.
Entry Ester R R'X




K 9a PhCH2 Me A >95:5 8 b
L 9a PhCH2 n-Bul A 89:11 8 b
M 9a PhCH2 n-BuI B 15:85 8 b
N 9a PhCH2 CH2 =CHCH2Br A 93:7 8 b
0 9b Me H-c14h291 A >98:2 8 a
P 9b Me —” ^14^29 ̂ B 4:96 8 b
Q 9b Me BnBr A 98:2 8 d
R 9b Me BnBr B 24:76 8 d
S 9b BnO EtI A 1 2 : 8 8 8 e
T 9b BnO EtI B 7:93 8 e
U 9c Me BnBr A 90:10 8 d
V 9c Me BnBr B 19:81 8 d
w 10a Me H -c16h33] A 6:94 8 b
X 10a Me BnBr A 14:86£ 8 b
Y 10a H-c16h33 Me A 17:83 8 b
Z 10a PhCH2 Me A 19:81— 8 b
AA l ib Me J2-C1 4 H2 9 I A <3:97 8 b
BB l ib Me JQ.- C1 4 H2 9 1 B 98:2 8 b
CC l ib Me 16 A 2:98 8 c
DD l ib Me 16 B 94:6 8 c
EE l ib Me 17 A 3:97 8 c
FF l ib Me BnBr A 3:97 8 d
GG l ib Me BnBr B 95:5 8 d
- 2 2 6 -
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Entry Ester R R'X
Alkyl  a t i o n i  
Conditions
Rat i ô - 
D1:D2 Ref.
HH l i b BnO Mel A 8 8 : 1 2 8 e
I I l i b BnO Mel B 91:9 8 e
JJ l i b BnO EtI A 8 8 : 1 2 8 e
KK l i b BnO EtI B 95:5 8 e
LL l i b BnO H~c1 0 h21 A 91:9 8 e
MM l i b BnO H"c1 0 h21 B 93:7 8e
(a) A = The l i t h i u m  e n o la te  was generated in  THF w i t h  l i t h i u m  
i s o p r o p y l c y c lo h e x y la m id e  (LICA) f o r  0.5 h a t -78°C; To the  
l i t h i u m  e n o la te  s o l u t i o n  was added 2.2 equ iv  o f  HMPA and the  
e le c t r o p h i 1e; enola te  a l k y l a t i o n  was al lowed to  proceed a t -78°C 
to  -40°C. B = The l i t h i u m  enolate was generated in  4:1 THF/HMPA 
w i t h  LICA f o r  0.5 h a t -78°C, then a l k y l a t e d  as above. (b) 
Unless otherwise noted, the diastereomer r a t i o  (Q1:D2) was de te r ­
mined by HPLC. (c) Diastereomer r a t i o  determined by NMR.
f
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Table 8 . Diastereosel.ect ive A lky la t io n  of Chiral  Ester Enolates.
Entry Ester R R'X




A 12 Me BnBr A 16:84 8 d
B 12 Me BnBr B 70:30 8 d
C 13 Me BnBr A 81:19 8 d
D 13 Me BnBr B 43:57 8 d
E 14 Me BnBr A 35:65 8 d
F 14 Me BnBr B 58:42 8 d
G 15 Me BnBr A 14:86 8 d
H 15 Me BnBr B 69:31 8 d
(a) A = The l i t h i u m  e n o la te  was generated in  THF w i t h  l i t h i u m  
is o p r o p y l  c y c lo h e x y la m id e  (LICA) f o r  0.5 h a t  -78°C; To th e  - 
l i t h i u m  e n o la te  s o l u t i o n  was added 2.2 e q u iv  o f  HMPA and the  
e le c t r o p h i1e; enolate  a l k y l a t i o n  was a l lowed to  proceed a t  -78°C 
to  -40°C. B = The l i t h i u m  enolate was generated in  4:1 THF/HMPA 
w i t h  LICA f o r  0.5 h a t  -78°C, then a l k y l a t e d  as above, (b) 
The diastereomer r a t i o  (D1:D2) was determined by HPLC.
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APPENDIX I I
THE ENANTIOSELECTIVE SYNTHESIS OF (R) AND (S)-THIORPHAN, 
AN ENKEPHALINASE INHIBITOR.1
- 2 3 0 -
ABSTRACT.
The enant iosel ec t i  ve synthesis o f  (R) and (S)-thiorphan (1) v ia  a 
s ix -s te p  sequence is  reported. The key step, e s ta b l i sh in g  the absolute 
stereochemistry in the ta rg e t  molecule,  is  the d ia s te re o se le c t i ve  a l k y ­
l a t i o n  o f  the c h i r a l  2 -oxazo l id inone imide enolates 6  and 7 with benzyl 
bromomethyl s u l f i d e  (5b). The l e v e l  o f d ias te reose lec t ion  is  in  excess 
o f  95:5. F u l l  experimental  d e t a i l s  are provided fo r  the preparat ion of 
the 2-oxazo l id inone c h i r a l  a u x i l i a r i e s  3a and 4a.
- 2 3 1 -
INTRODUCTION.
The endogenous o p io i d  pen ta pe p t id es ,  l e u c in e  and m e th ion in e -  
e n k e p h a l in  are n e u r o t r a n s m i t te r s  i n v o l v e d  w i t h  the  i n d u c t i o n  o f  
analgesia.^ Hydro lys is  o f  the enkephalin Gly3 -Phe^ bond by a membrane- 
bound metal 1 oendopeptidases, "enkephal inase," located near the enkepha­
l i n  and o p io i d  r e c e p to r s ,  has been p o s tu la te d  t o  mediate enkephal i n ­
induced analgesia . 3 Thiorphan [(±)-N-{ l-oxo~2-mercaptomethy 1 -3 -ph e n y l  - 
propy 1 )g 1 y c i  ne] ( 1 ) i s  re po r ted  to  i n h i b i t  enkephal inase,^ extend the 
dura t ion  of analgesia induced by enkephalin analogs or noxious s t im u l i , ^  
and induce analgesia i t s e l f .®  Several re la ted  z inc-conta in ing  metal 1 o- 
p e p t id a s e s ,  i n c l u d i n g  a n g io te n s in  c o n v e r t i n g  enzyme (ACE), a l s o  are 
re p o r te d  t o  be i n h i b i t e d  by (±)- l .®»? Both enant iomers  o f  th io rp h a n  
were required to eva luate  the absolute stereochemical requirements o f 
th iorphan mediated--enkephalin and AC E-- inh ib i t ion ,  as w e l l  as thiorphan 
induced analgesia . 8 Therefore, we developed a p r a c t i c a l ,  enant iose lec- 
t i v e  s y n th e s is  o f  both  (R) and ( S) - 1h io rphan ,  t h a t  en joys s u f f i c i e n t  
f l e x i b i l i t y  to  be d i r e c t l y  a p p l i c a b le  f o r  th e  c o n s t r u c t i o n  o f  c h i r a l  
th iorphan homologs.
By inspect ion, the enant iosel e c t i v e  synthesis o f  thiorphan reduces 
to  th e  c o n s t r u c t i o n  o f  a s u i t a b l y  p ro te c te d  form o f  (R) and (S )-2 -  
m e rcap tom e th y l -3 -ph e n y l  propario ic ac id  (2) (eq 1). This 2 -subs t i tu ted  
c a r b o x y l i c  ac id  was e n v is io n e d  as being d i r e c t 1 y a c c e s s ib le  v ia  the  
c h i r a l  enolate methodology developed in  our labo ra to r ies .^  The c h i ra l  
2-oxazo l id inone imide enolates 6  and 7, i l l u s t r a t e d  in Scheme 1, would 
serve as p ra c t ica l  precursors to  (R) and (S)-thiorphan, re spec t ive ly .
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RESULTS AND DISCUSSION.
The re q u is i te  c h i ra l  2-oxazol idinones 3a and 4a are prepared from
i nt h e i r  respect ive amino a lcoho ls  and a carbonyl d ica t io n  equ iva len t .  
( l$ ,2 R ) -N o re p h e d r in e ,  c o m m e rc ia l l y  a v a i l a b l e  as the  h y d r o c h lo r i d e  
sal t , H  can be t rans fo rm ed  i n t o  2 -oxazo l  i d in o n e  3a by t re a tm e n t  w i th  
p h o s g e n e , d i e t h y l  carbonate,13 or diphenyl carbonate. A f te r  eva lua­
t i n g  several carbonyl d ica t ion  equ iva len ts ,  we found th a t  the diphenyl 
carbonate procedure described herein, i s  the most r e l i a b l e  method fo r  
preparing 3a on a labo ra to ry  sca le (up to  3 mol). Norephedrine-derived 
2-oxazol id inone 3a produced v ia  t h i s  procedure, and p u r i f i e d  by simple 
c r y s t a l l i z a t i o n  [mp 121-122°C ( L i t . l 2 mp 117°C)] i s  afforded in  82-95% 
y i e l d .  (S)-Va l ino 1,14 on the other hand, i s  most conven ien t ly  t ra n s ­
formed in to  2-oxazol id inone 4a with  d ie thy l  carbonate. This procedure 
a f fo rds  v a l i n o l - d e r i v e d  2-oxazol id inone 4a, a f t e r  p u r i f i c a t i o n  by simple 
c r y s t a l l i z a t i o n  [mp 69-70°C ( L i t . l ^  mp 71.5°C)], in  85-95% y ie ld .  The 
e n an t io m e r ic  p u r i t y  o f  the  c h i r a l  2 - o xa zo 1 i d i n o n e s , prepared by the 
above procedures, was shown to  be >99%.l®
The ch i ra l  2 -oxazol id inones 3a and 4a are conven ient ly  metalated 
w i th  j i - b u t y l 1 ithiurn and N-acylated with  3-phenylpropanoyl ch lo r ide  to  
a f fo rd  the c r y s t a l l i n e  imides 3a (mp 95-96°C) and 4a (mp 63-64°C) in 89% 
and91% y ie ld s ,  re s p e c t iv e ly . ! 7 i n i t i a l  a t te m p ts  t o  a l k y l a t e  l i t h i u m  
e n o la te  6 w i th  benzyl  ch io ro m e th y l  s u l f i d e  (5 a ) l°  were unsuccess fu l  
(Scheme 1). Only recovered s ta r t in g  materia l  and enolate decomposition 
products were d e te c te d .^  We found tha t  the more re a c t ive  benzyl bromo- 
methyl s u l f i d e  (5b),20 however, funct ions admirably.
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E n o l i  zat i on o f  imide 3b w i th  l i t h i u m  di i sop ropy1 ami de (LDA) and 
subsequent treatment o f  the re su l tan t  l i t h iu m  enola te 6 w i th  1.1 equiv 
o f  a l k y l  bromide 5b (2 h a t  -25°C, 2 h a t  0°C) a f f o r d s  a l k y l a t e d  imide 
8a along with  a minor amount o f the diasteromer ic a l k y l a t i o n  product 9a. 
Ana lys is  o f  the unfract ionated product by c a p i l l a r y  GC ind icated a 98:2 
r a t i o  o f  8a t o  9a. In a d d i t i o n  to  the  p ro du c t ,  both im ide 3b (ca. 8 %) 
and 2-oxazol id inone 3a (ca. 5%) were a lso  detected. Product i s o la t i o n  
by l i q u i d  chromatography (Waters Prep-500) a ffords 8a in  76% y i e l d  as a 
viscous c o lo r le s s  o i l  (8a:9a = 98:2). Al though the use o f  excess e lec -  
t r o p h i l e  (2-5 equ iv )  improves the  e x te n t  o f  e n o la te  a l k y l a t i o n ,  the  
remaining e le c t r o p h i le  complicates product i s o la t i o n .  A l k y la t i o n  of the 
co r resp o n d in g  sodium e n o la te  d e r i v e d  from imide 3b [NaN(SiMe3 )2 ]  
decreases both the le v e l  o f a l k y l a t i o n  d ias te reose lec t ion  and the y i e l d  
of i so la te d  product. The other diastereomeric imide 9b is  obtained by 
a l k y l a t i o n  of l i t h iu m  enola te  7. Thus, treatment of l i t h i u m  enolate 7 
w i t h  1.1 equ iv  o f  a l k y l  bromide 5b (2 h a t -25°C) a f f o r d s  a 3:97 r a t i o  
o f  8b to  9b. Product i s o la t i o n  by l i q u i d  chromatography (Waters Prep- 
500) a ffords 9b in 83% y i e l d  as a viscous c o lo r le s s  o i l  (8b:9b = 2:98).
The completion o f  the synthesis o f  (R)-thiorphan is  i l l u s t r a t e d  in  
Scheme 2. Based on p r io r  experience, we were not surpr ised tha t  d i re c t  
h y d r o l y s i s  (KOH, EtOH/H^O, 0°C) o f  a l k y l a t e d  im ide 8 a to  c a r b o x y l i c  
acid R - l l  was unsuccessful . Only products r e s u l t in g  from attack at the 
urethane ( r ing)  carbonyl and base catalyzed retro-Michael  e l im in a t io n  o f  
benzyl t h i o l  were obtained. We have observed tha t  the r e l a t i v e  rates o f  
n u c l e o p h i l i c  a t ta c k  at e i t h e r  ca rbony l  f u n c t i o n  depend on a s u b t l e  
i n t e rp la y  of e le c t ro n ic  and s te r i c  e f fec ts .  For example, w ith  two C-2 
imide subst i tuents  with s te r i c  requirements greater or equal to  methyl
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Scheme 2
groups ,  d i r e c t  bas ic  h y d r o l y s i s  s t r o n g l y  p re fe rs  a t ta c k  at the  endo- 
c y c l i c  ( r ing) carbonyl. For tunate ly ,  we have found that t r a n s e s t e r i f i -  
ca t ion  o f  a lky la te d  imides with l i t h iu m  benzyloxide s e le c t i v e l y  removes 
the a lk y la te d  product from the ch i ra l  a u x i l i a r y .  This react ion exh ib i ts  
less substrate dependency, and is qu ite r e l i a b l e . ^ 3 Accord ingly,  t r e a t ­
ment of a lky la te d  imide 8 a with l i t h iu m  benzyloxide (1.5 equiv , THF,
- 2 3 6 -
-10°C to  0°C) a f f o r d s ,  a f t e r  p u r i f i c a t i o n  by l i q u i d  chromatography, 
benzyl  e s te r  R -10 ( U l g g g  = 436.2° (c. 0.86, CHgCI 2 )) i n 83% y i e l  d. The 
accompanying norephedr ine-derived 2 -oxazo l  i d in o n e  3a a ls o  can be r e ­
covered  and re c y c le d .  Treatment o f  a l k y l a t e d  imide 9b w i t h  l i t h i u m  
benzyloxide (1.5 equiv , THF, 0°C) a f fo rd s ,  a f t e r  p u r i f i c a t i o n  by l i q u i d  
chromatography, the enantiomeric benzyl es te r  S-10 ([aDggg = -34.6° (c 
2.46, CH2 C12 )) in  82% y i e l d .
In d i re c t  analogy to  the racemizat ion- f ree debenzyl e s t e r i f i c a t i o n  
o f  (S)-S-benzylcysteine benzyl e s t e r , t r e a t m e n t  o f  benzyl es te r  R-10 
w ith  anhydrous hydrogen bromide in  g la c ia l  acet ic acid a f fo rds  carbox­
y l  i c  ac id  R - l l  ( [ a l s g g  = 54.1° {£  1.54, abs. EtOH)) i n  85% y i e l d .  
S im i l a r  treatment of benzyl ester  S-10 af fo rds the enant iomeric carbox- 
y l i c  ac id  S - l l  ( [a jg g g  - -50 .6°  (c 1.57, abs. EtOH)) i n  83% y i e l d .  
Di phenyl phosphoryl azide was employed to  a f fe c t  the pept ide bond con­
s t r u c t i o n  between R - l l  and benzyl g l y c in a t e . ^ 2  Thus, t re a tm e n t  o f  
ca rboxy l ic  acid R - l l ,  the jo- toluenesul fonate s a l t  o f  benzy lg lyc ina te ,  
and t r i e t h y l  amine in  dimethyl formamide (DMF) w i th  di  phenyl phosphory l  
a z ide  (4 h a t  -10°C and 18 h a t  0°C) a f f o r d s ,  a f t e r  p u r i f i c a t i o n  by 
f l a s h  chromatography,23 the benzyl es te r  o f  (R)-S-benzylthiorphan (R-12) 
i n  91% y i e l d  as a c r y s t a l l i n e  s o l i d  (mp 72-73°C, [a lg g g  = +25.2° (c. 
1.61, abs. EtOH)). Performing the same react ion with  ca rboxy l ic  acid S- 
11 a f fo rds  the enant iomeric benzyl es te r  S-12 in 85% y i e l d  as a c r y s t a l -  
1 ine  sol id  (mp 73.5-74°C, [ a ] 5 gg = -24.5° (c 1.82, abs. EtOH)).
Bi s-debenzyl a t i  on o f R-12 under c a r e f u l l y  c o n t ro l le d  d is s o lv in g  
metal condit ions completes the synthesis.24 Thus, R-12 in  l i q u i d  ammo- 
nia/THF (1:1) i s  t r e a te d  w i t h  5 equ iv  o f  sodium metal o ve r  a 15-min
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p e r io d .  The heterogeneous b lue  s o l u t i o n  i s  m a in ta ined  a t  - 3 3 °C foran 
a d d i t io n a l  15 min, then is  quenched by the add i t ion  o f  anhydrous ammo­
nium c h l o r i d e .  Product i s o l a t i o n  a f f o r d s  {R ) - th io rp h a n  ( R - l )  i n  91% 
y i e l d  as a viscous c o lo r le s s  o i l  which s low ly  c r y s t a l l i z e d  on standing 
(mp 108-110°C, [ oe]5 g9 = -40.1° (_c 2.25, abs. EtOH)). In a s i m i l a r  
manner, b i s - d e b e n z y l a t i o n  o f  S-12 a f f o r d s  (S ) - th io rp h a n  ( S - l )  in  96% 
y i e l d  (mp 110-111°C, [a ]5 8 9  = +39.6 ° ( £ 2 .7 8 ,  EtOH)). Dur ing th e  o p t i ­
mizat ion o f t h i s  reduct ive  debenzylat ion, we noted tha t  when less than 5 
equiv o f sodium metal are employed, a mixture of thiorphan and S-benzyl-
t h i o r p h a n  i s  ob ta ined .  The use o f  a l a r g e  excess o f  sodium m e ta l ,
*
however, r e s u l t s  i n  a s i g n i f i c a n t  decrease in  the  i s o l a t e d  y i e l d  o f  
th io rphan.
The complementary s p e c i f i c  r o t a t i o n s  ( -4 0 .1 ° ,  +39.6°) f o r  (R) and
(S)-th iorphan are w i th in  experimental error.  This demonstrates a good 
degree of i n te rna l  consistency in  regard to  the o v e r a l l  d iastereose lec-  
t i o n  and ra c e m iz a t io n  (o r  la c k  th e r e o f )  d u r in g  the  syn th e s is  o f  each 
enantiomer. Nonetheless, we desired an independent, unequivocal assess­
ment o f  e n a n t io m e r ic  p u r i t y .  (± ) -Th io rphan methy l e s te r  r e a c ts  w i th  
( R ) - l - ( l - n a p h t h y l ) e t h y 1 isocyana te  (13) to  a f f o r d  the d ia s te re o m e r ic  
thiourethanes 14 and 15 (eq 2 ) . ^  Al though the thiourethane d iastereo- 
mers are not separab le  by HPLC on c o n v e n t io n a l  suppo r ts ,  they  are r e ­
so lved on a P i r k le  cova lent phenyl gl ycine column (a = 1 . 4 6 ) . The same 
d e r i v a t i v a t i o n  process and HPLC ana lys is  es tab l ished a lower l i m i t  o f  
ca. 95% e n a n t io m e r ic  p u r i t y  f o r  both R - l  and S - l .  Peak broadening in  
t h i s  a n a l y s i s  p re ven ts  a more accu ra te  assessment o f  enan t iom er ic  
p u r i t y .
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BIOLOGICAL STUDIES.
Although a d e ta i le d  biochemical eva lua t ion  o f  (R) and (S)-thiorphan 
w i l l  be reported elsewhere , 8 the in te re s t in g  conclusions drawn from t h i s  
s tudy  are no tewor thy .  F i r s t ,  s y n th e t ic  (S)-thiorphan is  approximately 
tw e n ty - fo u r - fo ld  more e f f e c t i v e  as an ACE i n h i b i t o r  than(R)-thiorphan. 
The low l e v e l s  o f  ACE i n h i b i t i o n  observed f o r  (R ) - th io rp h a n  c o u ld  
l a r g e l y ,  i f  not e x c lu s i v e ly ,  be the r e s u l t  o f  enant iomeric contamina­
t io n .  In con tras t ,  both enantiomers o f  thiorphan e x h ib i t  s i m i l a r  l e v e l s  
o f  i n h i b i t i o n  o f  e n kepha l inase  A. F i n a l l y ,  the  a n a lg e s ic  p r o p e r t i e s  
re p o r te d  f o r  ( ± ) - t h i o r p h a n , 6  are m a in ly  assoc ia ted  w i t h  the  (R) 
enantiomer.
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EXPERIMENTAL SECTION
General. M elt ing  points were determined with a Buchi SMP-20 mel­
t i n g  point apparatus and are uncorrected. IR spectra were recorded on a 
Beckman 4210 spec t rom ete r  and are repor ted  in rec iprocal  centimeters.
NMR spectra were recorded on a Varian Associates EM-390 (90 MHz) or a 
Bruker WM-500 (500 MHz) spectrometer . ^ 7 Chemical s h i f t s  are reported in 
ppm from te t ram e thy ls i  1 ane on the 8  scale. Data are reported as fo l lo w s :  
chemical s h i f t ,  m u l t i p l i c i t y  (s = s in g le t ,  d = doub le t,  t  = t r i p l e t ,  q = 
quar te t ,  qn = qu in te t ,  m = m u l t i p l e t ,  and b = broad), coupl ing constant 
(Hz), i n te g ra t io n  and in te rp re ta t io n .  NMR were recorded on a JEOL
FX-90Q (22.5 MHz) spectrometer and are reported in  ppm from te t ramethy l -  
s i la n e  on the 8  scale. Optical  ro ta t ions  were determined w ith  a Jasco 
DIP-181 d i g i t a l  p o la r im e t e r .  Data are re p o r te d  as f o l  1ows: s p e c i f i c  
r o ta t io n  ( [ a ] ) ,  concentrat ion (£ = g/100 mL), and so lvent.
Combustion analyses were performed by G a lb ra i th  Laborator ies. Inc., 
( K n o x v i l l e ,  Tennessee) o r  by Mr. Lawrence H en l ing  at the C a l i f o r n i a  
I n s t i t u t e  o f  Technology M ic roana ly t ica l  Laboratory.
A n a l y t i c a l  gas chromatography (GC) was c a r r i e d  out on a Hew le t t  
Packard 5880A gas chromatograph equipped w i t h  a s p l i t  mode capi  1 1 ary 
i n j e c t o r  and flame io n iz a t io n  detector.  Hydrogen was used as the car­
r i e r  gas. The fo l lo w in g  w a l l  coated open tu b u la r  (WCOT) fused s i l i c a  
capi 1 1 ary co l  umns were empl oyed: 30 m x 0.32 mm DB-1 (J and W Assoc i ­
a te s )  and 30 m x 0.32 mm DB-5 (J and W Assoc ia tes ) .  S p e c i f i c  GC c o n d i ­
t i o n s  are re p o r te d  as f o l  1 ows: co l  urnn, oven tem pera tu re ,  c a r r i e r  gas 
f low  ra te ,  and re ten t ion  time. Unless otherwise noted, the i n je c to r  and 
de tector  temperatures were 250°C.
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Flash chromatography was performed according to  the general proce­
dure of S t i l l  23 employing EM Reagents s i l i c a  gel 60 (40-63 pm). Analy­
t i c a l  high performance l i q u i d  chromatography (HPLC) was car r ied  out on a 
Waters Associates ALC 202/401 HPLC equipped with a model 6000 high pres­
sure so lvent pump, a model U6 K in je c to r  and a d i f f e r e n t i a l  UV (254 nm) 
detecto r ,  and using the fo l lo w in g  columns: Waters Radial Pak ( 8  mm x 10 
cm, 5 pm s i l i c a  g e l )  o r  a Regis (4.6 mm x 25 cm, P i r k l e  p h e n y lg l y c i n e  
c o v a l e n t l y  bound to  5 pm aminopropyl s i l i c a  gel ).26 S p e c i f i c  HPLC 
condi t ions are reported as fo l lo w s :  column, e lu ta n t  composition, e lu tan t  
f low  rate, and re ten t ion  volume (k ‘ ). Preparat ive HPLC was performed on 
a Waters Associates PrepLC/System 500 l i q u id  chromatograph equipped with 
a r e f r a c t i v e  index d e te c to r  and us ing two PrepPak 500 s i l i c a  gel c a r -  
t r i d g e s  (5 x 30 cm). A n a l y t i c a l  t h i n  l a y e r  chromatography (TLC) was 
performed using EM Reagents 0.25 mm s i l i c a  gel 60-F p la tes.
When necessary, so lvents  were dr ied p r i o r  to  use. Tetrahydrofuran 
(THF) and benzene were d i s t i l l e d  from sodium/benzophenone k e ty l .  Boron 
t r i f 1 u o r ide - -d ie thy l  etherate and di isopropylamine were d i s t i l l e d  from 
ca lc iu m  hydr ide .  D imethy l fo rmamide (DMF) was d i s t i l l e d  from calcium 
hydride and stored over 4A molecular  sieves. n-Butyl  1i th ium was stan­
da rd ized  by doub le  t i t r a t i o n  ( t o t a l  base - i n o rg a n ic  base = o rgan ic  
base).
Unless o the rw ise  noted, a l l  non-aqueous react ions were performed 
under an oxygen-free atmosphere of argon or ni t rogen with r i g i d  exc lu ­
sion o f moisture.
(4 R ,5 S )-4 -M e th y l-5 -p h e n y l-2 -o xa zo lid in o n e  (3a). A mechanical l y  
s t i r r e d  m ix tu re  o f  151 g (1.00 mol) o f  ( lS ,2R )-no rephed r ine  ( [ ot3589 =
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+33.4° (c 7, water)  as the  h y d r o c h lo r i d e  s a l t ,  A l d r i c h  Chemical Co.). 
236 g (1.10 mol) o f d ipheny l  ca rbona te ,  and 152 g (1.10 mol) o f  anhy­
drous potassium carbonate was heated at 11Q°C fo r  4-6 h. The re s u l ta n t  
mixture was cooled to  < 60CC. Excess diphenyl carbonate was hydrolyzed 
by addi t ion of 600 mL of methanol and heat ing the mixture at r e f l u x  fo r  
0.5 h. S u f f i c i e n t  water  (400-600 mL) was added to  d i s s o l v e  the  p o ta s ­
sium carbonate. Methanol was removed j_n vacuo. The product and phenol 
were e x t ra c te d  i n t o  d ich io rom e thane  ( 3 x 1  L). The combined e x t r a c t s  
were washed w i th  2 M aqueous sodium hyd rox ide  (3 x 1 L) to  remove the 
phenol , 1 M aqueous hydroch l  o r i c  ac id  (1 x 1 L),  and b r in e ,  d r ie d  ove r  
anhydrous magnesium s u l f a t e ,  and co n cen t ra ted  i_n vacuo t o  g i v e  195 g 
(110% mass ba lance)  o f  a 1 ig h t  y e l  low sol id .  R e c ry s ta 1 1 i z a t i o n  from 
to luene (600 mL, 3 crops) afforded 145-165 g (82-93%) of 2-oxazol id inone 
3a as a w h i te  c r y s t a l l i n e  s o l i d :  mp 121-122°C ( L i t .  ^  H 7 ° c ) ;  Ik
(CHC13) 3460, 3400-3200, 3020, 2980, 1760, 1450, 1380, 1350, 1220, 1125, 
1000, 960, 690 cm- 1 ; NMR (CDC1 3 /90 MHz) 8  7.33 (s,  5H, a romat ic  H's), 
6 .3-6.0 (br s, 1H, N-H), 5.67 (d, J = 7.5 Hz, 1H, C5 -H), 4.17 (qn, J =
7.0 Hz, 1H, C4 -H),  0.80 (d, J = 7.C Hz, 3H, C4 -CH3); 13C NMR ( CDC 1 3 /22.5 
MHz) 8  159.9, 135.0, 128.4, 125.9, 81.0, 52.4, 17.4; S p e c i f i c  R o ta t io n  
Call589 = +177.2°, [ 0 1 5 7 7  = +186.1°, [ a ] 5 4g = +212.0°, [ a ] 43g = +368.6°, 
[ a ] 3 6 5 = +598.6° (c 2.21, CHC13), [ L i t . 12  U j g s g  = +158.4° (c 0.44, 
CHC13) ] ;  GC (30 m DB-1, 150°C, 81 cm/sec) t r  = 4.31 min; TLC ( e th y l  
a c e ta te ) ,  Rf = 0.45.
Anal.  Calcd. f o r  C1 0 H nN 02 : C, 67.78; H, 6.62; N, 7.90. Found: C, 
67.42; H, 6.19; N, 7.87.
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(4S)-4-(l-Methyl ethyl )-2-oxazol idinone (4a). I n to  a 500-mL f l a s k  
equipped with  a 20-cm Vigreux column was introduced 103 g (1.00 mol) o f 
(S)-va l ino l  , 14  133 mL (130 g, 1.10 mol) o f  d i e t h y l  ca rbona te ,  and 14 g 
(0.10 mol) o f anhydrous potassium carbonate. The m agne t ica l ly  s t i r r e d  
mix ture was heated at 125-126°C ( i n t e r n a l  r e a c t i o n  tem pera tu re )  u n t i l  
117 mL (92 g, 2.0 mol) o f  e thano l  d i s t i l l e d  (ca. 4-6 h ) . ^ 8  The r e s u l ­
ta n t  mixture was cooled to  room temperature, d isso lved  in  d ie thy l  ether 
(3 L), and the s o lu t io n  f i l t e r e d  through a 2 cm pad o f c e l i t e  to  remove 
the  potassium carbonate .  The e th e ra l  s o l u t i o n  was co n cen t ra ted  to  a 
volume o f  ca. 1 L, s l o w l y  coo led  to  0°C, and the  p roduc t  a l l o w e d  to  
c r y  s t a l l  i ze. C on c e n t ra t io n  o f  the  mother l i q u o r s  p ro v id e d  two a d d i ­
t i o n a l  crops o f c r y s ta ls .  The to ta l  y i e l d  o f  2-oxazol id inone 4a, was 
110-123 g (85-95%), as whi te needles: mp 69-70°C, [ L i t . ^  mp 71.5°C]; IR 
(CH2 C1 2 ) 3480, 3340-3240, 3060, 2980, 1760, 1400, 1240 cm"1; NMR 
( CDC 13 / 9 0  MHz) S 6.7 (b r  s, 1H, N-H), 4.42 ( t ,  J = 8 . 6  Hz, 1H, C5 - i i ) ,
4.07 (d o f  d, J = 8.5, 6.5 Hz, 1H, C5 -H), 3.58 (d o f  t ,  J = 8 . 6 , 6.5 Hz, 
1H, C^-H), 1 .9 -1 . 6  (m, 1H, C4 -CH), 0.95 ( o v e r l a p p in g  d 's ,  J = 6.0 Hz, 
6 H, CH( C143)2 )* S p e c i f i c  r o t a t i o n  [a lg g g  = -1 6 .6 ° ,  [ ot] 5 7 7  = -17 .3° ,
C 5 4 6  = -20 .2° ,  [ a ] 4 3 5  = -37 .3 ° ,  [ a ] 3 5 5  = -63 .7°  (£ 5 .8 1 ,  EtOH); GC (30 
m DB-5, 100°C, 94 cm/sec) t r  = 5.55 min; TLC (6:4 hexanes/ethyl  acetate) 
Rf = 0.19.
Ana l .  Calcd. f o r  C6 h1 1 N0 2 : C, 55.80; H, 8.58. Found: C, 55.63; H,
8.53.
Benzyl Chioromethyl Sulfide (5a). Anhydrous hydrogen c h lo r id e  was 
bubbled through a m agne t ica l ly  s t i r r e d ,c o o le d  (-10°C) s o lu t io n  of 25.0 g 
(0.278 mol) of _s-trioxane in 100 g (0.805 mol) of benzyl t h i o l  u n t i l
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saturated (ca. lh) .  A f te r  an add i t iona l  period of 12 h at room tempera­
tu re ,  the react ion mixture was dr ied over anhydrous calcium ch lo r ide .  
The product was decanted from the calcium ch lo r id e  and d i s t i l l e d  through 
a 5-cm Vigreux column to  a f fo rd  101 g (73%) of 5a as a c o lo r le s s  l i q u id :  
bp 74-76°C, 0.01 mm, (L i t .18  bp 102°C, 2 mm); *H NMR (CCl4/90 MHz) S 7.2 
(s,  5H, a rom a t ic  H's), 4.40 (s ,  2H, SCH^C 1 ),  3.80 (s ,  2H, PhC^S).
Benzyl Bromomethyl S u l f id e  (5b). The t i t l e  compound was prepared 
fo l lo w in g  the procedure of Hollowood et a 1.^-0 The product was p u r i f ie d  
by molecu lar  d i s t i l l a t i o n  (Kugelrohr,  140°C, 0.01 ,min) to  a f fo rd  5b (92%) 
as a c o l o r l e s s  l i q u i d ,  which s o l i d i f i e d  b e lo w -1 0 °C :  NMR (CC1 4 / ^ 0
MHz) 8  7.27 {s ,  5H, a romat ic  H's),  4.33 (s,  2H, SCH^Br), 3.82 (s ,  2H, 
PhCJHfcS).
(4R,5S)-3-(l-Oxo-3-phenylpropyl) -4-methyl-5-phenyl-2-oxazolidinone 
(3b). A r n e c h a n ic a l l y  s t i r r e d ,  coo led  (-78°C) s o l u t i o n  o f  44.3 g (250 
mmol ) o f  2 -o x a z o l i d i n o n e  3a (0.5 M in  THF), was m e ta la ted  w i th  150 mL 
(1.70 M in  hexane, 255 mmol ) o f  _n-butyl  1 i t h iu m  ( u n t i  1 the  orange-red 
c o l o r  o f  the  d ia n io n  j u s t  p e r s is t e d )  and a c y la te d  im m ed ia te ly  w i th
39.0 mL (44.3 g, 263 mmol) of f r e s h l y  d i s t i l l e d  3-phenyl propanoyl c h lo r ­
ide. The r e a c t i o n  m ix tu re  was warmed to  0°C and s t i r r e d  f o r  0.5 h. 
Excess acid ch lo r id e  was hydrolyzed by add i t ion  of 100 mL of 1 M aqueous 
potass ium carbonate  and s t i r r i n g  the  re s u l ta n t  two-phase mixture fo r  
1 h at room temperature. V o l a t i l e s  were removed i_n vacuo and the prod­
uct extracted in to  dichloromethane (3x). The combined organic extracts 
were s u c c e s s i v e l y  washed w i th  wate r  and b r in e ,  d r ie d  ove r  anhydrous
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magnesium s u l f a te ,  and concentrated in  vacuo to  g ive  83.2 g o f  a ye l lo w  
s o l i d .  Recrystal  1 iza t ion  from hexanes/ethyl  acetate (3 crops) afforded
69.1 g (89%) o f  3b as a white c r y s t a l l i n e  s o l i d :  mp 95-96°C; IR (CH2C12) 
3060, 3000, 1785, 1 700, 1370, 1350, 1250 c u r 1 ; 1h NMR (CDCI3 / 5 OO MHz) g 
7.44-7.19 (m, 10H, a rom at ic  H's),  5.63 (d, J = 7.5 Hz, 1H, C5 -HJ, 4.75 
(qn, J = 6.9 Hz, 1H, C4 _jh), 3.34 (m, 2H, C2 «-H2), 3.06-3.00 (m, 2H, C3>- 
H2 ), 0.89 (d, J = 6 . 8  Hz, 3H, C4 -H3 ); 13C NMR (CDC1 3 /22.5 MHz) 8  172.1,
152.9, 140.4, 133.4, 128.7, 126.2, 125.6, 79.0, 54.7, 37.2, 30.3, 14.5; 
S p e c i f i c  r o t a t i o n  [a ]g g g  = +28.7°, [ a 35 7 7  = +28.9° , [ a ] 5 4 g = +32.9°,
[ a ] 4 3 5  = +60.1°, [ a ] 3 6 5  = +106.7 (c 0.45, CH2 C12); GC (30 m DB-1, 200°C, 
8 6  cm/sec) t r  = 9 .06 min; HPLC ( 8  mm x 10 cm Rad ia l  Pak (5 ym s i l i c a  
g e l ) ,  88:12 i s o o c t a n e / e t h y l  a c e ta te ,  2.0 mL/min) k' = 2.76; TLC (7:3 
hexanes/ethyl  acetate) Rf = 0.42.
A n a l .  Calcd. f o r  CjgHigNOg: 0, 73.77; H, 6.19. Found: C, 73.85; H,
6.28.
(4S)-3-(l-0xo-3-phenylpropyl) —4-(1-methyl e th y l)-2-oxazolidi none 
(4b). A mechanical l y  s t i r r e d ,  coo led  (-78°C) s o l u t i o n  o f  20.0 g (155 
mmol) o f  2 -oxazo l  i di  none 4a (0.3 M in  THF), was m e ta la te d  w i t h  95 mL 
(1.70 M in hexane, 162 mmol) of jo-buty 1 1 i th ium and acylated with  28.4 g 
(168 minol) of f r e s h l y  d i s t i l l e d  3-phenyl propanoyl ch lo r ide .  The reac­
t i o n  mixture was warmed to  0°C and s t i r r e d  f o r  0.5 h. Excess acid c h lo r ­
ide was h y d ro ly z e d  by the  a d d i t i o n  o f  100 mL o f  1 M aqueous potassium 
carbonate and s t i r r i n g  the resu l tan t  two-phase mixture fo r  1 h at r o o m  
temperature. V o l a t i l e s  were removed _i_n vacuo and the product extracted 
in to  dichioromethane (3x). The combined organic ex t rac ts  were succes­
s i v e l y  washed with  water and br ir ie, dr ied over anhydrous magnesium s u l -
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fa te ,  and concentrated ji_n vacuo to  g ive  41.5 g o f  a p a le -y e l lo w  so l id .  
R e c ry s ta l  1 i z a t i o n  from hexanes a f fo rd e d  37.0 g (91%) o f  4b as a wh i te  
c r y s t a l l i n e  s o l i d :  mp 63-64°C; IR (CH2 C12) 3060, 2970, 1780, 1700, 1385, 
1210 cm"1; *H NMR (CDCI3 / 5 0 0  MHz) 8  7.3-7.17 (m, 5H, a romat ic  H's), 4.41 
(d o f  d o f  d, J = 8.5, 4.0, 3.2 Hz, 1H, C4 -H),  4.24 (d o f  d, J = 9.3, 
8.4 Hz, 1H, C5 -H) ,  4.19 (d o f  d, 0 = 9.3, 3.2 Hz, 1 H, C5 -H) ,  3.30 (d o f  
d o f  d, J = 17.5, 8.7, 6.9 Hz, 1 H, C2 ' -H ) ,  3.22 (d o f  d o f  d, J = 17.5,
8.5, 7.2 Hz, 1H, C2 . -H) ,  3.1-2.9 (m, 2H, C3 ' -H2 ),  2.4-2.3 (m, 1H, C4 - 
CH), 0.90 (d ,  J = 7.4 Hz, 3H, C H ( CJi3 ) ) .  0.84 (d ,  J = 7.4 Hz, 3H, 
CH( CJH3 ) ) ;  13C NMR ( CDC 1 3 /22.5 MHz) 8  172.3, 154.0, 140.5, 128.5, 126.1,
63.4, 58.4, 37.0, 30.4, 28.4, 17.9, 14.6; S p e c i f i c  r o t a t i o n  [a lggg  = 
+ 71.0°, [ a ] 5 7 7  = +74.1°,  [ a ] 5 4 6  = +84.2°, [ 0O4 3 5  = +143.4°, M 3 6 5  = 
+225.3° (c 4.61, CH2 C12); GC (30 m DB-1, 175°C, 83 cm/sec) t r  = 4.75 
min; HPLC ( 8  mm x 10 cm Radial Pak (5 ym s i l i c a  g e l ) ,  88:12 isooctane/ 
e thy l  acetate, 2.0 mL/min) k' = 4.86; TLC (8:2 hexanes/ethyl  acetate) Rf 
= 0.47.
Ana l .  Calcd. f o r  C^3 H^gN0 3 : C, 68.94; H, 7.33. Found: C, 69.17; H,
7.42.
{4R, 5S) -3 -  ( ( 2R)-1 -Oxo-2-phertyl methyl t hi omethyl - 3 - phenyl propy l ) - 4 - 
methy l -5 -pheny l -2 -oxazo l id inone  (8 a). A magnetical l y  s t i r r e d ,  cooled 
(-78°C) s o lu t io n  o f  l i t h iu m  di isopropylamide (LDA, prepared from 9.5 ml 
(6.9 g, 67.8 mmol) o f d i isopropy l  amine and 40 mL (1.69 M in hexane, 67.6 
mmol) o f  _n-butyl  1 i t h iu m ) ,  (0.5 M in  THF), was used t o  enol i ze  20.0 g 
(64.6 mmol) o f  3b. A f t e r  s t i r r i n g  f o r  0.5 h a t  -78°C th e  r e s u l t a n t  
l i t h iu m  enol ate was a lk y la te d  with  10.6 mL (15.5 g, 71.3 mmol) of benzyl
- 2 4 6 -
bromomethyl s u l f i d e  (5b) f o r  2 h at -25°C and 2 h at 0°C. The react ion 
was quenched by a d d i t i o n  o f  h a l f - s a t u r a t e d  aqueous ammonium ch lo r ide. 
V o l a t i l e s  were removed in vacuo and the product extracted in to  d ich lo ro -  
methane (3x). The combined o rgan ic  e x t r a c t s  were success ive ly  washed 
w ith  1 M aqueous sodium b i s u l f a te  (2x), 1 aqueous potassium bicarbo­
nate (2x), and br ine ,  dr ieu over anhydrous magnesium s u l f a te ,  and con­
centra ted i_n v^cuo to  gi ve 31.3 g of a y e l lo w  o i l .  Analys is  by GC (30 m 
DB-1, 200°C f o r  10 min, 25°C/min to  275°C, ( i n j e c t o r  and d e te c to r  = 
300°C), 90 cm/sec) a f fo rd e d  a 98:2 r a t i o  o f  8a ( t r  = 17.92 min) to  9a 
U r = 18.12 min), and ind icated the presence of both 2-oxazol idinone 3a 
( t r  = 1.19 min, ca. 5%) and im ide 3b ( t r  = 8.60 min, ca. 8%). HPLC 
ana lys is  (8 mm x 10 cm Radial Pak (5 pm s i l i c a  ge l ) ,  88:12 isooctane/ 
e th y l  a c e ta te ,  2.0 mL/min) i n d i c a te d  k' 8a = 1.98, k 1 9a = 1.69, a =
1.17. The t i t l e  compound was iso la te d  by l i q u i d  chromatography (Waters 
Prep-500, two 5 x 30 cm s i l i c a  gel columns, ca. 9:1 hexaries/ethyl ace­
t a t e  (a d ju s te d  to  TLC Rf = 0.09), 250 mL/min) in  th re e  p o r t io n s  to  
a f f o r d  21.8 g (76%) o f  8a as a c o l o r l e s s  o i l  (8a:9a = 93:2):  IR (neat) 
3030, 2920, 1780, 1700, 1490, 1450, 1380, 1340, 1190, 1 120 c m '1; NMR 
(CDC 1 3 / 5 0 0  MHz) 8 7.42-7.20 (m, 15H, a romat ic  H's), 5.18 ( d , J = 7.0 Hz, 
1H, C5 -H) ,  4.61-4.52 (m, 2H, C4 -H, 'C2 ' -H ) ,  3.77 (d, J = 13.5 Hz, 1H, 
SCH(H)Ph), 3.72 (d, J = 13.5 Hz, 1H, SCH(H)Ph), 2.91 (d o f  d, J = 13.0, 
8 . 8  Hz, 1H, C3 ‘ -H) ,  2.86 (d o f  d, J = 13.0, 7.3 Hz, 1H, C3 *-H), 2.83 (d 
o f  d, J = 13.8, 9.9 Hz, 1H, C2 ' -CH(H)S), 2.53 (d o f  d, J = 13.7, 5.0 Hz, 
1H, C2 ' -CH(H)S), 0.89 (d, J = 6.5 Hz, 3H, C4 -CH3 ) ;  13C NMR (CDC 1 3 /22.5 
MHz) 8  174.5, 152.6, 138.2, 138.0, 133.1 , 129.1 , 128.9, 128.6, 128.4 ,
126.9, 126.6, 125.5, 78.7, 55.0, 44.6, 39.0, 35.9, 32.2, 14.4; S p e c i f i c  
r o t a t i o n  [a ]ggg  = +70.6°, [ a.35 7 7  = +74.2°, [ a ] 5 4 g = +84.5°, [ a ] 4 3 5  =
- 2 4 7-
+150.0° , [a ]365  = +253.1° (c 1.42, C ^ C l g ) ;  TLC ( 7 : 3  he xan e s /e th y l  
a c e ta te )  Rf  = 0.44.
Ana l .  Calcd. f o r  C2 7 H2 7 NO3 S: C, 72.78; H, 6.11. Found: C, 73.03; 
H, 6.07.
(45)-3-((2S)-l-Oxo-2-phenylmethylthiomethyl-3-phenyl p ro p y l) -4 - ( l -  
methylethyl )-2-oxazolidinones (9b). A m agne t ica l ly  s t i r r e d ,  cooled 
(-78°C) s o l u t i o n  o f  LDA (prepared from 15.4 mL (11.1 g, 110 mmol) o f  
d i isopropy l  amine and 65 mL (1.69 M in hexane, 110 mmol) o f ^ -b u ty l  l i t h ­
ium), (0.75 M in  THF), was used to  e n o l i z e  26.1 (100 mmol ) o f  4b. A f t e r  
s t i r r i n g  f o r  0,5 h at -78°C the re s u l ta n t  l i t h i u m  enola te was a lky la te d  
w ith  23.9 g (110 mmol) of benzyl bromomethyl s u l f i d e  (5b) f o r  2 h at 
-20°C. The react ion was quenched by add i t ion  o f  h a l f - s a tu ra te d  aqueous 
ammoni um chi o r  id  e. V o l a t i l e s  were removed j_n vacuo and the  product 
extracted in to  dichloromethane (3x). The combined organic ex t rac ts  were 
success ive ly  washed w ith  1 M aqueous sodium b i s u l f a t e  (2 x), 1 M aqueous 
potass ium b ic a rb o n a te  (2 x),  and b r i n e ,  d r ie d  o ve r  anhydrous magnesium 
s u l f a t e ,  and concen t ra ted  _in vacuo to  g i v e  53.0 g o f  a y e l  1 ow o i l .  
A n a ly s i s  by GC (30 m DB-1, 175°C f o r  5 min, 20°C/min to  250°C,
60 cm/sec) a f fo rd e d  a 3:97 r a t i o  o f  8b ( t r  = 11.74 min) to  9b ( t r =
11.53 min) ,  and i n d i c a te d  the presence o f  imide 4b ( t r  = 4.17 min, ca. 
10%). The t i t l e  compound was iso la ted  by l i q u i d  chromatography (Waters 
Prep-500, two 5 x 30 cm s i l i c a  gel columns, 87:13 hexanes/ethyl  acetate, 
250 mL/min) in  two p o r t i o n s  t o  a f f o r d  33.1 g (83%) o f  9b as a v iscous  
c o lo r l e s s  l i q u i d  (8b:9b = 2:98): IR (neat) 3040, 2980, 2940, 1780, 1700, 
1495, 1455, 1390, 1300, 1250, 1200, 1100, 700 cm"1; 1 H NMR ( CDC13/500
- 2 4 8 -
MHz) 8  7.30-7.16 (m, 10H, a romat ic  H's),  4.60 (m, 1H, C2 1 -H),  4.27 (d o f  
d o f  d, J = 8.5, 3.8, 2.5, 1H, C4 -H).  4.09 (d o f  d, J = 9.3, 2.7 Hz, 1 H,
C5 -H),  3.92 (d o f  d, J = 9.3, 8.7 Hz, 1H, C5 -H),  3.76 {d, J = 14.0 Hz,
1H, SCH(H)Ph), 3.70 (d, J = 14.0 Hz, 1H, SCH(H)Ph), 2.90 (d o f  d, J = 
13.0, 8.0 Hz, 1H, C3 ._h), 2.80 {d o f  d, J = 13.5, 10.0 Hz, 1 H, C2' -  
CH(H)S), 2.78 (d o f  d, J = 13.0, 7.5 Hz, 1H, C3 f -H).  2.50 (d o f  d, J =
13.5, 4.5 Hz, 1H, C2 • - CHCJH)S), 2.37 (d o f  s e p te t ,  J = 3.8, 7.1 Hz, 1H,
C4 -CH(CH3 ) 2 ) ,  0.91 (d, J = 7.1 Hz, 3H, C H (CJH 3 ) ) ,  0.89 (d,  J = 7.1 Hz,
3H, CH(CH3) ) ; 13C NMR (CDC 13 / 22.5 MHz) 8  174.6, 153.7, 138.2, 138.0,
129.1 , 128.9, 128.4, 126.8, 126.5, 63.2, 58.7, 44.4, 38.7, 35.7, 32.3,
28.5, 17.9, 14.8; S p e c i f i c  r o t a t i o n  L a ^ g g  = -29.1° (c 2.34,
CH2C I 2 ); H80C ana lys is  ( 8  mm x 10 cm Radial Pak (5 uni s i l i c a  g e l ) ,  88:12 
isooctane/ethyl  acetate, 2.0 ml/rnin) k' 9b = 3.26; TLC (7:3 hexanes/ 
e th y l  ace ta te )  Rf = 0.54.
Anal.  Calcd. f o r  C2 3 H2 7 N0 3 S: C, 69.49; H, 6.85. Found: C, 69.62; 
H, 6.85.
Benzyl {2R)-2-Phenylmethyl thiomethyl -3-phenyl propanoate (R-IO). To
a magnet ica l ly  s t i r r e d ,  cooled (~10°C) s o lu t io n  o f l i t h iu m  benzyloxide 
(prepared from 3.7 mL (3.87 g, 35.8 mmol) o f benzyl alcohol and 15.6 mL 
(1.69 M in  hexane, 26.4 mmol ) o f  n -b u ty  1 1 i t h i  urn), (0.5 M in  THF) was 
added a s o lu t io n  of 7.86 g (17.6 mmol) of 8 a in  20 mL of THF over a 0.5- 
h per iod .  The r e a c t i o n  m ix tu re  was wanned to  0CC, s t i r r e d  f o r  1.5 h, 
and then quenched by addi t ion  of h a l f - sa tu ra ted  aqueous ammonium c h lo r ­
ide. Vol a t i  1 es were removed j!n vacuo and the product e x t r a c te d  i n t o  
dichioromethane (3x). The combined organic ex trac ts  were successive ly  
washed with water and br ine, dr ied over anhydrous magnesium s u l f a te ,  and
- 2 4 9 -
concent ra te d  j_n vacuo to  g iv e  11.2 g o f  a y e l l o w  o i l .  The t i t l e  com­
pound was iso la te d  by f l a s h  chromatography (5 x 30 cm s i l i c a  gel column, 
9:1 hexanes/ethyl  acetate) to  a f fo rd  5.5 g (83%) o f  benzyl es te r  R-10 as 
a c o lo r l e s s  l i q u id .  Fur ther e lu t io n  of the column with  e thy l  acetate 
afforded 2.3 g (75%) of 2 -oxazol id inone 3a.
R-10: 1R (neat )  3070, 3040, 1735, 1600, 1490, 1450, 1210, 1160, 690 
cm-1; 1h NMR (CDCl3/90 MHz) 8  7.3-6.9 (m, 15H, a rom a t ic  H's),  5.0 (s,  
2H, 0CH2 Ph), 3.6 (s ,  2H, SCH2 Ph), 3.0-2.3 (m, 5H, C2 -H, C2 -C j j2 S, C3 -H2h  
Spec i f ic  ro ta t io n  Lajgyg = +36.2°, [013577 = +39.0°, [013545 = +43.7°,
[ q 3 4 3 5  = +76.4°, U3365 = +126.6,° (c 0.856, CH2 C12); GC (30 m DB-1, 
200°C f o r  6 min, 25°C/min to  275°C, ( i n j e c t o r ,  d e t e c t o r  = 300°C), 
63 cm/sec) t r  = 10.80 min; HPLC ( 8  mm x 10 cm R ad ia l  Pak (5 ym s i l i c a  
g e l ) ,  88:12 i s o o c t a n e /e th y l  ace ta te ,  2.0 mL/min) k' = 0.56; TLC (8:2 
hexanes/ethyl  acetate) Rf = 0.50.
Ana l .  Calcd. f o r  C2 4 H2 4 0 2 S: C, 76.56; H, 6.42. Found: C, 76.52; H,
6.37.
Benzyl (2S)-2-Phenyl methyl thiomethyl-3-phenyl propanoate (S-10). To
a m agne t ica l ly  s t i r r e d ,  cooled (-10°C) s o lu t io n  o f  l i t h iu m  benzyloxide 
(prepared from 10.3 mL (10.8 g, 99.5 mmol ) o f  benzy l  a l  cohol and 44 mL 
(1.69 M in  hexane, 75.0 mmol ) o f  _n-butyl  1 i t h i  urn), (0.75 M in  THF) was 
added a s o l u t i o n  o f  19.8 g (49.7 mmol) o f  9b i n  50 niL o f  THF o ve r  a 
0.5 h p e r io d .  The r e a c t i o n  m ix tu re  was warmed t o  0 °C and s t i r r e d  f o r  
3 h. The r e a c t i o n  was quenched by a d d i t i o n  o f  h a l f - s a t u r a t e d  aqueous 
ammonium c h l o r i d e .  V o l a t i l e s  were removed in  vacuo and the product 
extracted in to  dichloromethane (3x). The combined organic ex t rac ts  were
-  2 5 0 -
success i v e 1y washed with water and br ine, dr ied over anhydrous magnesium 
sul fa te ,  and concentrated j_n vacuo to  gi ve 28.4 g o f a yel 1 ow o i l .  The 
t i t l e  compound was iso la ted  by l i q u id  chromatography (Waters Prep-500, 
two 5 x 30 cm s i l i c a  gel columns, 95:5 hexanes /e thy l  a c e ta te ,  250 
mL/min) t o  a f f o r d  15.3 g (82%) o f  benzyl e s te r  S-10 as a c o l o r l e s s  
1 i q u id .  F u r th e r  e l u t i o n  w i t h  e th y l  a ce ta te  a f fo rd e d  4.8 g (7 5%) o f  2- 
oxazol idinone 4a.
S-10: IR (neat) 3070, 3040, 2920, 1735, 1490, 1450, 1160, 695 cm~l;
NMR (CCI4 / 9 0  MHz) S 7.4-6.9 (m, 15H, a romat ic  H's),  5.0 (s,  2H, 
0CH2 Ph), 3.5 (s ,  2H, SCH^h) ,  2.9-2.2 (m, 5H, C2 -H, C2 -CH2 S, C3 -H3 ) ; 13C 
NMR (CDC 13 / 2 2 . 5  MHz) 173.7, 138.3, 138.0, 135.7, 128.9, 128.4, 128.1,
126.9, 126.5, 66.4, 47.6, 37.8, 36.3, 32.4; S p e c i f i c  r o t a t i o n  [ a ] 5 8 9  
= -34.6°  (c 2.46, CH2 c i 2 ); GC (30 m DB-1 , 200°C f o r  6 min, 25 °C/min to  
275°C, ( i n j e c t o r ,  d e te c to r  = 300°C), 94 cm/sec) t r  = 9.66 min; HPLC 
( 8  mm x 10 cm Radial Pak (5 pm s i l i c a  g e l ) ,  88:12 isooctane/ethyl  ace­
t a t e ,  2.0 mL/min) k ’ = 0.56; TLC (8:2 h exanes /e thy l  ace ta te )  Rf = 0.50.
Ana l .  Calcd. f o r  C2 4 H2 4 0 2 S: C, 76.56; H, 6.42. Found: C, 76.82; H,
6.51.
(2R)-2-Phenylmethyl th iom eth y l-3 -p heny l propanoic acid (R—1-1). A
m agnet ica l ly  s t i r r e d  s o lu t io n  of 2.01 g (5.35 mmol) of benzyl es te r  R-IO 
i n  9 mL o f  6 M anhydrous hydrogen bromide in  g l a c i a l  a c e t i c  ac id  was 
s t i r r e d  at 50°C fo r  15 min. The react ion mixture was d i lu te d  with 20 mL 
of water and extracted with dichloromethane (4 x 20 mL). The combined 
organic extracts were concentrated _i_n vacuo. The residue was d i lu te d  
w i t h  to lu e n e  (50 mL) and co ncen t ra ted  j_n vacuo th re e  t imes to  remove 
ace t ic  acid. The residue was d isso lved in  1 M aqueous potassium hydrox-
- 2 5 1 -
i d e ,  washed w i th  d ich io rom e th a n e ,  a c i d i f i e d  to  pH 1 w i t h  concen t ra ted  
aqueous hydroch lo r ic  acid, and extracted with dichioromethane. The com­
bined organic ex t rac ts  were concentrated j_n vacuo afforded 1.31 g (85%) 
of ca rboxy l ic  acid R - l l  as a co lo r le ss  o i l .  An a n a ly t i c a l  sample was 
p u r i f i e d  by m o le c u la r  d i s t i l l a t i o n  ( K u g e l r o h r ,  140°C, 0.01 mm): 1R 
(neat )  3400-2400, 1710, 1600, 1490, 1450, 1235, 690 c n r 1; NMR 
(CCI4 / 9 0  MHz) 8  11.4 (b r  s, 1H, C02 H), 7.1 (m, 10H, a rom a t ic  H‘ s),  3.6 
(s ,  2H, SCH2 Ph), 3.0-2.3 (m, 5H, C2 -H, C2 -CH2 S, C3 -H2 ); S p e c i f i c  r o t a ­
t i o n  [ a ] 3gg = +54.1°, [ a ] 5 7 7  = +05.3°, [ 0 3 5 4 5  = + 64.5° , [ cx̂  43  5 =
+ 113.2°, [ a ] 3 6 5  = +189.6° (c 1.54, abs. EtOH).
Anal.  Ca 1 cd. f o r  C1 7 H1 8 02 S: C, 71.30; H, 6.34. Found: C, 71.58; H,
6.52.
(2S)-2-Phertyl methyl th iom ethyl-3-phenyl propanoic acid (S - l l ) .  A
magne t ica l ly  s t i r r e d  s o lu t io n  of 9.13 g (24.2 mmol) o f benzyl ester  S-10 
i n  35 mL o f  6 M anhydrous hydrogen bromide in  g l a c i a l  a c e t i c  ac id  was 
s t i r r e d  at 50°C fo r  20 min. The react ion mixture was d i l u t e d  with  35 mL 
of water and extracted with d ich l  oromethane (3 x 50 mL). The combined 
organic ex trac ts  were concentrated j_n vacuo. The residue was d i lu te d  
w i t h  to lu e n e  (100 mL) and concen t ra ted  in  vacuo t h r e e  t im es  to  remove 
ace t ic  acid. The residue was d issolved in  1 M aqueous potassium hydrox­
id e ,  washed w i t h  d ich io rom e th a n e ,  a c i d i f i e d  to  pH 1 w i t h  concen t ra ted  
aqueous hydroch lo r ic  acid, and extracted with dichioromethane. The com­
bined organic ex t rac ts  were concentrated i_n vacuo afforded 5.77 g (83%) 
o f  ca rboxy l ic  acid S - l l  as a pa le -ye l low  o i l .  An a n a ly t i c a l  sample was 
p u r i f i e d  by m o le c u la r  d i s t i l l a t i o n  (K u g e l ro h r ,  140°C, 0.01 mm): 1R
- 2 5 2 -
(neat) 3500-2500, 1710, 1495, 1455, 1240, 700 cm-1; NMR (CC14/90 MHz) 
8  9.7-9.3 (b r  s, 1H, COgji), 7.2 (s,  10H, a rom a t ic  H 's),  3.6 (s,  2H, 
SCF^Ph), 3.0-2.5 (m, 5H, Cg-H, C2 -CH2 S, C3 -H2 ); 13C NMR ( C D C 1 3 / 22 . 5  MHz) 
8  180.1, 138.0, 137.9, 128.8, 128.5, 127.0, 126.6, 47.4, 37.3, 36.5, 
31.8; S p e c i f i c  r o t a t i o n  [a l s g g  = -50.6°  (ĉ  1.57, abs. EtOH).
Ana l .  Ca 1 cd. f o r  C1 7 h 1 8 02 S: C, 71.30; H, 6.34. Found: C, 71.12; H,
6.29.
Benzyl N-[(2R)-2-phenylmethyl thiomethyl -3-phenyl propanoyl )glycinate  
[(2R )-S -B en zy lth io rp h an , benzyl e s te r , (R-12)J. To a m a g n e t i c a l l y  
s t i r r e d ,  co o le d  {-30°C) s o l u t i o n  o f  1.66 g (5.79 mmol) o f  ca rboxy l  ic 
ac id  R - l l  and 2.15 g (6.37 mmol) o f  th e  £ - t o l u e n e s u l f o n a t e  s a l t  o f  
benzyl g l y c i n a t e  in  15 mL o f  anhydrous dirnethy 1 formamide was added 
1.37 mL (1.75 g, 6.36 mmol) o f  d ip h e n y lp h o s p h o ry l  az ide  f o l l o w e d  by 
1.77 mL (1.29 g, 12.7 mmol) of t r i e t h y l  amine. The react ion mixture was
s t i r r e d  f o r  4 h at -10°C, then o v e r n ig h t  a t room tempera tu re .  The
r e s u l t a n t  m ix tu r e  was d i l u t e d  w i t h  1, 1 , 1 - t r i c h l  oroethane (100 mL) and 
s u c c e s s i v e l y  washed w i th  water  (3x) ,  1 M aqueous potass ium hydrox ide  
(3x), 1 M aqueous sodium b i s u l f a te  (2x), and br ine, dr ied over anhydrous 
magnesium s u l f a t e ,  and concen t ra ted  _i_n vacuo t o  g i v e  3.5 g o f  a pa le  
y e l l o w  o i l .  The t i t l e  compound was i so la te d  by f l a s h  chromatography (5 
x 20 cm s i l i c a  gel column, 7:3 hexanes/ethyl  acetate) to  a f fo rd  2.28 g
(91%) of benzyl ester R-12 as a white s o l id .  An a n a ly t i c a l  sample was
r e c r y s t a l l  ized from hexanes/ethyl  acetate: mp 72-73°C; IR (CH2C I2 ) 3440, 
3050, 2990, 1750, 1680, 1270, 1250 cm"1 ; NMR (CC 1 4 /90 MHz) 8  7.3-6.9 
(m, 15H, a romat ic  H's), 6.0 (b r  t ,  J = 6 Hz, 1H, N-HJ, 5.0 (s,  2H, 
0CH2 Ph), 3.8 (m, 2H, NCj^CO). 3.5 (s,  2 H, SCj^Ph), 2 . 9 -2 . 2  (m, 5H, C2'-
- 2 5 3 -
H, C2 ._CH2 S, C3 --JI2 )*. 13c NMR (CDC 1 3 /22.5 MHz) S 173.6, 169.5, 138.9,
138.5, 135.1, 128.9, 128.5, 127.5, 126.4, 67.1, 49.7, 41.3, 38.3, 37.0, 
33.3; S p e c i f i c  r o t a t i o n  [ a ] 5gg = +25.2°, [ a ] s 77  = +26.7°, [ a ] 5 4 g = 
+ 30.6°, [ 0O4 3 5  = +53.6°, [a ]3 6 5  = +89.8° (c 1.61, abs. EtOH); GC (30 m 
DB-1, 275°C, ( i n j e c t o r ,  d e t e c t o r  = 300°C), 8 6  cm/sec) t r  = 6.19 min; 
HPLC ( 8  mm x 10 cm Radial Pak (5 ym s i l i c a  g e l ) ,  64:36 isooctane/e thy l  
a c e ta te ,  2.0 mL/min) k1 = 0.77; TLC (7:3 hexanes /e thy l  a ce ta te )  Rf = 
0.25.
Ana l .  Calcd. f o r  C2 6 h2 7 N0 3 S: C, 72.03; H, 6.28, Found: C, 72.14; 
H, 6.35.
Benzyl N-((2S)-2-phenyl methyl thiomethyl-3-phenylpropanoyl)glycinate, 
[ (2 S )-S -B en zy lth io rp h an , benzyl e s te r ,  (S -12 )] .  To a magnet ica l  l y  
s t i r r e d ,  coo led  (-30°C) s o l u t i o n  o f  5.70 g (19.9 mmol) o f  ca rboxy l  i c  
ac id  S - l l  and 7.43 g (22.0 mmol) o f  th e  £ - t o l u e n e s u l f o n a t e  s a l t  o f  
benzyl g l y c i n a t e  in  50 mL o f  anhydrous d im e thy l fo rm am ide  was added
4.7 mL (6.0 g, 21.8 mmol) o f di phenyl phosphoryl azide fo l low ed  by 6.1 mL 
(4.4 g, 44 mmol) o f  t r i e t h y l  amine. The react ion was s t i r r e d  f o r  4 h at 
-10°C, then o v e r n ig h t  a t  room temperature .  The r e s u l t a n t  m ix tu re  was 
d i l u te d  with 1 ,1 ,1 - t r i c h l  oroethane (100 mL) and successive ly  washed with  
wate r  (3x) ,  1 M aqueous potass ium hyd rox ide  (2x ) , 1 M aqueous sodium 
b is u l f a t e  (2 x), and br ine ,  dr ied over anhydrous magnesium s u l f a te ,  and 
co n cen t ra ted  j_n vacuo t o  g i v e  10.6 g o f  a y e l l o w  o i l .  The t i t l e  com­
pound was i s o l a t e d  by l i q u i d  chromatography (Waters Prep-500, two 
5 x 30 cm s i l i c a  gel columns, 9:1 hexanes/ethyl  acetate, 250 mL/min) to 
a f f o r d  7.34 g (85%) o f  benzyl e s te r  S-12 as a w h i te  sol id .  An a n a l y t -
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3070, 3040, 2930, 1750, 1660, 1450, 1180, 700 cm"; 1h NMR (CDC 13/90 MHz) 
S 7.5-7.0 (m, 15H, a romat ic  H's),  5.7 {b r  t ,  J = 6 Hz, 1H, N-JH), 5.1 (s ,  
2H, 0 CH2 Ph), 3.9 (m, 2H, NHCH2 CO), 3.6 (s,  2H, SCH2 ph)» 2.9-2.1 (m, 5H, 
C2 ' -H, C2 '-CH2 S, C3 1 -^12)i Spec if ic  ro ta t ion  [ “ 3589 = -24.5°, [ 0O577
= -26 .2 ° ,  [ a ] 5 4 6  = -29 .6° ,  [ a ] 435 = -52 .3 ° ,  [ a ] 365 = ' 87-9° (£
1.82, abs. EtOH); GC (30 m DB-1, 275°C, ( i n j e c t o r ,  d e t e c t o r  = 300°C), 
86  cm/sec) t r  = 6.14 min; HPLC ( 8  mm x 10 cm Radia l  Pak (5 ym s i l i c a  
g e l ) ,  64:36 i s o o c t a n e /e th y l  a c e ta te ,  2.0 mL/min) k' = 0.77; TLC (7:3 
hexaries/ethyl acetate) Rf = 0.25.
Ana l .  Calcd. f o r  C2 6 H2 7 N0 3 S: C, 72.03; H, 6.28. Found: C, 72.23; 
H, 6.35.
N-((2R)-l-0xo-2-mercaptomethyl -3-phenylpropyl Jglycine, [(2R)-Thior­
phan, (R—1 ) ] .  To a m a g n e t i c a l l y  s t i r r e d ,  coo led  (-33°C) s o l u t i o n  o f
0.462 g (1.07 mmol) o f  benzyl e s te r  R-12 i n  20 ml o f  THF and 30 mL o f  
anhydrous ammonia ( d i s t i l l e d  from sodium) was added 0.13 g (5.8 mmol) of 
sodium in six port ions over a 0.5 h period. A f te r  the react ion mixture 
had remained d a r k -b lu e  f o r  10-15 min, the r e a c t i o n  was quenched by 
a d d i t i o n  o f  0.37 g (6.9 mmol) o f  ammonium c h lo r i d e .  The ammonia was 
evapora ted  under a stream o f  n i t r o g e n ,  and the  THF removed j_n vacuo. 
The residue was d isso lved  in 5 mL of 1 M aqueous potassium hydroxide and 
washed with d ie thy l  ether to  remove toluene and d ibenzyl.  The aqueous 
s o lu t io n  was cooled to  0°C, a c id i f i e d  to  pH 1 with concentrated aqueous 
h y d r o c h l o r i c  a c id ,  and the  product  e x t ra c te d  i n t o  d i e t h y l  e th e r .  The 
e thera l  so lu t io n  was dr ied over anhydrous magnesium s u l f a te ,  and concen­
t r a t e d  j_n vacuo to  a f f o r d  0.246 g (91%) o f  (2 R ) - th io rphan  R - l  as a 
c o lo r le s s  o i l  which s low ly  s o l i d i f i e d  upon standing: mp 108-110°C; *H
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NMR (CDC1 3 / 5 OO MHz) S 7.16-7.09 (m, 5H, a romat ic  H's), 6.72 (b r  s, 1H, 
N-H), 4.05 (d o f  d, J = 15, 5 Hz, 1H, NCH(H)CO), 3.85 (d o f  d, J = 15, 5 
Hz, 1H, NCH(H)CO), 2.95-2.50 (m, 5H, Cg.-H, C2 >-CH2 S, C3 <-H2), I - 6 7  (br 
t ,  J = 7 Hz, 1H, S-H); 13C NMR (CDCl3 /22.5  MHz) 8  147.7, 172.6, 138.2, 
128.8, 128.5, 126.7, 52.8, 41.4, 38.0, 26.0; S p e c i f i c  r o t a t i o n  [a ]g89  
= -40.1°  (£ 2.25, abs. EtOH); TLC (98:2 e th y l  a c e t a t e / a c e t i c  ac id )  Rf =
0.31.
Ana l .  Ca lcd .  f o r  CgH 1 5 NO3 S: C, 56.90; H, 5.97; S, 12.66. Found: 
C, 56.71; H, 6.19; S, 12.88.
N-((2S)-l-Oxo-2-mercaptomethyl-3-phenylpropylJglycine, [(2S)-Thior­
phan, ( S - l ) ) .  To a m a g n e t i c a l l y  s t i r r e d ,  coo led  (-33°C) s o l u t i o n  o f  
4.33 g (10.0 mmol ) o f  benzyl e s te r  S-12 in  100 mL o f  THF and 100 ml o f  
anhydrous ammonia ( d i s t i l l e d  from sodium) was added 0.92 g (40 mmol) of 
sodium in  ca. s i x  p o r t i o n s  over  a 0.5 h pe r iod .  A f t e r  the  re a c t i o n  
mixture had remained dark-b lue fo r  10-15 min the react ion was quenched 
by a d d i t i o n  o f  2.14 g (40 mmol) of ainmoni u m c h lo r i d e .  The ammoni a was 
evaporated under a stream of ni trogen and the THF was removed j_n vacuo. 
The re s id u e  was d i s s o l  ved in  20 ml o f  1 M aqueous potassium hydrox ide  
and washed w i t h  d i e t h y l  e the r  to  remove to lu e n e  and d ib e n z y l .  The 
aqueous s o lu t io n  was cooled to  0°C, a c id i f i e d  to  pH 1 with  concentrated 
aqueous hyd roch lo r ic  acid, and the product extracted in to  d ie thy l  ether. 
The e t h e r a l  s o l u t i o n  was d r ie d  ove r  anhydrous magnesium s u l f a t e ,  and 
concentrated j j i  vacuo to afford 2.43 g (96%) of (2S)-thiorphan S -l  as a 
c o lo r l e s s  o i l ,  which s low ly  s o l i d i f i e d :  mp 110-111°C; IR (neat) 3500- 
2500, 1740, 1650, 1540, 1210, 700 cm"1; NMR (CDC 1 3 /90 MHz) S 9.2 (br
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s, 1H, C02.H), 7.2 (m, 5H, aromat ic  H's), 6.3 (b r  t ,  J = 6 Hz, 1H, N-JH),
4.1 (d o f  d, J = 18, 6 Hz, 1H, NCH(H)CO), 3.8 (d o f  d, J = 18, 6 Hz, 1H, 
NCH(H)CO), 3.0-2.4 (m, 5H, C2 ' -H, C2 «-CH2 S, C3 ' -H 2),  1-6 (b r  t ,  J = 9 
Hz, S^H); s p e c i f i c  r o t a t i o n  [ 0 1 5 3 9  = +39.6° (£ 2.78, abs. EtOH); TLC 
(98:2 ethyl  ace ta te /ace t ic  acid) Rf = 0*31.
Ana l .  Ca 1 cd. f o r  C1 2 h1 5 N03 S: C, 56.90; H, 5.97; S, 12.66.
Found: C, 56.79; H, 6.00; S, 12.53.
Determination of the Enantiomeric Purity of (R) and (S)-Thiorphan.
A magne t ica l ly  s t i r r e d  so lu t ion  of 89.5 mg (353 jjmo 1) of (+)-thiorphan, 
44 yL (51 mg, 360 ymol) o f boron t r i f l u o r i d e - - d i e t h y l  etherate in 5 mL 
o f  anhydrous methanol was heated at 50°C f o r  4 h ( u n t i l  no s t a r t i n g  
m a t e r ia l  rema i ned by TLC ana 1 y si  s ). The mi x tu re  was d i 1 uted wi th  di - 
chioromethane, washed with 1 M aqueous potassium carbonate, water and 
br ine, dr ied over anhydrous magnesium s u l fa te ,  and concentrated in vacuo 
to  a f fo rd  102  mg (108% mass balance) o f (±)-thiorphan, methyl ester as a 
pale y e l 1 ow o i 1 .
A mixture o f 27 mg (100 ymol) o f  (±)-thiorphan, methyl este r ,  20 mg 
(100 ymol) o f  ( R ) - l - ( l - n a p h t h y l ) e t h y l  isocyana te  ( 1 3 ) ,H  and 10 mg of 
anhydrous potassium carbonate in  2 mL of benzene was heated at 80°C fo r  
4 h ( u n t i l  no s ta r t in g  material  remained by TLC ana lys is ) .  The mixture 
was d i l u t e d  wi th  di  c h 1 oromethane, washed w i th  wate r  and b r in e  d r ie d  
over anhydrous magnesium s u l f a te ,  and concentrated jjn vacuo to a f fo rd  50 
mg (106% mass balance) o f  a mixture of thiourethane diastereomers 14 and
15. The unfract ionated product was analyzed by HPLC (Regis, 4.6 mm x 25 
cm, P i r k l e  c h i r a l  phases c o v a l e n t l y  bound to  5 ym ami nopropy 1 s i l i c a  
g e l ;  84:16 i s o o c ta n e / i s o p ro p a n o l  ; 4.0 mL/min) k' 14 = 8.16, k' 15 =
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11.91; a = 1.46).
The react ions were repeated separate ly  with (2R) and (2S)-thiorphan
1. HPLC a n a l y s i s  o f  the u n f r a c t i o n a te d  product  ob ta ined  from (2R)- 
th io rp h a n  ( R - l ) ,  showed a _> 95:5 r a t i o  o f  14 t o  15. L ike w ise ,  HPLC 
ana lys is  o f the unfract ionated product obtained from (S)-thiorphan (S-  
1), showed a 5:95 r a t i o  o f  14 t o  15. T h e re fo re ,  the e n an t iom er ic  
r a t i o  of the syn the t ic  (2R) and (2S)-thiorphan is  > 95:5.
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PROPOSITIONS
PROPOSITION 1. The is o l a t i o n  and s t ru c tu ra l  c h a ra c te r iza t io n  of 
bacter ioc in  JH1000, a small peptide a n t i b i o t i c  e f f e c t i v e  against  
Streptococcus mutans s tra ins  responsib le  fo r  human dental c a r ie s ,  is 
proposed.
PROPOSITION 2. Two thiorphan analogs are proposed to  in v e s t ig a te  
thiorphan induced analgesia. NMR topography is proposed to map the
in v ivo  d i s t r ib u t io n  of both enantiomers of a f lu o r in e  contain ing  
thiorphan derivat ive.  A photoactivated analog of thiorphan, capable of 
c o v a le n t ly  binding to the receptors fo r  analgesia  is  proposed to  
determine i f  thiorphan binds to an opiate receptor.
PROPOSITION 3. The use of labeled metabolites is proposed to study the 
biosynthesis of the brevetoxins, an unusual family of polyether marine 
toxins isolated from the "red tide" dinof 1 age! 1 ate Pt.ychodiscus brevis 
Davis.
PROPOSITION 4. The use of a labeled precursor is proposed to determine 
whether the epoxidation of 5-hexen-2-one with potassium peroxymono- 
s u l fa te  is i n t e r -  or in t ra m ole c u la r .  I f  the reaction is shown to be 
intramolecular, experiments are proposed to investigate internal asym­
metric induction in the peroxymonosulfate epoxidation of chiral 1,5- and 
1 ,6-enones.
PROPOSITION 5 Experiments are proposed to investigate the epoxidation 
step in the biosynthesis of polyether ionophore antibiotics.
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PROPOSITION 1
ABSTRACT. The isolation and structural characterization of bacteriocin 
JH1000, a small peptide a n t ib io t i c  e f f e c t i v e  against  Streptococcus 
mutans strains responsible for human dental caries, is proposed.
Streptococcus mutans, a bacteria indigenous to the oral cavity, is 
general ly  accepted as the principle  e t io logical agent of dental caries 
in humans.* In 1969, Kelstrup and Gibbons reported that  some strains of 
S. mutans, is o la te d  from humans and rodents, produced an e x o c e l l u l a r  
bacteriocin e f fect ive  against other mutans strains.^ Of 143 strains 
of  S. mutans in ve s t ig a te d  by Rogers, 70% produced one or more bac­
teriocins.^ Based on th e i r  size and the effect various proteases exert 
on t h e i r  a n t ib a c te r ia l  a c t i v i t y ,  the bacter ioc ins  are assumed to be 
proteins. Only a few of the mutans bacteriocins have been isolated  
and purif ied, and none have had the ir  structure elucidated.
Paul and Slade reported the i s o l a t i o n  of a b ac te r ioc in  from S. 
mutans s t ra in  E14 (serotype c) with a mw of 20,000 daltons.^  Bac­
ter ioc in  E14 is mainly act ive against S. mutans serotypes a, c, d, g, 1, 
and o. Both t ryp s in  and pronase i n h i b i t  i t s  a c t i v i t y .  Ikeda et a l .  
reported the isolation of a d if ferent  bacteriocin from S. mutans strain  
C3603 (serotype c).^ Bacter ioc in C3603 is  a basic prote in  with a pi 
v a lu e  of 10 and a mw of 4800 daltons. I t  is  mainly a c t iv e  against  
mutans serotypes b, c, e, and f .  Pronase, papian, phospholipase C,
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t ry p s in  and a-amylase had no e f f e c t  on i t s  a c t i v i t y ,  whereas both a- 
chymotrypsin and pancreatin p a r t i a l l y  i n h i b i t  i t s  a c t i v i t y .  These 
workers also demonstrated that bacteriocin C3603 is  an e f fec t ive  an t i ­
caries agent. Bacteriocin C3603 fed to rats previously infected with 
S. mutans PS-14 had s i g n i f i c a n t l y  fewer car ies  than those not t rea ted  
with the antib iotic.
Recent ly ,  Hi 1 1 man et a l . have reported th a t  mutans s t ra in  
JH1000 produces a bacteriocin with novel properties. ̂  Unlike the pre­
vious two bac te r ioc ins ,  th is  a n t ib io t i c  is a c t iv e  against 124 of 125 
s t ra in s  of  mutans tes ted ,  and a lso is a c t iv e  against a v a r ie t y  of 
other  Gram-posit ive bacter ia .  Both t ryp s in  and pronase i n h i b i t  the 
antibacteria l a c t iv i ty  of a cel 1 - free  solution of bacteriocin JH1000, 
whereas DNase, RNase, l ipases, thermolysin, and lysozyme had no effect  
on i t s  a c t i v i t y .  S u rp r is in g ly ,  experiments with d i a l y s i s  membranes 
in d ic a te  tha t  the mw of  the a n t ib io t i c  is < 1000 daltons.  Bacter ioc in  
JH1000, however, has not been isolated and purif ied.
The unusually small size of bacteriocin JH1000--probably less than 
ten amino acids in 1ength--indicates i ts  potential for puri f ication and 
sequencing. I propose to isolate  and identify  the structure of bacteri ­
ocin JH1000. With i t s  s tructure  known, b a c te r io c in  JH1000 could be 
prepared on a large  scale  in the la b o ra to ry ,  and i t s  use as a d i re c t  
a n t ic a r ie s  agent evaluated.  Furthermore, i t s  mode of  a n t ib a c t e r ia l  
a c t iv i ty  could be investigated.
Before the s t ruc ture  of bacter ioc in  JH1000 can be determined, i t  
w i l l  be necessary to obtain the peptide ant ib iot ic  in a pure form. The 
fol lowing isolation and purif icat ion sequence is based on the observed 
properties of the bacteriocin. The eff ic iency of the sequence would be
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evaluated by assaying for ant ibacterial ac t iv i ty .  I n i t i a l l y ,  the small 
s ize  of the ba c te r ioc in  would be exp lo i ted  to separate i t  from la rg e r  
prote ins.  Both d i a l y s i s  and g e l - f i 1t r a t i o n  chromatography separate 
molecules on the basis of size. As previously noted, bacteriocin JH1000 
passes through a d ia lys is  membrane. Therefore, d ia lysis  would be the 
f i r s t  puri f icat ion technique evaluated.
Trypsin inhib its  the antibacterial a c t iv i ty  of bacteriocin JH1000. 
This indicates that the molecule contains lysine or arginine, and thus 
possesses a basic side chain. Therefore, ion-exchange chromatography or 
electrophoresis could be employed to further purify the bacteriocin. By 
judicious use of one or more of the separation techniques, i t  should be 
possible to obtain a pure sample of the bacteriocin.
Once puri f ied, the structure of the bacteriocin would be determined 
by classical means, such as the Edman degradation procedure. ̂  Based on 
i t s  small size, bacteriocin JH1000 could be a cycl ic  peptide, s imilar  to 
the decapeptide antamanide^ or the pentapeptide gramacidin S.^ Both 
antamanide and the gramacidins are peptide ionophores. Like bacteriocin 
JH1000, gramacidin S is an a n t ib io t i c  a c t iv e  against  Gram-positive  
bacteria. I f  bacteriocin JH1000 is a cyclic peptide, i t  would be neces­
sary to open the chain prior to sequencing. Presumably, trypsin could 
be employed fo r  th is  purpose. The small peptide a n t ib io t i c s  often  
contain unnatural (D)-amino acids. Therefore, the absolute stereochem­
is try  of the amino acids in bacteriocin 0H1000 would also be determined.
In terest ingly , the biosynthesis of ionophore peptide antibiot ics is 
independent of the usual protein biosynthetic pathway, involving ribo-  
somal , messenger, and transfer-RNA. Rather, a multienzyme complex,
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u t i l i z i n g  a mechanism related to fa t ty  acid biosynthesis is employed.^® 
Since bacteriocin JH1000 is a r e la t i v e ly  small peptide, i t s  biosynthesis 
may also involve a s imilar  nonribosomal mechanism.
Hillman et a l .  have shown that S. mutans JH10QQ and a tetracycline  
resistant  strain JH1001 both possess plasmid DNA.®a By using the plas­
mids from S. mutans JH1001, they were able to induce tetracycline resis­
tance into S. mutans GS5 (previously tetracycline sensitive). Half  of 
the transformants also produced a bacteriocin with the same spectrum of 
a c t iv i t y  as bacteriocin JH1000. Presumably, the plasmid is responsible 
for  JH1000 bacteriocin. Therefore, depending on which method of protein 
synthesis is employed for the construction of bacteriocin JH1000, the 
plasmid would e i th e r  contain a gene fo r  the synthesis of the b a c t e r i ­
ocin, or a gene for the nonribosomal enzymes responsible for the synthe­
sis of the bacteriocin.
By knowing the structure of bacteriocin JH1000, i t  would be possi­
ble to construct a sequence of radiolabeled complementary DNA corres­
ponding to the bacter ioc in .  This sequence could then be employed to 
detect  i f  the bacter ioc in  gene is  present in the JH1000 plasmid, and 
thus indicate which method of protein synthesis is responsible for the 
construction of the bacteriocin. A l te rn a t iv e ly ,  S. mutans JH1000 could 
be feed an ant ib iot ic  known to inhib it  ribosomal protein synthesis, such 
as chloramphenicol or puromycin. I f  bacteriocin JH1000 continues to be 
produced, a nonribosomal enzyme system is probably responsible for its  
synthesis. This information would be important i f  an j j i  vivo technique 
were to be employed for the preparation of bacteriocin JH1000 on a large 
scale.
- 4 0 6 -
REFERENCES
(1) (a) Krass, B.; Jordan, H. V.; Edwardsson, S.; Svensson, I . ;  T v e l l ,  
*-• Arch. Oral B i o l . 1968, IJ3» 911-918. (b) Loesche, W.; Rowan, J.; 
S tra f fo n ,  L. H.; Loos, P. J. In fe c t .  Immun. 1975, lj^, 1252-1260.  
(c) Loesche, W.; S t ra f fo n ,  L. H. In fe c t .  Immun. 1979, 26, 498-507.
(2) K e ls trup ,  J.; Gibbons, R. J. Arch. Oral B i o l . 1969,  JU, 251-258.
(3) (a) Rogers, A. H. Arch. Oral B i o l . 1976, 2 ± ,  99-104. (b) Rogers,
A. H. Arch. Oral B i o l . 1976, 21, 243-249.
(4) Paul , D.; Si ade, H. D. In fe c t .  Immun. 1975, 1_2, 1375-1385.
(5) Ikeda, T.; Iwanami, T.; Hirasawa, M,; Watanabe, C.; McGhee, J. R.; 
Shiota, T. In fe c t .  Immun. 1982, 35, 861-868.
(6) (a) H i l lm a n ,  J. D.; Johnson, K. P.; Yaphe, B. I .  J. Dent. Res.
1983, £2, 241. (b) H i l lm a n ,  J. 0.; Johnson, K. P.; Yaphe, B. I.
In fe c t .  Immun. 1984, 44, 141-144.
(7) Needleman, S. B., Ed. in "Advanced Methods in Prote in  Sequence 
Determination;" Springer-Veriag: Berl in, 1977.
(8) Wieland, T.; Luben, G.; Ottenheym, H.; Faesel , J.; DeVries, J. X.; 
Konz, W.; Prux, A.; Schmid, J. Agnew. Chem. 1968, 80^ 209.
(9) Hotchkiss, R. D. Adv. Enzymol. 1944, 4_, 153.
(10) Perlman, D.; Bodanszky, M. Ann. Rev. Biochem. 1977, 40̂ , 499-464.
- 4 0 7 -
PROPOSITION 2
ABSTRACT. Two thiorphan analogs are proposed to investigate thiorphan 
induced anal gesia.  * 9 f NMR topography is  proposed to map the in vi vo 
d i s t r i b u t i o n  of both enantiomers of a f l u o r i n e  conta in ing thiorphan  
der ivat ive .  A photoactivated analog of thiorphan, capable of covalently  
binding to the receptors fo r  analgesia  is  proposed to determine i f  
thiorphan binds to an opiate receptor.
* *  *r **■* * * * * * *  * * * * * * * * * * * * * * *  At*  * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * * * * * * * * *
The endogenous opioid pentapeptides, leuc ine  and methionine-  
enkephalin are neurotransmitter candidates thought to be responsible for  
the induction of analgesia.* In the absence of a specific uptake mecha­
nism, hydrolysis of the enkephalin Gly^-Phe^ bond by a membrane-bound 
metall oendopeptidase, "enkephalinase," is postulated to mediate enkepha­
l i n  induced anal ges ia .2 Racemic thiorphan [ ( ± ) - l ]  is  reported to i n ­
h ib i t  enkephal inase,3 extend the duration of  analgesia  induced by en­
kephalin analogs or noxious s t i m u l i /  and even induce analgesia i t s e l f /  
Recently, Scott et a l .  have reported that (S)-thiorphan is s l ig h t ly  more 
e f fec t ive  (ca. three-fo ld)  an inhib itor  of purif ied enkephalinase A than 
(R)-thiorphan/  Surprisingly, (R)-thi  orphan is signi f  i c a n t l y  more po­
tent an analgesic in the hot plate test than (S)-thiorphan. Therefore, 
a mechanism other than enkephalinase inhibition may be responsible for 
the analgesic properties of thiorphan.





Several explanations can be advanced for the apparent dissociation 
of antinociception from enkephalinase inhibition. I t  is possible that 
(R) and (S)-thiorphan are metabolized at d i f ferent  rates in vivo. Both 
enantiomers o f  th iorphan, however, r e ta in  t h e i r  a b i l i t y  to in h i b i t  
purified enkephalinase A, even a f ter  prolonged preincubation with rat  
bra in  homogenate.® A l t e r n a t i v e l y ,  (R)- th iorphan could be a stereo-  
specific agonist for  one of the opiate receptors. Naloxone, an opiate 
antagonist, mediates thiorphan induced analgesia.^ I t  is unclear, how­
ever, whether naloxone prevents thiorphan, the enkephalins, or both from 
binding to an op ia te  receptor. The fo l  1 owi ng two sets of experiments 
are designed to determine i f  thiorphan induces analgesia by binding to 
an opiate receptor.
Several opiate receptors have been proposed; however, only two—the 
y and k-receptors— are thought to be d i re c t ly  involved with the induc­
t io n  of  a n a lg e s ia .? The opiate  receptors are highly stereospecific: 
(-)-morphine induces analgesia, while (+)-morphine exhibits essent ia l ly  
no antinociceptive a c t iv i ty .  The stereospecif ici ty of the opiate recep­
tors could explain why only (R)-thiorphan induces analgesia.
I f  (R)- th iorphan s te re o s p e c i f ica l  ly  binds to an opiate receptor, 
then i ts  _in vivo distr ibut ion should correspond to the distr ibution of 
the opiate  receptor. The d is t r ib u t io n  of (S ) - th iorphan,  on the other  
hand, should more closely  resemble the distr ibution of enkephalinase.
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In the CNS, the distr ibution of enkephalinase and the opiate receptors 
are s im i lar ,  both having th e i r  highest concentration in the striatum.® 
This is not the case, however, in  other  regions of the body. High 
l e v e l s  o f  enkephal inase are found in the lung and thyro id  with Tow 
l e v e ls  in the ileum, while high le v e ls  of opiate receptors are found in 
the ileum.9» 10 By mapping the distribut ions of (R) and (S)-thiorphan, 
and comparing this  with the d i f fe re n t ia l  distr ibut ions of enkephalinase 
and the op ia te  receptors, i t  should be possib le  to determine i f  the  
distr ibution of (R)-thiorphan corresponds to that of the opiate recep­
to r s ,  and the d i s t r i b u t i o n  o f  (S) - th iorphan corresponds to tha t  of 
enkephalinase.
I propose to prepare both enantiomers of  a f l u o r i n e  contain ing  
thiorphan analog (2 ) ,  and to employ *^F NMR topography to  map t h e i r  
distribut ions j_n vivo. NMR topography can be employed to map the two- 
and three-dimensional distr ibution of a drug within a l i v in g  animal.** 
Fluorine is chosen to label the thiorphan because of the high sensit iv ­
i t y  of 19F NMR (second only to *-H NMR), and the low natural abundance of 
other f luorine-containing molecules within the body.*^ 1®F NMR topogra­
phy could also be employed to map the distr ibutions of enkephal inase and 
the opiate receptors by using fluorine-containing analogs of the enkeph­
a l ins  and the opiates, respectively.
Smith and Wilkinson have shown that the antinociceptive a c t iv i t y  of 
enkephalin analogs increases by p lac ing an e lec tron-w i thdraw ing  sub­
st ituent on the Phe  ̂ phenyl ring (Figure l ) . la For example, a ja-chloro 
and j ) -n i tro  substituent increases the antinociceptive a c t iv i t y  eight and 
twenty-eight-fold, respectively, as compared to the parent unsubstituted
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Figure 1. Binding of Enkephalins and Thiorphan to Enkephalinase.
enkephalin. Therefore, an el ectron-withdrawing £ - t r i f l  uromethyl sub­
st ituent on the phenyl ring of thiorphan would be expected to increase 
i ts  antinociceptive act iv i ty .
A synthet ic  plan fo r  the preparat ion of (R) and (S)-2 is shown in 
Scheme 1. The synthesis c lo s e ly  resembles the method we employed to  
construct both enantiomers of thiorphan.^3 The major bond construction, 
generating the c h i r a l i t y ,  is based on the diastereoselective a lky la t ion  
of chiral 2-oxazolidinone imide enolates .^  Alkylat ion of the l ithium  
enolate derived from imide 3a with bromomethyl £-nitrobenzyl s u l f i d e ^  
would af ford  a lk y la te d  imide 4a. T ra n s b e n z y le s te r i f ic a t io n  of  4a 
(LiOBn, THF)13 followed by acid-catalyzed hydrolysis of the resultant  
benzyl ester (6 M HBr in HOAc)^ would afford acid (R)-5. Condensation 
of (R)-5 with benzyl glycinate [(Ph0)2p(0)N3, Et3N, DMF]^ followed by 
deprotection [Pd/C, H ,̂ 10 equiv 1 HC1]*® would afford {R)-2. The
Enkephalinase
H CH, 0
Tyr-G ly -G ly  — C —  N —  C H - C —
X
m m
I  CH, 0 H
I II I
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ja-nitrobenzyl group is chosen to protect the sulfur  since i t  can be re­
moved by c a ta ly t ic  hydrogenation under acidic conditions.*® The a l t e r ­
nate dissolving metal reduction conditions, employed for  the construc­
tion of thiorphan, po te n t ia l ly  would remove f luor ine  from the t r i f lu o r o -  
methyl subst i tuent .  The enantiomeric (S)-2 could be prepared by sub­
st i tu t ing the norephedrine-derived 2-oxazolidinone (Xn) shown in Scheme 
1 with the (S)-val inol  derived 2-oxazolidinone (Xv)'
The two enantiomers, (R) and (S)-2 would f i r s t  be assayed fo r  
enkephal inase i n h i b i t i o n  and analgesia  in the hot p la t e  t e s t  on ra ts .  
Assuming that the s tructure-act iv i ty  relationship is s im i lar  to th ior ­
phan, ( i . e . ,  (R)-2 induces analgesia, while (S)-2 is mainly responsible 
for enkephalinase inhibition) the in vivo distr ibution of (R) and (S)-2 
in rats would be determined by 19F NMR topography. Since (R)-thiorphan 
also inhibits  angiotensin converting enzyme (ACE),® i t  would be neces­
sary to p re t re a t  the animal with c a p to p r i1, a s e l e c t i  ve i n h i b i t o r  of  
ACE.la 19F NMR topography coul d al so be empl oyed to measure the ra te  
the drugs are distr ibuted throughout the body. This information could 
then be correlated with the onset of analgesia.
Presuming th a t  the above set of experiments in d ic a te  th a t  (R)-2  
binds to an op iate  receptor ,  the fo l lo w in g  set o f  experiments are 
designed to i d e n t i f y  and possib ly  is o l a t e  the receptor.  Toward th is  
purpose, I propose to synthesize a labeled, photoactivated19 th io r ­
phan analog [ (R )-6 ]  that is capable of covalently  binding to' the opiate 
receptor.
A synthet ic  plan fo r  the construction of  (R) -6  is  shown in Scheme 
2. As before, the synthesis closely  resembles the method we employed to 
construct both enantiomers of  th iorphan.1® Since both the n i t r o  and
- 4 1 3 -
azido substituents are l a b i l e  to reduction, the protecting groups would 
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Scheme 2
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The phofoactivated analog (R)-6 would f i r s t  be assayed for  anal­
gesia in the hot plate test on rats. Those tissues, previously shown to 
have a high a f f i n i t y  fo r  (R ) -2 ,  would then be t rea te d  with (R)-6  and 
exposed to l igh t .  Fractionation of the tissue would a llow the iso la t ion  
and ident i f icat ion of those components binding to the thiorphan analog. 
A comparison could then be made with p re v io u s ly  i s o la te d  opiate  
receptors.^
- 4 1 5 -
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PROPOSITION 3
ABSTRACT. The use of labeled metabolites is proposed to study the bio­
synthesis  of the brevetoxins,  an unusual f a m i ly  of p o ly e th er  marine 
toxins isolated from the "red tide" dinof 1 agel 1 ate Pt.ychodiscus brevis 
Davis.
•k 'k 'k 'k ifk 'k -k 'k 'k 'k 'k  A "k-k-kic id c k lc k  4t* * * * *  •k 'k-kic'k'k'k-k •k-k-k'k'kic  * * * ■ * ■ * ★ + ★ *
The marine phenomenon known as "red t id e"  is  caused by the rapid  
growth, or bloom, of u n ic e l lu la r  dinofl agel 1 ate algae. Dinofl agel1 ate 
blooms by Ptychodiscus brevis Davis (Gymnodium brevis Davis), along the 
FI or i da coast and in the Gulf  of Mexico, are responsib le  fo r  massive 
f ish  k i l l s ,  mollusk poisoning, human food poisoning, and human respi­
ra to ry  a i lm e n ts .1 Several di nofl agel 1 ate toxi ns have been isol ated, 
including saxitoxin (1), gonyautoxin (2), and two phosphorus containing 
molecules 3 and 4. Recently, three members of an e n t i re ly  new family of 
dinoflagel 1 ate toxins, the brevetoxins (5a-c) ,  have been isolated from 
P. brevis.  ̂ Unlike saxitoxin and gonyautoxin, which are water soluble 
and block the sodium channels, the brevetoxins are l ip id -s o lu b le  neuro­
toxins that activate the sodium channels.1*3
The brevetoxins represent a unique class of natural products. The 
s t ru c tu re  of brevetoxin  B (5b) was e luc ida ted  by X-ray c ry s ta l  1 o- 
graphy.2a Soon thereafter ,  the structures of brevetoxins A (5a) and C 
(5c) were determined by high f i e l d  *9 and NMR spectroscopy.2b, 2c 
Structural ly ,  the brevetoxins are characterized by a long carbon chain
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locked into a r ig id ladder- l ike  skeleton, consisting of 11 contiguous 
trans-fused ether rings. Other than the ir  structure and acute tox ic i ty ,  
l i t t l e  is known about these molecules.
A p la u s ib le  b iosynthet ic  pathway th a t  accounts f o r  the s tereo­
chemistry at the numerous oxygen centers in brevetoxin A (5a) is i l l u s ­
t r a te d  in Scheme 1. The ten d i -  and t r i s u b s t i t u t e d  (E) o l e f i n s  of  
polyene 6a are s t e r e o s e le c t iv e ly  epoxidized from the ( s i , s i )  face to 
a f fo rd  polyepoxide 7a, which then undergoes a chain of epoxide r in g -  
opening cycl i z a t io n s  to g ive  5 a. Cane et a l .  have proposed a s im i l a r  
scheme to account fo r  the stereochemistry of most polyether ionophore
•5
ant ib iot ics .
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The biosynthesis of the postulated polyene intermediate 6a, how­
ever ,  is not immedi at el y ob v i ous. One possi bi 1 i ty  is tha t  the carbon 
framework is constructed in a l inear  manner, analogous to the biosynthe­
sis of fa t ty  acids, from simple acetate and propanoate building blocks 
(Scheme 2, Path A). The carbon backbone of the po lyether  ionophore 
antib iotics is constructed in t h i s  fashion.^ This pathway, however, 
does not account for the methyl substituents at C-3, C-13, and C-25, nor 
the methylene substituent at C-41. Presumably, these Cj substituents  
could be derived from methionine or malonyl CoA ( vide in f ra ). Alterna­
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2, Path B). This pathway, however, would require  the incorporat ion  of 
three unusual Cg isoprene homologs.'* A t h i r d  p o s s i b i l i t y ,  re la ted  to  
th e  f i r s t ,  i s  a 1 i n e a r  p o l y k e t i d e  s y n th e s is  from a c e ta te ,  propanoate , 
and 3 - h y d r o x y - 3 - m e th y lp e n ta n -1 ,5 - d io a te  8  b u i l d in g  blocks (Scheme 3,
Path C).
Me Me Me Me
OH
I propose to  use labeled metabol i tes to  d i f f e r e n t i a t e  between the 
th re e  b io s y n t h e t i c  pathways le a d in g  to  po lyene 6 a. C u l tu re s  o f  f \
and the re s u l ta n t  brevetoxins i so la te d  according to  the reported pro­
cedure.  ̂  The in c o r p o r a t i o n  o f  the  l a b e le d  p recurso rs  would then be 
determined by NMR spectroscopy.
c
Scheme 3
b rev is  would be grown in  the presence of var ious labe led  precursors,
- 423
I n i t i a l l y ,  the incorporat ion o f  [ 1 - * 3C]- and [2-13C]acetate would 
be evaluated. The s p e c i f i c  pos it ions predicted to  be enriched by in co r ­
pora t ion  of var ious labe led  precursors are shown in  Table 1 (X = enr ich­
ment,  0 = no enr ichment ,  U = unknown). The t r a n s f o r m a t i o n  o f  l a b e l e d  
a c e ta te  to  isop e n te n y l  pyrophosphate and 3-hydroxy-3-methylpentan-1,5- 
d ioa te  (8 ), required f o r  Paths B and C, re s p e c t iv e ly ,  i s  i l l u s t r a t e d  in  
Scheme 4. By examining the enrichment, or lack the reo f ,  at  C-20, C-23, 
C-37, C-38, C-22(Me), and C-36(Me), by incorporat ion o f  [ 1 - 1 3 C]- and [2 -  
^ C ] a c e t a t e ,  i t  would be p o s s ib l e  to  d i f f e r e n t i a t e  Paths A and C from 
Path B. Confirmation o f  Paths A and C would be provided by e va lua t ing  
th e  i n c o r p o r a t i o n  o f  [ 3 - ^ 3 C]propanoate  at C-8 (Me), C-18(Me), C-22(Me), 
and C-36(Me). Path B would be confirmed by eva lua t ing  the incorporat ion  
o f  [ 5 - l 3C]mel val  onate at C - l ,  C-20, C-27, C-38, and C-39.
o o O 0
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Table 1. Predicted Enrichment Pattern for  Incorporation of * 3C Labeled Precursors.
t l - 13C >  [ 2 - 13C]- [ 3 - 13C]-  [ 5 - 13C]- [ 13C]- [ 2 - 13Cj-  [ 3 - 13C>  [ 13C]-
acetate acetate propanoate melvalonate methionine acetate  serine B
Carbon/
Path A B c A B C A B C A B C A1 A2 A2 C A2 C B c
C-l X X X 0 0 0 0 0 0 0 X 0 0 0 X X
C-2 0 0 0 X X X 0 0 0 0 0 0 0 0 X X
C-3 X X X 0 0 0 0 0 0 0 0 0 0 0 X X
C-4 0 0 0 X X X 0 0 0 0 0 0 0 0 X X
C-5 X u X 0 u 0 0 0 0 0 0 0 0 0 u 0
C-6 0 u 0 X u X 0 0 0 0 0 0 0 0 u 0
C-7 u u u u u u 0 0 0 0 0 0 0 0 u 0
C-8 u u u u u u 0 0 0 0 0 0 0 0 u 0
C-9 X u X 0 u 0 0 0 0 0 0 0 0 0 u 0
C-10 0 u 0 X u X 0 0 0 0 0 0 0 0 u 0
C - l l X u X 0 u 0 0 0 0 0 0 0 0 0 u X
C-l 2 0 u 0 X u X 0 0 0 0 0 0 0 0 u X
C-13 X u X 0 u 0 0 0 0 0 0 0 0 0 u X
C-14 0 u 0 X u X 0 0 0 0 0 0 0 0 u X
C-l 5 X u X 0 u 0 0 0 0 0 0 0 0 0 u 0
C-l G 0 u 0 X u X 0 0 0 0 0 0 0 0 u 0
C-17 u 0 u u u u 0 0 0 0 0 0 0 0 u 0
C -l 8 u u u u u u 0 0 0 0 0 0 0 0 u 0
C -19 X u X 0 u 0 0 0 0 0 0 0 0 0 u 0
C-20 0 X 0 X 0 X 0 0 0 • 0 X 0 0 0 X 0
C-21 u 0 u u X u 0 0 0 0 0 0 0 0 X 0
C-22 u X u u 0 u 0 0 0 0 0 0 0 0 X 0
C-23 X 0 X 0 X 0 0 0 0 0 0 0 0 0 X X
C-24 0 0 0 X X X 0 0 0 0 0 0 0 0 X X
C-25 X X X 0 0 0 0 0 0 0 0 0 0 0 X X
C-26 0 0 0 X X X 0 0 0 0 0 0 0 0 X X
C-2 7 X X X 0 0 0 0 0 0 0 X 0 0 0 X 0
C-28 0 u 0 X u X 0 0 0 0 0 0 0 0 u 0
C-29 X u X 0 u 0 0 0 0 0 0 0 0 0 u 0
C-30 0 u 0 X u X 0 0 0 0 0 0 0 0 u 0
C-31 X u X 0 u 0 0 0 0 0 0 0 0 0 u 0
C-32 0 u 0 X u X 0 0 0 0 0 0 0 0 u 0
C-33 X u X 0 u D 0 0 0 0 0 0 0 0 u 0
C-34 0 u 0 X u X 0 0 0 0 0 0 0 0 y 0
C-35 11 0 u u X u 0 0 0 0 0 0 0 0 X 0
C-36 u X u u 0 u 0 0 0 0 0 0 0 0 X 0
C-37 X 0 X 0 X 0 0 0 0 0 0 0 0 0 X 0
C-38 0 X 0 X 0 X 0 0 0 0 X 0 0 0 X 0
C-39 X X X 0 0 0 0 0 0 0 X 0 0 0 X X
C-40 0 0 0 X X X 0 0 0 0 0 0 0 0 X X
C-41 X X X u 0 0 0 0 0 0 0 0 0 0 X X
C-42 0 0 0 X X X 0 0 0 0 0 0 0 0 X X
C-3(Me) u 0 u u X X 0 0 0 0 0 0 X 0 X X X 0 X X
C-8(Me) u 0 y u u u X 0 X 0 0 0 0 0 0 0 0 0 u 0
C-13(Me) u 0 y u u X 0 0 0 0 0 0 X 0 X X X 0 u X
C-18(«e) u 0 u 0 u 0 X 0 X 0 0 0 0 0 0 0 0 0 u 0
C-22(Me) u 0 u u X 0 X 0 X 0 0 0 0 0 0 0 0 0 X 0
C-25(Me) u 0 u u X X 0 0 0 0 0 0 X 0 X X X 0 X X
C -36( Me) u 0 u u X 0 X 0 X 0 0 0 0 0 0 0 0 0 u 0
C-41(CH2 ) u 0 u u X X 0 Q 0 0 0 0 X 0 X X X 0 X X
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A d i s t i n c t i o n  between Paths A l ,  A2, and C c o u ld  be made by d e t e r ­
m in ing  th e  source o f  th e  Ci s u b s t i t u e n t s  at C-3, C-13, C-25, and C-41. 
In Paths Al and A2 they are introduced by methy la t ion o f  the po lyke t ide  
chain, whereas in  Path C they are incorporated as par t  o f  the po lyke t ide  
chain. The source o f  the methyl groups in  Path Al i s  methionine. There­
fo re ,  Path Al can be d i f f e r e n t i a t e d  from Paths A2 and C by e va lua t ing  the 
incorpora t ion  o f  [ ^ c ]m e th io n in e .
R e c e n t l y ,  w h i l e  i n v e s t i g a t i n g  the biosynthesis  o f  v i rg in iamyc in ,  
Kingston et a l .  uncovered a new po lyke t ide  methy la t ion reaction.® As 
i l l u s t r a t e d  in Scheme 5, the methyl group o f  acetate ( v ia  malonyl CoA) 
provides the source o f  the new carbon atom. Un fo r tuna te ly ,  the inco r ­
porat ion  o f  [ 2 - ^ C ]a c e ta te  would not d is t in g u ish  between Paths A2 and C. 
The two pathways, however, could be d i f f e r e n t ia te d  by using [ 3 - ^ C ] s e r -  
ine  as a de layed source o f  [ 2 - ^ C ] a c e t a t e .  In Path A2, th e  C-3, C-13, 
C-25, and C-41 subs t i tuents  are introduced a f t e r  the po lyke t ide  chain is  
formed,and the re fo re ,  w ith  a delayed source o f [ 2 - ^ c ] a c e t a t e ,  would be 
expected to  be enriched to  a greater  extent than the po lyke t ide  chain.
In c o n c lu s io n ,  i t  i s  necessary t o  comment about Path C. Rather 
than  o n l y  i n c o r p o r a t i n g  a ce ta te  and propanoate b u i l d i n g  b lo c k s ,  3- 
h yd roxy -3 -m e th y l  p e n ta n -1 ,5 -d io a te  (8 ) (or an equ iva len t )  i s  introduced 
i n t o  th e  p o l y k e t i d e  cha in .  Th is  process i s  i 1 1u s t r a te d  in  Scheme 6 . 
The incorporat ion  of f u l l y  labe led  8  as ind icated in  Table 1 would be 
evaluated to conf irm t h i s  p o s s ib i l i t y .
- 4 2 6 -
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PROPOSITION 4
ABSTRACT. The use o f  a l a b e l e d  p re cu rso r  i s  proposed to  de term ine  
whether th e  e p o x id a t i o n  o f  5-hexen-2-one w i th  potass ium peroxymono- 
s u l f a t e  i s  i n t e r -  o r  i n t r a m o l e c u l a r .  I f  the  r e a c t i o n  i s  shown to  be 
in t ram o lecu la r ,  experiments are proposed to  in ve s t ig a te  in te rn a l  asym­
metr ic  induct ion in  the peroxymonosulfate epoxidat ion o f  c h i r a l  1,5- and 
1 , 6 -enones.
* * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * * * * *  * * * *
The s te re o se le c t i ve  generation o f  carbon-oxygen bonds i s  an impor­
ta n t  aspect in  the construc t ion  o f  po ly-hydroxy la ted natura l  products. 
A v a r i e t y  o f  procedures to  accompl ish  t h i s  goal have been r e p o r te d . 1 
S ig n i f i c a n t  among these are the s te reose lec t ive  epoxidat ion o f ch i ra l  
a l l y l i c , ^  homoal l y l i c , 3  and b is h o m o a l l y l i c  alcohol s,^ as we l l  as the 
asymmetric a l k y l a t i o n  o f  p roch i ra l  al l y l i c  a lcoho ls .5 The overal 1 u t i l ­
i t y  o f  these epoxidat ion procedures has been demonstrated by t h e i r  use 
in  numerous syn the t ic  pro jects .
Recently,  potassium peroxymonosul fa te  (KHSOg), in  the presence o f 
acetone and under neutra l  cond i t ions ,  has been shown to  epoxidize a wide 
v a r i e t y  o f  o l e f i n s  (Scheme 1).® The peroxymonosul f a t e — acetone system 
is  both h ig h ly  re a c t i v e  and s te reose lec t ive .  For example, (E)-cinnamic 
acid,  a substrate not epoxidized by e i t h e r  a l k a l i n e  hydrogen peroxide or 
m-chloroperbenzoic ac id , reacts w ith  potassium peroxymonosulfate in  the 
presence o f  acetone to  a f f o r d  th e  t r a n s  epoxide. The r e a c t i o n  co n d i -
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t i o n s  are both  m i l d  (pH = 7 -8 ,  2-10°C) and v e r s a t i l e .  Water s o lu b l e  
o le f i n s  are epoxidized in  aqueous s o lu t io n ;  non-aqueous so lu b le  o le f in s  
are epox id ized  under b ip h a s ic  co n d i t io n s  v ia  phase t r a n s fe r  c a ta ly s is  
(PTC). In the absence o f  a ketone, potassium peroxymonosulfate does not 
react with  o le f in s .  K in e t ic  experiments suggest th a t  d iox i rane 1 is  the 
re a c t ive  intermediate responsib le  f o r  peroxymonosu 1 f a t e  e p o x id a t i o n s ,  
and tha t  the ketone merely acts to  cata lyze the process (Scheme 2) . 7
The epoxidat ion o f  5-hexen-2-one with potassium peroxymonosulfate 
does not requi re  acetone (Eq 1).® Presumably, the ketone present w i th in  
t h i s  substrate is  s u f f i c i e n t  to  ca ta lyze  the react ion. I t  i s  not known, 
however, whether the oxygen is  t rans fe r red  i n t e r -  or in t ram o lecu !a ra l  l y .  
The use of an [ ^ o ] - l a b e l e d  substrate i s  proposed to  answer t h i s  ques­
t i o n .  A s tudy would  then be undertaken t o  de te rm ine  both th e  minimum 
and the  optimum number o f  c o n n e c t iv e  atoms between ketone and o l e f i n  
necessary f o r  in t ra m o le cu la r  oxygen t r a n s fe r .8  i f  the react ion  is shown 
to  be in t ram o lecu la r ,  i t  would be in te re s t in g  to  in ve s t ig a te  the poten­
t i a l  f o r  g e n e ra t in g  epoxide s te re o c h e m is t r y  by r e l a t i v e  asymmetr ic 
q
induct ion.
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I n i t i a l  l y ,  an exper iment  would be performed to  demonstra te  t h a t  
acetone cata lyzed peroxymonosul fa te  epoxidat ions proceed v ia  a d iox i rane 
in te rm e d ia te .  Assuming a n e g l i g i b l e  i so to p e  e f f e c t ,  e i t h e r  o f  the  
oxygen atoms o f  d i o x i r a n e  1 c o u ld  be in c o rp o ra te d  i n t o  t h e  o l e f i n .  
Therefore, treatment o f  1-hexene w ith  potassium peroxymonosul fa te  in  the 
presence o f  [^® 0 ]ace tone  shou ld  a f f o r d  a 1 : 1  m ix tu re  o f  l a b e l e d  to  
un labeled 1,2-epoxyhexane (Eq 2). Two a l t e rn a te  re a c t i ve  in termediates, 
the carbonyl oxide 2 or  the methylene peroxide b i ra d ic a l  3, would g ive  
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The e p o x id a t io n  o f  [  18o]-5-hexen-2-one with  potassium peroxymono­
sul fa te ,  in  the absence of acetone, would be inves t iga ted  to  determine 
whether the  oxygen is  t r a n s f e r r e d  i n t e r  or  intramol ecu la ra l  l y  (Eq 3). 
The in t ram o lecu la r  t ra n s fe r  of oxygen would a f fo rd  a 1:1 mixture of 4a 
to  4b. The intermol ecul ar t r a n s fe r  o f oxygen, in add i t ion  to  4a and 4b, 
would a f f o r d  4c and 4d. The presence o f  4c and 4d cou ld  r e a d i l y  be 
determined by mass spectrometry.
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I f  th e  e p o x id a t i o n  o f  5-hexen-2-one i s  shown to  proceed v ia  an 
in t ra m o le c u la r  oxygen t ra n s fe r ,  i t  would be in te re s t in g  to  inves t iga te  
th e  p o t e n t i a l  f o r  i n t e r n a l  asymmetr ic i n d u c t i o n .  The e p o x id a t io n  o f  
(3R)-3,5-dimethyl-5-hexen-2-one (5) with  potassium peroxymonosulfate can 
a f fo rd  two diastereomeric epoxides 6a and 6b (Scheme 3). The t ra n s i t i o n  
s ta te  leading to  6b would be de s ta b i l ize d  in  respect to  the t ra n s i t i o n  
s t a t e  l e a d in g  t o  6a due to  an u n fa v o ra b le  1,3 d i a x i a l  m e thy l -m e thy l  
i n t e r a c t i o n .  T h e re fo re ,  6a i s  p re d i c te d  t o  be the  major epox ide d i a ­
s te r  eomer.
L ik e w is e ,  the  e p o x id a t io n  o f  (3R,5S)-3,5-d imethyl-6-hepten-2-one
( 7 ) w i t h  potass ium peroxymonosu l fa te  can a f f o r d  two d ia s te re o m e r ic  
epoxides 8a and 8b (Scheme 4). The t r a n s i t i o n  s ta te  leading to  8b would 
be d e s ta b i l i z e d  with  respect to  the t r a n s i t i o n  s ta te  leading to  8a due 
t o  an unfavorab le  1,3 d ia x ia l  methyl-methyl in te rac t ion .  Therefore, 8a 
i s  predicted to  be the major epoxide diastereomer.
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By analogy to  the epoxidat ion of 7, the epoxidat ion of (4S,6R)-4,6- 
d im e th y l - 7 -oc ten -3 -one ( 9 ) with potassium peroxymonosul fa te  should p re f ­
e r e n t i a l  l y  a f f o r d  epoxide 10 (Eq 4). Treatment o f  10 w i th  t i n  t e t r a -  
c h l o r i d e  p r e v i o u s l y  has been shown to  a f f o r d  a - m u l t i s t r i a t i n  ( 1 1 ), a 
component of the European elm bark beet le  aggregation pheromone (Eq 5).
KHSO,
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PROPOSITION 5
ABSTRACT. Experiments are proposed to  in ve s t ig a te  the epoxidat ion step 
in  the  b iosynthesis  o f  po lye ther  ionophore a n t i b io t i c s .
* * * * *  * * * * * * *  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * *
Most i n v e s t ig a t io n s  in to  the b io s y n th e s i  s o f  p o l y e t h e r  ionophore 
a n t i b i o t i c s  have focused on e s ta b l i sh in g  the i d e n t i t y  and lo c a t io n  of 
p re c u rs o r  i n c o r p o r a t i o n . ^  Th is  i s  r o u t i n e l y  accompl ished by fe e d in g  
a n t ib io t i c -p ro d u c in g  cu l tu re s  var ious labe led  precursors and analyzing 
the incorpora t ion  pattern in  the r e s u l t a n t  a n t i b i o t i c . ^  Numerous studies 
o f  t h i s  t yp e  have shown t h a t  p o l y e t h e r  ionophores are d e r i v e d  from 
simple acetate, propanoate, and butanoate b u i ld in g  blocks. Therefore, 
the b iosynthes is  o f  t h i s  fa m i ly  o f  natura l  products i s  thought to pro­
ceed v ia  a p o l y k e t i d e  pathway, in  a manner analogous to  f a t t y  ac id  
b io s y n t h e s i s .  Less, however, i s  known about th e  s teps i n v o l v e d  in  
t r a n s f o r m in g  th e  p o l y k e t i d e  in te r m e d ia te  t o  th e  p o l y e th e r  ionophore 
a n t i b i o t i c — e s p e c ia l l y  those steps responsib le  f o r  generat ing the num-
1 p
erous stereocenters. ^
Based on the i s o l a t i o n  o f  la s a lo c id  A (1) and i s o la s a lo c id  (2) from 
the  same fermentat ion broth , Westley has proposed a biochemical pathway 
whereby both molecules are der ived from a common p r e c u r s o r .  3 According 
to  h is  hypothesis,  i l l u s t r a t e d  in Scheme 1, the po lyke t ide  backbone is  
constructed and transformed in to  diene 3.^ S te reose lec t ive  diepoxida- 
t i o n  fo l lo w e d  by acid catalyzed c y c l i z a t i o n  then a f fo rds  e i t h e r  1 or  2 .
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Support f o r  t h i s  proposa l  i s  p ro v id e d  by H u tch inson ,  who, by 
feeding double labe led  r!3q18q2H precursors to  Streptomyces l a s a l i e n s i s , 
has shown t h a t  i s  in t ro d u ce d  at C - l ,  C-3, C- l  1, C-13, and C-15, but 
not at C-19 or C-22.5 The absence o f  labe led oxygen at C-19 and C-22 is  
the r e s u l t  predicted assuming a diene--diepoxide pathway. Presumably, 
t h e  oxygen a t  these  two p o s i t i o n s  i s  ob ta ined  from mol ecul a r  oxygen . 6 
The same d iene--d iepoxide o r  an analogous t r ie n e - - t r i e p o x id e  pathway has 
been proposed by Cane e t  a l .  as the f i n a l  s tep  in  b io s y n th e s i s  o f  ove r  
30 po lye the r  ionophore a n t i b i o t i c s . ^
One method o f  i n v e s t i g a t i n g  the  e p o x id a t io n  s tep  in  p o l y e th e r  
ionophore  b io s y n th e s i s  i s  to  feed th e  a n t i b i o t i c - p r o d u c i n g  organism 
labe led  diene or  t r i e n e  precursor. The i s o la t i o n  o f  labe led  a n t i b i o t i c  
would provide f u r t h e r  conformation o f  t h i s  pathway. ̂  A l t e r n a t i v e l y ,  the 
e p o x id a t i o n  o f  s im p le  o l e f i n i c  substrates by po lye ther  ionophore-pro- 
ducing organisms could be invest igated.
An examination o f  the proposed diene and diepoxide intermediates, 
i l l u s t r a t e d  in  Scheme 2, i n d i c a te s  a h igh degree o f  s te reochem ica l  
homology. Id  O ther  than th e  A(20-21) doub le  bond in  th e  i n te rm e d ia te  
l e a d in g  t o  f e re n s im y c in  A and l y s o c e l l i n ,  a l l  o f  t h e  o l e f i n s  are 
e p o x id iz e d  from the  ( r e , r e )  face o f  the doub le  bond. Presumably, the  
same--or  a v e r y  s i m i 1 a r - -e p o x id a se  i s  re s p o n s ib le  f o r  these  s te re o ­
s e le c t i v e  epoxidat ions .8  i t  would be in te res t in g  to  in v e s t ig a te  whether 
the bac te r ia  responsib le  f o r  the synthesis o f  these po lye ther  ionophores 
are capable o f  stereosel  ec t i  v e ly  epoxidizing simple o l e f i n i c  substrates.
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I n i t i a l  experiments would i n v o l v e  feeding labe led  o le f i n s ,  such 
as 4 and 5, to  a s a l in o m y c in  p roduc ing  c u l t u r e ,  and assay ing the 
fermentat ion broth f o r  labeled products. The re s u l t a n t  labe led  products 
would be analyzed to  determine whether the substrate i s  epoxidized or 
degraded. By using substrates lack ing  a hydroxyl subs t i tuen t  i t  may be 
poss ib le  to  i s o la te  the re su l ta n t  mono- or diepoxide. Information con­
cerning the recogni t ion  requirements o f  the epoxidase would be gained by 




Contingent on the previous experiments being successfu l ,  a fu r th e r  
se t o f  exper iments  would be conducted to  i n v e s t i g a t e  the  r e v e r s a l  in  
e p o x id a t i o n  s te re o c h e m is t r y  in  the  case o f  f e re n s im y c in  A and l y s o -  
c e l l i n .  A comparison o f  the s t r u c t u r e s  o f  the  d iene p recu rso rs  in  
Scheme 2 suggests tha t  the C-18 methyl subst i tuent  may be responsible 
f o r  the reversa l  in  epoxidat ion stereochemistry. I f  t h i s  is  the case, 
then fe e d in g  d iene 5 and 6 t o  a l y s o c e l l i n  p roduc ing  c u l t u r e  should  














I f  p o l y e t h e r  ionophore  producing organisms are shown to  s te re o -  
s e le c t i v e l y  epoxidize simple o l e f i n i c  substrates, work would be d irected 
at i s o la t i n g  the epoxidase system.^ The s te re o se le c t i ve  epoxidat ion of 
s im p le  d i -  and t r i s u b s t i t u t e d  (E) o l e f i n s  t o  g i v e  p roduc ts  o f  high 
enantiomeric p u r i t y  i s  g e ne ra l ly  d i f f i c u l t  to  accompl ish .^  Therefore, 
the  i s o l a t i o n  o f  an e n a n t io s e l  e c t i v e  epoxidase f o r  d i -  and t r i ­
subs t i tu ted  (E) o le f i n s  could be s y n th e t i c a l l y  use fu l .
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